{"2022-01-04": {"status": "ok", "totalResults": 6, "articles": [{"source": {"id": null, "name": "Poynter"}, "author": "Tom Kertscher", "title": "Claims that six-month Pfizer data show its COVID-19 vaccine causes more illness than it prevents are false", "description": "A headline widely shared on Facebook alleges that Pfizer\u2019s own data show that the company\u2019s COVID-19 vaccine causes more harm than good. \u201cAlarming Six Month Pfizer Data Show COVID Vaccine [\u2026]\nThe post Claims that six-month Pfizer data show its COVID-19 vaccin\u2026", "url": "https://www.poynter.org/fact-checking/2022/claims-that-six-month-pfizer-data-show-its-covid-19-vaccine-causes-more-illness-than-it-prevents-are-false/", "urlToImage": "https://www.poynter.org/wp-content/uploads/2022/01/AP_21365312489816.jpg", "publishedAt": "2022-01-04T10:55:33Z", "content": "A headline widely shared on Facebook alleges that Pfizers own data show that the companys COVID-19 vaccine causes more harm than good.\r\n\u201cAlarming Six Month Pfizer Data Show COVID Vaccine Causes More \u2026 [+2121 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "Michael Seale", "title": " Pfizer Booster For Kids + Pedestrian Struck On I-20", "description": "The quickest way to get caught up on the most important things happening today in Birmingham.", "url": "https://news.yahoo.com/pfizer-booster-kids-pedestrian-struck-040038601.html", "urlToImage": "https://s.yimg.com/uu/api/res/1.2/sn.sYjVcy6M3oyP_7CAB.A--~B/aD03MjA7dz05NjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/patch_hosted_articles_700/f91bca38017882896024d1b8f4cc3289", "publishedAt": "2022-01-04T04:00:38Z", "content": "Good day, people of Birmingham! It's me again, Michael Seale, your host of the Birmingham Daily. I hope everyone survived Birmingham's first (and maybe last) snow day of 2022. Luckily, the accumulati\u2026 [+3401 chars]"}, {"source": {"id": null, "name": "Thegatewaypundit.com"}, "author": "Cristina Laila", "title": "Healthy 57-Year-Old Nashville Doctor Dies Shortly After Receiving Pfizer Vaccine \u2013 Media Blames Death on Covid-19", "description": "A longtime Nashville doctor died a few days after receiving the Pfizer vaccine and the media is blaming his death on Covid-19. Dr. Dimitri Ndina was a loving father, husband, grandfather and doctor at Tennessee Oncology. Dr. Ndina, who was reportedly in excel\u2026", "url": "https://www.thegatewaypundit.com/2022/01/healthy-57-year-old-nashville-doctor-dies-shortly-receiving-pfizer-vaccine-media-blames-death-covid-19/", "urlToImage": "https://www.thegatewaypundit.com/wp-content/uploads/IMG_8787-2.jpg", "publishedAt": "2022-01-04T01:23:29Z", "content": "A longtime Nashville doctor died a few days after receiving the Pfizer vaccine and the media is blaming his death on Covid-19.\r\nDr. Dimitri Ndina was a loving father, husband, grandfather and doctor \u2026 [+1863 chars]"}, {"source": {"id": "the-times-of-india", "name": "The Times of India"}, "author": "Reuters", "title": "USFDA backs Pfizer booster shot for kids aged 12 to 15", "description": "US News: NEW YORK: The US FDA has authorised the use of a third dose of the Pfizer and BioNTech Covid-19 vaccine for children aged between 12 and 15 years, and.", "url": "https://timesofindia.indiatimes.com/world/us/usfda-backs-pfizer-booster-shot-for-kids-aged-12-to-15/articleshow/88678201.cms", "urlToImage": "https://static.toiimg.com/thumb/msid-88678260,width-1070,height-580,imgsize-0,resizemode-75,overlay-toi_sw,pt-32,y_pad-40/photo.jpg", "publishedAt": "2022-01-04T01:32:58Z", "content": "USFDA backs Pfizer booster shot for kids aged 12 to 15"}, {"source": {"id": "business-insider", "name": "Business Insider"}, "author": "gdean@insider.com (Grace Dean)", "title": "Boeing and Pfizer are among the companies and trade groups to have donated $8 million to Republicans who voted against certifying Biden's election victory, a report says", "description": "Accountable.US, a nonpartisan watchdog, named 30 companies and groups to have donated to the 147 Republican members of the so-called Sedition Caucus.", "url": "https://www.businessinsider.com/sedition-caucus-donald-trump-joe-biden-election-donations-capitol-siege-2022-1", "urlToImage": "https://i.insider.com/609bba60ba78eb001906ed30?width=1200&format=jpeg", "publishedAt": "2022-01-04T12:02:10Z", "content": "Top US companies and trade groups have donated more than $8.1 million to the Republican lawmakers who voted against Joe Biden's certification as president, according to a report by the nonpartisan wa\u2026 [+2990 chars]"}, {"source": {"id": null, "name": "Business Standard"}, "author": "IANS", "title": "US FDA authorises Pfizer-BioNTech booster shots for kids aged 12-15", "description": "The US FDA has expanded the emergency use authorisation for the Pfizer-BioNTech Covid-19 vaccine boosters to children aged 12 to 15.", "url": "https://www.business-standard.com/article/international/us-fda-authorises-pfizer-biontech-booster-shots-for-kids-aged-12-15-122010400297_1.html", "urlToImage": "https://bsmedia.business-standard.com/_media/bs/img/article/2021-05/24/full/1621857595-3349.jpg", "publishedAt": "2022-01-04T04:57:00Z", "content": "The US Food and Drug Administration (FDA) has expanded the emergency use authorization for the Pfizer-BioNTech Covid-19 vaccine boosters to children aged 12 to 15.\r\nOn Monday, the FDA also shortened \u2026 [+2238 chars]"}]}, "2022-01-03": {"status": "ok", "totalResults": 86, "articles": [{"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "Belgium to buy 10000 courses each of Pfizer and Merck COVID-19 pills - Reuters", "description": "Belgium will buy 10,000 courses each of the COVID-19 antiviral oral treatments developed by Pfizer <a href=\"https://www.reuters.com/companies/PFE.N\" target=\"_blank\">(PFE.N)</a> and Merck & CO <a href=\"https://www.reuters.com/companies/MRK.N\" target=\"_blank\">(\u2026", "url": "https://www.reuters.com/world/europe/belgium-buy-10000-courses-each-pfizer-merck-covid-19-pills-2022-01-03/", "urlToImage": "https://www.reuters.com/resizer/SA2fUhv39Zb5KfPBqdSMUuZ8334=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/OWONSDP4GRPLZHGRIWIWIAYD3Y.jpg", "publishedAt": "2022-01-03T10:44:00Z", "content": "An experimental COVID-19 treatment pill, called molnupiravir and being developed by Merck &amp; Co Inc and Ridgeback Biotherapeutics LP, is seen in this undated handout photo released by Merck &amp; \u2026 [+907 chars]"}, {"source": {"id": null, "name": "NPR"}, "author": "Scott Hensley", "title": "FDA authorizes a Pfizer booster shot for children ages 12 to 15", "description": "The agency also shortened the time between the completion of primary vaccination of the Pfizer-BioNTech COVID-19 vaccine and a booster dose, down to five months from six.", "url": "https://www.npr.org/sections/health-shots/2022/01/03/1069886530/fda-authorizes-a-pfizer-booster-shot-for-children-ages-12-to-15", "urlToImage": "https://media.npr.org/assets/img/2022/01/03/gettyimages-1236368527_wide-f6f67356a9c8c710d1e09b2c23d226e257875382.jpg?s=1400", "publishedAt": "2022-01-03T15:01:47Z", "content": "A nurse practitioner fills a syringe with the Pfizer COVID-19 vaccine at the Beaumont Health offices in Southfield, Mich., on Nov. 5.\r\nJeff Kowalsky/AFP via Getty Images\r\nThe Food and Drug Administra\u2026 [+363 chars]"}, {"source": {"id": null, "name": "Castanet.net"}, "author": null, "title": "FDA expands Pfizer boosters for more teens as omicron surges - World News - Castanet.net", "description": "<ol><li>FDA expands Pfizer boosters for more teens as omicron surges - World News\u00a0\u00a0Castanet.net\r\n</li><li>U.S. FDA backs Pfizer COVID-19 booster shot for 12- to 15-year-olds\u00a0\u00a0CBC News\r\n</li><li>Pfizer vaccine has mostly mild side-effects in kids: CDC\u00a0\u00a0CTV New\u2026", "url": "https://www.castanet.net/news/World/355954/FDA-expands-Pfizer-boosters-for-more-teens-as-omicron-surges", "urlToImage": "https://www.castanet.net/content/2022/1/20220103100116-61d3134a1aac40972dc9bde2jpeg_p3569478.jpg", "publishedAt": "2022-01-03T15:22:00Z", "content": "The U.S. is expanding COVID-19 boosters as it confronts the omicron surge, with the Food and Drug Administration allowing extra Pfizer shots for children as young as 12.\r\nBoosters already are recomme\u2026 [+2948 chars]"}, {"source": {"id": null, "name": "CP24 Toronto's Breaking News"}, "author": null, "title": "FDA expands Pfizer boosters for more teens as omicron surges - CP24 Toronto's Breaking News", "description": "<ol><li>FDA expands Pfizer boosters for more teens as omicron surges\u00a0\u00a0CP24 Toronto's Breaking News\r\n</li><li>Pfizer vaccine has mostly mild side-effects in kids: CDC\u00a0\u00a0CTV News\r\n</li><li>FDA expands Pfizer boosters for more teens as omicron surges - World News\u2026", "url": "https://www.cp24.com/world/fda-expands-pfizer-boosters-for-more-teens-as-omicron-surges-1.5726208", "urlToImage": "https://www.cp24.com/polopoly_fs/1.5666263.1636982053!/httpImage/image.jpg_gen/derivatives/landscape_620/image.jpg", "publishedAt": "2022-01-03T15:18:12Z", "content": "The U.S. is expanding COVID-19 boosters as it confronts the omicron surge.\r\nThe Food and Drug Administration on Monday allowed extra Pfizer shots for children as young as 12.\r\nBoosters already are re\u2026 [+453 chars]"}, {"source": {"id": "time", "name": "Time"}, "author": "LAURAN NEERGAARD / AP", "title": "FDA Expands Pfizer Boosters for More Teens As Omicron Surges", "description": "The Centers for Disease Control and Prevention (CDC) must decide whether to recommend boosters for the younger teens", "url": "https://time.com/6132376/fda-approves-pfizer-boosters-12-to-15-year-olds/", "urlToImage": "https://api.time.com/wp-content/uploads/2020/10/Vaccine-and-teens-1.jpg?quality=85&w=1200&h=628&crop=1", "publishedAt": "2022-01-03T15:23:47Z", "content": "The U.S. is expanding COVID-19 boosters as it confronts the omicron surge, with the Food and Drug Administration (FDA) allowing extra Pfizer shots for children as young as 12.\r\nBoosters already are r\u2026 [+2264 chars]"}, {"source": {"id": "abc-news", "name": "ABC News"}, "author": "Cheyenne Haslett", "title": "FDA authorizes Pfizer boosters for 12- to 15-year olds", "description": "The FDA on Monday authorized Pfizer boosters for 12- to 15-year olds.", "url": "https://abcnews.go.com/Health/fda-authorizes-pfizer-boosters-12-15-year-olds/story?id=82051567", "urlToImage": "https://s.abcnews.com/images/Health/booster-califor_hpMain_20211221-203340_16x9_992.jpg", "publishedAt": "2022-01-03T15:03:14Z", "content": "The Food and Drug Administration on Monday approved Pfizer boosters for 12- to 15-year-olds.\r\nThe moves comes as schools reopen after the holiday break.\r\nIn a release, the FDA said it has amended the\u2026 [+357 chars]"}, {"source": {"id": "usa-today", "name": "USA Today"}, "author": "USA TODAY, Editors", "title": "Pfizer vaccine for kids, Rapid COVID-19 tests, Steelers vs. Browns: 5 things you need to know Monday", "description": "The FDA is close to authorizing a third Pfizer shot for kids ages 12-15, a winter storm looms in the eastern U.S. and more news to start your Monday.", "url": "https://www.usatoday.com/story/news/2022/01/03/pfizer-vaccine-kids-winter-storm-pittsburgh-5-things-know-monday/9007797002/", "urlToImage": "https://www.gannett-cdn.com/presto/2022/01/02/USAT/4594b5f1-35ed-4f61-bfe7-d3012ea713e5-AP_Flight_Cancellations.jpg?auto=webp&crop=5069,2851,x1,y49&format=pjpg&width=1200", "publishedAt": "2022-01-03T08:01:10Z", "content": "FDA reportedly close to authorizing third Pfizer shot for kids 12-15\r\nThe Food and Drug Administration is reportedly poised to authorize a third dose of the Pfizer-BioNTech coronavirus vaccine for ki\u2026 [+3559 chars]"}, {"source": {"id": null, "name": "WebMD"}, "author": "https://www.facebook.com/WebMD", "title": "FDA Backs Pfizer Booster for 12- to 15-Year-Olds", "description": "The agency also took two related actions in the revised emergency use authorization for the Pfizer/BioNTech vaccine.", "url": "https://www.webmd.com/vaccines/covid-19-vaccine/news/20220103/fda-backs-pfizer-booster", "urlToImage": "https://img.webmd.com/dtmcms/live/webmd/consumer_assets/site_images/article_thumbnails/reference_guide/meningitis_vaccination_ref_guide/650x350_meningitis_vaccination_ref_guide.jpg", "publishedAt": "2022-01-03T20:52:05Z", "content": "Marks also pointed out that most cases of myocarditis clear up quickly.\r\n\"We're not seeing long-lasting effects. That's not to say that we don't care about this and that it's not important,\" he said.\u2026 [+2059 chars]"}, {"source": {"id": null, "name": "Motley Fool"}, "author": "newsfeedback@fool.com (Kody Kester)", "title": "Pfizer Snagged Another Approval for This Immunology Drug", "description": "The Food and Drug Administration just gave the nod to Xeljanz to treat patients with ankylosing spondylitis.", "url": "https://www.fool.com/investing/2022/01/03/pfizer-snagged-another-approval-for-this-immunolog/", "urlToImage": "https://g.foolcdn.com/editorial/images/659225/a-doctor-discusses-with-a-patient.jpg", "publishedAt": "2022-01-03T11:30:00Z", "content": "Recently, the Food and Drug Administration (FDA) approved Pfizer's (NYSE:PFE) Xeljanz to treat adult patients with active ankylosing spondylitis who had failed to respond to at least one tumor necros\u2026 [+4254 chars]"}, {"source": {"id": null, "name": "Motley Fool"}, "author": "newsfeedback@fool.com (Keith Speights)", "title": "Why Pfizer, BioNTech, and Moderna Stocks Are Falling Today", "description": "Investors appear to be seeing a future where COVID-19 vaccines aren't needed nearly as much.", "url": "https://www.fool.com/investing/2022/01/03/why-pfizer-biontech-and-moderna-stocks-are-falling/", "urlToImage": "https://g.foolcdn.com/editorial/images/659670/vaccine-being-given-to-a-young-man.jpg", "publishedAt": "2022-01-03T17:01:00Z", "content": "What happened\r\nShares of several leading COVID-19 vaccine makers were falling as of 11:38 a.m. ET on Monday. Pfizer(NYSE:PFE) stock was down 3.5%. Shares of BioNTech(NASDAQ:BNTX) and Moderna(NASDAQ:M\u2026 [+2692 chars]"}, {"source": {"id": "axios", "name": "Axios"}, "author": "Erin Doherty", "title": "FDA authorizes Pfizer boosters for 12- to 15-year-olds", "description": "The Food and Drug Administration expanded COVID-19 vaccine booster eligibility on Monday to allow 12- to 15-year-olds to receive a third shot of the Pfizer-BioNTech vaccine.Why it matters: The expansion comes as coronavirus cases soar to record numbers due to\u2026", "url": "https://www.axios.com/fda-approves-pfizer-boosters-12-to-15-year-olds-aa37b9a7-253a-4ed6-8a21-823df83495ab.html", "urlToImage": "https://images.axios.com/-hV3Cyd2ICnmGeURZjgMedhRsfo=/0x144:5167x3050/1366x768/2021/12/30/1640884596494.jpg", "publishedAt": "2022-01-03T14:38:25Z", "content": "The Food and Drug Administrationexpanded COVID-19 vaccine booster eligibility on Monday to allow 12- to 15-year-olds to receive a third shot of the Pfizer-BioNTech vaccine.\r\nWhy it matters: The expan\u2026 [+1687 chars]"}, {"source": {"id": null, "name": "Forbes"}, "author": "Anna Kaplan, Forbes Staff, \n Anna Kaplan, Forbes Staff\n https://www.forbes.com/sites/annakaplan-1/", "title": "FDA Authorizes Pfizer Booster Shot For Children Ages 12 To 15", "description": "The FDA shortened the time between primary vaccination and a booster dose to five months.", "url": "https://www.forbes.com/sites/annakaplan/2022/01/03/fda-authorizes-pfizer-booster-shot-for-children-ages-12-to-15/", "urlToImage": "https://thumbor.forbes.com/thumbor/fit-in/1200x0/filters%3Aformat%28jpg%29/https%3A%2F%2Fspecials-images.forbesimg.com%2Fimageserve%2F61d3112201002baa5c554673%2F0x0.jpg%3FcropX1%3D0%26cropX2%3D5033%26cropY1%3D191%26cropY2%3D3024", "publishedAt": "2022-01-03T15:10:05Z", "content": "The Food and Drug Administration authorized a third dose of Pfizers Covid-19 vaccine for 12- to 15-year-olds on Monday, as the U.S. faces the largest surge of cases since the pandemic began. The FDA \u2026 [+298 chars]"}, {"source": {"id": null, "name": "Snopes.com"}, "author": "AP News", "title": "FDA Expands Pfizer Boosters for More Teens as Omicron Surges", "description": "The U.S. is expanding COVID-19 boosters as it confronts the omicron surge, with the Food and Drug Administration allowing extra Pfizer shots for children as young as 12.", "url": "https://www.snopes.com/ap/2022/01/03/fda-expands-pfizer-boosters-for-more-teens-as-omicron-surges/", "urlToImage": "https://www.snopes.com/tachyon/2022/01/Virus_Outbreak-Pfizer-Teen_Boosters_63235-scaled.jpg", "publishedAt": "2022-01-03T15:53:50Z", "content": "This article is republished here with permission from The Associated Press. This content is shared here because the topic may interest Snopes readers; it does not, however, represent the work of Snop\u2026 [+3159 chars]"}, {"source": {"id": null, "name": "Euronews"}, "author": null, "title": "US FDA expands Pfizer boosters for more teens amid Omicron surge", "description": "Boosters already are recommended for everyone 16 and older, and federal regulators on Monday decided they're also warranted for 12- to 15-year-olds once enough time has passed since their last dose.", "url": "https://www.euronews.com/2022/01/03/us-fda-expands-pfizer-boosters-for-more-teens-amid-omicron-surge", "urlToImage": "https://static.euronews.com/articles/stories/06/34/41/26/1000x563_cmsv2_3890da1d-3609-5d6d-a2e8-10eac863fd5f-6344126.jpg", "publishedAt": "2022-01-03T17:51:33Z", "content": "The US Food and Drug Administration has announced it will allow extra Pfizer shots for children as young as 12, thus expanding its COVID-19 boosters rollout as it confronts the Omicron surge.\r\nBooste\u2026 [+1315 chars]"}, {"source": {"id": null, "name": "WBAL TV Baltimore"}, "author": null, "title": "As omicron surges, the FDA has expanded access to Pfizer boosters for more teens - WBAL Baltimore", "description": "<ol><li>As omicron surges, the FDA has expanded access to Pfizer boosters for more teens\u00a0\u00a0WBAL Baltimore\r\n</li><li>LIVE: Bloomberg Quicktake Latest News for January 3\u00a0\u00a0Bloomberg Quicktake: Now\r\n</li><li>Listen Live: FDA speaks after authorizing Pfizer's COVID\u2026", "url": "https://www.wbaltv.com/article/fda-expands-pfizer-boosters-for-teens/38656211", "urlToImage": "https://kubrick.htvapps.com/htv-prod-media.s3.amazonaws.com/images/ap-pfizer-for-kids-1635889343.jpg?crop=1.00xw:0.846xh;0,0&resize=1200:*", "publishedAt": "2022-01-03T14:56:00Z", "content": "The U.S. is expanding COVID-19 boosters as it confronts the omicron surge, with the Food and Drug Administration allowing extra Pfizer shots for children as young as 12.\r\nBoosters already are recomme\u2026 [+2214 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "Michael Seale", "title": " Crashes On I-459 + Pfizer Booster For Kids", "description": "The quickest way to get caught up on the most important things happening today in Trussville.", "url": "https://news.yahoo.com/crashes-459-pfizer-booster-kids-222510029.html", "urlToImage": "https://s.yimg.com/ny/api/res/1.2/d5pemcpJXbR.hvI8VVmmiQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD05MDA-/https://s.yimg.com/uu/api/res/1.2/NuxxekTl9BEEZdD4ovUjkw--~B/aD0xMjAwO3c9MTYwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/patch_hosted_articles_700/d2efce7cbf434c1e4a8065807bd97f76", "publishedAt": "2022-01-03T22:25:10Z", "content": "Greetings, people of Trussville! It's me again, Michael Seale, your host of the Trussville Daily. I hope everyone stayed warm today amid the surprising snowfall overnight. Speaking of which, the snow\u2026 [+2884 chars]"}, {"source": {"id": null, "name": "KETV Omaha"}, "author": null, "title": "As omicron surges, the FDA has expanded access to Pfizer boosters for more teens - KETV Omaha", "description": "<ol><li>As omicron surges, the FDA has expanded access to Pfizer boosters for more teens\u00a0\u00a0KETV Omaha\r\n</li><li>LIVE: Bloomberg Quicktake Latest News for January 3\u00a0\u00a0Bloomberg Quicktake: Now\r\n</li><li>Listen Live: FDA speaks after authorizing Pfizer's COVID boo\u2026", "url": "https://www.ketv.com/article/fda-expands-pfizer-boosters-for-teens/38656211", "urlToImage": "https://kubrick.htvapps.com/htv-prod-media.s3.amazonaws.com/images/ap-pfizer-for-kids-1635889343.jpg?crop=1.00xw:0.846xh;0,0&resize=1200:*", "publishedAt": "2022-01-03T14:56:00Z", "content": "The U.S. is expanding COVID-19 boosters as it confronts the omicron surge, with the Food and Drug Administration allowing extra Pfizer shots for children as young as 12.\r\nBoosters already are recomme\u2026 [+2214 chars]"}, {"source": {"id": "independent", "name": "Independent"}, "author": "Eleanor Sly", "title": "How effective are the Pfizer, AstraZeneca and Moderna vaccines against Omicron?", "description": "Booster jabs provide up to 70 per cent protection, study finds", "url": "https://www.independent.co.uk/news/health/vaccines-omicron-pfizer-moderna-astrazeneca-b1985766.html", "urlToImage": "https://static.independent.co.uk/2021/12/09/16/GettyImages-89747046%20%281%29.jpg?width=1200&auto=webp&quality=75", "publishedAt": "2022-01-03T07:26:31Z", "content": "The more contagious Omicron Covid variant is spreading rapidly across the UK and is set to become the dominant strain in the UK.\r\nSo far more than deaths from the new variant have been recorded and t\u2026 [+7283 chars]"}, {"source": {"id": null, "name": "Raw Story"}, "author": "Agence France-Presse", "title": "US authorizes Pfizer booster for kids as young as 12", "description": "US health authorities on Monday approved Pfizer's Covid-19 booster shot for children as young as 12, and reduced the wait time between initial vaccination and an extra dose from six months to five, for all ages.The decision by the Food and Drug Administration\u2026", "url": "https://www.rawstory.com/us-authorizes-pfizer-booster-for-kids-as-young-as-12/", "urlToImage": "https://www.rawstory.com/media-library/pfizer-ceo-says-third-covid-19-booster-shot-likely-needed-within-a-year-of-getting-vaccinated.jpg?id=27238709&width=1200&coordinates=0%2C82%2C0%2C82&height=600", "publishedAt": "2022-01-03T17:54:00Z", "content": "Evidence shows they had every reason to believe they could get away it. And despite their Bud Light Putsch having failed, they are getting away with it. \r\nLawmakers have blasted U.S. Attorney General\u2026 [+6305 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "Caitlin Sievers", "title": "Pfizer Boosters For Kids 12-15: What Phoenix Parents Need To Know", "description": "The Food and Drug Administration authorization moves boosters for Arizona children ages 12-15 a step closer.", "url": "https://news.yahoo.com/pfizer-boosters-kids-12-15-232924874.html", "urlToImage": "https://s.yimg.com/uu/api/res/1.2/ukOTNDOf0Ic7siIDtzjDFg--~B/aD01MzM7dz03MTE7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/patch_hosted_articles_700/1d620a64f6ab4208a312212e80ea9eae", "publishedAt": "2022-01-03T23:29:24Z", "content": "PHOENIX, AZ The Food and Drug Administration on Monday authorized the Pfizer COVID-19 booster for children as young as 12 in our area, broadening access to the third dose of the vaccine as COVID-19 d\u2026 [+3307 chars]"}]}, "2022-01-02": {"status": "ok", "totalResults": 7, "articles": [{"source": {"id": "independent", "name": "Independent"}, "author": "Eleanor Sly", "title": "How effective are the Pfizer, AstraZeneca and Moderna vaccines against Omicron?", "description": "Booster jabs provide up to 70 per cent protection, study finds", "url": "https://www.independent.co.uk/news/health/vaccines-protection-omicron-pfizer-moderna-astrazeneca-b1985492.html", "urlToImage": "https://static.independent.co.uk/2021/12/09/16/GettyImages-89747046%20%281%29.jpg?width=1200&auto=webp&quality=75", "publishedAt": "2022-01-02T09:51:39Z", "content": "The more contagious Omicron Covid variant is spreading rapidly across the UK and is set to become the dominant strain in the UK.\r\nSo far more than deaths from the new variant have been recorded and t\u2026 [+7283 chars]"}, {"source": {"id": null, "name": "The Times of Israel"}, "author": null, "title": "Health officials reportedly fear new Pfizer COVID pills will end up on black market", "description": "Limited supply of Paxlovid anti-viral medication will be distributed to patients at home; 'Only a matter of time' until they are sold illegally, official says", "url": "https://www.timesofisrael.com/health-officials-reportedly-fear-new-pfizer-covid-pills-will-end-up-on-black-market/", "urlToImage": "https://static.timesofisrael.com/www/uploads/2021/12/AP21355638154179-1024x640.jpg", "publishedAt": "2022-01-02T03:32:04Z", "content": "Senior officials in the Health Ministry fear Pfizers new COVID-19 medication will end up on the black market in Israel, according to a Saturday report.\r\nThe Health Ministry granted emergency approval\u2026 [+3115 chars]"}, {"source": {"id": null, "name": "Thegatewaypundit.com"}, "author": "Jim Hoft", "title": "Here\u2019s the Powerful Pfizer Video that Got mRNA Vaccine Inventor Kicked Off Twitter", "description": "On Wednesday, the woke arbiters of truth at Twitter permanently suspended the inventor of mRNA vaccine technology, Dr. Robert Malone, from their platform. A few hours before the suspension, Dr. Malone shared a review from the Canadian Covid Care Alliance \u2013 an\u2026", "url": "https://www.thegatewaypundit.com/2022/01/powerful-pfizer-video-got-mrna-vaccine-inventor-kicked-off-twitter/", "urlToImage": "https://www.thegatewaypundit.com/wp-content/uploads/Screen-Shot-2022-01-02-at-12.01.13-PM.jpg", "publishedAt": "2022-01-02T19:00:04Z", "content": "On Wednesday, the woke arbiters of truth at Twitter permanently suspended the inventor of mRNA vaccine technology, Dr. Robert Malone, from their platform.\r\nA few hours before the suspension, Dr. Malo\u2026 [+1094 chars]"}, {"source": {"id": null, "name": "Investmentwatchblog.com"}, "author": "alexmark", "title": "Jimmy Dore goes off on Rachel Maddow. Calls her a lying propagandist who gets $30,000 a day to shill for Pfizer and the Military Industrial Complex.", "description": null, "url": "https://www.investmentwatchblog.com/jimmy-dore-goes-off-on-rachel-maddow-calls-her-a-lying-propagandist-who-gets-30000-a-day-to-shill-for-pfizer-and-the-military-industrial-complex/", "urlToImage": null, "publishedAt": "2022-01-02T14:59:10Z", "content": "InvestmentWatchBlog.com \u00a9 2013-2021. All Rights Reserved."}, {"source": {"id": null, "name": "Slashdot.org"}, "author": "feedfeeder", "title": "Merck and Pfizer antiviral COVID pill to reach Indiana pharmacies - Fox 59", "description": "Merck and Pfizer antiviral COVID pill to reach Indiana pharmaciesFox 59 View Full Coverage on Google News ...", "url": "https://slashdot.org/firehose.pl?op=view&amp;id=157059153", "urlToImage": null, "publishedAt": "2022-01-02T12:52:11Z", "content": "The Fine Print: The following comments are owned by whoever posted them. We are not responsible for them in any way."}, {"source": {"id": null, "name": "The Daily Star"}, "author": "The Daily Star", "title": "24.91 lakh Pfizer vaccines arrive from US", "description": "A consignment of 24.91 lakh doses of Pfizer\u2019s Covid-19 vaccines arrived at the Hazrat Shahjalal International Airport from the United States today.", "url": "https://www.thedailystar.net/health/disease/coronavirus/fallouts-fightback/vaccine/news/2491-lakh-pfizer-vaccines-arrive-us-2930836", "urlToImage": "https://img.thedailystar.net/sites/default/files/styles/social_share/public/feature/images/2021/06/21/pfizer_11.jpg?itok=WIRRr57m", "publishedAt": "2022-01-02T14:21:04Z", "content": "A consignment of 24.91 lakh doses of Pfizer's Covid-19 vaccines arrived at the Hazrat Shahjalal International Airport from the United States today.\r\nThe US government sent the vaccines under the Cova\u2026 [+151 chars]"}, {"source": {"id": null, "name": "Ctvnews.ca"}, "author": "Tom Yun", "title": "Pfizer vaccine has mostly mild side-effects in kids: CDC", "description": "A study from the U.S. Centers for Disease Control and Prevention has found that that the nearly all of the side-effects for the Pfizer-BioNTech COVId-19 vaccine for children five to 11 years of age have been mild.", "url": "https://www.ctvnews.ca/health/coronavirus/mostly-mild-side-effects-reported-for-pfizer-s-pediatric-vaccine-u-s-cdc-study-1.5725661", "urlToImage": "https://www.ctvnews.ca/polopoly_fs/1.5725664.1641138718!/httpImage/image.jpg_gen/derivatives/landscape_620/image.jpg", "publishedAt": "2022-01-02T16:04:32Z", "content": "TORONTO -- \r\nA study from the U.S. Centers for Disease Control and Prevention (CDC) has found that the nearly all of the side-effects for the Pfizer-BioNTech COVID-19 vaccine for children five to 11 \u2026 [+1657 chars]"}]}, "2022-01-01": {"status": "ok", "totalResults": 5, "articles": [{"source": {"id": null, "name": "Fox 59"}, "author": "Mike Sullivan", "title": "Merck and Pfizer antiviral COVID pill to reach Indiana pharmacies - Fox 59", "description": "INDIANAPOLIS \u2014 New COVID antiviral pills from Merck and Pfizer are expected to be in Indiana pharmacies by New Year\u2019s Day. The medications are the latest tools in the battle against the COVID-19, however drug supplies remain scarce. \u201cIt probably will take at \u2026", "url": "https://fox59.com/news/coronavirus/merck-and-pfizer-antiviral-covid-pill-to-reach-indiana-pharmacies/", "urlToImage": "https://fox59.com/wp-content/uploads/sites/21/2021/12/Merck-pill-1.jpg?w=1280", "publishedAt": "2022-01-01T04:34:32Z", "content": "INDIANAPOLIS \u2014 New COVID antiviral pills from Merck and Pfizer are expected to be in Indiana pharmacies by New Year\u2019s Day. The medications are the latest tools in the battle against the COVID-19, how\u2026 [+2198 chars]"}, {"source": {"id": null, "name": "Lewrockwell.com"}, "author": "Joseph Mercola", "title": "Pfizer Whistleblower Exposes Vaccine Data Cover-Up", "description": "According to Brook Jackson, a whistleblower who worked on Pfizer\u2019s Phase 3 COVID jab trial in the fall of 2020, data were falsified, patients were unblinded, the company hired poorly trained people to administer the injections, and follow-up on reported side \u2026", "url": "https://www.lewrockwell.com/2022/01/joseph-mercola/pfizer-whistleblower-exposes-vaccine-data-cover-up/", "urlToImage": "https://www.lewrockwell.com/wp-content/uploads/2021/12/post-authorization-adverse-event-reports.jpg", "publishedAt": "2022-01-01T04:01:00Z", "content": "According to Brook Jackson, a whistleblower who worked on Pfizers Phase 3 COVID jab trial in the fall of 2020, data were falsified, patients were unblinded, the company hired poorly trained people to\u2026 [+17131 chars]"}, {"source": {"id": null, "name": "SoyaCincau.com"}, "author": "soyacincau", "title": "MOH evaluating 2nd booster after study finds Sinovac with Pfizer booster less effective against Omicron", "description": "The Health Ministry was studying the need for a second booster dose following the increased prevalence of the highly infectious COVID-19 Omicron variant globally, said Khairy Jamaluddin. The health minister said so when asked whether his ministry was aware of\u2026", "url": "https://soyacincau.com/2022/01/01/malaysia-evaluating-2nd-covid-19-vaccine-booster-after-study-finds-sinovac-with-pfizer-booster-less-effective-omicron/", "urlToImage": "https://soyacincau.com/wp-content/uploads/2021/05/210519-covid-vaccination-WTC-KL-04.jpg", "publishedAt": "2022-01-01T15:25:56Z", "content": "The Health Ministry was studying the need for a second booster dose following the increased prevalence of the highly infectious COVID-19 Omicron variant globally, said Khairy Jamaluddin.\r\nThe health \u2026 [+2066 chars]"}, {"source": {"id": null, "name": "Freerepublic.com"}, "author": "The New American", "title": "Pfizer Vaccine EXPOSED! Less than 1% effective, Did More Harm Than Good, They Knew It and Tricked You", "description": "Pfizer used a math trick to make people believe their vaccine was 95% effective, but the truth is it was 0.8% effective.", "url": "https://freerepublic.com/focus/f-news/4025826/posts", "urlToImage": null, "publishedAt": "2022-01-01T05:39:42Z", "content": "Skip to comments.\r\nPfizer Vaccine EXPOSED! Less than 1% effective, Did More Harm Than Good, They Knew It and Tricked YouThe New American ^\r\n | December 31, 2021\r\n | Ben Armstrong\r\nPosted on 12/31/202\u2026 [+1857 chars]"}, {"source": {"id": null, "name": "Malay Mail"}, "author": "Malay Mail", "title": "Health Ministry evaluating second booster shot after study finds Sinovac with Pfizer booster still less effective against Omicron", "description": "KUALA LUMPUR, Jan 1 \u2014 The Health Ministry was studying the need for a second booster dose following the increased prevalence of the highly infectious Covid-19 Omicron variant globally, said Khairy Jamaluddin. The health minister said so when asked whether his\u2026", "url": "https://www.malaymail.com/news/malaysia/2022/01/01/health-ministry-evaluating-second-booster-shot-after-study-finds-sinovac-wi/2032378", "urlToImage": "https://media2.malaymail.com/resize_cache/uploads/articles/2021/2021-11/covid_booster_jab4_24112021-seo.JPG", "publishedAt": "2022-01-01T09:11:07Z", "content": "People receive their Covid-19 booster jabs at the UEM Learning Centre in Petaling Jaya November 24, 2021. Picture by Shafwan Zaidon\r\nKUALA LUMPUR, Jan 1 The Health Ministry was studying the need for \u2026 [+1842 chars]"}]}, "2021-12-31": {"status": "ok", "totalResults": 34, "articles": [{"source": {"id": null, "name": "Blogspot.com"}, "author": "noreply@blogger.com (Unknown)", "title": "F.D.A. Plans to Allow 12- to 15-Year-Olds to Receive Pfizer Boosters", "description": "The Food and Drug Administration to authorize booster doses of\u00a0Pfizer-BioNTech's coronavirus vaccine for 12- to 15-year-olds Monday. (Emily Elconin, Reuters)The United States Food and Drug Administration should receive a booster injection of the Pfizer vaccin\u2026", "url": "https://techncruncher.blogspot.com/2021/12/fda-plans-to-allow-12-to-15-year-olds.html", "urlToImage": "https://blogger.googleusercontent.com/img/a/AVvXsEje1XUrcxxAuDV9HF9HqRQkRCHnxteoVThiTn6ukqNtKu8exUn11Z5GTrXALPaq-PPUGJw4qFYD597eY49mMd4Ze3ILYlyCWGlo9oAmAzYYFPzGwICBYtbu20cWvrKZxlKl59jA-wQeNepBP7_J8yJgKtMqWvG9IDc8U8PMsRolmcCpadvDBuL9A8bRig=w1200-h630-p-k-no-nu", "publishedAt": "2021-12-31T07:27:00Z", "content": "The Food and Drug Administration to authorize booster doses of\u00a0Pfizer-BioNTech's coronavirus vaccine for 12- to 15-year-olds Monday. (Emily Elconin, Reuters)\r\nThe United States Food and Drug Administ\u2026 [+1338 chars]"}, {"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "Sinovac COVID-19 shot with Pfizer booster less effective against Omicron - study - Reuters", "description": "Sinovac's two-dose COVID-19 vaccine followed by a booster Pfizer-BioNTech shot showed a lower immune response against the Omicron variant compared with other strains, according to a study by researchers.", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/sinovac-covid-19-shot-with-pfizer-booster-less-effective-against-omicron-study-2021-12-31/", "urlToImage": "https://www.reuters.com/resizer/9VhmLm1Ht8FVhC-0u7CwbF6EMhw=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/TCOVXAY35FLKJBJ4NVDOLPQCZY.jpg", "publishedAt": "2021-12-31T11:55:00Z", "content": "Dec 31 (Reuters) - Sinovac's two-dose COVID-19 vaccine followed by a booster Pfizer-BioNTech shot showed a lower immune response against the Omicron variant compared with other strains, according to \u2026 [+1591 chars]"}, {"source": {"id": "bloomberg", "name": "Bloomberg"}, "author": "Deirdre Hipwell", "title": "U.K. Regulator Approves Use of Pfizer Covid-19 Pill", "description": "Britain\u2019s regulator approved Pfizer Inc.\u2019s Covid-19 antiviral pill as Prime Minister Boris Johnson\u2019s government races to build an armory of weapons against the resurgent pandemic.", "url": "https://www.bloomberg.com/news/articles/2021-12-31/pfizer-s-antiviral-covid-19-pill-approved-by-u-k-regulator", "urlToImage": "https://assets.bwbx.io/images/users/iqjWHBFdfxIU/iATBkowTHwk8/v0/1200x801.jpg", "publishedAt": "2021-12-31T11:38:17Z", "content": "Britains regulator approved \r\nPfizer Inc.s Covid-19 antiviral pill as Prime Minister Boris Johnsons government races to build an armory of weapons against the resurgent pandemic.\r\nThe Pfizer drug, Pa\u2026 [+1808 chars]"}, {"source": {"id": null, "name": "Atlanta Journal Constitution"}, "author": "Helena Oliviero", "title": "Georgia gets first shipments of Merck, Pfizer Covid pills - Atlanta Journal Constitution", "description": "<ol><li>Georgia gets first shipments of Merck, Pfizer Covid pills\u00a0\u00a0Atlanta Journal Constitution\r\n</li><li>Pfizer's New Covid Pill Could Spark a Fiery Ethical Debate\u00a0\u00a0Bloomberg\r\n</li><li>Opinion: Deciding Who Should Get The Covid Pill Will Be Tough\u00a0\u00a0NDTV\r\n</li\u2026", "url": "https://www.ajc.com/news/atlanta-news/georgia-gets-first-shipments-of-merck-pfizer-covid-pills/KVN7CXIVXZAPRNLXRDGJ4TQLTQ/", "urlToImage": "https://www.ajc.com/resizer/onV5TsIc_eOgpQpv_Ij_iqg13oU=/1200x630/cloudfront-us-east-1.images.arcpublishing.com/ajc/WWANSUHOEVVPZCWBMJC4K6XJ44.jpg", "publishedAt": "2021-12-31T07:46:57Z", "content": "Pfizers version appears to be the more effective treatment with a research trial showing it reduced the risk of hospitalization or death among high-risk patients by about 85%. Mercks version reduced \u2026 [+898 chars]"}, {"source": {"id": "rt", "name": "RT"}, "author": "RT", "title": "At least a quarter of Britons now eligible for Pfizer Covid pill", "description": "The UK\u2019s medical regulator has given the green light to Pfizer\u2019s coronavirus pill, Paxlovid. The drug will be made available to anyone deemed at risk of developing severe Covid symptoms, including those over the age of 60. Read Full Article at RT.com", "url": "https://www.rt.com/news/544915-uk-covid-pill-pfizer-virus/", "urlToImage": "https://cdni.rt.com/files/2021.12/article/61cf215f85f5405f20455ef2.JPG", "publishedAt": "2021-12-31T15:31:54Z", "content": "The UKs medical regulator has given the green light to Pfizers coronavirus pill, Paxlovid. The drug will be made available to anyone deemed at risk of developing severe Covid symptoms, including thos\u2026 [+1653 chars]"}, {"source": {"id": "independent", "name": "Independent"}, "author": "Matt Mathers", "title": "Paxlovid: Covid pill from Pfizer approved in UK for those most at risk", "description": "A Covid treatment developed by vaccine-maker Pfizer has been approved in the UK for people who are most at risk from developing serious disease.", "url": "https://www.independent.co.uk/news/uk/home-news/paxlovid-covid-pill-pfizer-uk-b1984885.html", "urlToImage": "https://static.independent.co.uk/2020/08/19/11/breaking-news.png?width=1200&auto=webp&quality=75", "publishedAt": "2021-12-31T11:58:25Z", "content": "A Covid treatment developed by vaccine-maker Pfizer has been approved in the UK for people who are most at risk from developing serious disease.\r\nThe UK's Medicines and Healthcare products Regulatory\u2026 [+827 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "Reuters", "title": "Sinovac COVID-19 shot with Pfizer booster less effective against Omicron - study", "description": "The study, which has not been peer-reviewed yet, was conducted by researchers from Yale University, the Dominican Republic's Ministry of Health and other...", "url": "https://news.yahoo.com/sinovac-covid-19-shot-pfizer-115525155.html", "urlToImage": "https://s.yimg.com/uu/api/res/1.2/jdbyVF9ZH1HLTBn2.M8Tsw--~B/aD01MzQ7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/54c1216701bdd9b4465a16e2d64331be", "publishedAt": "2021-12-31T11:55:25Z", "content": "(Reuters) - Sinovac's two-dose COVID-19 vaccine followed by a booster Pfizer-BioNTech shot showed a lower immune response against the Omicron variant compared with other strains, according to a study\u2026 [+1395 chars]"}, {"source": {"id": null, "name": "MarketWatch"}, "author": "Steve Goldstein", "title": "U.K. approves Pfizer oral antiviral Paxlovid for COVID-19", "description": "The U.K. Medicines and Healthcare products Regulatory Agency said it's approved Pfizer's Paxlovid oral antiviral for people with mild to moderate COVID-19 and have at least one risk factor for developing severe illness. The regulator last month had approved M\u2026", "url": "https://www.marketwatch.com/story/uk-approves-pfizer-oral-antiviral-paxlovid-for-covid-19-2021-12-31", "urlToImage": "https://s.wsj.net/public/resources/MWimages/MW-GP644_MicroS_ZG_20180906154215.jpg", "publishedAt": "2021-12-31T11:41:47Z", "content": "The U.K. Medicines and Healthcare products Regulatory Agency said it's approved Pfizer's \r\n PFE,\r\n +1.42%\r\nPaxlovid oral antiviral for people with mild to moderate COVID-19 and have at least one risk\u2026 [+532 chars]"}, {"source": {"id": null, "name": "Mercola.com"}, "author": "communities@mercola.com (Dr. Joseph Mercola)", "title": "Pfizer Whistleblower Exposes Vaccine Data Cover-Up", "description": "According to Brook Jackson, a whistleblower who worked on Pfizer\u2019s Phase 3 COVID jab trial in the fall of 2020, data were falsified, patients were unblinded, the company hired poorly trained people to administer the injections, and follow-up on reported side \u2026", "url": "https://articles.mercola.com/sites/articles/archive/2021/12/31/pfizer-whistleblower-exposes-vaccine-data-cover-up.aspx", "urlToImage": "https://media.mercola.com/ImageServer/Public/2021/December/FB/pfizer-whistleblower-exposes-vaccine-data-cover-up-fb.jpg", "publishedAt": "2021-12-31T00:00:00Z", "content": "Mercola proudly supports these charities and organizations. View All \r\nDisclaimer: The entire contents of this website are based upon the opinions of Dr. Mercola, unless otherwise noted. Individual a\u2026 [+1007 chars]"}, {"source": {"id": null, "name": "Seeking Alpha"}, "author": "Jonathan Block", "title": "Pfizer COVID antiviral treatment Paxlovid approved by U.K. regulators", "description": "The U.K.\u00a0Medicines and Healthcare products Regulatory Agency has approved Pfizer COVID-19 antiviral treatment Paxlovid.", "url": "https://seekingalpha.com/news/3784408-pfizer-covid-antiviral-treatment-paxlovid-approved-by-uk-regulators", "urlToImage": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1247644805/large_image_1247644805.jpg", "publishedAt": "2021-12-31T20:01:07Z", "content": "saovadee/iStock via Getty Images"}, {"source": {"id": null, "name": "Seeking Alpha"}, "author": "Jonathan Block", "title": "Side effects rare in young children given Pfizer/BioNTech COVID vaccine - CDC", "description": "A CDC study found that serious side effects are rare in children ages 5-11 years old given the Pfizer/Moderna COVID-19 vaccine.", "url": "https://seekingalpha.com/news/3784376-side-effects-rare-in-young-children-given-pfizer-biontech-covid-vaccine-cdc", "urlToImage": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1349253411/large_image_1349253411.jpg", "publishedAt": "2021-12-31T15:37:45Z", "content": "portishead1/E+ via Getty Images"}, {"source": {"id": null, "name": "TheJournal.ie"}, "author": "Press Association", "title": "UK approves \u2018life-saving\u2019 Pfizer antiviral to help at-risk Covid-19 patients", "description": "Paxlovid can reduce the risks of being admitted to hospital and death in people with mild to moderate infection.", "url": "https://www.thejournal.ie/pfizer-antiviral-treatment-covid-19-5643716-Dec2021/", "urlToImage": "https://img2.thejournal.ie/article/5643716/river/?height=400&version=5643773", "publishedAt": "2021-12-31T16:10:23Z", "content": "THE UK HAS approved the use of Pfizers Covid-19 antiviral after it was found to help prevent the virus from multiplying in at-risk sufferers.\r\nThe Medicines and Healthcare products Regulatory Agency \u2026 [+3140 chars]"}, {"source": {"id": null, "name": "Thegatewaypundit.com"}, "author": "Jim Hoft", "title": "MUST WATCH: Canadian COVID Care Alliance Explains Why Pfizer Shots Can Do More Harm Than Good", "description": "The Canadian Covid Care Alliance, which consists of over 500 independent Canadian doctors, scientists, and health care practitioners, released an in-depth analysis of the Pfizer COVID-19 vaccine claiming that it can do more harm than good to people. According\u2026", "url": "https://www.thegatewaypundit.com/2021/12/must-watch-canadian-covid-care-alliance-explains-pfizer-shots-can-harm-good/", "urlToImage": "https://www.thegatewaypundit.com/wp-content/uploads/6A0830C8-FB69-4650-B7A8-690B091821E8.jpeg", "publishedAt": "2021-12-31T14:30:48Z", "content": "The Canadian Covid Care Alliance, which consists of over 500 independent Canadian doctors, scientists, and health care practitioners, released an in-depth analysis of the Pfizer COVID-19 vaccine clai\u2026 [+6020 chars]"}, {"source": {"id": "the-times-of-india", "name": "The Times of India"}, "author": "Viswanath Pilla", "title": "India may have to wait longer for Pfizer, GSK's Covid drugs", "description": "Last month Pfizer had announced an agreement with the UN's Medicines Patent Pool (MPP) for licensing antiviral intellectual property to MPP with the goal of making the drug available in low and middle-income countries.", "url": "https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/india-may-have-to-wait-longer-for-pfizer-gsks-covid-drugs/articleshow/88604444.cms", "urlToImage": "https://img.etimg.com/thumb/msid-88603416,width-1070,height-580,imgsize-58282,overlay-etmarkets/photo.jpg", "publishedAt": "2021-12-31T01:15:45Z", "content": "There is uncertainty over the availability in India of 's antiviral drug Paxlovid and GSK's monoclonal antibody Sotrovimab (sold under the brand name Xevudy) - two therapies that appear to be effecti\u2026 [+2313 chars]"}, {"source": {"id": null, "name": "Thegatewaypundit.com"}, "author": "Jim Hoft", "title": "Part 2: Canada COVID Care Alliance Analysis Shows Pfizer\u2019s Vaccination to Kids is \u2018ALL RISK\u2019 and No Benefit \u2013 Pfizer Acknowledges it Will Cause Myocarditis in Children (VIDEO)", "description": "Earlier today, The Gateway Pundit published a damning report released by the Canadian COVID Care Alliance explaining why Pfizer shots can do more harm than good to people. You can read the first part here: Damning Report: Canadian COVID Care Alliance Explains\u2026", "url": "https://www.thegatewaypundit.com/2021/12/part-2-canada-covid-care-alliance-analysis-shows-pfizers-vaccination-kids-risk-no-benefit-pfizer-acknowledges-will-cause-myocarditis-children-video/", "urlToImage": "https://www.thegatewaypundit.com/wp-content/uploads/Screen-Shot-2021-12-31-at-11.22.54-AM.jpg", "publishedAt": "2021-12-31T18:37:36Z", "content": "Earlier today, The Gateway Pundit published a damning report released by the Canadian COVID Care Alliance explaining why Pfizer shots can do more harm than good to people.\r\nYou can read the first par\u2026 [+8182 chars]"}, {"source": {"id": null, "name": "CNBC"}, "author": "Peter Schacknow", "title": "Stocks making the biggest moves premarket: Exxon Mobil, Pfizer, Peloton and others", "description": "These are the stocks posting the largest moves before the bell.", "url": "https://www.cnbc.com/2021/12/31/stocks-making-the-biggest-moves-premarket-exxon-mobil-pfizer-peloton-and-others.html", "urlToImage": "https://image.cnbcfm.com/api/v1/image/106151390-1569531287094gettyimages-1171361545.jpeg?v=1640954470", "publishedAt": "2021-12-31T12:41:58Z", "content": "Check out the companies making headlines before the bell:\r\nExxon Mobil (XOM) The energy giant signaled that it will report a fourth consecutive quarterly profit, thanks in large part to stronger oil \u2026 [+1437 chars]"}, {"source": {"id": "independent", "name": "Independent"}, "author": "Patrick Daly", "title": "UK approves \u2018life-saving\u2019 Pfizer antiviral to help at-risk Covid patients", "description": "The Health Secretary said 2.75 million courses of Paxlovid have been secured.", "url": "https://www.independent.co.uk/news/uk/medicines-and-healthcare-products-regulatory-agency-pfizer-health-secretary-sajid-javid-covid-b1984961.html", "urlToImage": "https://static.independent.co.uk/2021/12/31/14/b67758d69abd7074725463e73489e189Y29udGVudHNlYXJjaGFwaSwxNjQxMDQzNzQw-2.11408833.jpg?width=1200&auto=webp&quality=75", "publishedAt": "2021-12-31T14:04:50Z", "content": "The UK has become one of the first in the world to approve the use of Pfizers Covid-19 antiviral after it was found to help prevent the virus from multiplying in at-risk sufferers.\r\nA potentially lif\u2026 [+3336 chars]"}, {"source": {"id": "the-times-of-india", "name": "The Times of India"}, "author": "Viswanath Pilla", "title": "Bangladeshi firm launches first generic of Pfizer drug", "description": "Bangladesh's directorate general of drug administration on Thursday granted emergency use authorisation for the oral antiviral drug to treat mild-to-moderate Covid-19 in adults and children of 12 years and above.", "url": "https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/bangladeshi-firm-launches-first-generic-of-pfizer-drug/articleshow/88603468.cms", "urlToImage": "https://img.etimg.com/thumb/msid-88603470,width-1070,height-580,imgsize-34538,overlay-economictimes/photo.jpg", "publishedAt": "2021-12-31T01:22:33Z", "content": "Bangladesh drugmaker Beximco Pharmaceuticals has become the first company to launch a generic version of Pfizer's Covid-19 treatment Paxlovid. Paxlovid is a combination of nirmatrelvir and ritonavir \u2026 [+864 chars]"}, {"source": {"id": null, "name": "Mirror Online"}, "author": "mirrornews@mirror.co.uk (Bradley Jolly)", "title": "BREAKING: New Pfizer pill approved in UK for people at high risk from Covid", "description": "We'll be bringing you the very latest updates, pictures and video on this breaking news story", "url": "https://www.mirror.co.uk/news/breaking-new-pfizer-pill-approved-25823464", "urlToImage": "https://i2-prod.mirror.co.uk/incoming/article25823573.ece/ALTERNATES/s1200/0_Mirror-Online-69.jpg", "publishedAt": "2021-12-31T11:45:53Z", "content": "A new pill has been approved for adults in Britain who are at high risk of developing severe Covid-19.\r\n Paxlovid, created by Pfizer Inc, is designed for over 18s with mild to moderate illness who ar\u2026 [+3201 chars]"}, {"source": {"id": null, "name": "Mirror Online"}, "author": "mirrornews@mirror.co.uk (Harry Thompson)", "title": "Is the vaccine safe for children? New CDC report weighs up Pfizer jab benefits for kids", "description": "The idea of injecting children with vaccines can be scary, but now through cutting edge research the Covid jab's safety has been confirmed. Read on for everything you need to know about children and the vaccine", "url": "https://www.mirror.co.uk/news/uk-news/vaccine-safe-children-new-cdc-25825283", "urlToImage": "https://i2-prod.mirror.co.uk/incoming/article25804106.ece/ALTERNATES/s1200/1_JS245808111.jpg", "publishedAt": "2021-12-31T16:35:27Z", "content": "The coronavirus pandemic has seen nearly all of us faced with many firsts. \r\n For most, going into lockdown was a first, as were social distancing and travel restrictions. \r\nGetting a Covid jab too -\u2026 [+3080 chars]"}]}, "2021-12-30": {"status": "ok", "totalResults": 31, "articles": [{"source": {"id": null, "name": "New York Times"}, "author": "Sharon LaFraniere and Noah Weiland", "title": "F.D.A. Plans to Allow 12- to 15-Year-Olds to Receive Pfizer Boosters", "description": "Regulators will also allow even younger children with immune deficiencies to get an extra shot.", "url": "https://www.nytimes.com/2021/12/30/us/politics/boosters-12-15-year-olds-omicron.html", "urlToImage": "https://static01.nyt.com/images/2021/12/30/us/politics/30dc-boosters/merlin_187711275_c1f6feae-7f30-48df-91c0-f1188f1bfe64-facebookJumbo.jpg", "publishedAt": "2021-12-30T17:48:44Z", "content": "More than 70 percent of people 12 years and older in the United States are fully vaccinated, according to the C.D.C. Children can better withstand coronavirus infections, but in rare instances still \u2026 [+1630 chars]"}, {"source": {"id": null, "name": "Motley Fool"}, "author": "newsfeedback@fool.com (Justin Pope)", "title": "Why Pfizer Stock Is a Surefire Winner in 2022", "description": "The pandemic will last through the new year, creating a continued windfall for Pfizer.", "url": "https://www.fool.com/investing/2021/12/30/why-pfizer-stock-is-a-surefire-winner-in-2022/", "urlToImage": "https://g.foolcdn.com/editorial/images/658208/gettyimages-1317943078.jpg", "publishedAt": "2021-12-30T12:15:00Z", "content": "Pharmaceutical giant Pfizer(NYSE:PFE) has been at the front of the industry, developing treatments for COVID since the pandemic started. While it's unfortunate that the world continues to grapple wit\u2026 [+4711 chars]"}, {"source": {"id": null, "name": "Motley Fool"}, "author": "newsfeedback@fool.com (Eric Volkman)", "title": "Why Pfizer, BioNTech, and Moderna Shot Higher Today", "description": "One coronavirus vaccine will apparently be authorized as a booster for younger people in the U.S.", "url": "https://www.fool.com/investing/2021/12/30/why-pfizer-biontech-and-moderna-shot-higher-today/", "urlToImage": "https://g.foolcdn.com/editorial/images/659417/gloved-hand-filling-a-syringe-from-a-vial.jpg", "publishedAt": "2021-12-30T23:15:43Z", "content": "What happened\r\nThree of the top coronavirus stocks, Pfizer(NYSE:PFE), BioNTech(NASDAQ:BNTX), and Moderna(NASDAQ:MRNA), saw plenty of action on the market Thursday. Encouraging news for Pfizer and Bio\u2026 [+1502 chars]"}, {"source": {"id": "bloomberg", "name": "Bloomberg"}, "author": "Timothy Annett", "title": "Pfizer Covid-19 Booster Shot Set to Be Cleared for Younger Teens, NYT Reports", "description": "", "url": "https://www.bloomberg.com/news/articles/2021-12-30/pfizer-booster-shot-to-be-cleared-for-younger-teens-nyt-reports", "urlToImage": "https://assets.bwbx.io/images/users/iqjWHBFdfxIU/iKlBSRHM2d2s/v0/1200x801.jpg", "publishedAt": "2021-12-30T17:08:53Z", "content": "U.S. regulators are planning to clear \r\nPfizer Inc.s Covid-19 booster shot for younger adolescents on Monday, expanding access at a time when researchers have found that an additional vaccine dose pr\u2026 [+1201 chars]"}, {"source": {"id": "bloomberg", "name": "Bloomberg"}, "author": "Anna Edney", "title": "Pfizer Covid Vaccine Safe for Children Aged 5 to 11, CDC Data Show", "description": "", "url": "https://www.bloomberg.com/news/articles/2021-12-30/covid-vaccine-safe-for-children-5-to-11-years-old-cdc-data-show", "urlToImage": "https://assets.bwbx.io/images/users/iqjWHBFdfxIU/i4JVUH4ES670/v1/1200x800.jpg", "publishedAt": "2021-12-30T18:00:00Z", "content": "Pfizer Inc.s Covid-19 vaccine caused mostly mild side effects for children ages 5 to 11, according to data from the Centers for Disease Control and Prevention.\r\nResults of a survey covering 30,000 ch\u2026 [+233 chars]"}, {"source": {"id": null, "name": "Business Wire"}, "author": null, "title": "Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference", "description": "NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) invites investors and the general public to listen to a webcast of a discussion with Albert Bourla, Chairman and CEO, at the Goldman Sachs 14th Annual Healthcare CEOs Unscripted Conference on Thursday, Januar\u2026", "url": "https://www.businesswire.com/news/home/20211230005012/en/Pfizer-Invites-Public-to-Listen-to-Webcast-of-Pfizer-Discussion-at-Healthcare-Conference", "urlToImage": "https://mms.businesswire.com/media/20211230005012/en/1045874/23/Pfizer_Logo_Color_RGB_APPROVED.jpg", "publishedAt": "2021-12-30T15:09:55Z", "content": "NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) invites investors and the general public to listen to a webcast of a discussion with Albert Bourla, Chairman and CEO, at the Goldman Sachs 14th Annu\u2026 [+3530 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "PR Newswire", "title": "Global Naloxone Spray Market 2021-2025: Notable Players Include Emergent BioSolutions, Pfizer and Teva Pharmaceutical Industries", "description": "The \"Naloxone Spray Global Market Report 2021: COVID-19 Implications and Growth\" report has been added to ResearchAndMarkets.com's offering.", "url": "https://finance.yahoo.com/news/global-naloxone-spray-market-2021-164500084.html", "urlToImage": "https://s.yimg.com/uu/api/res/1.2/wDGPSO44TROYKbQSONxNmQ--~B/aD00Mjt3PTQwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/prnewswire.com/e75ef6f3096d7cb6f5dd43ba82eca2fe", "publishedAt": "2021-12-30T16:45:00Z", "content": "DUBLIN, Dec. 30, 2021 /PRNewswire/ -- The \"Naloxone Spray Global Market Report 2021: COVID-19 Implications and Growth\" report has been added to ResearchAndMarkets.com's offering.\r\nResearch and Market\u2026 [+4394 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "Research and Markets", "title": "Global Neurodegenerative Disorder Therapeutics Market (2021 to 2030) - Featuring Biogen, Pfizer and Novartis Among Others", "description": "Dublin, Dec. 30, 2021 (GLOBE NEWSWIRE) -- The \"Neurodegenerative Disorder Therapeutics Global Market Report 2021: COVID-19 Growth and Change to 2030\" report ...", "url": "https://finance.yahoo.com/news/global-neurodegenerative-disorder-therapeutics-market-115300031.html", "urlToImage": "https://s.yimg.com/uu/api/res/1.2/HP.E8HUfnyGeLtMAKwLgAQ--~B/aD01ODt3PTQ4MDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/93d5b27580f67db722dd7c112e43e8bc", "publishedAt": "2021-12-30T11:53:00Z", "content": "Dublin, Dec. 30, 2021 (GLOBE NEWSWIRE) -- The \"Neurodegenerative Disorder Therapeutics Global Market Report 2021: COVID-19 Growth and Change to 2030\" report has been added to ResearchAndMarkets.com's\u2026 [+10563 chars]"}, {"source": {"id": null, "name": "The Times of Israel"}, "author": null, "title": "Israel\u2019s first shipment of Pfizer COVID pills set to arrive", "description": "20,000 doses of Paxlovid reportedly arriving in first delivery of the coronavirus treatment, days after Health Ministry's emergency approval of pill", "url": "https://www.timesofisrael.com/israels-first-shipment-of-pfizer-covid-pills-set-to-arrive/", "urlToImage": "https://static.timesofisrael.com/www/uploads/2021/12/AP21355638154179-1024x640.jpg", "publishedAt": "2021-12-30T13:04:15Z", "content": "Israel is set to receive its first shipment of the Pfizer antiviral COVID pill on Thursday afternoon, the Kan public broadcaster reported.\r\nPrime Minister Naftali Bennett had said earlier this week t\u2026 [+3021 chars]"}, {"source": {"id": null, "name": "The Boston Globe"}, "author": "Timothy Annett", "title": "Pfizer COVID-19 booster shot to be cleared for younger teens", "description": "US regulators are planning to clear Pfizer's COVID-19 booster shot for younger adolescents on Monday, expanding access at a time when researchers have found that an additional vaccine dose provides better protection against the widely circulating Omicron vari\u2026", "url": "https://www.bostonglobe.com/2021/12/30/nation/pfizer-covid-19-booster-shot-be-cleared-younger-teens/", "urlToImage": "https://bostonglobe-prod.cdn.arcpublishing.com/resizer/ZzQ-b_BGQXO2Czz6RcUc4skfjf8=/506x0/cloudfront-us-east-1.images.arcpublishing.com/bostonglobe/JWRT6BDENLZGJZVPPNNX4E2IDU.jpg", "publishedAt": "2021-12-30T17:28:45Z", "content": "U.S. regulators are planning to clear Pfizer Inc.s Covid-19 booster shot for younger adolescents on Monday, expanding access at a time when researchers have found that an additional vaccine dose prov\u2026 [+1180 chars]"}, {"source": {"id": null, "name": "Sputnik International"}, "author": "Sputnik International", "title": "Children 5-11 Years of Age Report Systemic Reactions to Pfizer Vaccine", "description": "WASHINGTON (Sputnik) - Children who are 5-11 years old are reporting local and systemic reactions after receiving the coronavirus vaccines produced by Pfizer and BioNTech, the Centers for Disease Control and Prevention (CDC) said in a report on Thursday.", "url": "https://sputniknews.com/20211230/children-5-11-years-of-age-report-systemic-reactions-to-pfizer-vaccine--1091923826.html", "urlToImage": "https://cdnn1.img.sputniknews.com/images/sharing/article/eng/1091923826.jpg?10913416961640896288", "publishedAt": "2021-12-30T20:30:38Z", "content": "Registration was successful!Please follow the link from the email sent to \r\nhttps://sputniknews.com/20211230/children-5-11-years-of-age-report-systemic-reactions-to-pfizer-vaccine--1091923826.html\r\nC\u2026 [+4093 chars]"}, {"source": {"id": null, "name": "Mercola.com"}, "author": "communities@mercola.com (Dr. Joseph Mercola)", "title": "Pfizer Whistleblower Exposes Vaccine Data Cover-Up", "description": "According to Brook Jackson, a whistleblower who worked on Pfizer\u2019s Phase 3 COVID jab trial in the fall of 2020, data were falsified, patients were unblinded, the company hired poorly trained people to administer the injections, and follow-up on reported side \u2026", "url": "https://articles.mercola.com/sites/articles/archive/2021/12/31/pfizer-whistleblower-exposes-vaccine-data-cover-up.aspx", "urlToImage": "https://media.mercola.com/ImageServer/Public/2021/December/FB/pfizer-whistleblower-exposes-vaccine-data-cover-up-fb.jpg", "publishedAt": "2021-12-31T00:00:00Z", "content": "Mercola proudly supports these charities and organizations. View All \r\nDisclaimer: The entire contents of this website are based upon the opinions of Dr. Mercola, unless otherwise noted. Individual a\u2026 [+1007 chars]"}, {"source": {"id": "cnn", "name": "CNN"}, "author": "Kaitlan Collins, CNN", "title": "FDA expected to broaden Pfizer Covid-19 vaccine booster eligibility to youths ages 12 to 15 in the coming days, source says", "description": "The US Food and Drug Administration is expected to broaden eligibility for Pfizer Covid-19 vaccine boosters to youths ages 12 to 15 in the coming days, according to a person familiar with the agency's plan.", "url": "https://www.cnn.com/2021/12/30/health/fda-pfizer-booster-teens/index.html", "urlToImage": "https://cdn.cnn.com/cnnnext/dam/assets/211123105626-01-israel-pfizer-covid-19-vaccine-08-24-2021-super-tease.jpg", "publishedAt": "2021-12-30T17:31:10Z", "content": "(CNN)The US Food and Drug Administration is expected to broaden eligibility for Pfizer Covid-19 vaccine boosters to youths ages 12 to 15 in the coming days, according to a person familiar with the ag\u2026 [+1517 chars]"}, {"source": {"id": null, "name": "New York Post"}, "author": "Jack Morphet", "title": "FDA to greenlight Pfizer COVID booster shot for teens: report", "description": "Teens aged 12 to 15 will soon be able to receive booster jabs of the Pfizer-BioNTech COVID-19 vaccine under new guidance expected to be announced by the FDA next week.", "url": "https://nypost.com/2021/12/30/fda-to-greenlight-pfizer-covid-booster-shot-for-teens-report/", "urlToImage": "https://nypost.com/wp-content/uploads/sites/2/2021/12/teen-vaccine-1.jpg?quality=90&strip=all&w=1024", "publishedAt": "2021-12-30T20:08:04Z", "content": "Teens aged 12 to 15 will soon be able to receive booster jabs of the Pfizer-BioNTech COVID-19 vaccine under new guidance expected to be announced by the US Food and Drug Administration (FDA) next wee\u2026 [+1811 chars]"}, {"source": {"id": null, "name": "Investmentwatchblog.com"}, "author": "alexmark", "title": "Study of Pfizer & Moderna vaccines against Omicron shows they have NEGATIVE effectiveness!", "description": null, "url": "https://www.investmentwatchblog.com/study-of-pfizer-moderna-vaccines-against-omicron-shows-they-have-negative-effectiveness/", "urlToImage": null, "publishedAt": "2021-12-30T14:02:21Z", "content": "I kid you not, the last line of the study is still these findings highlight the need for massive rollout of vaccinations and booster vaccinations.\r\n\u2014 Ezra Levant (@ezralevant) December 23, 2021\r\nSHOC\u2026 [+118 chars]"}, {"source": {"id": null, "name": "Memeorandum.com"}, "author": null, "title": "FDA expected to authorize Pfizer-BioNTech booster shots for 12-to-15-year-olds by early next week (Dan Diamond/Washington Post)", "description": "Dan Diamond / Washington Post:\nFDA expected to authorize Pfizer-BioNTech booster shots for 12-to-15-year-olds by early next week\u00a0 \u2014\u00a0 The Food and Drug Administration is expected by early next week to authorize booster shots of the Pfizer-BioNTech coronavirus \u2026", "url": "https://www.memeorandum.com/211230/p42", "urlToImage": "https://www.washingtonpost.com/wp-apps/imrs.php?src=https://arc-anglerfish-washpost-prod-washpost.s3.amazonaws.com/public/H5K7PTTCWMI6ZG2ROEY7UGIMLY.jpg&w=1440", "publishedAt": "2021-12-30T18:30:00Z", "content": "memeorandum is an auto-generated summary of the stories that US political commentators are discussing online right now.\r\nUnlike sister sites Techmeme and Mediagazer, it is not a human-edited news out\u2026 [+72 chars]"}, {"source": {"id": null, "name": "Daily Mail"}, "author": "Mansur Shaheen U.S.", "title": "FDA to greenlight Pfizer COVID-19 booster for children aged 12 to 15 on Monday, report says", "description": "The U.S. Food and Drug Administration (FDA) plans to allow for children aged 12 to 15 to receive the Pfizer-BioNTech COVID-19 booster in the new year, according to a report by the New York Times.", "url": "https://www.dailymail.co.uk/health/article-10356359/FDA-greenlight-Pfizer-COVID-19-booster-children-aged-12-15-Monday-report-says.html", "urlToImage": "https://i.dailymail.co.uk/1s/2021/12/30/17/52379275-0-image-a-34_1640884005991.jpg", "publishedAt": "2021-12-30T17:06:56Z", "content": "The U.S. Food and Drug Administration (FDA) plans to allow for children aged 12 to 15 to receive the Pfizer-BioNTech COVID-19 booster in the new year, according to a report by the New York Times.\r\nCu\u2026 [+642 chars]"}, {"source": {"id": null, "name": "Cdc.gov"}, "author": "CDC", "title": "Interim Estimate of Vaccine Effectiveness of BNT162b2 (Pfizer-BioNTech) Vaccine in Preventing SARS-CoV-2 Infection Among Adolescents Aged 12-17 Years - Arizona, July-December 2021", "description": "This report describes interim estimate of vaccine effectiveness among adolescents who received the COVID-19 Pfizer-BioNTech vaccine.", "url": "https://www.cdc.gov/mmwr/volumes/70/wr/mm705152a2.htm", "urlToImage": "https://www.cdc.gov/mmwr/volumes/70/wr/social-media/mm705152a2_InterimVEArizona_IMAGE_31Dec21_1200x627.jpg?_=39274", "publishedAt": "2021-12-30T18:00:00Z", "content": "Karen Lutrick, PhD1; Patrick Rivers, MPP1; Young M. Yoo, MSPH2; Lauren Grant, MS2; James Hollister1; Krystal Jovel, MA1; Sana Khan, MPH1; Ashley Lowe, PhD1; Zoe Baccam1; Hanna Hanson1; Lauren E.W. Ol\u2026 [+29100 chars]"}, {"source": {"id": "nbc-news", "name": "NBC News"}, "author": "Berkeley Lovelace Jr.", "title": "FDA expected to authorize Pfizer booster shot for children 12 to 15", "description": "The FDA plans to authorize Pfizer Covid vaccine boosters to children ages 12 to 15 in the coming days, a person with knowledge of the plan said.", "url": "https://www.nbcnews.com/health/health-news/covid-booster-shots-kids-12-15-fda-rcna10473", "urlToImage": "https://media-cldnry.s-nbcnews.com/image/upload/t_nbcnews-fp-1200-630,f_auto,q_auto:best/rockcms/2021-12/211230-pfizer-covid-vaccine-se-446p-eed96b.jpg", "publishedAt": "2021-12-30T22:19:09Z", "content": "The Food and Drug Administration plans to broaden eligibility for Pfizer-BioNTech Covid-19 booster shots to children ages 12 to 15 in the coming days, a person with knowledge of the plan said.\r\nThe o\u2026 [+1729 chars]"}, {"source": {"id": null, "name": "Freerepublic.com"}, "author": "https://thenationalpulse.com", "title": "Pfizer Partnered With China\u2019s Vaccine Passport Platform, Admits Being \u2018Proud To Stand With China Leaders.\u2019", "description": "Pfizer Inc partnered with a Chinese Communist Party payment platform which has been used to implement \u201cvaccine passports\u201d in China since the outbreak of COVID-19. The company said it was \u201cproud to stand with China leaders.\u201d The pharmaceutical giant \u2013 whose U.\u2026", "url": "https://freerepublic.com/focus/f-news/4025379/posts", "urlToImage": null, "publishedAt": "2021-12-30T14:55:50Z", "content": "Skip to comments.\r\nPfizer Partnered With Chinas Vaccine Passport Platform, Admits Being Proud To Stand With China Leaders.\r\nhttps://thenationalpulse.com ^\r\n | December 29, 2021\r\n | by Natalie Winters\u2026 [+7006 chars]"}]}, "2021-12-29": {"status": "ok", "totalResults": 13, "articles": [{"source": {"id": "independent", "name": "Independent"}, "author": "Eleanor Sly", "title": "How effective are the Pfizer, AstraZeneca and Moderna vaccines against Omicron?", "description": "Booster jabs provide up to 70 per cent protection, study finds", "url": "https://www.independent.co.uk/news/health/omicron-covid-booster-pfizer-moderna-astrazeneca-b1983744.html", "urlToImage": "https://static.independent.co.uk/2021/12/09/16/GettyImages-89747046%20%281%29.jpg?width=1200&auto=webp&quality=75", "publishedAt": "2021-12-29T10:14:51Z", "content": "The more contagious Omicron Covid variant is spreading rapidly across the UK and is set to become the dominant strain in the UK.\r\nSo far more than deaths from the new variant have been recorded and t\u2026 [+7283 chars]"}, {"source": {"id": null, "name": "PJ Media"}, "author": "Glenn Reynolds", "title": "ICYMI: LETTER FROM \u201cPUBLIC HEALTH\u201d EXPERTS URGING PFIZER TO HOLD THE VACCINE UNTIL AFTER THE ELECTI\u2026", "description": "ICYMI: LETTER FROM \u201cPUBLIC HEALTH\u201d EXPERTS URGING PFIZER TO HOLD THE VACCINE UNTIL AFTER THE ELECTION: \u201cI didn\u2019t even remember this but wow. I doubt the same letter would have been sent had 2020 not been an election year or had a Democrat been in office.\u201d Tha\u2026", "url": "https://pjmedia.com/instapundit/493886/", "urlToImage": null, "publishedAt": "2021-12-29T12:00:01Z", "content": "ICYMI: LETTER FROM \u201cPUBLIC HEALTH\u201d EXPERTS URGING PFIZER TO HOLD THE VACCINE UNTIL AFTER THE ELECTION: \u201cI didn\u2019t even remember this but wow. I doubt the same letter would have been sent had 2020 not \u2026 [+364 chars]"}, {"source": {"id": null, "name": "Seeking Alpha"}, "author": "Jonathan Block", "title": "Walmart set to dispense Pfizer, Merck COVID antiviral pills at certain stores", "description": "Walmart said it is now able to dispense prescriptions for COVID antiviral pills from Merck and Pfizer at select stores in some states.", "url": "https://seekingalpha.com/news/3784041-walmart-set-to-dispense-pfizer-merck-covid-antiviral-pills-at-certain-stores", "urlToImage": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1318710655/large_image_1318710655.jpg", "publishedAt": "2021-12-29T22:12:35Z", "content": "Joe Raedle/Getty Images News"}, {"source": {"id": null, "name": "Investmentwatchblog.com"}, "author": "alexmark", "title": "James Smith, 'till 2020 CEO of R(EU)TERS, also a board member of Pfizer! UPDATE: Also a seat in the Economic Council of the World Economic Forum!", "description": null, "url": "https://www.investmentwatchblog.com/james-smith-till-2020-ceo-of-reuters-also-a-board-member-of-pfizer-update-also-a-seat-in-the-economic-council-of-the-world-economic-forum/", "urlToImage": null, "publishedAt": "2021-12-29T15:18:45Z", "content": "Well, Well Well\u2026. Looks like we have another Coincidence\u2026James C Smith, board member of Thompson Reuters, \"The Big Fact Checkers\" and is Coincidentally on the board of Pfizer\u2026. pic.twitter.com/GcbEz3\u2026 [+585 chars]"}, {"source": {"id": null, "name": "Seeking Alpha"}, "author": "Dulan Lokuwithana", "title": "Codex DNA partners with Pfizer to advance the DNA platform", "description": "Codex DNA (DNAY) is\u00a0trading ~8.1%\u00a0higher in the pre-market after the company announced an agreement with Pfizer (PFE) to jointly advance its synthetic DNA platform BioXP.Under the...", "url": "https://seekingalpha.com/news/3783887-codex-dna-partners-with-pfizer-to-advance-the-dna-platform", "urlToImage": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1060711170/large_image_1060711170.jpg", "publishedAt": "2021-12-29T13:51:37Z", "content": "phototechno/iStock via Getty Images"}, {"source": {"id": null, "name": "Freerepublic.com"}, "author": "Canadian Covid Care Alliance", "title": "The Pfizer Inoculations For COVID-19 \u2013 More Harm Than Good \u2013 VIDEO", "description": "Watch this video of the Pfizer 6 month data which shows that Pfizer\u2019s COVID-19 inoculations cause more illness than they prevent. Plus, an overview of the Pfizer trial flaws in both design and execution. (click link for video) (a pdf link is also provided)", "url": "https://freerepublic.com/focus/f-chat/4025176/posts", "urlToImage": null, "publishedAt": "2021-12-29T20:41:34Z", "content": "Skip to comments.\r\nThe Pfizer Inoculations For COVID-19 More Harm Than Good VIDEOCanadian Covid Care Alliance ^\r\n | Canadian Covid Care Alliance\r\nPosted on 12/29/2021 12:41:34 PM PST by Mount Athos\r\n\u2026 [+2408 chars]"}, {"source": {"id": null, "name": "The Daily Caller"}, "author": "Henry Rodgers", "title": "EXCLUSIVE: Rep. Andy Biggs Demands Answers From Biden Admin Over 75-Year Timeline For FOIA Requests Related To Pfizer Vaccine", "description": "Rep. Andy Biggs sent a letter to the HHS and the FDA demanding answers over their claim to need 75 years to answer FOIA requests about the Pfizer COVID vaccine.", "url": "https://dailycaller.com/2021/12/29/andy-biggs-letter-joe-biden-health-human-services-food-drug-administration-hhs-fda-timeline-foia-requests-pfizer-covid-vaccine/", "urlToImage": "https://cdn01.dailycaller.com/wp-content/uploads/2021/12/Photo-by-Joshua-Roberts-PoolGetty-Images-12321-e1640802823783.jpg", "publishedAt": "2021-12-29T19:33:12Z", "content": "Republican Arizona Rep. Andy Biggs sent a letter Thursday to the Department of Health and Human Services (HHS) and the U.S. Food and Drug Administration (FDA) demanding answers over their claim that \u2026 [+2799 chars]"}, {"source": {"id": null, "name": "Www.bna.bh"}, "author": null, "title": "Germany buys a million Pfizer pills to treat Covid", "description": null, "url": "https://www.bna.bh/en/news?cms=q8FmFJgiscL2fwIzON1%2bDgGWrZjb4ojhMBDXEa%2bucKI%3d", "urlToImage": "https://bna-media.s3-eu-west-1.amazonaws.com/Media/Images/News/World-News/3-db304ab4-b631-49e7-b918-5b743aad8667.jpeg", "publishedAt": "2021-12-29T08:35:00Z", "content": "Berlin, Dec. 29 (BNA): Germany has purchased a million pills to treat Covid-19 from US pharmaceuticals company Pfizer, Health Minister Karl Lauterbach said in Berlin on Tuesday.\r\n The first deliverie\u2026 [+2225 chars]"}, {"source": {"id": null, "name": "Globalresearch.ca"}, "author": "Global Research News", "title": "Selected Articles: Video: Ex-Pfizer Chief Scientist Dr. Michael Yeadon: Mass Murder with Vaccine Passports/Top Up Vaccines", "description": "Video: Ex-Pfizer Chief Scientist Dr. Michael Yeadon: Mass Murder with Vaccine Passports/Top Up Vaccines\nBy Dr. Mike Yeadon, December 28, 2021\nThis system is being put in place using lies, and it\u2019s being put in place using lies for \u2026\nThe post Selected Articles\u2026", "url": "https://www.globalresearch.ca/selected-articles-video-ex-pfizer-chief-scientist-dr-michael-yeadon-mass-murder-vaccine-passports-top-up-vaccines/5765737", "urlToImage": "https://www.globalresearch.ca/wp-content/uploads/2021/05/yeadon19521_810_500_75_s_c1.jpg", "publishedAt": "2021-12-29T13:41:34Z", "content": "Video: Ex-Pfizer Chief Scientist Dr. Michael Yeadon: Mass Murder with Vaccine Passports/Top Up Vaccines\r\nBy Dr. Mike Yeadon, December 28, 2021\r\nThis system is being put in place using lies, and its b\u2026 [+3732 chars]"}, {"source": {"id": null, "name": "Slashdot.org"}, "author": "feedfeeder", "title": "COVID vaccine cocktails: A guide to mixing and matching Pfizer, Moderna, J&J booster shots - USA TODAY", "description": "COVID vaccine cocktails: A guide to mixing and matching Pfizer, Moderna, J&amp;J booster shotsUSA TODAY View Full Coverage on Google News ...", "url": "https://slashdot.org/firehose.pl?op=view&amp;id=156971009", "urlToImage": null, "publishedAt": "2021-12-29T11:13:45Z", "content": "The Fine Print: The following comments are owned by whoever posted them. We are not responsible for them in any way."}, {"source": {"id": null, "name": "Slashdot.org"}, "author": "feedfeeder", "title": "The U.S. is rolling out Pfizer and Merck's COVID-19 antivirals to states but 'complex' manufacturing process may limit launch - MarketWatch", "description": "The U.S. is rolling out Pfizer and Merck's COVID-19 antivirals to states but 'complex' manufacturing process may limit launchMarketWatch COVID-19 pills in short supply in NevadaFOX5 Las Vegas Pfizer COVID-19 pill heading to Arizona after FDA emergency authori\u2026", "url": "https://slashdot.org/firehose.pl?op=view&amp;id=156974343", "urlToImage": null, "publishedAt": "2021-12-29T13:32:06Z", "content": "The Fine Print: The following comments are owned by whoever posted them. We are not responsible for them in any way."}, {"source": {"id": null, "name": "Ctvnews.ca"}, "author": "Christy Somos", "title": "Pfizer is 70 per cent effective against Omicron with two doses", "description": "New research from South Africa has found the Pfizer vaccine is 70 per cent effective against the Omicron variant after two doses.", "url": "https://www.ctvnews.ca/health/coronavirus/two-shots-of-pfizer-vaccine-70-per-cent-effective-against-omicron-variant-research-shows-1.5722568", "urlToImage": "https://www.ctvnews.ca/polopoly_fs/1.5722575.1640814062!/httpImage/image.jpg_gen/derivatives/landscape_620/image.jpg", "publishedAt": "2021-12-29T22:04:52Z", "content": "New research out of the Gauteng province of South Africa is providing more data on how effective the Pfizer-BioNtech COVID-19 vaccine is against the Omicron variant.\r\nPublished in the New England Med\u2026 [+3635 chars]"}, {"source": {"id": null, "name": "Cw33.com"}, "author": "Sarakshi Rai, The Hill via Nexstar Media Wire", "title": "Pfizer antiviral pill could be risky with other widely used medications", "description": "The Food and Drug Administration (FDA) recently authorized two antiviral pills, one from Pfizer and one from Merck, making them the first at-home treatment for COVID-19 that has been touted as a game-changer in the fight against the pandemic.", "url": "https://cw33.com/news/pfizer-antiviral-pill-could-be-risky-with-other-widely-used-medications/", "urlToImage": "https://cw33.com/wp-content/uploads/sites/8/2021/12/pfizerpill.jpg?w=1280", "publishedAt": "2021-12-29T14:26:04Z", "content": "(The Hill) \u2014 The Food and Drug Administration (FDA) recently authorized two antiviral pills, one from Pfizer and one from Merck, making them the first at-home treatment for\u00a0COVID-19\u00a0that\u00a0has been tou\u2026 [+3241 chars]"}]}, "2021-12-28": {"status": "ok", "totalResults": 13, "articles": [{"source": {"id": "business-insider", "name": "Business Insider"}, "author": "insider@insider.com (Marguerite Ward)", "title": "A Pfizer exec leading the world's vaccine efforts says a \"high-growth mindset\" drives innovation at the company", "description": "Biopharma leader Angela Hwang told Insider about her top leadership strategy to inspire groundbreaking research.", "url": "https://www.businessinsider.com/pfizer-exec-angela-hwang-says-high-growth-mindset-drives-innovation-2021-12", "urlToImage": "https://i.insider.com/61c389663bbcdd0012a06908?width=1200&format=jpeg", "publishedAt": "2021-12-28T14:29:42Z", "content": "Containing the spread of COVID-19 is arguably the world's most pressing challenge right now. Over 5.4 million people, including at least 818,00 Americans, have died from the virus. There's a legion o\u2026 [+3858 chars]"}, {"source": {"id": null, "name": "MarketWatch"}, "author": "Jaimy Lee", "title": "Coronavirus Update: The U.S. is rolling out Pfizer and Merck\u2019s COVID-19 antivirals to states but \u2018complex\u2019 manufacturing process may limit launch", "description": "CDC shortens isolation times for people testing positive, while the daily average of new cases continues to spike to the highest levels in nearly a year", "url": "https://www.marketwatch.com/story/the-u-s-is-rolling-out-pfizer-and-mercks-covid-19-antivirals-to-states-but-complex-manufacturing-process-may-limit-launch-11640708710", "urlToImage": "https://images.mktw.net/im-458833/social", "publishedAt": "2021-12-28T16:25:00Z", "content": "The U.S. has started shipping some doses of the recently authorized COVID-19 antivirals developed by Pfizer Inc. and Merck &amp; Co. Inc. as the number of new cases in the country continues to soar.T\u2026 [+4180 chars]"}, {"source": {"id": null, "name": "Investor's Business Daily"}, "author": "Investor's Business Daily", "title": "Dow Jones Aims For 5th Straight Gain As Boeing, Disney Lead The Way; Pfizer Stock Poised For Key Test - Investor's Business Daily", "description": "<ol><li>Dow Jones Aims For 5th Straight Gain As Boeing, Disney Lead The Way; Pfizer Stock Poised For Key Test\u00a0\u00a0Investor's Business Daily\r\n</li><li>S&P eases from record, oil hits $76 level\u00a0\u00a0Fox Business\r\n</li><li>Stocks start higher on Wall Street, helped by \u2026", "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-aims-for-fifth-straight-gain-boeing-disney-lead-the-way/", "urlToImage": "https://www.investors.com/wp-content/uploads/2017/03/stock-nyse-22-shutter.jpg", "publishedAt": "2021-12-28T18:43:00Z", "content": "The Nasdaq composite took a modest step back in afternoon trading Tuesday after a bullish four-session rally. The Dow Jones Industrial Average held a 0.3% gain, boosted by gains of least 1.5% by Boei\u2026 [+3966 chars]"}, {"source": {"id": null, "name": "PJ Media"}, "author": "Glenn Reynolds", "title": "LETTER FROM \u201cPUBLIC HEALTH\u201d EXPERTS URGING PFIZER TO HOLD THE VACCINE UNTIL AFTER THE ELECTION: \u201cI \u2026", "description": "LETTER FROM \u201cPUBLIC HEALTH\u201d EXPERTS URGING PFIZER TO HOLD THE VACCINE UNTIL AFTER THE ELECTION: \u201cI didn\u2019t even remember this but wow. I doubt the same letter would have been sent had 2020 not been an election year or had a Democrat been in office.\u201d That\u2019s Nat\u2026", "url": "https://pjmedia.com/instapundit/493884/", "urlToImage": null, "publishedAt": "2021-12-28T21:46:51Z", "content": "As an Amazon Associate,I earn from qualifying purchases."}, {"source": {"id": null, "name": "Globalresearch.ca"}, "author": "Dr. Mike Yeadon", "title": "Video: Ex-Pfizer Chief Scientist Dr. Michael Yeadon: Mass Murder with Vaccine Passports/Top Up Vaccines", "description": "All Global Research articles\u00a0can be read in 51 languages by activating the \u201cTranslate Website\u201d\u00a0drop down menu on the top banner of our home page (Desktop version).\nTo receive Global Research\u2019s Daily Newsletter (selected articles),\u00a0click here.\nVisit \u2026\nThe post\u2026", "url": "https://www.globalresearch.ca/video-ex-pfizer-chief-scientist-dr-michael-yeadon-mass-murder-vaccine-passports-top-up-vaccines/5765708", "urlToImage": "https://www.globalresearch.ca/wp-content/uploads/2021/05/yeadon19521_810_500_75_s_c1.jpg", "publishedAt": "2021-12-28T23:04:04Z", "content": "All Global Research articles\u00a0can be read in 51 languages by activating the Translate Website\u00a0drop down menu on the top banner of our home page (Desktop version).\r\nTo receive Global Researchs Daily Ne\u2026 [+474 chars]"}, {"source": {"id": null, "name": "Business Wire"}, "author": null, "title": "Pfizer Invites Public to View and Listen to Webcast of February 8 Conference Call with Analysts", "description": "NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10 a.m. EST on Tuesday, February 8, 2022. The purpose of the call is to provide an upd\u2026", "url": "https://www.businesswire.com/news/home/20211228005049/en/Pfizer-Invites-Public-to-View-and-Listen-to-Webcast-of-February-8-Conference-Call-with-Analysts", "urlToImage": "https://mms.businesswire.com/media/20211228005049/en/1045874/23/Pfizer_Logo_Color_RGB_APPROVED.jpg", "publishedAt": "2021-12-28T15:07:11Z", "content": "NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10 a.m. EST on Tuesday, Fe\u2026 [+3912 chars]"}, {"source": {"id": null, "name": "SoyaCincau.com"}, "author": "Alexander Wong", "title": "Khairy: Pfizer and AstraZeneca recipients will now get COVID-19 vaccine booster 3 months after receiving the second dose", "description": "Health Ministery Khairy Jamaluddin has announced a shorter COVID-19 vaccine booster dose interval for Pfizer and AstraZeneca recipients from 6 to 3 months. Previously, the technical working group of the COVID-19 immunisation task force recommends individuals \u2026", "url": "https://soyacincau.com/2021/12/28/khairy-pfizer-and-astrazeneca-recipients-will-now-get-covid-19-vaccine-booster-3-months-after-receiving-the-second-dose/", "urlToImage": "https://soyacincau.com/wp-content/uploads/2021/06/210603-khairy-jamaluddin-malaymail-sayuti-zainuddin.jpg", "publishedAt": "2021-12-28T08:17:41Z", "content": "Health Ministery Khairy Jamaluddin has announced a shorter COVID-19 vaccine booster dose interval for Pfizer and AstraZeneca recipients from 6 to 3 months. Previously, the technical working group of \u2026 [+1424 chars]"}, {"source": {"id": "abc-news", "name": "ABC News"}, "author": "The Associated Press", "title": "Vista Outdoor, PulteGroup rise; Kiniksa, Pfizer fall", "description": "Stocks that traded heavily or had substantial price changes Tuesday: Vista Outdoor, PulteGroup rise; Kiniksa, Pfizer fall", "url": "https://abcnews.go.com/Business/wireStory/vista-outdoor-pultegroup-rise-kiniksa-pfizer-fall-81976244", "urlToImage": "null", "publishedAt": "2021-12-28T21:49:45Z", "content": "Stocks that traded heavily or had substantial price changes Tuesday:\r\nVista Outdoor Inc., up $1.64 to $43.07\r\nThe maker of outdoor sports gear said it would buy Stone Glacier, a hunting gear maker, f\u2026 [+1015 chars]"}, {"source": {"id": null, "name": "The Star Online"}, "author": "The Star Online", "title": "Pfizer, AZ booster shots can be given at least three months after primer dose, says Khairy", "description": "PETALING JAYA: Pfizer and AstraZeneca vaccine booster shots can be given at least three months after the primer dose, says Khairy Jamaluddin. Read full story", "url": "https://www.thestar.com.my/news/nation/2021/12/28/pfizer-az-booster-shots-can-be-given-at-least-three-months-after-primer-dose-says-khairy", "urlToImage": "https://apicms.thestar.com.my/uploads/images/2021/12/28/1422820.jpg", "publishedAt": "2021-12-28T08:40:00Z", "content": "PETALING JAYA: Pfizer and AstraZeneca vaccine booster shots can be given at least three months after the primer dose, says Khairy Jamaluddin (pic).\r\nThe Health Minister made the announcement on the s\u2026 [+735 chars]"}, {"source": {"id": null, "name": "seattlepi.com"}, "author": null, "title": "Vista Outdoor, PulteGroup rise; Kiniksa, Pfizer fall", "description": "Stocks that traded heavily or had substantial price changes Tuesday:\nVista Outdoor Inc., up $1.64 to $43.07\nThe maker of outdoor sports gear said it would buy Stone Glacier, a hunting gear maker, for an undisclosed amount.\nKiniksa Pharmaceuticals Ltd., down 3\u2026", "url": "https://www.seattlepi.com/business/article/Vista-Outdoor-PulteGroup-rise-Kiniksa-Pfizer-16734655.php", "urlToImage": "https://www.seattlepi.com/img/pages/article/opengraph_default.png", "publishedAt": "2021-12-28T22:08:27Z", "content": "The maker of outdoor sports gear said it would buy Stone Glacier, a hunting gear maker, for an undisclosed amount.\r\nKiniksa Pharmaceuticals Ltd., down 36 cents to $12.13\r\nThe company announced disapp\u2026 [+1507 chars]"}, {"source": {"id": null, "name": "Dpa-international.com"}, "author": null, "title": "Germany buys a million Pfizer pills to treat Covid", "description": "Top Stories from around the globe brought to you by dpa International.", "url": "http://www.dpa-international.com/topic/germany-buys-million-pfizer-pills-treat-covid-urn%3Anewsml%3Adpa.com%3A20090101%3A211228-99-527945", "urlToImage": "https://projektor.dpa-newslab.com/standard/image/resize/urn:newsml:dpa.com:20090101:211225-99-502950?ltrb=0%2C0%2C%2C&s=1024&a=16%2C10&signature=KrHMylHTfTwI1qPiIWp37J_ZMEw%3D&expires=1655251200&accesskey=7c555a2de3c8f56cc6b", "publishedAt": "2021-12-28T19:12:06Z", "content": "You can swipe right and left to navigate between articles.\r\nOK"}, {"source": {"id": null, "name": "Slashdot.org"}, "author": "feedfeeder", "title": "COVID vaccine cocktails: A guide to mixing and matching Pfizer, Moderna, J&J booster shots - Yahoo! Voices", "description": "COVID vaccine cocktails: A guide to mixing and matching Pfizer, Moderna, J&amp;J booster shotsYahoo! Voices View Full Coverage on Google News ...", "url": "https://slashdot.org/firehose.pl?op=view&amp;id=156941861", "urlToImage": null, "publishedAt": "2021-12-28T11:12:27Z", "content": "The Fine Print: The following comments are owned by whoever posted them. We are not responsible for them in any way."}, {"source": {"id": null, "name": "Slashdot.org"}, "author": "feedfeeder", "title": "Dow Jones Aims For 5th Straight Gain As Boeing, Disney Lead The Way; Pfizer Stock Poised For Key Test - Investor's Business Daily", "description": "Dow Jones Aims For 5th Straight Gain As Boeing, Disney Lead The Way; Pfizer Stock Poised For Key TestInvestor's Business Daily S&P eases from record, oil hits $76 levelFox Business S&P 500 closes at record high on retail sales cheerReuters S&P 500 hits new re\u2026", "url": "https://slashdot.org/firehose.pl?op=view&amp;id=156953197", "urlToImage": null, "publishedAt": "2021-12-28T21:13:44Z", "content": "The Fine Print: The following comments are owned by whoever posted them. We are not responsible for them in any way."}]}, "2021-12-27": {"status": "ok", "totalResults": 16, "articles": [{"source": {"id": null, "name": "The Guardian"}, "author": "Philip Oltermann in Berlin", "title": "Pfizer/BioNTech tax windfall brings Mainz an early Christmas present", "description": "German city where early Covid vaccine was developed uses its new-found wealth to slash debt and attract other biotech firmsThe Pfizer/BioNTech jab is having an unexpected side-effect on the German municipality where scientists first developed it: for the firs\u2026", "url": "https://amp.theguardian.com/world/2021/dec/27/pfizer-biontech-tax-windfall-brings-mainz-an-early-christmas-present", "urlToImage": "https://i.guim.co.uk/img/media/3f538004c68847fb9fba2fc7addcebca8e4817ca/0_146_3992_2395/master/3992.jpg?width=1200&height=630&quality=85&auto=format&fit=crop&overlay-align=bottom%2Cleft&overlay-width=100p&overlay-base64=L2ltZy9zdGF0aWMvb3ZlcmxheXMvdGctZGVmYXVsdC5wbmc&enable=upscale&s=9236aca6715e354c7d9ffb8902bbb4ac", "publishedAt": "2021-12-27T12:40:29Z", "content": "The Pfizer/BioNTech jab is having an unexpected side-effect on the German municipality where scientists first developed it: for the first time in three decades the city of Mainz expects to become deb\u2026 [+4670 chars]"}, {"source": {"id": "cbs-news", "name": "CBS News"}, "author": null, "title": "Israel testing fourth Pfizer COVID vaccine shot", "description": "The clinical trial involves 150 volunteers from the staff of a hospital near Tel Aviv who are at least four months removed from their third vaccine shot and have signs of waning antibodies.", "url": "https://www.cbsnews.com/news/covid-19-israel-testing-fourth-pfizer-vaccine-shot/", "urlToImage": "https://cbsnews1.cbsistatic.com/hub/i/r/2021/12/27/a9065408-9d5c-468b-a386-39ba2728cb76/thumbnail/1200x630/df4e2b55e83cc65e6e513d113bf60b2f/sheba-medical-center-near-tel-aviv.jpg", "publishedAt": "2021-12-27T12:36:40Z", "content": "An Israeli hospital launched a clinical trial Monday on the impact of a fourth shot of the Pfizer-BioNTech coronavirus vaccine, as the health ministry weighs a national fourth jab rollout.\r\n The stud\u2026 [+2141 chars]"}, {"source": {"id": "usa-today", "name": "USA Today"}, "author": "Lindsey Leake, Treasure Coast Newspapers", "title": "COVID vaccine cocktails: A guide to mixing and matching Pfizer, Moderna, J&J booster shots", "description": "If you're eligible for a COVID-19 vaccine booster shot, you don't have to stick with the same company that manufactured your primary dose(s).", "url": "https://www.usatoday.com/story/news/health/2021/12/27/covid-vaccine-booster-shots-pfizer-moderna/9022187002/", "urlToImage": "https://s.yimg.com/ny/api/res/1.2/AmSHMSMQQ3RngTSNNzty8w--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD0xNTc1/https://s.yimg.com/uu/api/res/1.2/fRf50w.rstPoKFFL8KRa8w--~B/aD0yMTAwO3c9MTYwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/usa_today_news_641/107e3bd3f45e75eef28289b15d964c85", "publishedAt": "2021-12-27T12:38:34Z", "content": "So, youre thinking of getting your COVID-19 vaccine booster shot.\r\nAs recently as mid-October, only select populations that had completed their primary, two-dose Pfizer series were eligible for a boo\u2026 [+5397 chars]"}, {"source": {"id": null, "name": "Sputnik International"}, "author": "Elizabeth Blade", "title": "Israel is Set to Offer 4th Dose of Pfizer Vaccine; Expert Says It Should Not Be Mandatory", "description": "The decision to start mass vaccination yet again hasn't been taken yet, but the Jewish state is already encouraging its medical staff, people above 60 and those at risk to get the jab.", "url": "https://sputniknews.com/20211227/israel-is-set-to-offer-4th-dose-of-pfizer-vaccine-expert-says-it-should-not-be-mandatory--1091828138.html", "urlToImage": "https://cdnn1.img.sputniknews.com/images/sharing/article/eng/1091828138.jpg?10825952661640590707", "publishedAt": "2021-12-27T07:38:26Z", "content": "We know that there will be an added value if a person chooses to get a fourth dose. We don't know how much it will be but we know for a fact that it exists. Plus, the vaccine is totally safe,\" he rea\u2026 [+6 chars]"}, {"source": {"id": "newsweek", "name": "Newsweek"}, "author": "Jenni Fink", "title": "Pfizer COVID Pill Could Be Dangerous for Some High Risk Americans", "description": "COVID pills could help reduce strains on hospitals, but it may require some Americans to weigh the risks of COVID-19 against the risk of the pill.", "url": "https://www.newsweek.com/pfizer-covid-pill-could-dangerous-some-high-risk-americans-1663425", "urlToImage": "https://d.newsweek.com/en/full/1959207/pfizer-pill-covid-pandemic-high-risk.jpg", "publishedAt": "2021-12-27T21:21:50Z", "content": "PAXLOVID, a drug cocktail designed to help prevent a person from being hospitalized with COVID-19, could have serious side effects for its target demographic: high-risk Americans.\r\nThe Food and Drug \u2026 [+5141 chars]"}, {"source": {"id": null, "name": "Childrenshealthdefense.org"}, "author": "Mike Rivero", "title": "Exclusive: 30-Year-Old Still Seeking Answers 6 Months After Developing Neurological Complications Following Pfizer Vaccine", "description": "On March 18 \u2014 two days before her big move \u2014 she and her now husband received their first and only dose of Pfizer\u2019s vaccine.\nShortly after, Dominique said she felt the typical fatigue she was warned about before getting the vaccine, but she also noticed chang\u2026", "url": "https://childrenshealthdefense.org/defender/dominique-de-silva-covid-vaccine-injury-neurological/", "urlToImage": "https://childrenshealthdefense.org/wp-content/uploads/Dominique-DeSilva-Covid-vaccine-injury-feature.jpg", "publishedAt": "2021-12-27T18:45:16Z", "content": "Miss a day, miss a lot.Subscribe to The Defender's Top News of the Day. It's free.\r\nDominique De Silva, 30, is still searching for answers from doctors after developing a long list of debilitating co\u2026 [+10630 chars]"}, {"source": {"id": "independent", "name": "Independent"}, "author": "Vishwam Sankaran", "title": "Pfizer antiviral pills for Covid may be risky when taken with other medications, experts warn", "description": "FDA says drug combination is not recommended for people with severe kidney and liver disease", "url": "https://www.independent.co.uk/news/health/pfizer-covid-antiviral-pill-medications-b1982690.html", "urlToImage": "https://static.independent.co.uk/2021/12/26/14/Virus_Outbreak_Treatment_Explainer_55362.jpg?width=1200&auto=webp&quality=75", "publishedAt": "2021-12-27T05:40:49Z", "content": "Pfizers new antiviral pills against Covid-19 may not be safe for everyone, experts have cautioned, adding that the new drug could be life-threatening when taken with other medications.\r\nThe US Food a\u2026 [+3578 chars]"}, {"source": {"id": null, "name": "WGN TV Chicago"}, "author": "Sarakshi Rai, The Hill via Nexstar Media Wire", "title": "Pfizer antiviral pill could be risky with other widely used medications", "description": "The Food and Drug Administration (FDA) recently authorized two antiviral pills, one from Pfizer and one from Merck, making them the first at-home treatment for COVID-19 that has been touted as a game-changer in the fight against the pandemic.", "url": "https://wgntv.com/news/pfizer-antiviral-pill-could-be-risky-with-other-widely-used-medications/", "urlToImage": "https://wgntv.com/wp-content/uploads/sites/5/2021/12/pfizerpill.jpg?w=1280", "publishedAt": "2021-12-27T17:34:24Z", "content": "(The Hill) \u2014 The Food and Drug Administration (FDA) recently authorized two antiviral pills, one from Pfizer and one from Merck, making them the first at-home treatment for\u00a0COVID-19\u00a0that\u00a0has been tou\u2026 [+3241 chars]"}, {"source": {"id": null, "name": "AllAfrica - Top Africa News"}, "author": "GhanaToday", "title": "U.S. Donates 1.7 Million Doses of Pfizer Vaccines to Ghana", "description": "[GhanaToday] Mr Kwaku Agyemang Manu, Minister for Health (Right) receiving the vaccines from US Ambassador to Ghana, Stephanie Sullivan", "url": "https://allafrica.com/stories/202112270097.html", "urlToImage": "https://cdn08.allafrica.com/static/images/structure/aa-logo-rgba-no-text-square.png", "publishedAt": "2021-12-27T08:22:51Z", "content": "Mr Kwaku Agyemang Manu, Minister for Health (Right) receiving the vaccines from US Ambassador to Ghana, Stephanie Sullivan\r\nGhana has received another 1.7 million doses of Pfizer Covid-19 vaccines fr\u2026 [+1124 chars]"}, {"source": {"id": null, "name": "Freerepublic.com"}, "author": "twitter", "title": "Journalist: Here's the head of Pfizer claiming the shot was a dead end to infection and transmission... \"Lying through his teeth\"", "description": "@JordanSchachtel Here's the head of Pfizer claiming the shot was a dead end to infection and transmission. Therefore, mass \"inoculation\" is warranted, because, under his paradigm, COVID would have been eradicated akin to Polio. Of course, he's lying through h\u2026", "url": "https://freerepublic.com/focus/f-chat/4024610/posts", "urlToImage": null, "publishedAt": "2021-12-27T19:24:41Z", "content": "Skip to comments.\r\nJournalist: Here's the head of Pfizer claiming the shot was a dead end to infection and transmission... \"Lying through his teeth\"twitter ^\r\n | Dec 27\r\n | Jordan Schachtel \r\nPosted \u2026 [+1619 chars]"}, {"source": {"id": null, "name": "PRNewswire"}, "author": null, "title": "Thinking about trading options or stock in Pfizer, Marathon Digital, Automatic Data Processing, Broadcom, or Apple?", "description": "NEW YORK, Dec. 27, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for PFE, MARA, ADP, AVGO, and AAPL. Click a link below then choose between in-depth options trade idea report or a stock score report. Options Report \u2013 Ideal trade ide\u2026", "url": "https://www.prnewswire.com/news-releases/thinking-about-trading-options-or-stock-in-pfizer-marathon-digital-automatic-data-processing-broadcom-or-apple-301450889.html", "urlToImage": "https://mma.prnewswire.com/media/1333368/InvestorsObserver_Logo.jpg?p=facebook", "publishedAt": "2021-12-27T14:31:00Z", "content": "NEW YORK, Dec. 27, 2021 /PRNewswire/ --\u00a0InvestorsObserver\u00a0issues critical PriceWatch Alerts for PFE, MARA, ADP, AVGO, and AAPL.\r\nClick a link below then choose between in-depth options trade idea rep\u2026 [+848 chars]"}, {"source": {"id": null, "name": "Slashdot.org"}, "author": "feedfeeder", "title": "Pfizer antiviral pill could be risky with other widely used medications | TheHill - The Hill", "description": "Pfizer antiviral pill could be risky with other widely used medications | TheHillThe Hill EXPLAINER: New easy-to-use COVID-19 pills come with a catchYahoo News S. Korea to announce decision on whether to authorize antiviral COVID-19 pills for emergency useAri\u2026", "url": "https://slashdot.org/firehose.pl?op=view&amp;id=156893609", "urlToImage": null, "publishedAt": "2021-12-27T04:52:53Z", "content": "If A = B and B = C, then A = C, except where void or prohibited by law.\r\n-- Roy Santoro"}, {"source": {"id": null, "name": "Slashdot.org"}, "author": "feedfeeder", "title": "Pfizer Covid pills for Covid symptoms may be risky with other drugs. - NBC News", "description": "Pfizer Covid pills for Covid symptoms may be risky with other drugs.NBC News EXPLAINER: New easy-to-use COVID-19 pills come with a catchYahoo News S. Korea to announce decision on whether to authorize antiviral COVID-19 pills for emergency useArirang News Edi\u2026", "url": "https://slashdot.org/firehose.pl?op=view&amp;id=156890505", "urlToImage": null, "publishedAt": "2021-12-27T02:32:25Z", "content": "It was pity stayed his hand.\r\n\"Pity I don't have any more bullets,\" thought Frito.\r\n-- _Bored_of_the_Rings_, a Harvard Lampoon parody of Tolkein"}, {"source": {"id": null, "name": "WXYZ"}, "author": "Dr. Partha Nandi", "title": "Israel studies 4th dose of Pfizer COVID-19 vaccine", "description": "As the world deals with the sudden surge of the highly contagious COVID-19 omicron variant, public health experts say vaccine booster shots are the best way to get added protection.", "url": "https://www.wxyz.com/news/health/ask-dr-nandi/israel-begins-studying-fourth-dose-of-pfizer-covid-19-vaccine", "urlToImage": "https://ewscripps.brightspotcdn.com/dims4/default/0bd3180/2147483647/strip/true/crop/1412x741+0+41/resize/1200x630!/quality/90/?url=http%3A%2F%2Fewscripps-brightspot.s3.amazonaws.com%2F94%2F79%2F63fdcf074806b06c7b62590ca238%2Fscreen-shot-2021-02-23-at-3.10.01%20PM.png", "publishedAt": "2021-12-27T21:43:45Z", "content": "(WXYZ) As the world deals with the sudden surge of the highly contagious COVID-19 omicron variant, public health experts say vaccine booster shots are the best way to get added protection.\r\nAnd now, \u2026 [+1952 chars]"}, {"source": {"id": null, "name": "8News"}, "author": "Sarakshi Rai, The Hill via Nexstar Media Wire", "title": "Pfizer antiviral pill could be risky with other widely used medications", "description": "The Food and Drug Administration (FDA) recently authorized two antiviral pills, one from Pfizer and one from Merck, making them the first at-home treatment for COVID-19 that has been touted as a game-changer in the fight against the pandemic.", "url": "https://www.wric.com/health/coronavirus/pfizer-antiviral-pill-could-be-risky-with-other-widely-used-medications/", "urlToImage": "https://www.wric.com/wp-content/uploads/sites/74/2021/12/pfizerpill.jpg?w=1280", "publishedAt": "2021-12-27T17:38:00Z", "content": "(The Hill) \u2014 The Food and Drug Administration (FDA) recently authorized two antiviral pills, one from Pfizer and one from Merck, making them the first at-home treatment for\u00a0COVID-19\u00a0that\u00a0has been tou\u2026 [+3218 chars]"}, {"source": {"id": null, "name": "WNCT"}, "author": "Sarakshi Rai, The Hill via Nexstar Media Wire", "title": "Pfizer antiviral pill could be risky with other widely used medications", "description": "The Food and Drug Administration (FDA) recently authorized two antiviral pills, one from Pfizer and one from Merck, making them the first at-home treatment for COVID-19 that has been touted as a game-changer in the fight against the pandemic.", "url": "https://www.wnct.com/health/coronavirus/pfizer-antiviral-pill-could-be-risky-with-other-widely-used-medications/", "urlToImage": "https://www.wnct.com/wp-content/uploads/sites/99/2021/12/pfizerpill.jpg?w=1280", "publishedAt": "2021-12-27T12:55:20Z", "content": "(The Hill) \u2014 The Food and Drug Administration (FDA) recently authorized two antiviral pills, one from Pfizer and one from Merck, making them the first at-home treatment for\u00a0COVID-19\u00a0that\u00a0has been tou\u2026 [+3218 chars]"}]}, "2021-12-26": {"status": "ok", "totalResults": 10, "articles": [{"source": {"id": "independent", "name": "Independent"}, "author": "Eleanor Sly", "title": "How effective are the Pfizer, AstraZeneca and Moderna vaccines against Omicron?", "description": "Booster jabs provide up to 70 per cent protection, study finds", "url": "https://www.independent.co.uk/news/health/omicron-covid-vaccine-booster-pfizer-moderna-astrazeneca-b1982448.html", "urlToImage": "https://static.independent.co.uk/2021/12/09/16/GettyImages-89747046%20%281%29.jpg?width=1200&auto=webp&quality=75", "publishedAt": "2021-12-26T10:10:32Z", "content": "The more contagious Omicron Covid variant is spreading rapidly across the UK and is set to become the dominant strain in the UK.\r\nSo far more than deaths from the new variant have been recorded and t\u2026 [+7283 chars]"}, {"source": {"id": "nbc-news", "name": "NBC News"}, "author": "Benjamin Ryan", "title": "Pfizer Covid pills may be risky with other medications", "description": "Pfizer Covid pills for symptoms may cause harmful reactions if taken with other prescription medications.", "url": "https://www.nbcnews.com/health/health-news/pfizer-covid-pills-covid-symptoms-may-risky-drugs-rcna9683", "urlToImage": "https://media-cldnry.s-nbcnews.com/image/upload/t_nbcnews-fp-1200-630,f_auto,q_auto:best/rockcms/2021-12/211222-stack-pills-stock-se-158p-39616a.jpg", "publishedAt": "2021-12-26T09:30:36Z", "content": "As the omicron surge pummels a pandemic-weary nation, the first antiviral pills for Covid-19 promise desperately needed protection for people at\u00a0risk of severe disease. However, many people prescribe\u2026 [+5979 chars]"}, {"source": {"id": null, "name": "Business Standard"}, "author": "ANI", "title": "US donates 5 million doses of Pfizer coronavirus vaccine to Pakistan", "description": "The United States has announced shipping an additional five million doses of Pfizer's coronavirus vaccine to Pakistan through the COVAX facility.", "url": "https://www.business-standard.com/article/current-affairs/us-donates-5-million-doses-of-pfizer-coronavirus-vaccine-to-pakistan-121122600032_1.html", "urlToImage": "https://bsmedia.business-standard.com/_media/bs/img/article/2020-11/10/full/1604952252-2271.jpg", "publishedAt": "2021-12-26T02:08:00Z", "content": "The United States has announced shipping an additional five million doses of Pfizer's coronavirus vaccine to Pakistan through the COVAX facility.\r\n\"The United States asked Santa to bring an additiona\u2026 [+2938 chars]"}, {"source": {"id": "the-hill", "name": "The Hill"}, "author": "Sarakshi Rai", "title": "Pfizer antiviral pill could be risky with other widely used medications", "description": "The Food and Drug Administration (FDA) recently authorized two antiviral pills, one from Pfizer and one from Merck, making them the first at-home treatment for\u00a0COVID-19\u00a0that\u00a0has been touted as e a game-changer in the figh...", "url": "https://thehill.com/policy/healthcare/public-global-health/587334-pfizer-antiviral-pill-could-be-risky-with-other-widely", "urlToImage": "https://thehill.com/sites/default/files/pfizer_010721ap_lead.jpg", "publishedAt": "2021-12-26T18:10:13Z", "content": "The Food and Drug Administration (FDA) recently authorized two antiviral pills, one from Pfizer and one from Merck, making them the first at-home treatment for\u00a0COVID-19\u00a0that\u00a0has been touted as e a ga\u2026 [+1984 chars]"}, {"source": {"id": null, "name": "Ynetnews"}, "author": "i24NEWS", "title": "Israel to receive first shipment of Pfizer anti-COVID pills in coming week", "description": "PM spoke with pharma giant's CEO Bourla over the weekend to finalize purchase of some 100,000 doses, which will be available free of charge to Israelis in high-risk groups", "url": "https://www.ynetnews.com/health_science/article/s1bx00wijy", "urlToImage": "https://ynet-images1.yit.co.il/picserver5/crop_images/2021/12/22/S1MWXkWoF/S1MWXkWoF_0_0_2000_1334_0_large.jpg", "publishedAt": "2021-12-26T16:42:09Z", "content": "<ul><li>facebook</li><li>print</li><li>send to friend</li><li>comment</li></ul>\r\n<ul><li>comment</li><li>send to friend</li><li>share</li><li>share</li></ul>"}, {"source": {"id": null, "name": "Haaretz"}, "author": "Ido Efrati \u05d5Reuters", "title": "Israel authorizes use of Pfizer antiviral COVID pill Paxlovid", "description": "Paxlovid, the first at-home treatment for the coronavirus, is expected to arrive in Israel in the next few days", "url": "https://www.haaretz.com/israel-news/israel-authorizes-use-of-pfizer-antiviral-covid-pill-paxlovid-1.10495082", "urlToImage": "https://www.haaretz.com/polopoly_fs/1.10495091.1640537313!/image/3302704606.jpg_gen/derivatives/headline_1200x630/3302704606.jpg", "publishedAt": "2021-12-26T16:40:42Z", "content": "Israel's Health Ministry authorized on Sunday the use of Pfizer's antiviral COVID-19 pill, Paxlovid,\u00a0the first at-home treatment for coronavirus that is expected to become an important tool in the fi\u2026 [+1351 chars]"}, {"source": {"id": null, "name": "Slashdot.org"}, "author": "feedfeeder", "title": "Protection From Pfizer Booster Drops Significantly After 10 Weeks: Study - The Daily Wire", "description": "Protection From Pfizer Booster Drops Significantly After 10 Weeks: StudyThe Daily Wire Why an Omicron wave may not be as severe as DeltaTimes of India Individuals Affected by Omicron are 50-70% Less Likely to Need Hospital Care in Comparison to Other Variants\u2026", "url": "https://slashdot.org/firehose.pl?op=view&amp;id=156872403", "urlToImage": null, "publishedAt": "2021-12-26T13:12:04Z", "content": "The Fine Print: The following comments are owned by whoever posted them. We are not responsible for them in any way."}, {"source": {"id": null, "name": "Slashdot.org"}, "author": "feedfeeder", "title": "UK agency: Pfizer booster\u2019s ability to prevent symptomatic COVID wanes within weeks - The Times of Israel", "description": "UK agency: Pfizer booster\u2019s ability to prevent symptomatic COVID wanes within weeksThe Times of Israel Why an Omicron wave may not be as severe as DeltaTimes of India Individuals Affected by Omicron are 50-70% Less Likely to Need Hospital Care in Comparison t\u2026", "url": "https://slashdot.org/firehose.pl?op=view&amp;id=156877925", "urlToImage": null, "publishedAt": "2021-12-26T16:32:11Z", "content": "The Fine Print: The following comments are owned by whoever posted them. We are not responsible for them in any way."}, {"source": {"id": null, "name": "Slashdot.org"}, "author": "feedfeeder", "title": "Israel to receive first shipment of Pfizer anti-COVID pills in coming week \u2014 report - The Times of Israel", "description": "Israel to receive first shipment of Pfizer anti-COVID pills in coming week \u2014 reportThe Times of Israel Approval of new pills for COVID-19 treatment gives stocks a boostDetroit Free Press SC to receive 800 sets of COVID-19 pillLive 5 News WCSC Editorial: Waiti\u2026", "url": "https://slashdot.org/firehose.pl?op=view&amp;id=156856777", "urlToImage": null, "publishedAt": "2021-12-26T00:32:33Z", "content": "The Fine Print: The following comments are owned by whoever posted them. We are not responsible for them in any way."}, {"source": {"id": null, "name": "CNN Philippines"}, "author": "Paul R.", "title": "Albert Bourla of Pfizer is the CNN Business CEO of the Year", "description": "Albert Bourla of Pfizer is the CNN Business CEO of the Yearcnnphilippines.com", "url": "http://cnnphilippines.com/business/2021/12/26/Albert-Bourla-CNN-Business-CEO-of-the-Year.htmlhttps://cnnphilippines.com/business/2021/12/26/Albert-Bourla-CNN-Business-CEO-of-the-Year.html", "urlToImage": "http://cnnphilippines.com/.imaging/mte/demo-cnn-new/750x450/dam/cnn/2021/12/26/Albert-Bourla_CNNPH.jpg/jcr:content/Albert-Bourla_CNNPH.jpg", "publishedAt": "2021-12-26T14:38:33Z", "content": "(CNN) -- The COVID-19 pandemic is far from over. But life in many ways has returned to something resembling normal for many. That's in large part because there are now multiple coronavirus vaccines, \u2026 [+7066 chars]"}]}, "2021-12-25": {"status": "ok", "totalResults": 6, "articles": [{"source": {"id": "cnn", "name": "CNN"}, "author": "Paul R. La Monica, CNN Business", "title": "Albert Bourla of Pfizer is the CNN Business CEO of the Year - CNN", "description": "The Covid-19 pandemic is far from over. But life in many ways has returned to something resembling normal for many. That's in large part because there are now multiple coronavirus vaccines, including one from Pfizer.", "url": "https://www.cnn.com/2021/12/25/investing/ceo-of-the-year-2021/index.html", "urlToImage": "https://cdn.cnn.com/cnnnext/dam/assets/211220170142-pfizer-ceo-albert-bourla-0423-super-tease.jpg", "publishedAt": "2021-12-25T15:20:00Z", "content": "New York (CNN Business)The Covid-19 pandemic is far from over. But life in many ways has returned to something resembling normal for many. That's in large part because there are now multiple coronavi\u2026 [+7053 chars]"}, {"source": {"id": null, "name": "The Daily Wire"}, "author": "Joseph Curl", "title": "Protection From Pfizer Booster Drops Significantly After 10 Weeks: Study - The Daily Wire", "description": "<ol><li>Protection From Pfizer Booster Drops Significantly After 10 Weeks: Study\u00a0\u00a0The Daily Wire\r\n</li><li>COVID-19 vaccine booster protection against Omicron fades within 10 weeks, says new study\u00a0\u00a0Republic World\r\n</li><li>Pfizer booster's efficacy to prevent\u2026", "url": "https://www.dailywire.com/news/protection-from-pfizer-booster-drops-significantly-after-10-weeks-study", "urlToImage": "https://dw-wp-production.imgix.net/2021/09/Vaccine.jpg?w=1200&h=800&ixlib=react-9.3.0", "publishedAt": "2021-12-25T18:30:15Z", "content": "The protection that a Pfizer booster shot gives against the new coronavirus variant Omicron, following a Pfizer primary course, drops to just 45% after 10-plus weeks, according to a new study.\r\nA boo\u2026 [+3187 chars]"}, {"source": {"id": "independent", "name": "Independent"}, "author": "Eleanor Sly", "title": "How effective are the Pfizer, AstraZeneca and Moderna vaccines against Omicron?", "description": "Booster jabs provide up to 70 per cent protection, study finds", "url": "https://www.independent.co.uk/news/health/covid-vaccine-omicron-pfizer-moderna-astrazeneca-b1982240.html", "urlToImage": "https://static.independent.co.uk/2021/12/09/16/GettyImages-89747046%20%281%29.jpg?width=1200&auto=webp&quality=75", "publishedAt": "2021-12-25T09:49:34Z", "content": "The more contagious Omicron Covid variant is spreading rapidly across the UK and is set to become the dominant strain in the UK.\r\nSo far more than deaths from the new variant have been recorded and t\u2026 [+7283 chars]"}, {"source": {"id": null, "name": "The Times of Israel"}, "author": null, "title": "Israel to receive 100,000 Pfizer anti-COVID pills in coming week \u2014 report", "description": "PM Naftali Bennett speaks to Pfizer CEO over weekend to finalize deal for at-home treatment shown to reduce risk of hospitalization, death in high-risk groups by 90%", "url": "https://www.timesofisrael.com/israel-to-receive-100000-pfizer-anti-covid-pills-in-coming-week-report/", "urlToImage": "https://static.timesofisrael.com/www/uploads/2021/11/AP21320681843352-1024x640.jpg", "publishedAt": "2021-12-25T21:00:54Z", "content": "Israel has finalized an agreement to purchase about 100,000 of Pfizer\u2019s antiviral COVID-19 pills and is set to receive the first shipment in about a week, Channel 12 reported Saturday.\r\nThe network s\u2026 [+4074 chars]"}, {"source": {"id": "cnn", "name": "CNN"}, "author": null, "title": "Pfizer CEO shares thoughts on boosters and the future of Covid - CNN Video", "description": "Pfizer CEO Albert Bourla spoke with CNN Business' Paul R. La Monica about annual Covid-19 vaccines, the future of the virus, and getting the vaccine to low-income countries.", "url": "https://www.cnn.com/videos/business/2021/12/19/albert-bourla-pfizer-ceo-interview-mc-orig.cnn-business", "urlToImage": "https://cdn.cnn.com/cnnnext/dam/assets/211207174111-omicron-news-042321-super-tease.jpg", "publishedAt": "2021-12-25T12:54:49Z", "content": ""}, {"source": {"id": null, "name": "Justthenews.com"}, "author": "Aaron Kliegman", "title": "Pfizer to continue distributing version of COVID-19 vaccine not fully approved by FDA", "description": "Pharma giant says no medical difference between the two; others point to major legal distinctions affecting vaccine mandates", "url": "https://justthenews.com/politics-policy/health/pfizer-continue-distributing-version-covid-19-vaccine-not-fully-approved-fda", "urlToImage": "https://justthenews.com/sites/default/files/styles/social_media_share/public/2021-12/pfizer%20vaccine.jpg?h=58c8a5e7&itok=CjeKx4RO", "publishedAt": "2021-12-25T08:19:50Z", "content": "Pfizer's vaccine against COVID-19 has been fully approved by the Food and Drug Administration, yet the pharmaceutical giant is still providing distributors across the country with an earlier version \u2026 [+6348 chars]"}]}, "2021-12-24": {"status": "ok", "totalResults": 13, "articles": [{"source": {"id": "independent", "name": "Independent"}, "author": "Eleanor Sly", "title": "How effective are the Pfizer, AstraZeneca and Moderna vaccines against Omicron?", "description": "Booster jabs provide up to 70 per cent protection, study finds", "url": "https://www.independent.co.uk/news/health/omicron-vaccine-pfizer-moderna-astrazeneca-b1982064.html", "urlToImage": "https://static.independent.co.uk/2021/12/09/16/GettyImages-89747046%20%281%29.jpg?width=1200&auto=webp&quality=75", "publishedAt": "2021-12-24T15:11:40Z", "content": "The more contagious Omicron Covid variant is spreading rapidly across the UK and is set to become the dominant strain in the UK.\r\nSo far more than deaths from the new variant have been recorded and t\u2026 [+7283 chars]"}, {"source": {"id": null, "name": "Childrenshealthdefense.org"}, "author": "Mike Rivero", "title": "Pfizer, FDA Dodge Media Questions About Pfizer Comirnaty Vaccine", "description": "Two media outlets last week requested, but failed to obtain, clarity from Pfizer on whether its fully licensed Comirnaty COVID vaccine is available in the U.S.\nReporting by The Ohio Star and National File highlighted the ongoing debate over whether the vaccin\u2026", "url": "https://childrenshealthdefense.org/defender/pfizer-fda-media-pfizer-comirnaty-vaccine/", "urlToImage": "https://childrenshealthdefense.org/wp-content/uploads/Pfizer-FDA-dodge-comments-Comirnaty-feature-1.jpg", "publishedAt": "2021-12-24T13:40:34Z", "content": "Miss a day, miss a lot.Subscribe to The Defender's Top News of the Day. It's free.\r\nTwo media outlets last week requested, but failed to obtain, clarity from Pfizer on whether its fully licensed Comi\u2026 [+9513 chars]"}, {"source": {"id": null, "name": "Sputnik International"}, "author": "Sputnik International", "title": "Two Doses of Pfizer or Moderna Fail to Protect Against Omicron After 6 Months, Scientists Say", "description": "MOSCOW (Sputnik) - A study by a group of scientists from the United States has found that two doses of COVID-19 vaccines from Pfizer or Moderna do not provide protection against the Omicron strain six months after the second vaccination.", "url": "https://sputniknews.com/20211224/two-doses-of-pfizer-or-moderna-fail-to-protect-against-omicron-after-6-months-scientists-say-1091777362.html", "urlToImage": "https://cdnn1.img.sputniknews.com/images/sharing/article/eng/1091777362.jpg?10910565181640352859", "publishedAt": "2021-12-24T13:34:17Z", "content": "Registration was successful!Please follow the link from the email sent to \r\nThe new COVID variant was initially detected in South Africa and Botswana and sparked major concerns due to its high number\u2026 [+3002 chars]"}, {"source": {"id": null, "name": "The Times of Israel"}, "author": null, "title": "UK agency: Pfizer booster\u2019s ability to prevent symptomatic COVID wanes within weeks", "description": "Data shows 3rd shot 70% effective in preventing illness after 2 weeks but only 45% after 10 weeks; Moderna seems to offer more durable protection, staying at 70% after 10 weeks", "url": "https://www.timesofisrael.com/uk-agency-pfizer-boosters-ability-to-prevent-symptomatic-covid-wanes-within-weeks/", "urlToImage": "https://static.timesofisrael.com/www/uploads/2021/12/iStock-1355780408-1024x640.jpg", "publishedAt": "2021-12-24T15:23:30Z", "content": "New data from the UK indicates that the effectiveness of Pfizer vaccine booster shots in preventing symptomatic COVID-19 as a result of the Omicron variant drops considerably within 10 weeks of recei\u2026 [+1959 chars]"}, {"source": {"id": null, "name": "Uniindia.com"}, "author": "Uniindia News Service", "title": "Two doses of Pfizer or Moderna fail to protect against Omicron after 6 months: Scientists - United News of India", "description": "<ol><li>Two doses of Pfizer or Moderna fail to protect against Omicron after 6 months: Scientists\u00a0\u00a0United News of India\r\n</li><li>Vaccines, pills and data - Some good news in face of Omicron gloom\u00a0\u00a0Mint\r\n</li><li>Omicron can evade protection offered by Covid \u2026", "url": "http://www.uniindia.com/~/two-doses-of-pfizer-or-moderna-fail-to-protect-against-omicron-after-6-months-scientists/World/news/2602887.html", "urlToImage": "", "publishedAt": "2021-12-24T19:01:00Z", "content": "More News25 Dec 2021 | 2:18 AMWashington, Dec 24 (UNI/Sputnik) Tesla will modify features allowing people to play video games using a built-in touch screen during the ride following the US National H\u2026 [+1113 chars]"}, {"source": {"id": null, "name": "New York Post"}, "author": "Jackie Salo", "title": "Pfizer booster protection against Omicron drops in 10 weeks, study says", "description": "The effectiveness of Pfizer's booster shot against symptomatic Omicron significantly dwindles after 10 weeks.", "url": "https://nypost.com/2021/12/24/booster-protection-against-omicron-drops-within-10-weeks-study/", "urlToImage": "https://nypost.com/wp-content/uploads/sites/2/2021/12/pfizer-booster-00.jpg?quality=90&strip=all&w=1024", "publishedAt": "2021-12-24T18:35:54Z", "content": "The effectiveness of Pfizer\u2019s booster shot against symptomatic Omicron significantly wanes after 10 weeks, a new study said this week \u2014 as experts weigh whether fourth shots are necessary.\r\nThe\u00a0UK He\u2026 [+2061 chars]"}, {"source": {"id": null, "name": "NDTV News"}, "author": null, "title": "Merck, Pfizer Pills Cleared For Use, Now US To Focus On Rationing", "description": "The US has cleared its first two Covid-19 treatment pills, and now comes another hurdle -- deciding who should get which one.", "url": "https://www.ndtv.com/world-news/merck-pfizer-pills-cleared-for-use-now-us-to-focus-on-rationing-2668779", "urlToImage": "https://c.ndtvimg.com/2021-12/4luj96r_pfizer-covid-pill-afp_625x300_22_December_21.jpg", "publishedAt": "2021-12-24T04:33:11Z", "content": "Pfizer Inc.'s Paxlovid was authorised earlier this week\r\nThe US has cleared its first two Covid-19 treatment pills, and now comes another hurdle -- deciding who should get which one.\r\nMerck &amp; Co.\u2026 [+5097 chars]"}, {"source": {"id": null, "name": "Womensystems.com"}, "author": "mayaleo", "title": "Will The US Consider A FOURTH COVID Vaccination? Speculation Mounts That Yet Another Shot Is On The Horizon To Deal With Soaring Omicron Cases After Pfizer CEO Backed Them, With Germany And Israel Both Preparing To Roll Them Out", "description": "Women Entertainment Sysytem", "url": "http://www.womensystems.com/2021/12/will-us-consider-fourth-covid.html", "urlToImage": "https://lh5.googleusercontent.com/proxy/ekzJEpFnHVIXLQXVGSap-Ccw0kUoipOj3dn-OQlgQ7F4A0UsK93wT6aYKjSVnTx5usD3GumT1DJ5Wy6TKztWqRdO8rMRS-E3ve8RTECu86pHy1CX2eWhpUellIFh_o377FuUDoEfCjnUgb71FA=w1200-h630-p-k-no-nu", "publishedAt": "2021-12-24T13:52:38Z", "content": "Speculation is mounting that the United States could offer people a fourth COVID vaccine shot in the coming months as the Omicron variant surges.\u00a0\r\nIsrael and Germany are both on the verge of rolling\u2026 [+11870 chars]"}, {"source": {"id": null, "name": "Business Standard"}, "author": "Press Trust of India", "title": "United States donates 664,560 doses of Pfizer vaccines to Nepal", "description": "The United States has donated 664,560 new doses of Pfizer vaccine to Nepal to help it intensify its fight against the coronavirus, the US Embassy said here on Friday.\nThe new doses of Pfizer vaccine given to Nepal free of cost is in addition to the doses the \u2026", "url": "https://www.business-standard.com/article/international/united-states-donates-664-560-doses-of-pfizer-vaccines-to-nepal-121122400863_1.html", "urlToImage": "https://bsmedia.business-standard.com/_media/bs/img/article/2021-02/25/full/1614255646-8333.jpg", "publishedAt": "2021-12-24T13:21:00Z", "content": "The United States has donated 664,560 new doses of Pfizer vaccine to Nepal to help it intensify its fight against the coronavirus, the US Embassy said here on Friday.\r\nThe new doses of Pfizer vaccine\u2026 [+2798 chars]"}, {"source": {"id": null, "name": "Freerepublic.com"}, "author": "dailyexpose.uk", "title": "Pfizer/BioNTech Covid Injections reprogram both adaptive and innate immune responses", "description": "A study posted on the preprint site medRxiv shows that Covid mRNA injections are causing immune system dysregulation, a breakdown of immune system processes. In other words, researchers are finding that the injections reprogram not only your adaptive immune s\u2026", "url": "https://freerepublic.com/focus/f-chat/4023939/posts", "urlToImage": null, "publishedAt": "2021-12-24T05:09:23Z", "content": "Skip to comments.\r\nPfizer/BioNTech Covid Injections reprogram both adaptive and innate immune responsesdailyexpose.uk ^\r\n | 12/23/2021\r\n | RHODA WILSON\r\nPosted on 12/23/2021 9:09:23 PM PST by ransomn\u2026 [+5282 chars]"}, {"source": {"id": null, "name": "Freerepublic.com"}, "author": "dailyexpose.uk", "title": "Pfizer Injection Contents: La Quinta Columna Confirms Findings of Polish Scientist and Dr. Carrie Madej", "description": "Using optical microscopy, La Quinta Columna finds the famous \u201cnano-octopus\u201d that appeared in the Pfizer vaccine vial analysed by Dr. Campra, observed by Dr. Carrie Madej under the microscope, and also found by the Polish scientist Dr. Franc Zalewksi.\u201cIt looks\u2026", "url": "https://freerepublic.com/focus/f-chat/4023944/posts", "urlToImage": null, "publishedAt": "2021-12-24T05:49:33Z", "content": "Skip to comments.\r\nPfizer Injection Contents: La Quinta Columna Confirms Findings of Polish Scientist and Dr. Carrie Madejdailyexpose.uk ^\r\n | December 23, 2021\r\n | Rhoda WIlson\r\nPosted on 12/23/2021\u2026 [+5593 chars]"}, {"source": {"id": "the-times-of-india", "name": "The Times of India"}, "author": "Monit Khanna", "title": "After Pfizer, Merck\u2019s Anti-COVID-19 Pill Gets Emergency Use Approval In US", "description": "Yesterday we saw Pfizer\u2019s pill for COVID-19 treatment get approved by the FDA and today, Merck\u2019s pill dubbed 'Molnupiravir'\u00a0 for COVID-19 treatment gets emergency use authorization.                        APAlso Read:\u00a0United States Approves Use Of World's Fir\u2026", "url": "https://www.indiatimes.com/technology/science-and-future/merck-anti-covid-19-pill-approved-557589.html", "urlToImage": "https://im.indiatimes.in/content/2021/Dec/Facebook-Image---2021-12-24T130445601_61c57907b368a.jpg", "publishedAt": "2021-12-24T07:28:11Z", "content": "Yesterday we saw Pfizers pill for COVID-19 treatment get approved by the FDA and today, Mercks pill dubbed 'Molnupiravir'\u00a0 for COVID-19 treatment gets emergency use authorization.\r\nAP\r\nAlso Read:\u00a0Uni\u2026 [+1459 chars]"}, {"source": {"id": null, "name": "Slashdot.org"}, "author": "feedfeeder", "title": "Pfizer booster protection against Omicron drops in 10 weeks, study says - New York Post", "description": "Pfizer booster protection against Omicron drops in 10 weeks, study saysNew York Post COVID-19: Data suggests Omicron 'less severe'Sky News Omicron up to 70% less likely to need hospital careBBC News UK Omicron IS less severe studies show as ministers urged to\u2026", "url": "https://slashdot.org/firehose.pl?op=view&amp;id=156803301", "urlToImage": null, "publishedAt": "2021-12-24T20:12:36Z", "content": "The Fine Print: The following comments are owned by whoever posted them. We are not responsible for them in any way."}]}, "2021-12-23": {"status": "ok", "totalResults": 41, "articles": [{"source": {"id": null, "name": "Zacks.com"}, "author": "Zacks Equity Research", "title": "Pfizer (PFE) Gets FDA's Emergency Use Nod for COVID Pill", "description": "Pfizer's (PFE) COVID-19 pill Paxlovid is the first oral antiviral medicine, which can be prescribed as an at-home treatment for mild-to-moderate COVID-19.", "url": "http://www.zacks.com/stock/news/1842876/pfizer-pfe-gets-fda-s-emergency-use-nod-for-covid-pill?cid=CS-ENTREPRENEUR-FT-analyst_blog|company_news_-_medical_sector-1842876", "urlToImage": "https://assets.entrepreneur.com/providers/zacks/hero-image-zacks-404477.jpeg", "publishedAt": "2021-12-23T15:30:00Z", "content": "Pfizer PFE announced that the FDA has granted Emergency Use Authorization (EUA) to its promising oral antiviral candidate for COVID-19, Paxlovid, amid rising infection rates. The Omicron variant of t\u2026 [+6384 chars]"}, {"source": {"id": null, "name": "Zacks.com"}, "author": "Zacks Equity Research", "title": "Moderna (MRNA) Down as Pfizer Paxlovid EUA May Fuel Competition", "description": "Moderna's (MRNA) COVID-19 vaccine may face stiffer competition following the FDA's emergency approval of an oral COVID-19 pill, Pfizer's Paxlovid, which may result in lower sales.", "url": "http://www.zacks.com/stock/news/1842878/moderna-mrna-down-as-pfizer-paxlovid-eua-may-fuel-competition?cid=CS-ENTREPRENEUR-FT-analyst_blog|company_news_-_medical_sector-1842878", "urlToImage": "https://assets.entrepreneur.com/providers/zacks/hero-image-zacks-404475.jpeg", "publishedAt": "2021-12-23T15:39:00Z", "content": "Shares of popular COVID-19 vaccine-maker, ModernaMRNA were down 6.3% on Wednesday, following the news of emergency use authorization (EUA) for Pfizers PFE promising oral COVID-19 pill, Paxlovid, in t\u2026 [+7367 chars]"}, {"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "Merck and Pfizer COVID-19 pills effective against Omicron -U.S. FDA official - Reuters", "description": "Available data indicates that both Merck's <a href=\"https://www.reuters.com/companies/MRK.N\" target=\"_blank\">(MRK.N)</a> and Pfizer's <a href=\"https://www.reuters.com/companies/PFE.N\" target=\"_blank\">(PFE.N)</a> COVID-19 anti-viral treatments are effective ag\u2026", "url": "https://www.reuters.com/world/us/merck-pfizer-covid-19-pills-effective-against-omicron-us-fda-official-2021-12-23/", "urlToImage": "https://www.reuters.com/resizer/Ym2-lihEXiC1sjyMdF3KbAdpiLg=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/TUAWFANQXJLVFM76ZJH5H7A4CM.jpg", "publishedAt": "2021-12-23T17:10:00Z", "content": "Vials labelled \"VACCINE Coronavirus COVID-19\" and a syringe are seen in front of a displayed U.S. flag in this illustration taken December 11, 2021. REUTERS/Dado RuvicWASHINGTON, Dec 23 (Reuters) - A\u2026 [+928 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "CBS News Videos", "title": "FDA authorizes Pfizer pill to treat COVID-19 as Omicron hits all 50 sates", "description": "The Food and Drug Administration announced Wednesday it has authorized Pfizer's antiviral pill to treat COVID-19 as the new Omicron variant hits all 50 U.S. ...", "url": "https://news.yahoo.com/fda-authorizes-pfizer-pill-treat-012154903.html", "urlToImage": "https://s.yimg.com/ny/api/res/1.2/rBdcVmE03PRrGNQVdLNdBQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzU-/https://s.yimg.com/hd/cp-video-transcode/prod/2021-12/23/61c3d484709d502188af5a14/61c3d484709d502188af5a15_o_U_v2.jpg", "publishedAt": "2021-12-23T01:21:54Z", "content": "Rep. Madison Cawthorn and his wife are divorcing after less than a year of marriage, with the North Carolina Republican citing his job in Congress as part of the reason for the split.\"When my wife Ch\u2026 [+252 chars]"}, {"source": {"id": null, "name": "Nature.com"}, "author": "Sandile Cele, Laurelle Jackson, David S. Khoury, Khadija Khan, Thandeka Moyo-Gwete, Houriiyah Tegally, James Emmanuel San, Deborah Cromer, Cathrine Scheepers, Daniel Amoako, Farina Karim, Mallory Bernstein, Gila Lustig, Derseree Archary, Muneerah Smith, Yashica Ganga, Zesuliwe Jule, Kajal Reedoy, Shi-Hsia Hwa, Jennifer Giandhari, Jonathan M. Blackburn, Bernadett I. Gosnell, Salim S. Abdool Karim, Willem Hanekom, Network for Genomic Surveillance in South Africa, COMMIT-KZN Team, Anne von Gottberg, Jinal Bhiman, Richard J. Lessells, Mahomed-Yunus S. Moosa, Miles P. Davenport, Tulio de Oliveira, Penny L. Moore, Alex Sigal", "title": "Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization", "description": "Discover the world\u2019s best science and medicine  | Nature.com", "url": "https://www.nature.com/articles/d41586-021-03824-5", "urlToImage": "https://media.nature.com/lw1024/magazine-assets/d41586-021-03824-5/d41586-021-03824-5_19974342.jpg", "publishedAt": "2021-12-23T00:00:00Z", "content": "National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa. MRC Antibody Immunity Research Unit, School of Pathology, Faculty of Health Science\u2026 [+249 chars]"}, {"source": {"id": null, "name": "BNNBloomberg.ca"}, "author": "Bloomberg News", "title": "USA Weighs How To Ration PFIZER Pills...", "description": "USA Weighs How To Ration PFIZER Pills...\r\n\n \n \n \n (Top headline, 9th story, link)\r\n\n \r\n\n \r\n\n \n Related stories:HOPE: Omicron may bring record cases but fewer deaths, forecast says...\r\n60% of Americans infected by March?\r\nMarches Toward Endemic Status...\r\nIn h\u2026", "url": "http://www.bnnbloomberg.ca/u-s-weighs-how-to-ration-pfizer-pills-early-on-among-high-risk-1.1699825", "urlToImage": "http://www.bnnbloomberg.ca/img/tsn/logos/tsn-logo.png", "publishedAt": "2021-12-23T15:19:36Z", "content": "(Bloomberg) -- The U.S. has cleared Pfizer Inc.s Covid pill, and now comes another hurdle -- deciding who should get it.\r\nPfizers Paxlovid, authorized Wednesday by the Food and Drug Administration, h\u2026 [+1880 chars]"}, {"source": {"id": null, "name": "Motley Fool"}, "author": "newsfeedback@fool.com (Jim Halley)", "title": "The Worst Mistake Pfizer Investors Can Make in 2022", "description": "The company's share price and revenue have soared in 2021, and that's likely only the beginning.", "url": "https://www.fool.com/investing/2021/12/23/the-worst-mistake-pfizer-investors-can-make-in-202/", "urlToImage": "https://g.foolcdn.com/editorial/images/658089/pfizer.jpg", "publishedAt": "2021-12-23T12:23:00Z", "content": "It's been a great year for Pfizer(NYSE:PFE) and its investors as the company's share price is up more than 62% this year. Also, Pfizer has said it expects to record annual revenue of between $81 bill\u2026 [+4737 chars]"}, {"source": {"id": "bloomberg", "name": "Bloomberg"}, "author": null, "title": "Pfizer Covid Pill Cleared for High-Risk Patients in US(Podcast)", "description": "Understand every aspect of the global economy \u2013 and know how to make your next move.", "url": "https://www.bloomberg.com/news/audio/2021-12-23/pfizer-covid-pill-cleared-for-high-risk-patients-in-us-podcast", "urlToImage": null, "publishedAt": "2021-12-23T02:37:12Z", "content": "Robert Langreth, Bloomberg Healthcare Reporter, discusses Pfizer's Covid pill with Bryan Curtis and Rishaad Salamat on Bloomberg Daybreak Asia.\r\nDec 23, 2021"}, {"source": {"id": null, "name": "TheStreet"}, "author": "Scott Rutt", "title": "Cramer's Mad Money Recap 12/23: Pfizer, Nvidia, Tesla", "description": "Jim Cramer's got a list of who's naughty, who's nice and which companies deserve a lump of coal.", "url": "https://www.thestreet.com/jim-cramer/cramers-mad-money-recap-dec-23-2021", "urlToImage": "https://www.thestreet.com/.image/t_share/MTg1NDg3NTI3ODUzOTU4MzA1/stocks-markets-holiday-lights-sh.jpg", "publishedAt": "2021-12-23T18:58:00Z", "content": "Santa took his time getting to Wall Street this year, but\u00a0Jim Cramer told his Mad Money viewers that it looks like the so-called Santa Claus Rally started on Monday and has been delivering gifts to i\u2026 [+7301 chars]"}, {"source": {"id": null, "name": "Moneycontrol"}, "author": null, "title": "Pfizer pill becomes 1st US-authorised home COVID treatment", "description": "The long-awaited milestone comes as U.S. cases, hospitalisations and deaths are all rising and health officials warn of a tsunami of new infections from the omicron variant that could overwhelm hospitals.", "url": "https://www.moneycontrol.com/news/world/pfizer-pill-becomes-1st-us-authorised-home-covid-treatment-7856481.html", "urlToImage": "https://images.moneycontrol.com/static-mcnews/2021/09/pfizer-770x433.jpg", "publishedAt": "2021-12-23T02:56:14Z", "content": "U.S. health regulators on Wednesday authorised the first pill against COVID-19, a\u00a0Pfizer\u00a0drug that Americans will be able to take at home to head off the worst effects of the virus.\r\nThe long-awaited\u2026 [+4511 chars]"}, {"source": {"id": "independent", "name": "Independent"}, "author": "Eleanor Sly", "title": "How effective are the Pfizer, AstraZeneca and Moderna vaccines against Omicron?", "description": "Booster jabs provide up to 70 per cent protection, study finds", "url": "https://www.independent.co.uk/news/health/omicron-vaccine-pfizer-astrazeneca-moderna-b1981500.html", "urlToImage": "https://static.independent.co.uk/2021/12/09/16/GettyImages-89747046%20%281%29.jpg?width=1200&auto=webp&quality=75", "publishedAt": "2021-12-23T15:17:19Z", "content": "The more contagious Omicron Covid variant is spreading rapidly across the UK and is set to become the dominant strain in the UK.\r\nSo far more than deaths from the new variant have been recorded and t\u2026 [+7283 chars]"}, {"source": {"id": "cbs-news", "name": "CBS News"}, "author": "CBS News", "title": "FDA authorizes Pfizer pill to treat COVID-19 as Omicron hits all 50 sates", "description": "The Food and Drug Administration announced Wednesday it has authorized Pfizer's antiviral pill to treat COVID-19 as the new Omicron variant hits all 50 U.S. states. CBS News correspondent Nancy Chen reports on how the new strain is causing disruptions across \u2026", "url": "https://www.cbsnews.com/video/fda-authorizes-pfizer-pill-to-treat-covid-19-as-omicron-hits-all-50-sates/", "urlToImage": "https://cbsnews3.cbsistatic.com/hub/i/r/2021/12/23/cac15539-3030-4b53-a36f-3a9fc4a3a97e/thumbnail/1200x630/0c4cc6507e672d30f245c747bdc20138/cbsn-fusion-fda-authorizes-pfizer-pill-to-treat-covid-19-as-omicron-hits-all-50-sates-thumbnail-861641-640x360.jpg", "publishedAt": "2021-12-23T01:25:24Z", "content": "Watch CBSN Live\r\nCopyright \u00a9 2021 CBS Interactive Inc. All rights reserved.\r\nGet browser notifications for breaking news, live events, and exclusive reporting.\r\nNot NowTurn On"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "Reuters", "title": "Merck and Pfizer COVID-19 pills effective against Omicron -U.S. FDA official", "description": "Available data indicates that both Merck's and Pfizer's COVID-19 anti-viral treatments are effective against the Omicron variant of the coronavirus, a top...", "url": "https://news.yahoo.com/merck-pfizer-covid-19-pills-171022056.html", "urlToImage": "https://s.yimg.com/uu/api/res/1.2/zud1gbh2kOslNaNAGDAHcA--~B/aD01MjI7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/2733226d78192706fa2e0f53f0ec0b7b", "publishedAt": "2021-12-23T17:10:22Z", "content": "WASHINGTON (Reuters) - Available data indicates that both Merck's and Pfizer's COVID-19 anti-viral treatments are effective against the Omicron variant of the coronavirus, a top U.S. Federal Drug Adm\u2026 [+629 chars]"}, {"source": {"id": "breitbart-news", "name": "Breitbart News"}, "author": "Ian Hanchett, \nIan Hanchett", "title": "Biden: It Will Be 'Weeks to a Month' Before Hospitals Get Pfizer COVID Pill", "description": "During an interview aired on Wednesday\u2019s edition of ABC\u2019s \u201cWorld News Tonight,\u201d President Joe Biden stated that it will take \u201cweeks to a month\u201d to get the Pfizer coronavirus pill to hospitals, but \u201cit won\u2019t be enough to get to", "url": "https://www.breitbart.com/clips/2021/12/22/biden-it-will-be-weeks-to-a-month-before-hospitals-get-pfizer-covid-pill/", "urlToImage": "https://media.breitbart.com/media/2021/11/Joe-Biden-Flubs-a-Joke-640x335.jpg", "publishedAt": "2021-12-23T00:49:46Z", "content": "During an interview aired on Wednesday\u2019s edition of ABC\u2019s \u201cWorld News Tonight,\u201d President Joe Biden stated that it will take \u201cweeks to a month\u201d to get the Pfizer coronavirus pill to hospitals, but \u201ci\u2026 [+552 chars]"}, {"source": {"id": "breitbart-news", "name": "Breitbart News"}, "author": "Ian Hanchett, \nIan Hanchett", "title": "Biden: If People Get Vaccinated and Boosted, They Won't Need Pfizer COVID Pill", "description": "During an interview aired on Wednesday\u2019s edition of ABC\u2019s \u201cWorld News Tonight,\u201d President Joe Biden stated that the government has ordered millions of the Pfizer coronavirus antiviral pills, but \u201cI hope we don\u2019t get there. Because if people get the", "url": "https://www.breitbart.com/clips/2021/12/22/biden-if-people-get-vaccinated-and-boosted-they-wont-need-pfizer-covid-pill/", "urlToImage": "https://media.breitbart.com/media/2021/11/GettyImages-1236914951-640x335.png", "publishedAt": "2021-12-23T00:49:43Z", "content": "During an interview aired on Wednesday\u2019s edition of ABC\u2019s \u201cWorld News Tonight,\u201d President Joe Biden stated that the government has ordered millions of the Pfizer coronavirus antiviral pills, but \u201cI h\u2026 [+610 chars]"}, {"source": {"id": null, "name": "Sputnik International"}, "author": "Sputnik International", "title": "Hong Kong Scientists Say Pfizer/BioNTech Vaccine Effective Against Omicron Variant", "description": "MOSCOW (Sputnik) \u2013 Scientists from the University of Hong Kong said on Thursday that a booster dose of the Comirnaty vaccine against the coronavirus jointly developed by Pfizer and BioNTech companies provides a high level of protection from the Omicron strain\u2026", "url": "https://sputniknews.com/20211223/hong-kong-scientists-say-pfizerbiontech-vaccine-effective-against-omicron-variant-1091754189.html", "urlToImage": "https://cdnn1.img.sputniknews.com/images/sharing/article/eng/1091754189.jpg?10910565181640271832", "publishedAt": "2021-12-23T15:03:51Z", "content": "\"A third dose of Comirnaty vaccine given to those who received two doses of either Comirnaty or CoronaVac provides protective levels of protective antibody against the Omicron variant\", the statement\u2026 [+33 chars]"}, {"source": {"id": null, "name": "Memeorandum.com"}, "author": null, "title": "U.S. authorizes Pfizer oral COVID-19 treatment, first for at-home use (Reuters)", "description": "Reuters:\nU.S. authorizes Pfizer oral COVID-19 treatment, first for at-home use\u00a0 \u2014\u00a0 The United States on Wednesday authorized Pfizer Inc's (PFE.N) antiviral COVID-19 pill for people ages 12 and older at risk of severe illness, the first oral and at-home treatm\u2026", "url": "https://www.memeorandum.com/211223/p44", "urlToImage": "https://www.reuters.com/resizer/6ajCUtrS6UDOyJ4bG5tJuu6YRLg=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/QDROFKF225L55I36I7TMPUEFZA.jpg", "publishedAt": "2021-12-23T16:00:55Z", "content": "memeorandum is an auto-generated summary of the stories that US political commentators are discussing online right now.\r\nUnlike sister sites Techmeme and Mediagazer, it is not a human-edited news out\u2026 [+72 chars]"}, {"source": {"id": null, "name": "Memeorandum.com"}, "author": null, "title": "Pfizer pill becomes 1st US-authorized home COVID treatment (Matthew Perrone/Associated Press)", "description": "Matthew Perrone / Associated Press:\nPfizer pill becomes 1st US-authorized home COVID treatment\u00a0 \u2014\u00a0 WASHINGTON (AP) \u2014 U.S. health regulators on Wednesday authorized the first pill against COVID-19, a Pfizer drug that Americans will be able to take at home to h\u2026", "url": "https://www.memeorandum.com/211222/p118", "urlToImage": "https://storage.googleapis.com/afs-prod/media/9d9e826c49e24b1c933a1f5b43b266a1/1905.jpeg", "publishedAt": "2021-12-23T02:50:06Z", "content": "memeorandum is an auto-generated summary of the stories that US political commentators are discussing online right now.\r\nUnlike sister sites Techmeme and Mediagazer, it is not a human-edited news out\u2026 [+72 chars]"}, {"source": {"id": null, "name": "Lewrockwell.com"}, "author": "Thomas DiLorenzo", "title": "Congressman James Clyburn (D-Pfizer) was \u201cVaccinated\u201d and \u201cBoosted\u201d", "description": "And he still got COVID, he announced today.\u00a0 He explained the obvious lesson he learned from this by saying:\u00a0 \u201cI urge anyone who has not done so to protect themselves by getting vaccinated and boosted.\u201d Maryland Governor Larry Hogan (R-Pfizer) did the exact s\u2026", "url": "https://www.lewrockwell.com/lrc-blog/congressman-james-clyburn-d-pfizer-was-vaccinated-and-boosted/", "urlToImage": "https://s3.amazonaws.com/lrc-cdn/assets/2021/02/LRC-share.jpg", "publishedAt": "2021-12-23T20:19:31Z", "content": "https://www.lewrockwell.com/lrc-blog/congressman-james-clyburn-d-pfizer-was-vaccinated-and-boosted/And he still got COVID, he announced today.\u00a0 He explained the obvious lesson he learned from this by\u2026 [+466 chars]"}, {"source": {"id": null, "name": "Womensystems.com"}, "author": "mayaleo", "title": "JUST IN: FDA Authorizes Pfizer Antiviral Pill For COVID-19 Home Treatment \u2026Sort Of Like Ivermectin", "description": "Women Entertainment Sysytem", "url": "http://www.womensystems.com/2021/12/just-in-fda-authorizes-pfizer-antiviral.html", "urlToImage": "https://lh6.googleusercontent.com/proxy/LG4fkrFZHnY4kuf18Y2D-KOCoDVV4VkYAHMfZAkgU13ghoQuUO8bvjOE9R6q2TAkH1QwXkjbbK-WQQfO7hsGOOj3pFEe-4gdPxAOba5M3EyeXHqCMjJspKWYCPneqgHH1H5KbcAXL8ur_7zyWHHuXg=w1200-h630-p-k-no-nu", "publishedAt": "2021-12-23T16:57:47Z", "content": "The U.S. Food and Drug Administration issued an\u00a0emergency use authorization for Pfizer\u2019s antiviral pill for the treatment of mild-to-moderate COVID-19 infection\u00a0on Wednesday.\r\n\u201cToday\u2019s authorization \u2026 [+3646 chars]"}]}, "2021-12-22": {"status": "ok", "totalResults": 103, "articles": [{"source": {"id": "reuters", "name": "Reuters"}, "author": "Reuters Editorial", "title": "Pfizer COVID pill gets US authorization - Reuters", "description": "Pfizer Inc said on Wednesday the U.S. Food and Drug Administration authorized its antiviral COVID-19 pill, making it the first at-home treatment for the coronavirus that is expected to become an important tool in the fight against the fast-spreading Omicron v\u2026", "url": "https://www.reuters.com/video/watch/idPBIk?now=true", "urlToImage": "https://ajo.prod.reuters.tv/api/v2/img/61c3a4dde4b09631b0e4480b-1640211677447?location=LANDSCAPE", "publishedAt": "2021-12-22T23:22:03Z", "content": "Posted \r\nPfizer Inc said on Wednesday the U.S. Food and Drug Administration authorized its antiviral COVID-19 pill, making it the first at-home treatment for the coronavirus that is expected to becom\u2026 [+75 chars]"}, {"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "Britain approves Pfizer-BioNTech shot for younger children - Reuters", "description": "Britain's medicines regulator on Wednesday approved use of the COVID-19 vaccine from partners Pfizer <a href=\"https://www.reuters.com/companies/PFE.N\" target=\"_blank\">(PFE.N)</a> and BioNTech <a href=\"https://www.reuters.com/companies/22UAy.DE\" target=\"_blank\u2026", "url": "https://www.reuters.com/world/uk/britain-approves-pfizer-biontech-shot-younger-children-2021-12-22/", "urlToImage": "https://www.reuters.com/resizer/_2y_4Zwvoz8kCxzNgLT7L-KHh7E=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/MHRGN3LT7VKTZF7XJCIYS2RBSI.jpg", "publishedAt": "2021-12-22T14:33:00Z", "content": "Nurse Christina McCavana prepares the vials of the Pfizer coronavirus disease (COVID-19) vaccine for use at a pop-up vaccination clinic in the Central Fire Station in Belfast, Northern Ireland, Decem\u2026 [+814 chars]"}, {"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "Pfizer oral COVID-19 pill gets U.S. authorization for at-home use - Reuters", "description": "Pfizer Inc <a href=\"https://www.reuters.com/companies/PFE.N\" target=\"_blank\">(PFE.N)</a> said on Wednesday the U.S. Food and Drug Administration authorized its antiviral COVID-19 pill, making it the first at-home treatment for the coronavirus that is expected\u2026", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-oral-covid-19-pill-gets-us-authorization-at-home-use-2021-12-22/", "urlToImage": "https://www.reuters.com/resizer/6ajCUtrS6UDOyJ4bG5tJuu6YRLg=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/QDROFKF225L55I36I7TMPUEFZA.jpg", "publishedAt": "2021-12-22T17:26:00Z", "content": "Dec 22 (Reuters) - Pfizer Inc (PFE.N) said on Wednesday the U.S. Food and Drug Administration authorized its antiviral COVID-19 pill, making it the first at-home treatment for the coronavirus that is\u2026 [+2523 chars]"}, {"source": {"id": null, "name": "Castanet.net"}, "author": null, "title": "Pfizer pill becomes 1st US-authorized home COVID treatment - World News - Castanet.net", "description": "<ol><li>Pfizer pill becomes 1st US-authorized home COVID treatment - World News\u00a0\u00a0Castanet.net\r\n</li><li>Pfizer\u2019s oral COVID-19 pill approved by U.S. FDA for at-home use\u00a0\u00a0Global News\r\n</li><li>Antiviral pill for COVID-19 unlikely to be approved by Health Canad\u2026", "url": "https://www.castanet.net/news/World/355260/Pfizer-pill-becomes-1st-US-authorized-home-COVID-treatment", "urlToImage": "https://www.castanet.net/content/2021/12/20211222121228-61c36107874d33425336addfjpeg_p3568384.jpg", "publishedAt": "2021-12-22T17:36:00Z", "content": "U.S. health regulators on Wednesday authorized the first pill against COVID-19, a Pfizer drug that Americans will be able to take at home to head off the worst effects of the virus.\r\nThe long-awaited\u2026 [+4521 chars]"}, {"source": {"id": null, "name": "CP24 Toronto's Breaking News"}, "author": "Matthew Perrone", "title": "Pfizer pill becomes 1st US-authorized home COVID treatment - CP24 Toronto's Breaking News", "description": "<ol><li>Pfizer pill becomes 1st US-authorized home COVID treatment\u00a0\u00a0CP24 Toronto's Breaking News\r\n</li><li>Pfizer\u2019s oral COVID-19 pill approved by U.S. FDA for at-home use\u00a0\u00a0Globalnews.ca\r\n</li><li>'Game changer': FDA authorizes first pill to treat Covid-19\u00a0\u00a0C\u2026", "url": "https://www.cp24.com/world/pfizer-pill-becomes-1st-us-authorized-home-covid-treatment-1.5717077", "urlToImage": "https://www.cp24.com/polopoly_fs/1.5717083.1640204942!/httpImage/image.jpg_gen/derivatives/landscape_620/image.jpg", "publishedAt": "2021-12-22T20:31:10Z", "content": "WASHINGTON (AP) - U.S. health regulators on Wednesday authorized the first pill against COVID-19, a Pfizer drug that Americans will be able to take at home to head off the worst effects of the virus.\u2026 [+4788 chars]"}, {"source": {"id": "time", "name": "Time"}, "author": "MATTHEW PERRONE / AP", "title": "The FDA Just Authorized the First COVID-19 Pill, a Pfizer Drug That Can Be Taken At Home", "description": "U.S. health regulators on Wednesday authorized the first pill against COVID-19, a Pfizer drug that Americans will be able to take at home to head off the worst effects of the virus. The long-awaited milestone comes as U.S. cases, hospitalizations and deaths a\u2026", "url": "https://time.com/6131058/pfizer-covid-19-pill-authorized/", "urlToImage": "https://api.time.com/wp-content/uploads/2021/12/pfizer-pill-covid-19.jpg?quality=85&w=1024&h=628&crop=1", "publishedAt": "2021-12-22T17:34:17Z", "content": "U.S. health regulators on Wednesday authorized the first pill against COVID-19, a Pfizer drug that Americans will be able to take at home to head off the worst effects of the virus.\r\nThe long-awaited\u2026 [+4888 chars]"}, {"source": {"id": null, "name": "Nature.com"}, "author": "Sandile Cele, Laurelle Jackson, David S. Khoury, Khadija Khan, Thandeka Moyo-Gwete, Houriiyah Tegally, James Emmanuel San, Deborah Cromer, Cathrine Scheepers, Daniel Amoako, Farina Karim, Mallory Bernstein, Gila Lustig, Derseree Archary, Muneerah Smith, Yashica Ganga, Zesuliwe Jule, Kajal Reedoy, Shi-Hsia Hwa, Jennifer Giandhari, Jonathan M. Blackburn, Bernadett I. Gosnell, Salim S. Abdool Karim, Willem Hanekom, Network for Genomic Surveillance in South Africa, COMMIT-KZN Team, Anne von Gottberg, Jinal Bhiman, Richard J. Lessells, Mahomed-Yunus S. Moosa, Miles P. Davenport, Tulio de Oliveira, Penny L. Moore, Alex Sigal", "title": "Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization", "description": "Discover the world\u2019s best science and medicine  | Nature.com", "url": "https://www.nature.com/articles/d41586-021-03824-5", "urlToImage": "https://media.nature.com/lw1024/magazine-assets/d41586-021-03824-5/d41586-021-03824-5_19974342.jpg", "publishedAt": "2021-12-23T00:00:00Z", "content": "National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa. MRC Antibody Immunity Research Unit, School of Pathology, Faculty of Health Science\u2026 [+249 chars]"}, {"source": {"id": "associated-press", "name": "Associated Press"}, "author": "Matthew Perrone", "title": "PFIZER pill becomes 1st authorized home treatment...", "description": "PFIZER pill becomes 1st authorized home treatment...\r\n\n \n \n \n (Top headline, 11th story, link)\r\n\n \r\n\n \r\n\n \n Related stories:'21 on track to surpass '20 as nation's deadliest...\r\nHalf Call It Worst Year Of Lives!\r\nWill USA Be Open in January?\r\nHoliday travel p\u2026", "url": "https://apnews.com/article/coronavirus-pandemic-pfizer-medication-f5f65e7e61d6aa9c7dfa193053e8878a", "urlToImage": "https://storage.googleapis.com/afs-prod/media/9d9e826c49e24b1c933a1f5b43b266a1/1905.jpeg", "publishedAt": "2021-12-22T18:19:36Z", "content": "WASHINGTON (AP) U.S. health regulators on Wednesday authorized the first pill against COVID-19, a Pfizer drug that Americans will be able to take at home to head off the worst effects of the virus.\r\n\u2026 [+4783 chars]"}, {"source": {"id": "bloomberg", "name": "Bloomberg"}, "author": "Tara Patel", "title": "France Scraps Order for Merck Antiviral Pill, Looks to Pfizer", "description": "France canceled an order for Merck & Co.\u2019s antiviral pill on disappointing test results and is now counting on a treatment from Pfizer Inc., according to the country\u2019s health minister.", "url": "https://www.bloomberg.com/news/articles/2021-12-22/france-scraps-order-for-merck-antiviral-pill-looks-to-pfizer", "urlToImage": "https://assets.bwbx.io/images/users/iqjWHBFdfxIU/iA24OVvu_J.s/v1/1200x800.jpg", "publishedAt": "2021-12-22T15:22:13Z", "content": "France canceled an order for \r\nMerck &amp; Co.s antiviral pill on disappointing test results and is now counting on a treatment from \r\nPfizer Inc., according to the countrys health minister.\r\nWe had \u2026 [+1005 chars]"}, {"source": {"id": null, "name": "WebMD"}, "author": "https://www.facebook.com/WebMD", "title": "FDA Authorizes Pfizer Antiviral Pill for COVID-19", "description": "The FDA was also expected to authorize an antiviral pill from Merck, but as of Wednesday afternoon, only Pfizer's had been authorized for use.", "url": "https://www.webmd.com/lung/news/20211222/fda-authorizes-pfizer-pill", "urlToImage": "https://img.webmd.com/dtmcms/live/webmd/consumer_assets/site_images/article_thumbnails/other/virus_3d_render_skeleton_01_other/1800x1200_virus_3d_render_skeleton_01_other.jpg", "publishedAt": "2021-12-22T17:45:55Z", "content": "Dec. 22, 2021 The FDA on Wednesday granted emergency use authorization of a new antiviral pills to treat people with symptomatic COVID-19.\r\nPfizers ritonavir, name brand Paxlovid, can now be taken by\u2026 [+1298 chars]"}, {"source": {"id": "al-jazeera-english", "name": "Al Jazeera English"}, "author": "Al Jazeera", "title": "Pfizer COVID-19 pill approved for at-home use by US", "description": "Trial data shows oral pill is 90 percent effective in preventing deaths and hospitalisations in high-risk patients.", "url": "https://www.aljazeera.com/news/2021/12/22/pfizer-covid-19-pill-approved-by-us-for-at-home-use", "urlToImage": "https://www.aljazeera.com/wp-content/uploads/2021/12/AP21355638154179.jpg?resize=1200%2C630", "publishedAt": "2021-12-22T18:49:31Z", "content": "Health regulators in the United States have authorised the first oral pill against COVID-19, a Pfizer drug that users will be able to take at home to head off the worst effects of the coronavirus.\r\nT\u2026 [+3604 chars]"}, {"source": {"id": "axios", "name": "Axios"}, "author": "Axios", "title": "FDA authorizes Pfizer COVID antiviral pill for high-risk individuals", "description": "The Food and Drug Administration on Wednesday authorized Pfizer's antiviral pill for the treatment of individuals at high risk of severe illness from COVID-19. Why it matters: At-home COVID-19 treatments, especially Pfizer's Paxlovid, are seen as possible gam\u2026", "url": "https://www.axios.com/fda-pfizer-covid-antiviral-pill-paxlovid-authorization-274ee4ed-3b4e-49c1-afbf-b5861dc2ef2c.html", "urlToImage": "https://images.axios.com/XoNFb_9PUdRdOchX3xTuZavKRrM=/0x209:2000x1334/1366x768/2021/12/21/1640118156101.jpg", "publishedAt": "2021-12-22T17:15:46Z", "content": "The Food and Drug Administration on Wednesday authorized Pfizer's antiviral pill for the treatment of individuals at high risk of severe illness from COVID-19. \r\nWhy it matters: At-home COVID-19 trea\u2026 [+2222 chars]"}, {"source": {"id": null, "name": "Snopes.com"}, "author": "AP News", "title": "Pfizer Pill Becomes 1st US-Authorized Home COVID Treatment", "description": "U.S. health regulators on Wednesday authorized the first pill against COVID-19, a Pfizer drug that Americans will be able to take at home to head off the worst effects of the virus.", "url": "https://www.snopes.com/ap/2021/12/22/pfizer-pill-becomes-1st-us-authorized-home-covid-treatment/", "urlToImage": "https://www.snopes.com/tachyon/2021/12/Virus-Outbreak-Treatments_54179-c80e719f2-733x412.jpg", "publishedAt": "2021-12-22T18:43:37Z", "content": "This article is republished here with permission from The Associated Press. This content is shared here because the topic may interest Snopes readers; it does not, however, represent the work of Snop\u2026 [+4746 chars]"}, {"source": {"id": null, "name": "TheBlaze"}, "author": "Daniel Horowitz", "title": "Horowitz: The indefensible approval of Pfizer and Merck drugs compared to the snubbing of ivermectin", "description": "Later this week, the FDA plans to approve, as the first outpatient COVID drugs, therapeutics that are extremely dangerous and unproven, even as the agency goes to war against cheap, safe, and proven drugs with a track record of no serious adverse events. The \u2026", "url": "https://www.theblaze.com/op-ed/horowitz-the-indefensible-approval-of-pfizer-and-merck-drugs-compared-to-the-snubbing-of-ivermectin", "urlToImage": "https://assets.rebelmouse.io/eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJpbWFnZSI6Imh0dHBzOi8vYXNzZXRzLnJibC5tcy8yODI3NzgzOS9vcmlnaW4uanBnIiwiZXhwaXJlc19hdCI6MTY1NzE2NDY1MH0.OjXgRTnNSnmYWBx9BlWU6ggdWEMqPFg5CNeU7WQQEKs/img.jpg?width=1200&coordinates=0%2C113%2C0%2C58&height=600", "publishedAt": "2021-12-22T15:15:02Z", "content": "Later this week, the FDA plans to approve, as the first outpatient COVID drugs, therapeutics that are extremely dangerous and unproven, even as the agency goes to war against cheap, safe, and proven \u2026 [+7479 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "Reuters", "title": "Britain approves Pfizer-BioNTech shot for younger children", "description": "Britain's medicines regulator on Wednesday approved use of the COVID-19 vaccine from partners Pfizer and BioNTech for children aged 5 to 11 years, after the ...", "url": "https://news.yahoo.com/britain-approves-pfizer-biontech-shot-143253326.html", "urlToImage": "https://s.yimg.com/uu/api/res/1.2/9s9fxhxELGCBUul27XsZTg--~B/aD01MzM7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/3f4ff2178d642587415ecea5a5aeda03", "publishedAt": "2021-12-22T14:32:53Z", "content": "LONDON (Reuters) - Britain's medicines regulator on Wednesday approved use of the COVID-19 vaccine from partners Pfizer and BioNTech for children aged 5 to 11 years, after the watchdog found the shot\u2026 [+444 chars]"}, {"source": {"id": "independent", "name": "Independent"}, "author": "The Independent", "title": "FDA authorises use of Pfizer-made pill to treat Covid-19", "description": "The US Food and Drug Administration has issued an emergency use authorisation for a pill made by Pfizer that can be used to treat Covid-19.", "url": "https://www.independent.co.uk/news/world/americas/pfizer-covid-pill-fda-authorised-b1980963.html", "urlToImage": "https://static.independent.co.uk/2020/08/19/11/breaking-news.png?width=1200&auto=webp&quality=75", "publishedAt": "2021-12-22T17:32:05Z", "content": "The US Food and Drug Administration has issued an emergency use authorisation for a pill made by Pfizer that can be used to treat Covid-19. \r\nThe agency issued the statement on Wednesday, announcing \u2026 [+915 chars]"}, {"source": {"id": "independent", "name": "Independent"}, "author": "Nina Massey", "title": "Pfizer Covid jab approved for use in vulnerable primary school children", "description": "In response to the Omicron variant, the JCVI has also advised that some older children be offered a booster dose.", "url": "https://www.independent.co.uk/news/uk/omicron-pfizer-kevin-courtney-biontech-medicines-and-healthcare-products-regulatory-agency-b1980917.html", "urlToImage": "https://static.independent.co.uk/2021/12/22/16/34f9b5c868f929be97a7f968679ee451Y29udGVudHNlYXJjaGFwaSwxNjQwMjc1MDM2-2.61672331.jpg?width=1200&auto=webp&quality=75", "publishedAt": "2021-12-22T18:21:51Z", "content": "The PfizerBioNTech coronavirus vaccine has been approved for use in vulnerable primary school children.\r\nThe Joint Committee on Vaccination and Immunisation (JCVI) updated its advice after the UKs Me\u2026 [+5748 chars]"}, {"source": {"id": "independent", "name": "Independent"}, "author": "Nina Massey", "title": "Pfizer Covid jab approved for use in some five to 11-year-olds", "description": "Further advice regarding Covid vaccination for the age group will be issued in due course.", "url": "https://www.independent.co.uk/news/uk/pfizer-mhra-biontech-omicron-b1980808.html", "urlToImage": "https://static.independent.co.uk/2021/12/22/14/72a2469e44e15125456e3ad9e06b156eY29udGVudHNlYXJjaGFwaSwxNjQwMjY5MTAz-2.64454561.jpg?width=1200&auto=webp&quality=75", "publishedAt": "2021-12-22T14:30:00Z", "content": "A new formulation of the PfizerBioNTech coronavirus vaccine has been approved for use in children aged five to 11.\r\nThe UKs Medicines and Healthcare products Regulatory Agency (MHRA) made the approva\u2026 [+2962 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "Reuters", "title": "Pfizer oral COVID-19 pill gets U.S. authorization for at-home use", "description": "Data from Pfizer's clinical trial showed its antiviral regimen was 90% effective in preventing hospitalizations and deaths in patients at high risk of severe...", "url": "https://news.yahoo.com/pfizer-oral-covid-19-pill-172151590.html", "urlToImage": "https://s.yimg.com/uu/api/res/1.2/F76_37omlGhsJSZy1rPw9Q--~B/aD01MzQ7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/767b46e09b00181bff6903de7e1becac", "publishedAt": "2021-12-22T17:21:51Z", "content": "(Reuters) -Pfizer Inc said on Wednesday the U.S. Food and Drug Administration authorized its antiviral COVID-19 pill, making it the first at-home treatment for the coronavirus that is expected to bec\u2026 [+2326 chars]"}, {"source": {"id": null, "name": "The Boston Globe"}, "author": "MATTHEW PERRONE", "title": "Pfizer pill becomes first FDA-authorized home COVID treatment", "description": "The drug, Paxlovid, is a faster, cheaper way to treat early COVID-19 infections, though initial supplies will be extremely limited.", "url": "https://www.bostonglobe.com/2021/12/22/nation/pfizer-pill-becomes-first-us-authorized-home-covid-treatment/", "urlToImage": "https://bostonglobe-prod.cdn.arcpublishing.com/resizer/AAOhmk7Z5Oz4wgvDxOyXzGChxsI=/506x0/cloudfront-us-east-1.images.arcpublishing.com/bostonglobe/O7RKABUQGVHLBUFUDP3P5PGPRY.jpg", "publishedAt": "2021-12-22T17:36:57Z", "content": "An antiviral pill from Merck also is expected to soon win authorization. But Pfizers drug is all but certain to be the preferred option because of its mild side effects and superior effectiveness, in\u2026 [+3913 chars]"}]}, "2021-12-21": {"status": "ok", "totalResults": 30, "articles": [{"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "U.S. FDA set to authorize Pfizer, Merck COVID-19 pills this week - Bloomberg News - Reuters", "description": "The U.S. Food and Drug Administration is set to authorize COVID-19 treatment pills from both Pfizer Inc <a href=\"https://www.reuters.com/companies/PFE.N\" target=\"_blank\">(PFE.N)</a> and Merck <a href=\"https://www.reuters.com/companies/MRK.N\" target=\"_blank\">(\u2026", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-set-authorize-pfizer-merck-covid-19-pills-this-week-bloomberg-news-2021-12-21/", "urlToImage": "https://www.reuters.com/resizer/6ajCUtrS6UDOyJ4bG5tJuu6YRLg=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/QDROFKF225L55I36I7TMPUEFZA.jpg", "publishedAt": "2021-12-21T15:57:00Z", "content": "Dec 21 (Reuters) - The U.S. Food and Drug Administration is set to authorize COVID-19 treatment pills from both Pfizer Inc (PFE.N) and Merck (MRK.N) as early as Wednesday, Bloomberg News reported on \u2026 [+758 chars]"}, {"source": {"id": null, "name": "Motley Fool"}, "author": "newsfeedback@fool.com (Keith Speights)", "title": "Why Pfizer Stock Is Sinking Today", "description": "The pharma stock is moving in the opposite direction of the overall market.", "url": "https://www.fool.com/investing/2021/12/21/why-pfizer-stock-is-sinking-today/", "urlToImage": "https://g.foolcdn.com/editorial/images/658400/omicron-variant.jpg", "publishedAt": "2021-12-21T16:44:09Z", "content": "What happened\r\nShares of Pfizer(NYSE:PFE) were sinking 4.4% as of 11:18 a.m. ET on Tuesday. The big drugmaker didn't report any new developments. Today's decline appears to be a by-product of the ove\u2026 [+1486 chars]"}, {"source": {"id": "independent", "name": "Independent"}, "author": "Eleanor Sly", "title": "How effective are the Pfizer, AstraZeneca and Moderna vaccines against Omicron?", "description": "Booster jabs provide up to 70 per cent protection, study finds", "url": "https://www.independent.co.uk/news/health/omicron-vaccine-pfizer-astrazeneca-moderna-booster-b1980055.html", "urlToImage": "https://static.independent.co.uk/2021/12/09/16/GettyImages-89747046%20%281%29.jpg?width=1200&auto=webp&quality=75", "publishedAt": "2021-12-21T12:15:06Z", "content": "The Omicron variant of Covid-19 has begun to spread widely in the UK, with Boris Johnson warning of a tidal wave of infections hitting these shores if the public do not observe social restrictions an\u2026 [+7631 chars]"}, {"source": {"id": null, "name": "PJ Media"}, "author": "Glenn Reynolds", "title": "THE VACCINES SEEM TO BE UNDERPERFORMING: Study: Moderna, Pfizer COVID-19 vaccines less effective in\u2026", "description": "THE VACCINES SEEM TO BE UNDERPERFORMING: Study: Moderna, Pfizer COVID-19 vaccines less effective in seniors with chronic health woes.", "url": "https://pjmedia.com/instapundit/492539/", "urlToImage": null, "publishedAt": "2021-12-21T18:00:23Z", "content": "As an Amazon Associate,I earn from qualifying purchases."}, {"source": {"id": null, "name": "The Week Magazine"}, "author": "Brigid Kennedy", "title": "FDA reportedly could authorize Pfizer, Merck COVID pills this week: 'The biggest thing to happen in the pandemic after vaccines'", "description": "FDA reportedly could authorize Pfizer, Merck COVID pills this week: 'The biggest thing to happen in the pandemic after vaccines'", "url": "https://theweek.com/coronavirus/1008306/fda-reportedly-could-authorize-pfizer-merck-covid-pills-this-week-the-biggest", "urlToImage": "https://mediacloud.theweek.com/image/upload/s--X-WVjvBW--/f_auto,t_content-image-full-desktop@1/v1640103687/GettyImages-1237290895.jpg", "publishedAt": "2021-12-21T17:02:19Z", "content": "The U.S. Food and Drug Admnistration could authorize revolutionary COVID-19 antiviral pills from both Pfizer and Merck as soon as this week, Bloomberg reports, \"a milestone in the fight against the p\u2026 [+1414 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "PR Newswire", "title": "Clayton, Dubilier & Rice Appoints Jon Selib, former Pfizer Policy & Public Affairs Leader, as Global External Affairs Leader", "description": "Clayton, Dubilier & Rice today announced the appointment of Jon Selib, former Senior Vice President of Global Policy & Public Affairs at Pfizer, as Managing ...", "url": "https://finance.yahoo.com/news/clayton-dubilier-rice-appoints-jon-140000834.html", "urlToImage": "https://s.yimg.com/uu/api/res/1.2/NhMzJqBYdftRA6XEHbUhAQ--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/74a228b886f044b7628f5fafb2f27077", "publishedAt": "2021-12-21T14:00:00Z", "content": "NEW YORK, Dec. 21, 2021 /PRNewswire/ -- Clayton, Dubilier &amp; Rice today announced the appointment of Jon Selib, former Senior Vice President of Global Policy &amp; Public Affairs at Pfizer, as Man\u2026 [+3276 chars]"}, {"source": {"id": null, "name": "FierceBiotech"}, "author": "Annalee Armstrong", "title": "Pfizer reports patient death in early-stage Duchenne gene therapy trial, halts enrollment", "description": "Pfizer reported the death of a young male patient who was participating in an an early-stage trial for the Big Pharma\u2019s Duchenne muscular dystrophy gene therapy. The company paused screening and dosing in the study while it works with the trial site investiga\u2026", "url": "https://www.fiercebiotech.com/biotech/pfizer-reports-death-patient-duchenne-trial-halts-enrolment", "urlToImage": "https://qtxasset.com/fiercebiotech/1640093978/PfizerHQsignone.jpg/PfizerHQsignone.jpg?VersionId=rP49e7awFiMyi_azFHqLhDaepKm8Iakr", "publishedAt": "2021-12-21T13:39:57Z", "content": "Pfizer reported the death of a young male patient who was participating in an an early-stage trial for the Big Pharmas Duchenne muscular dystrophy (DMD) gene therapy.\r\nThe company paused screening an\u2026 [+3240 chars]"}, {"source": {"id": null, "name": "The Boston Globe"}, "author": "Josh Wingrove, Jennifer Jacobs, Robert Langreth", "title": "FDA expected to authorize Pfizer and Merck COVID pills this week", "description": "The US Food and Drug Administration is poised to authorize a pair of pills from Pfizer and Merck to treat COVID-19 as soon as this week, according to people familiar with the matter -- a milestone in the fight against the pandemic that will soon expand therap\u2026", "url": "https://www.bostonglobe.com/2021/12/21/nation/fda-expected-authorize-pfizer-merck-covid-pills-this-week/", "urlToImage": "https://bostonglobe-prod.cdn.arcpublishing.com/resizer/AAOhmk7Z5Oz4wgvDxOyXzGChxsI=/506x0/cloudfront-us-east-1.images.arcpublishing.com/bostonglobe/O7RKABUQGVHLBUFUDP3P5PGPRY.jpg", "publishedAt": "2021-12-21T15:59:28Z", "content": "The U.S. Food and Drug Administration is poised to authorize a pair of pills from Pfizer Inc. and Merck &amp; Co. to treat Covid-19 as soon as this week, according to people familiar with the matter \u2026 [+1347 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "Research and Markets", "title": "Global $3.11 Bn Erythropoietin (EPO) Markets, 2015-2020, 2020-2025F, 2030F Featuring Amgen, Johnson & Johnson, Roche Group, Pfizer Inc., Novartis, Celltrion, and LG Life Sciences", "description": "Dublin, Dec. 21, 2021 (GLOBE NEWSWIRE) -- The \"Erythropoietin (EPO) Global Market Report 2021: COVID-19 Growth and Change to 2030\" report has been added to...", "url": "https://finance.yahoo.com/news/global-3-11-bn-erythropoietin-105300361.html", "urlToImage": "https://s.yimg.com/uu/api/res/1.2/HP.E8HUfnyGeLtMAKwLgAQ--~B/aD01ODt3PTQ4MDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/93d5b27580f67db722dd7c112e43e8bc", "publishedAt": "2021-12-21T10:53:00Z", "content": "Dublin, Dec. 21, 2021 (GLOBE NEWSWIRE) -- The \"Erythropoietin (EPO) Global Market Report 2021: COVID-19 Growth and Change to 2030\" report has been added to ResearchAndMarkets.com's offering.\r\nThe glo\u2026 [+4478 chars]"}, {"source": {"id": null, "name": "Investor's Business Daily"}, "author": "Investor's Business Daily", "title": "Pfizer Stock Falls As FDA Reportedly Nears Covid Pill Decision - Investor's Business Daily", "description": "<ol><li>Pfizer Stock Falls As FDA Reportedly Nears Covid Pill Decision\u00a0\u00a0Investor's Business Daily\r\n</li><li>US FDA to Authorize Covid Pills\u00a0\u00a0Bloomberg Markets and Finance\r\n</li><li>FDA reportedly could authorize Pfizer, Merck COVID pills this week: 'The bigge\u2026", "url": "https://www.investors.com/news/technology/pfizer-stock-falls-as-fda-reportedly-nears-covid-pill-decision/", "urlToImage": "https://www.investors.com/wp-content/uploads/2017/10/stock-Pfizer-01-shutter.jpg", "publishedAt": "2021-12-21T21:10:00Z", "content": "The Food and Drug Administration could authorize Covid pills from Pfizer (PFE) and Merck (MRK) this week, according to a Tuesday report. But Pfizer stock toppled while Merck shares also fell.\r\nXA dec\u2026 [+2624 chars]"}, {"source": {"id": null, "name": "Memeorandum.com"}, "author": null, "title": "FDA Expected to Authorize Pfizer and Merck Covid Pills This Week (Bloomberg)", "description": "Bloomberg:\nFDA Expected to Authorize Pfizer and Merck Covid Pills This Week\u00a0 \u2014 Two drugs would be first at-home treatments for Covid-19\u00a0 \u2014 U.S. has ordered 13 million courses of medicines so far\u00a0 \u2014\u00a0 The U.S. Food and Drug Administration is poised to authorize\u2026", "url": "https://www.memeorandum.com/211221/p43", "urlToImage": "https://assets.bwbx.io/images/users/iqjWHBFdfxIU/ilKMtjRgyIVY/v0/1200x800.jpg", "publishedAt": "2021-12-21T16:25:00Z", "content": "memeorandum is an auto-generated summary of the stories that US political commentators are discussing online right now.\r\nUnlike sister sites Techmeme and Mediagazer, it is not a human-edited news out\u2026 [+72 chars]"}, {"source": {"id": null, "name": "101morefm.ca"}, "author": "Linda Morgan", "title": "Canada Gets Over A Million Pediatric Pfizer COVID -19 Shots - 101.1 More FM", "description": "<ol><li>Canada Gets Over A Million Pediatric Pfizer COVID -19 Shots\u00a0\u00a0101.1 More FM\r\n</li><li>Vaccination rates rising in Prince George\u00a0\u00a0CKPGToday.ca\r\n</li><li>SA Health site crashes as slots open for kids\u2019 jabs\u00a0\u00a0The Advertiser\r\n</li><li>Pfizer COVID vaccine b\u2026", "url": "http://www.101morefm.ca/news/local-news/canada-gets-over-a-million-pediatric-pfizer-covid-19-shots/", "urlToImage": "https://mm.aiircdn.com/122/588027.jpg", "publishedAt": "2021-12-21T18:27:11Z", "content": "A shipment of 1.136 million doses of the pediatric Pfizer shot has arrived in Canada. \r\nOver a million more child-sized Pfizer COVID-19 doses have arrived in Canada.\u00a0\r\nProcurement Minister Filomena T\u2026 [+1061 chars]"}, {"source": {"id": null, "name": "Stationgossip.com"}, "author": "orraz", "title": "Government Panel: 26-Year-Old's Death 'Probably' Due to Pfizer COVID Vaccine", "description": "Your Daily Station of Entertainment !!", "url": "http://www.stationgossip.com/2021/12/government-panel-26-year-olds-death.html", "urlToImage": null, "publishedAt": "2021-12-21T14:21:42Z", "content": "A 26-year-old New Zealand man\u2019s death from myocarditis has been linked to the Pfizer/BioNTech vaccine by New Zealand officials.\r\n\u201cWith the current available information, the board has considered that\u2026 [+3107 chars]"}, {"source": {"id": null, "name": "Seeking Alpha"}, "author": "Dulan Lokuwithana", "title": "Pfizer, Merck could receive FDA OK for COVID-19 pills this week - Bloomberg", "description": "The FDA is set to authorize the COVID-19 pills developed by Merck (MRK)/ Ridgeback Biotherapeutics and Pfizer (PFE) as early as this week,\u00a0Bloomberg\u00a0reports, citing people familiar with...", "url": "https://seekingalpha.com/news/3782385-pfizer-merck-could-receive-fda-ok-for-covid-19-pills-this-week-bloomberg", "urlToImage": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1286971249/large_image_1286971249.jpg", "publishedAt": "2021-12-21T15:55:18Z", "content": "Grandbrothers/iStock Editorial via Getty Images"}, {"source": {"id": null, "name": "Rumble.com"}, "author": "Mike Rivero", "title": "BREAKING: FOIA Confirms Jab is Deadly: Pfizer, FDA Caught Hiding Bioweapon Deaths", "description": "!function(r,u,m,b,l,e){r._Rumble=b,r[b]||(r[b]=function(){(r[b]._=r[b]._||[]).push(arguments);if(r[b]._.length==1){l=u.createElement(m),e=u.getElementsByTagName(m)[0],l.async=1,l.src=\"https://rumble.com/embedJS/u4\"+(arguments[1].video?'.'+arguments[1].video:'\u2026", "url": "https://rumble.com/vr4w8g-breaking-foia-confirms-jab-is-deadly-pfizer-fda-caught-hiding-bioweapon-dea.html", "urlToImage": "https://sp.rmbl.ws/s8/1/W/C/3/T/WC3Tc.qR4e-small-BREAKING-FOIA-Confirms-Jab-.jpg", "publishedAt": "2021-12-21T15:32:34Z", "content": "RumbleThank God for the Freedom of Information Act. Public Health and Medical Professionals for Transparency is a professional organization of scientists and doctors. They recently filed a FOIA reque\u2026 [+796 chars]"}, {"source": {"id": null, "name": "Investmentwatchblog.com"}, "author": "alexmark", "title": "CLOWN WORLD! New Zealand links death (of 26 year old) to Pfizer COVID vaccine: 'it remains safer to be vaccinated'\"", "description": null, "url": "https://www.investmentwatchblog.com/clown-world-new-zealand-links-death-of-26-year-old-to-pfizer-covid-vaccine-it-remains-safer-to-be-vaccinated/", "urlToImage": null, "publishedAt": "2021-12-21T00:44:45Z", "content": "We have reached peak idiocracy.Health authorities in New Zealand have said they believe a 26-year-old man\u2019s death\u00a0is connected to a side effect\u00a0from\u00a0Pfizer\u2019s COVID-19 vaccine.\r\nA preliminary postmort\u2026 [+685 chars]"}, {"source": {"id": null, "name": "Thegatewaypundit.com"}, "author": "Jim Hoft", "title": "New Zealand Health Authorities Link Death of 26-Year-Old Man Who Suffered Myocarditis to Pfizer COVID-19 Vaccine", "description": "New Zealand health authorities said on Monday that they had linked the death of a 26-year-old man who developed myocarditis after receiving his first dose of the Pfizer COVID-19 vaccine. The man, who was not identified, was believed to die with myocarditis tw\u2026", "url": "https://www.thegatewaypundit.com/2021/12/new-zealand-health-authorities-link-death-26-year-old-man-suffered-myocarditis-pfizer-covid-19-vaccine/", "urlToImage": "https://www.thegatewaypundit.com/wp-content/uploads/6A0830C8-FB69-4650-B7A8-690B091821E8.jpeg", "publishedAt": "2021-12-21T03:53:08Z", "content": "New Zealand health authorities said on Monday that they had linked the death of a 26-year-old man to\u00a0Pfizer COVID-19 vaccine.\r\nThe man, who was not identified, was believed to die with myocarditis tw\u2026 [+1414 chars]"}, {"source": {"id": null, "name": "Womensystems.com"}, "author": "mayaleo", "title": "New Zealand Health Authorities Link Death Of 26-Year-Old Man Who Suffered Myocarditis To Pfizer COVID-19 Vaccine", "description": "Women Entertainment Sysytem", "url": "http://www.womensystems.com/2021/12/new-zealand-health-authorities-link.html", "urlToImage": "https://lh4.googleusercontent.com/proxy/V1A1ewtxGuwyUXb5pjKskDjFTym1IfbyGk19RxJSgCzyr5lMqoZ-uoZroyS0m6e4cu7KtFi_sDVmTNV3np_pLupy3gRif5Yi2C_GcOdiZRB7Sk6W23xiUypZTU9G7IxY30fhBAdkSYWCIuV9yUg9iFA=w1200-h630-p-k-no-nu", "publishedAt": "2021-12-21T17:07:10Z", "content": "New Zealand health authorities said on Monday that they had linked the death of a 26-year-old man to\u00a0Pfizer COVID-19 vaccine.\r\nThe man, who was not identified, was believed to die with myocarditis tw\u2026 [+1273 chars]"}, {"source": {"id": null, "name": "Daily Mail"}, "author": "Mansur Shaheen U.S.", "title": "FDA to authorize the use of antiviral Covid pills developed by Pfizer and Merck later this week", "description": "Both molnupiravir and paxlovid are expected to receive authorization from the FDA at some point this week. The antiviral pills are believed to become important tools in the fight against Covid.", "url": "https://www.dailymail.co.uk/health/article-10333161/FDA-authorize-use-antiviral-Covid-pills-developed-Pfizer-Merck-later-week.html", "urlToImage": "https://i.dailymail.co.uk/1s/2021/12/21/19/52075469-0-image-a-13_1640115263094.jpg", "publishedAt": "2021-12-21T19:46:47Z", "content": "Two new weapons in America's fight against COVID-19 could be added to the arsenal later this week.\r\nBloomberg reports that authorization from the Food and Drug Administration (FDA)\u00a0 for two different\u2026 [+4185 chars]"}, {"source": {"id": null, "name": "City A.M."}, "author": "Amy O'Brien", "title": "FDA set to give both Pfizer and Merck Covid pills the green light this week", "description": "The US Food and Drug Administration is poised to authorise two pills developed by Pfizer and Merck for the treatment of Covid as early as Wednesday this week. Continuing a trend for rapid drugs innovation in the fight against Covid this year, the US watchdog \u2026", "url": "https://www.cityam.com/fda-set-to-give-both-pfizer-and-merck-covid-pills-the-green-light-this-week/", "urlToImage": "https://www.cityam.com/wp-content/uploads/2021/10/pills-getty-1024-57ff78e66dccb-57ff78e69deba.jpg", "publishedAt": "2021-12-21T17:34:18Z", "content": "Tuesday 21 December 2021 5:34 pm\r\nThe US Food and Drug Administration is poised to authorise two pills developed by Pfizer and Merck for the treatment of Covid as early as Wednesday this week. \r\nCont\u2026 [+2020 chars]"}]}, "2021-12-20": {"status": "ok", "totalResults": 57, "articles": [{"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "New Zealand links 26-year-old man's death to Pfizer COVID-19 vaccine - Reuters", "description": "New Zealand authorities on Monday said they had linked a 26-year-old man's death to Pfizer Inc's <a href=\"https://www.reuters.com/companies/PFE.N\" target=\"_blank\">(PFE.N)</a> COVID-19 vaccine after the person suffered myocarditis, a rare inflammation of the h\u2026", "url": "https://www.reuters.com/world/asia-pacific/new-zealand-links-26-year-old-mans-death-pfizer-covid-19-vaccine-2021-12-20/", "urlToImage": "https://www.reuters.com/resizer/2--FEEmjzEwvdEaHLu0qIB6fJCY=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/WET7VB5NVZJT5CMFVWZMXAU5VE.jpg", "publishedAt": "2021-12-20T04:15:00Z", "content": "SYDNEY, Dec 20 (Reuters) - New Zealand authorities on Monday said they had linked a 26-year-old man's death to Pfizer Inc's (PFE.N) COVID-19 vaccine after the person suffered myocarditis, a rare infl\u2026 [+1423 chars]"}, {"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "Biontech, Pfizer to provide EU with extra 200 mln COVID doses - Reuters", "description": "BioNTech SE <a href=\"https://www.reuters.com/companies/22UAy.DE\" target=\"_blank\">(22UAy.DE)</a> and Pfizer <a href=\"https://www.reuters.com/companies/PFE.N\" target=\"_blank\">(PFE.N)</a> said on Monday that they would be providing the European Union with more t\u2026", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/biontech-pfizer-provide-eu-with-extra-200-mln-covid-doses-2021-12-20/", "urlToImage": "https://www.reuters.com/resizer/CNXruww6hVSpYJLQtdIWRtHNHKU=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/A6VBWB4WSVJOHB2MT633KD2D2Q.jpg", "publishedAt": "2021-12-20T12:23:00Z", "content": "Rodrigo Rojas Morilla, 11, reacts as he receives his first dose of the \"Comirnaty\" Pfizer BioNTech COVID-19 vaccine against coronavirus disease at the La Serrania de Ronda hospital as Spain continues\u2026 [+942 chars]"}, {"source": {"id": "bloomberg", "name": "Bloomberg"}, "author": "Jeannie Baumann", "title": "Pfizer, Moderna Vaccine Preference Applies to Boosters, CDC Says", "description": "", "url": "https://www.bloomberg.com/news/articles/2021-12-20/pfizer-moderna-vaccine-preference-applies-to-boosters-cdc-says", "urlToImage": "https://assets.bwbx.io/images/users/iqjWHBFdfxIU/ivk3OAiWZp5o/v0/1200x800.jpg", "publishedAt": "2021-12-20T17:48:42Z", "content": "People who got a \r\nJohnson &amp; Johnson Covid-19 vaccine in the U.S. should seek a messenger RNA booster shot, the Centers for Disease Control and Prevention clarified Monday to Bloomberg Law.\r\nThe \u2026 [+2219 chars]"}, {"source": {"id": null, "name": "National Post"}, "author": null, "title": "PFIZER-funded talks contained untrue information about rivals...", "description": "PFIZER-funded talks contained untrue information about rivals...\r\n\n \n \n \n (Top headline, 18th story, link)\r\n\n \r\n\n \r\n\n \n Related stories:JINGLE BELL LOCK!\r\nUK PROTESTS TURN VIOLENT...\r\nNew party allegations at Boris residence come to light...\r\nRIOTS ACROSS EUR\u2026", "url": "https://nationalpost.com/news/canada/pfizer-funded-talks-contained-untrue-negative-information-about-rival-covid-vaccines-experts-say", "urlToImage": "https://img-s-msn-com.akamaized.net/tenant/amp/entityid/AARZUBm.img?h=315&w=600&m=6&q=60&o=t&l=f&f=jpg", "publishedAt": "2021-12-20T21:07:37Z", "content": "\u00a9 Provided by National Post\r\n Experts told the National Post that the first two disadvantage statements in a Powerpoint slide shown to Canadian health professionals were untrue with respect to non-re\u2026 [+7757 chars]"}, {"source": {"id": "bloomberg", "name": "Bloomberg"}, "author": "Matthew Brockett", "title": "New Zealand Says Man's Death May Be Linked to Pfizer Vaccine", "description": "New Zealand health authorities said they believe a man\u2019s death may be linked to the Pfizer Covid-19 vaccine.", "url": "https://www.bloomberg.com/news/articles/2021-12-20/new-zealand-says-man-s-death-may-be-linked-to-pfizer-vaccine", "urlToImage": "https://assets.bwbx.io/images/users/iqjWHBFdfxIU/i4P7BhPT9VbU/v0/1200x800.jpg", "publishedAt": "2021-12-20T02:34:44Z", "content": "New Zealand health authorities said they believe a mans death may be linked to the Pfizer Covid-19 vaccine.\r\nThe 26-year-old man died within two weeks of his first dose of Pfizer and preliminary post\u2026 [+1526 chars]"}, {"source": {"id": null, "name": "Forbes"}, "author": "Dario Sabaghi, Contributor, \n Dario Sabaghi, Contributor\n https://www.forbes.com/sites/dariosabaghi/", "title": "Pfizer To Enter The Medical Cannabis Industry With $6.7 Billion Acquisition", "description": "Pfizer is to enter the medical cannabis industry betting on a promising cannabinoid-based bowel disease treatment.", "url": "https://www.forbes.com/sites/dariosabaghi/2021/12/20/pfizer-to-enter-the-medical-cannabis-industry-with-67-billion-acquisition/", "urlToImage": "https://thumbor.forbes.com/thumbor/fit-in/1200x0/filters%3Aformat%28jpg%29/https%3A%2F%2Fspecials-images.forbesimg.com%2Fimageserve%2F61c08499428b8b334890eb8d%2F0x0.jpg", "publishedAt": "2021-12-20T13:33:01Z", "content": "Brussels, Belgium. 21st December 2020. Exterior view of Pfizer Pharmaceutical company's offices.\r\ngetty\r\nPfizer is to enter the medical cannabis industry betting on a promising cannabinoid-based bowe\u2026 [+3923 chars]"}, {"source": {"id": null, "name": "Forbes"}, "author": "Trefis Team, Contributor, \n Trefis Team, Contributor\n https://www.forbes.com/sites/greatspeculations/people/trefis/", "title": "Pfizer, Merck, Regeneron: Covid Treatment Stocks Back In Focus As Infections Soar", "description": "Our indicative theme on Covid-19 Treatment Stocks \u2013 which includes biotech and pharma companies selling or developing treatments for the Covid-19 virus \u2013 is up by 25% year-to-date, compared to the S&P 500 which is up about 26% over the same period. Although w\u2026", "url": "https://www.forbes.com/sites/greatspeculations/2021/12/20/pfizer-merck-regeneron-covid-treatment-stocks-back-in-focus-as-infections-soar/", "urlToImage": "https://thumbor.forbes.com/thumbor/fit-in/1200x0/filters%3Aformat%28jpg%29/https%3A%2F%2Fspecials-images.forbesimg.com%2Fimageserve%2F5fc9f88165fd2c07cd02256e%2F0x0.jpg", "publishedAt": "2021-12-20T14:00:42Z", "content": "The logo of US multinational pharmaceutical company Pfizer, is pictured at a factory in Puurs, where ... [+] Covid-19 vaccines are being produced for Britain, on December 3, 2020. - Britain on Decemb\u2026 [+5228 chars]"}, {"source": {"id": null, "name": "NBC Chicago"}, "author": "NBC Chicago", "title": "Booster Shots and Omicron: Is Moderna or Pfizer Performing Better? Here's the Data So Far - NBC Chicago", "description": "<ol><li>Booster Shots and Omicron: Is Moderna or Pfizer Performing Better? Here's the Data So Far\u00a0\u00a0NBC Chicago\r\n</li><li>Moderna says COVID-19 booster appears to work against Omicron\u00a0\u00a0Reuters\r\n</li><li>Moderna Says Its Booster Significantly Raises Antibodies \u2026", "url": "https://www.nbcchicago.com/news/coronavirus/booster-shots-and-omicron-is-moderna-or-pfizer-performing-better-heres-the-data-so-far/2711734/", "urlToImage": "https://media.nbcchicago.com/2021/12/GettyImages-1237348301.jpg?quality=85&strip=all&resize=1200%2C675", "publishedAt": "2021-12-20T23:09:42Z", "content": "Both Moderna and Pfizer have released early data showing the effectiveness of their vaccines and booster doses as the new omicron variant begins to take hold and as COVID cases rise across the U.S. \r\u2026 [+8841 chars]"}, {"source": {"id": null, "name": "Forbes"}, "author": "Siladitya Ray, Forbes Staff, \n Siladitya Ray, Forbes Staff\n https://www.forbes.com/sites/siladityaray/", "title": "Death Of 26-Year-Old In New Zealand Likely Caused By Rare Heart Inflammation Linked To Pfizer Covid-19 Vaccine, Authorities Say", "description": "Health authorities say the person\u2019s death was likely caused by myocarditis\u2014inflammation of the heart muscle\u2014which is believed to be a rare side effect of the Pfizer vaccine.", "url": "https://www.forbes.com/sites/siladityaray/2021/12/20/death-of-26-year-old-in-new-zealand-likely-caused-by-rare-heart-inflammation-linked-to-pfizer-covid-19-vaccine-authorities-say/", "urlToImage": "https://thumbor.forbes.com/thumbor/fit-in/1200x0/filters%3Aformat%28jpg%29/https%3A%2F%2Fspecials-images.forbesimg.com%2Fimageserve%2F61c077935dd81cb0bb1d3877%2F0x0.jpg%3FcropX1%3D0%26cropX2%3D1820%26cropY1%3D92%26cropY2%3D1116", "publishedAt": "2021-12-20T12:33:01Z", "content": "Health authorities in New Zealand on Monday said that a 26-year-old mans death may be linked to a rare side effect of the Pfizer vaccine, a finding that does not however alter the authorities' view t\u2026 [+3165 chars]"}, {"source": {"id": null, "name": "ABC15 Arizona"}, "author": "Crystal Bedoya", "title": "ADHS: Johnson and Johnson vaccine recipients should get Pfizer, Moderna booster shot - ABC15 Arizona", "description": "<ol><li>ADHS: Johnson and Johnson vaccine recipients should get Pfizer, Moderna booster shot\u00a0\u00a0ABC15 Arizona\r\n</li><li>UPDATE: Virginia adopts CDC preferential recommendation to use mRNA COVID-19 vaccines\u00a0\u00a0The News Leader\r\n</li><li>Pfizer, Moderna Vaccine Pref\u2026", "url": "https://www.abc15.com/news/vaccine-in-arizona/adhs-johnson-and-johnson-vaccine-recipients-should-get-pfizer-moderna-booster-shot", "urlToImage": "https://ewscripps.brightspotcdn.com/dims4/default/2d3a612/2147483647/strip/true/crop/2636x1384+0+62/resize/1200x630!/quality/90/?url=https%3A%2F%2Fewscripps.brightspotcdn.com%2F7d%2F72%2F0890a0bd407a8b534e0978c6e642%2Fcovidvaccine.png", "publishedAt": "2021-12-20T22:07:00Z", "content": "PHOENIX State health officials are recommending Arizonans who received the Johnson and Johnson vaccine should get a Pfizer or Moderna booster shot.\r\nIn a blog post Monday, the Arizona Department of H\u2026 [+1290 chars]"}, {"source": {"id": "independent", "name": "Independent"}, "author": "Eleanor Sly", "title": "How effective are the Pfizer, AstraZeneca and Moderna vaccines against Omicron?", "description": "Booster jabs provide up to 70 per cent protection, study finds", "url": "https://www.independent.co.uk/news/health/omicron-vaccine-booster-pfizer-astrazeneca-moderna-b1979508.html", "urlToImage": "https://static.independent.co.uk/2021/12/09/16/GettyImages-89747046%20%281%29.jpg?width=1200&auto=webp&quality=75", "publishedAt": "2021-12-20T15:14:41Z", "content": "The Omicron variant of Covid-19 has begun to spread widely in the UK, with Boris Johnson warning of a tidal wave of infections hitting these shores if the public do not observe social restrictions an\u2026 [+7631 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "Reuters", "title": "Thai agency approves Pfizer vaccine for use in children aged 5-11", "description": "Thailand's Food and Drug Administration said on Monday it has approved the use of the Pfizer-BioNTech COVID-19 vaccine for children between the age of five...", "url": "https://news.yahoo.com/thai-agency-approves-pfizer-vaccine-080254049.html", "urlToImage": "https://s.yimg.com/uu/api/res/1.2/Jpq0vqSAw2BKlGP1lX.Flw--~B/aD01MzM7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/484b0065d216e70c20e43be72eedd279", "publishedAt": "2021-12-20T08:02:54Z", "content": "BANGKOK (Reuters) - Thailand's Food and Drug Administration said on Monday it has approved the use of the Pfizer-BioNTech COVID-19 vaccine for children between the age of five and 11.\r\nThe Comirnaty \u2026 [+267 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "Reuters", "title": "Biontech, Pfizer to provide EU with extra 200 million COVID doses", "description": "BioNTech SE and Pfizer said on Monday that they would be providing the European Union with more than 200 million additional doses of the COVID-19 vaccine...", "url": "https://news.yahoo.com/biontech-pfizer-eu-extra-200-122233396.html", "urlToImage": "https://s.yimg.com/uu/api/res/1.2/gPyp9FqJrr.fH7mUn5pB4Q--~B/aD01MjY7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/02a97abf1fd551c7fefaf4fff0a6ab53", "publishedAt": "2021-12-20T12:22:33Z", "content": "BERLIN (Reuters) - BioNTech SE and Pfizer said on Monday that they would be providing the European Union with more than 200 million additional doses of the COVID-19 vaccine they produce.\r\nThe two vac\u2026 [+531 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "Reuters", "title": "New Zealand links 26-year-old man's death to Pfizer COVID-19 vaccine", "description": "New Zealand authorities on Monday said they had linked a 26-year-old man's death to Pfizer Inc's COVID-19 vaccine after the person suffered myocarditis, a...", "url": "https://news.yahoo.com/zealand-links-26-old-mans-041523888.html", "urlToImage": "https://s.yimg.com/uu/api/res/1.2/KR1DA9qCrEz5wx1wivddyw--~B/aD01MzM7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/e24148cb2c90d02a0573ece30583a1f5", "publishedAt": "2021-12-20T04:15:23Z", "content": "SYDNEY (Reuters) - New Zealand authorities on Monday said they had linked a 26-year-old man's death to Pfizer Inc's COVID-19 vaccine after the person suffered myocarditis, a rare inflammation of the \u2026 [+1234 chars]"}, {"source": {"id": "rt", "name": "RT"}, "author": "RT", "title": "26-year-old dies after one dose of Pfizer Covid vaccine", "description": "New Zealand officials announced on Monday that a 26-year-old\u2019s death has been formally linked to the Pfizer-BioNTech vaccine after he suffered a rare heart inflammation following his first dose of the Covid jab. Read Full Article at RT.com", "url": "https://www.rt.com/news/543732-pfizer-covid-vaccine-death-myocarditis/", "urlToImage": "https://cdni.rt.com/files/2021.12/article/61c0518320302706b51c15cc.JPG", "publishedAt": "2021-12-20T10:29:50Z", "content": "In a statement, the country\u2019s Covid-19 Vaccine Independent Safety Monitoring Board, confirmed the myocarditis that had led to his death \u201cwas probably due to vaccination.\u201d\r\nThe man died within two wee\u2026 [+1530 chars]"}, {"source": {"id": null, "name": "Moneycontrol"}, "author": null, "title": "New Zealand links 26-year-old man#39;s death to Pfizer COVID-19 vaccine", "description": "The death is New Zealand#39;s second linked to a known but rare side effect from the vaccine after health authorities in August reported a woman had died after taking her doses.", "url": "https://www.moneycontrol.com/news/trends/health-trends/new-zealand-links-26-year-old-mans-death-to-pfizer-covid-19-vaccine-7845221.html", "urlToImage": "https://images.moneycontrol.com/static-mcnews/2021/10/Pfizer-_-covid-770x433.jpg", "publishedAt": "2021-12-20T09:44:39Z", "content": "New Zealand authorities on Monday said they had linked a 26-year-old man's death to Pfizer Inc's\u00a0COVID-19 vaccine after the person suffered myocarditis, a rare inflammation of the heart muscle, after\u2026 [+1335 chars]"}, {"source": {"id": null, "name": "Theepochtimes.com"}, "author": null, "title": "CDC Director: People Unable or Unwilling to Get Pfizer or Moderna Vaccines Should Get Johnson & Johnson\u2019s - The Epoch Times", "description": "<ol><li>CDC Director: People Unable or Unwilling to Get Pfizer or Moderna Vaccines Should Get Johnson & Johnson\u2019s\u00a0\u00a0The Epoch Times\r\n</li><li>JJ\u00a0\u00a0LOCAL 12\r\n</li><li>Advocate Aurora Pauses Johnson & Johnson COVID-19 Vaccine\u00a0\u00a0Patch.com\r\n</li><li>COVID-19 vaccine\u2026", "url": "https://www.theepochtimes.com/cdc-director-people-unable-or-unwilling-to-get-pfizer-or-moderna-vaccine-should-get-johnson-johnsons_4167126.html", "urlToImage": "https://img.theepochtimes.com/assets/uploads/2021/12/20/walensky-with-black-mask-1200x793-1200x793.jpg", "publishedAt": "2021-12-20T11:14:10Z", "content": "Americans who are not willing or able to get the Pfizer or Moderna COVID-19 vaccines should get Johnson &amp; Johnson\u2019s COVID-19 shot, according to the director of the Centers for Disease Control and\u2026 [+2560 chars]"}, {"source": {"id": null, "name": "Bangkok Post"}, "author": "Post Reporters", "title": "Kids 5-11 allowed Pfizer shot", "description": "The Food and Drug Administration (FDA) on Monday gave the green light to allow children aged 5 to 11 to receive Pfizer's Comirnaty vaccine so as to build body immunity against Covid-19.", "url": "https://www.bangkokpost.com/thailand/general/2235131/kids-5-11-allowed-pfizer-shot", "urlToImage": "https://static.bangkokpost.com/media/content/20211221/c1_2235131_211221062800_700.jpg", "publishedAt": "2021-12-20T23:00:00Z", "content": "The Food and Drug Administration (FDA) on Monday gave the green light to allow children aged 5 to 11 to receive Pfizer's Comirnaty vaccine so as to build body immunity against Covid-19.\r\nThe Comirnat\u2026 [+2096 chars]"}, {"source": {"id": null, "name": "BleepingComputer"}, "author": "Bill Toulas", "title": "Phishing attacks impersonate Pfizer in fake requests for quotation", "description": "Threat actors are conducting a highly targeted phishing campaign impersonating Pfizer to steal business and financial information from victims. [...]", "url": "https://www.bleepingcomputer.com/news/security/phishing-attacks-impersonate-pfizer-in-fake-requests-for-quotation/", "urlToImage": "pfizer", "publishedAt": "2021-12-20T11:00:00Z", "content": "Threat actors are conducting a highly targeted phishing campaign impersonating Pfizer to steal business and financial information from victims.\r\nPfizer is a well-known pharmaceutical company that enj\u2026 [+2957 chars]"}, {"source": {"id": null, "name": "Bangkok Post"}, "author": "Reuters", "title": "Thai FDA approves Pfizer vaccine for use in children aged 5-11", "description": "Thailand's Food and Drug Administration (FDA) said on Monday it has approved the use of the Pfizer-BioNTech Covid-19 vaccine for children between the age of five and 11.", "url": "https://www.bangkokpost.com/thailand/general/2234995/thai-fda-approves-pfizer-vaccine-for-use-in-children-aged-5-11", "urlToImage": "https://static.bangkokpost.com/media/content/20211220/c1_2234995_700.jpg", "publishedAt": "2021-12-20T08:34:00Z", "content": "Thailand's Food and Drug Administration (FDA) said on Monday it has approved the use of the Pfizer-BioNTech Covid-19 vaccine for children between the age of five and 11.\r\nThe Comirnaty vaccine, which\u2026 [+146 chars]"}]}, "2021-12-19": {"status": "ok", "totalResults": 16, "articles": [{"source": {"id": null, "name": "Motley Fool"}, "author": "newsfeedback@fool.com (Adria Cimino and Keith Speights)", "title": "Better Buy: Ocugen vs. Pfizer", "description": "Can they both win in the coronavirus vaccine space?", "url": "https://www.fool.com/investing/2021/12/19/better-buy-ocugen-vs-pfizer/", "urlToImage": "https://g.foolcdn.com/editorial/images/658061/gettyimages-young-man-gets-vaccine.jpg", "publishedAt": "2021-12-19T11:00:00Z", "content": "There are plenty of options when it comes to vaccine stock investing these days. You can choose a player that's already generating billions of dollars in sales from the vaccine and other products. Or\u2026 [+4032 chars]"}, {"source": {"id": null, "name": "Deseret News"}, "author": "Herb Scribner", "title": "Will COVID end in 2024? Pfizer leaders predict the future - Deseret News", "description": "<ol><li>Will COVID end in 2024? Pfizer leaders predict the future\u00a0\u00a0Deseret News\r\n</li><li>Pfizer tests extra COVID shot for kids under 5 in setback\u00a0\u00a0KSL.com\r\n</li><li>Pfizer says vaccine data for younger children delayed\u00a0\u00a0Reuters\r\n</li><li>Pfizer says pandemi\u2026", "url": "https://www.deseret.com/coronavirus/2021/12/18/22843056/covid-19-end-2024-pfizer-president-predicts-future-coronavirus", "urlToImage": "https://cdn.vox-cdn.com/thumbor/Aees8UX0irdVhwxilyHKAqBptUc=/0x99:1024x635/fit-in/1200x630/cdn.vox-cdn.com/uploads/chorus_asset/file/23110277/AP21351696345359.jpg", "publishedAt": "2021-12-19T03:00:00Z", "content": "The novel coronavirus could become an endemic disease by 2024, Pfizer executives said Friday.\r\nPer CNBC, executives with the vaccine developer said the novel coronavirus could become a constant prese\u2026 [+1684 chars]"}, {"source": {"id": null, "name": "Kingstonist"}, "author": null, "title": "Shipping delays impact Pfizer vaccine supply in KFL&A \u2013 Kingston News - Kingstonist", "description": "<ol><li>Shipping delays impact Pfizer vaccine supply in KFL&A \u2013 Kingston News\u00a0\u00a0Kingstonist\r\n</li><li>Only Moderna vaccine available for adults 30+ in Waterloo Region\u00a0\u00a0CTV News Kitchener\r\n</li><li>Public health to substitute vaccines in some cases\u00a0\u00a0Chatham Dai\u2026", "url": "https://www.kingstonist.com/news/shipping-delays-impact-pfizer-vaccine-supply-in-kfla/", "urlToImage": "https://www.kingstonist.com/wp-content/uploads/2021/01/MM1_9548.jpg", "publishedAt": "2021-12-19T16:23:35Z", "content": "Nursing staff at Kingston Health Sciences Centre administer the first dose of the Pfizer-BioNTech COVID-19 vaccine in southeastern Ontario to Nanette Isaac, from Extendicare as part of the province-w\u2026 [+2308 chars]"}, {"source": {"id": null, "name": "Investmentwatchblog.com"}, "author": "alexmark", "title": "Pfizer is now testing THREE doses in kids under 5 since two shots don't work", "description": null, "url": "https://www.investmentwatchblog.com/pfizer-is-now-testing-three-doses-in-kids-under-5-since-two-shots-dont-work/", "urlToImage": null, "publishedAt": "2021-12-19T14:02:50Z", "content": "<ul><li>Pfizer said\u00a0two jabs failed to produce the expected immunity in babies and preschoolers\u00a0</li><li>A preliminary analysis found 2- to 4-year-olds\u2019 immune response wasn\u2019t as strong as expected t\u2026 [+1282 chars]"}, {"source": {"id": "bloomberg", "name": "Bloomberg"}, "author": "Sara Marley", "title": "EU Orders Additional 20 Million BioNTech-Pfizer Vaccine Doses", "description": "", "url": "https://www.bloomberg.com/news/articles/2021-12-19/eu-orders-additional-20-million-biontech-pfizer-vaccine-doses", "urlToImage": "https://assets.bwbx.io/images/users/iqjWHBFdfxIU/iNBGbNziOyG8/v0/1200x800.jpg", "publishedAt": "2021-12-19T13:25:23Z", "content": "The European Commission said \r\nBioNTech-\r\nPfizer will deliver an additional 20 million vaccine doses in the first quarter, bringing the total number of deliveries in the first three months of 2022 to\u2026 [+273 chars]"}, {"source": {"id": null, "name": "Freerepublic.com"}, "author": "The West News", "title": "Pfizer believes that the pandemic might last until 2024", "description": "Pfizer\u2019s Chief Scientific Officer Mikael Dolsten told investors that the company expects pandemic levels of COVID-19 cases in some locations for the next year or two. During the same time span, other countries will become \u201cendemic\u201d with low caseloads. The dis\u2026", "url": "https://freerepublic.com/focus/f-news/4022454/posts", "urlToImage": null, "publishedAt": "2021-12-19T01:57:37Z", "content": "Skip to comments.\r\nPfizer believes that the pandemic might last until 2024The West News ^\r\n | December 18, 2021\r\n | The West News\r\nPosted on 12/18/2021 5:57:37 PM PST by conservative98\r\nPfizers Chief\u2026 [+6015 chars]"}, {"source": {"id": null, "name": "bdnews24.com"}, "author": null, "title": "US to send 1.78m more Pfizer doses to Bangladesh under COVAX", "description": "The US government has donated another 1.78 million doses of the Pfizer COVID-19 vaccine to Bangladesh through the global sharing platform COVAX.", "url": "https://bdnews24.com/bangladesh/2021/12/20/us-to-send-1.78m-more-pfizer-doses-to-bangladesh-under-covax", "urlToImage": "https://d30fl32nd2baj9.cloudfront.net/media/2021/08/26/vial-pfizer-biontech-smr-230821-01.jpg/BINARY/vial-pfizer-biontech-smr-230821-01.jpg", "publishedAt": "2021-12-19T19:43:46Z", "content": "The new doses take the number of shots donated by the US to Bangladesh to 18.5. They will help Bangladesh expand vaccinations for young people ages 12 and up, reaching all 64 districts across the cou\u2026 [+604 chars]"}, {"source": {"id": null, "name": "Freerepublic.com"}, "author": "Red State", "title": "Pfizer Now Says Two Covid Vax Jabs in Six-Month-Olds Don't Produce Desired Results, Moves on to Third Dose", "description": "How can it be said objectively any other way?Drug companies and the Biden administration continue to use America\u2019s children as young as six months old as human guinea pigs by injecting them with COVID \u201cvaccinations,\u201d in response to which serious side effects \u2026", "url": "https://freerepublic.com/focus/f-bloggers/4022500/posts", "urlToImage": null, "publishedAt": "2021-12-19T06:14:17Z", "content": "Skip to comments.\r\nPfizer Now Says Two Covid Vax Jabs in Six-Month-Olds Don't Produce Desired Results, Moves on to Third DoseRed State ^\r\n | 12/18/2021\r\n | Mike Miller\r\nPosted on 12/18/2021 10:14:17 \u2026 [+5925 chars]"}, {"source": {"id": null, "name": "The Japan Times"}, "author": null, "title": "Japan\u2019s prime minister speaks with Pfizer CEO on speeding vaccine boosters", "description": "The Japanese government wants to speed up vaccine imports and shorten the time between the first two shots and the booster, from eight months to six months.", "url": "https://www.japantimes.co.jp/news/2021/12/19/national/science-health/fumio-kishida-pfizer-talks/", "urlToImage": "https://cdn-japantimes.com/wp-content/uploads/2021/12/np_file_130268-870x489.jpeg", "publishedAt": "2021-12-19T11:48:23Z", "content": "Japanese Prime Minister Fumio Kishida on Friday spoke with the country\u2019s biggest supplier of COVID-19 vaccines amid media reports he will seek to speed up the booster shot program.\r\nChief government \u2026 [+1229 chars]"}, {"source": {"id": null, "name": "Stuff.co.nz"}, "author": "OLIVIA CALDWELL", "title": "Covid-19: Coroner investigating after autopsy links Dunedin man's death to 'very rare' side effect of Pfizer vaccine", "description": "Ashleigh Wilson was ready to marry the love of her life in just a few months. But Dunedin plumber Rory Nairn suddenly dropped dead in their bathroom at 3am.", "url": "https://www.stuff.co.nz/national/health/coronavirus/127324992/covid19-coroner-investigating-after-autopsy-links-dunedin-mans-death-to-very-rare-side-effect-of-pfizer-vaccine", "urlToImage": "https://resources.stuff.co.nz/content/dam/images/4/y/w/1/i/e/image.related.StuffLandscapeSixteenByNine.1420x800.23t0lc.png/1639880715141.jpg", "publishedAt": "2021-12-19T02:25:14Z", "content": "Ashleigh Wilson was ready to marry the love of her life in just a few months.\r\n But last month, Dunedin plumber Rory Nairn dropped dead in their bathroom at 3am, likely due to vaccine-related myocard\u2026 [+4473 chars]"}, {"source": {"id": null, "name": "Slashdot.org"}, "author": "EditorDavid", "title": "Covid Vaccines Fight Serious Illness, But Only Pfizer and Moderna With a Booster Stop Omicron Infections", "description": "\"A growing body of preliminary research suggests the COVID vaccines used in most of the world offer almost no defense against becoming infected by the highly contagious omicron variant,\" reports the New York Times. (Emphasis added, because they stress that \"A\u2026", "url": "https://science.slashdot.org/story/21/12/19/1727237/covid-vaccines-fight-serious-illness-but-only-pfizer-and-moderna-with-a-booster-stop-omicron-infections", "urlToImage": "https://a.fsdn.com/sd/topics/medicine_64.png?refresh=now", "publishedAt": "2021-12-19T17:34:00Z", "content": "\"A growing body of preliminary research suggests the COVID vaccines used in most of the world offer almost no defense against becoming infected by the highly contagious omicron variant,\" reports the \u2026 [+2647 chars]"}, {"source": {"id": "fox-news", "name": "Fox News"}, "author": "Peter Aitken", "title": "Pfizer COVID-19 pill may not see approval for 'months' despite 'impressive' data", "description": "The Pfizer pill boast a 90% effectiveness at preventing serious illness and death from COVID-19.", "url": "https://www.foxnews.com/health/pfizer-covid-pill-approval-months-impressive-data", "urlToImage": "https://static.foxnews.com/foxnews.com/content/uploads/2021/12/Pfizer-COVID-Pills.jpg", "publishedAt": "2021-12-19T18:05:39Z", "content": "The new Pfizer COVID-19pill may not see Emergency Use Authorization for another month as health officials continue to highlight the promising effects it may bring.\u00a0\r\nDr. Anthony Fauci praised the dat\u2026 [+3309 chars]"}, {"source": {"id": null, "name": "Slashdot.org"}, "author": "feedfeeder", "title": "Will COVID end in 2024? Pfizer leaders predict the future - Deseret News", "description": "Will COVID end in 2024? Pfizer leaders predict the futureDeseret News Pfizer pushing back plans to request emergency use for vaccinations in kids under 5WFAA Pfizer tests extra COVID shot for kids under 5 in setbackKSL.com Pfizer says vaccine data for younger\u2026", "url": "https://slashdot.org/firehose.pl?op=view&amp;id=156629909", "urlToImage": null, "publishedAt": "2021-12-19T08:12:16Z", "content": "The Fine Print: The following comments are owned by whoever posted them. We are not responsible for them in any way."}, {"source": {"id": null, "name": "Slashdot.org"}, "author": "feedfeeder", "title": "Pfizer tests extra COVID shot for kids under 5 in setback - KSL.com", "description": "Pfizer tests extra COVID shot for kids under 5 in setbackKSL.com Pfizer says vaccine data for younger children delayedReuters Will COVID end in 2024? Pfizer leaders predict the futureDeseret News Parents bide time as Pfizer extends vaccine trial for young chi\u2026", "url": "https://slashdot.org/firehose.pl?op=view&amp;id=156626955", "urlToImage": null, "publishedAt": "2021-12-19T03:52:34Z", "content": "Never ask two questions in a business letter. The reply will discuss\r\nthe one you are least interested, and say nothing about the other."}, {"source": {"id": null, "name": "The Daily Star"}, "author": "The Daily Star", "title": "Bangladesh receives 1.78mn Pfizer vaccines from US", "description": "The United States government has contributed 1.78 million doses of the Pfizer Covid-19 vaccine to Bangladesh through the COVAX facility.", "url": "https://www.thedailystar.net/health/disease/coronavirus/fallouts-fightback/vaccine/news/bangladesh-receives-178mn-pfizer-vaccines-us-2921036", "urlToImage": "https://img.thedailystar.net/sites/default/files/styles/social_share/public/images/2021/10/04/pfizer_2.jpg?itok=pbJSauQq", "publishedAt": "2021-12-19T11:36:49Z", "content": "The United States government has contributed 1.78 million doses of the Pfizer Covid-19 vaccine to Bangladesh through the COVAX facility.\u00a0\r\nWith this consignment, the US has provided a total of 18.5 m\u2026 [+1167 chars]"}, {"source": {"id": null, "name": "Dailyutahchronicle.com"}, "author": "By Vanessa Hudson, News Writer", "title": "FDA Approves Pfizer-BioNTech COVID-19 Vaccine for Children Ages 5-11", "description": "The Food and Drug Administration\u00a0approved the Pfizer-BioNTech COVID-19 vaccine for children ages 5-11 on Oct. 29, 2021. The vaccine gives children a way to protect themselves, their family and their friends from serious cases of COVID-19.\u00a0 According to the Ce\u2026", "url": "https://dailyutahchronicle.com/2021/12/19/fda-approves-pfizer-biontech-covid-19-vaccine-children-ages-5-11/", "urlToImage": "https://dailyutahchronicle.com/wp-content/uploads/2021/05/pexels-rfstudio-3825529.jpg", "publishedAt": "2021-12-19T14:00:40Z", "content": "The Food and Drug Administration\u00a0approved the Pfizer-BioNTech COVID-19 vaccine for children ages 5-11 on Oct. 29, 2021. The vaccine gives children a way to protect themselves, their family and their \u2026 [+2833 chars]"}]}, "2021-12-18": {"status": "ok", "totalResults": 39, "articles": [{"source": {"id": null, "name": "Motley Fool"}, "author": "newsfeedback@fool.com (Keith Speights and Brian Orelli, PhD)", "title": "What to Make of the FDA's Latest Warning to AbbVie and Pfizer", "description": "There's still a worst-case scenario that the FDA could unleash.", "url": "https://www.fool.com/investing/2021/12/18/what-to-make-of-the-fdas-latest-warning-to-abbvie/", "urlToImage": "https://g.foolcdn.com/editorial/images/657726/fda-blocks.jpg", "publishedAt": "2021-12-18T11:55:00Z", "content": "The U.S. Food and Drug Administration (FDA) has placed additional warnings on the labels for JAK inhibitors marketed by AbbVie(NYSE:ABBV) and Pfizer(NYSE:PFE).\u00a0In this Motley Fool Live video recorded\u2026 [+2469 chars]"}, {"source": {"id": null, "name": "KSL.com"}, "author": "Lauran Neergaard, Associated Press", "title": "Pfizer tests extra COVID shot for kids under 5 in setback - KSL.com", "description": "<ol><li>Pfizer tests extra COVID shot for kids under 5 in setback\u00a0\u00a0KSL.com\r\n</li><li>Pfizer says vaccine data for younger children delayed\u00a0\u00a0Reuters\r\n</li><li>Pfizer Announces Vaccine Provides Insufficient Protection for Young Children\u00a0\u00a0Yahoo! Voices\r\n</li><li\u2026", "url": "https://www.ksl.com/article/50314045/pfizer-tests-extra-covid-shot-for-kids-under-5-in-setback", "urlToImage": "https://img.ksl.com/slc/2856/285666/28566691.jpg?filter=kslv2/responsive_story_lg", "publishedAt": "2021-12-18T17:07:33Z", "content": "Estimated read time: 2-3 minutes\r\nWASHINGTON Pfizer said Friday it was changing plans and testing three doses of its COVID-19 vaccine in babies and preschoolers after the usual two shots didn't appea\u2026 [+2299 chars]"}, {"source": {"id": "rt", "name": "RT"}, "author": "RT", "title": "Pfizer to test Covid booster dose on infants, young kids", "description": "Pfizer will start testing Covid-19 vaccine booster doses in children aged six months to five years old after finding that its lower-dose shot may not provide enough protection in one age group. Read Full Article at RT.com", "url": "https://www.rt.com/usa/543582-pfizer-booster-test-children/", "urlToImage": "https://cdni.rt.com/files/2021.12/article/61bd445985f540162f45751a.JPG", "publishedAt": "2021-12-18T02:17:15Z", "content": "The pharmaceutical giant announced on Thursday that it would start testing a third dose on young children \u201cat least two months after the second dose\u201d in an effort \u201cto provide high levels of protectio\u2026 [+1293 chars]"}, {"source": {"id": null, "name": "The Japan Times"}, "author": null, "title": "Pfizer says pandemic could extend through 2023, studies three-dose vaccine course for children", "description": "Pfizer executives said the company believed that by 2024, the disease should be endemic around the globe, meaning it would no longer be a pandemic.", "url": "https://www.japantimes.co.jp/news/2021/12/18/world/science-health-world/covid-omicron-vaccines-pfizer/", "urlToImage": "https://cdn-japantimes.com/wp-content/uploads/2021/12/np_file_130080-870x489.jpeg", "publishedAt": "2021-12-18T01:11:03Z", "content": "MADRID/DUBLIN \u2013 Pfizer Inc. said on Friday the COVID-19 pandemic could extend through next year and announced plans to develop a three-dose vaccine regimen for children ages 2 to 16, a move that coul\u2026 [+4887 chars]"}, {"source": {"id": null, "name": "VOA News"}, "author": "webdesk@voanews.com (Reuters)", "title": "Pandemic Could Extend To 2024, Pfizer Says", "description": "Pfizer Inc on Friday forecast that the COVID-19 pandemic would not be behind us until 2024 and said a lower-dose version of its vaccine for 2- to 4-year-olds generated a weaker immune response than expected, potentially delaying authorization.\n\n\nPfizer Chief \u2026", "url": "https://www.voanews.com/a/pandemic-could-extend-to-2024-pfizer-says/6359993.html", "urlToImage": "https://gdb.voanews.com/1ABDB0C2-BA5E-479E-BFB8-EB10E81634C1_cx0_cy1_cw0_w1200_r1.jpg", "publishedAt": "2021-12-18T06:00:28Z", "content": "Pfizer Inc on Friday forecast that the COVID-19 pandemic would not be behind us until 2024 and said a lower-dose version of its vaccine for 2- to 4-year-olds generated a weaker immune response than e\u2026 [+3144 chars]"}, {"source": {"id": "usa-today", "name": "USA Today"}, "author": "Adrianna Rodriguez, USA TODAY", "title": "CDC says Moderna and Pfizer COVID-19 vaccines are preferred over Johnson & Johnson. What it means for you.", "description": "The CDC panel was persuaded by new data showing that blood clots linked to J&J\u2019s vaccine are not just in younger women as originally thought.", "url": "https://www.usatoday.com/story/news/health/2021/12/18/johnson-and-johnson-covid-vaccine-what-know-cdc-preference/8937706002/", "urlToImage": "https://s.yimg.com/ny/api/res/1.2/fPTTEMy5CgqlUKU3JgQ9EA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD03OTY-/https://s.yimg.com/uu/api/res/1.2/vpGS_yBpjJptxJgIj2Ay6A--~B/aD0yOTQxO3c9NDQzNDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/usa_today_news_641/58f50a129a504854e02125271be8f4ac", "publishedAt": "2021-12-18T11:01:17Z", "content": "An advisory panel to the Centers for Disease Control and Prevention expressed their preference for Pfizer-BioNTech and Modernas mRNA COVID-19 vaccines over Johnson &amp; Johnsons jab.\r\nMembers of the\u2026 [+7718 chars]"}, {"source": {"id": null, "name": "Sputnik International"}, "author": "Sputnik International", "title": "Study Shows Pfizer, AstraZeneca Vaccines Less Effective Against Omicron Strain, WHO Says", "description": "MOSCOW (Sputnik) - Preliminary results of a non-peer-reviewed study from the United Kingdom indicate reduced effectiveness of the Pfizer and AstraZeneca vaccines against the Omicron coronavirus variant, the World Health Organization (WHO) has said.", "url": "https://sputniknews.com/20211218/study-shows-pfizer-astrazeneca-vaccines-less-effective-against-omicron-strain-who-says-1091627507.html", "urlToImage": "https://cdnn1.img.sputniknews.com/images/sharing/article/eng/1091627507.jpg?10913290751639833181", "publishedAt": "2021-12-18T13:12:58Z", "content": "Registration was successful!Please follow the link from the email sent to \r\nThe new COVID variant was initially detected in South Africa and Botswana and sparked major concerns due to its high number\u2026 [+3192 chars]"}, {"source": {"id": null, "name": "Hindustan Times"}, "author": "Hindustantimes", "title": "Omicron detected in US returnee, who took 3 doses of Pfizer vaccine: BMC - Hindustan Times", "description": "<ol><li>Omicron detected in US returnee, who took 3 doses of Pfizer vaccine: BMC\u00a0\u00a0Hindustan Times\r\n</li><li>Man Back From US Positive For Omicron, Took 3 Jabs: Mumbai Civic Body\u00a0\u00a0NDTV\r\n</li><li>Mumbai News Live: Omicron patient from New York took 3 doses of P\u2026", "url": "https://www.hindustantimes.com/cities/mumbai-news/omicron-detected-in-us-returnee-who-took-3-doses-of-pfizer-vaccine-bmc-101639791054052.html", "urlToImage": "https://images.hindustantimes.com/img/2021/12/18/1600x900/BZRRXCZH75JSJCHVZ3NMAZMLJE_1639792528104_1639792539383.jpg", "publishedAt": "2021-12-18T01:58:02Z", "content": "One of the new patients in Mumbai who tested positive for the Omicron variant of the SARS-Cov-2 coronavirus after returning from New York had taken three doses of the Covid-19 vaccine, the Brihanmumb\u2026 [+2107 chars]"}, {"source": {"id": "news24", "name": "News24"}, "author": null, "title": "News24.com | Pfizer to test third vaccine shot for under-fives", "description": "Pfizer wants to test a third dose of the Covid-19 vaccine in the under-fives, as the low dosage such small children can handle may not offer the same protection that older children enjoy from just two shots.", "url": "https://www.news24.com/news24/World/News/pfizer-to-test-third-vaccine-shot-for-under-fives-20211218", "urlToImage": "https://cdn.24.co.za/files/Cms/General/d/516/8d733fb11fb94059b5f98048a676aacf.jpg", "publishedAt": "2021-12-18T07:08:44Z", "content": "<ul><li>Pfizer is set to test an extra dose of its Covid-19 for children under the age of five.</li><li>As part of its ongoing clinical trials, Pfizer has \r\nselected a dosage of three micrograms per \u2026 [+2103 chars]"}, {"source": {"id": null, "name": "Hurriyet Daily News"}, "author": "hurriyetdailynews.com", "title": "Pfizer tests extra COVID shot for kids under 5 in setback", "description": "Pfizer said on Dec. 17 it was changing plans and testing three doses of its COVID-19 vaccine in babies and preschoolers after the usual two shots didn\u2019t appear strong enough for some of the children.", "url": "https://www.hurriyetdailynews.com/pfizer-tests-extra-covid-shot-for-kids-under-5-in-setback-170157", "urlToImage": "https://i.hurimg.com/i/hdn/75/200x200/61bd878e4e3fe115ac0cffdb.jpg", "publishedAt": "2021-12-18T07:01:00Z", "content": "WASHINGTON\r\nPfizer said on Dec. 17 it was changing plans and testing three doses of its COVID-19 vaccine in babies and preschoolers after the usual two shots didnt appear strong enough for some of th\u2026 [+2241 chars]"}, {"source": {"id": null, "name": "The Indian Express"}, "author": "AP", "title": "Pfizer study tests extra covid-19 vaccine dose for kids under 5 in setback", "description": "Pfizer had expected data on how well the vaccines were working in children under 5 by year's end, and it's not clear how long the change will delay a final answer.", "url": "https://indianexpress.com/article/world/pfizer-study-tests-extra-covid-19-vaccine-dose-for-kids-under-5-in-setback-7678660/", "urlToImage": "https://images.indianexpress.com/2021/05/US-vaccine-2.jpg", "publishedAt": "2021-12-18T03:09:30Z", "content": "Pfizer said Friday it was changing plans and testing three doses of its COVID-19 vaccine in babies and preschoolers after the usual two shots didn\u2019t appear strong enough for some of the children.Pfiz\u2026 [+2237 chars]"}, {"source": {"id": null, "name": "Stationgossip.com"}, "author": "orraz", "title": "Pfizer Begins Testing Three-Dose COVID Vaccine for Babies and Toddlers", "description": "Your Daily Station of Entertainment !!", "url": "http://www.stationgossip.com/2021/12/pfizer-begins-testing-three-dose-covid.html", "urlToImage": null, "publishedAt": "2021-12-18T14:11:15Z", "content": "Pfizer said Friday it was changing plans and testing three doses of its COVID-19 vaccine in babies and preschoolers after the usual two shots didn\u2019t appear strong enough for some of the children.\r\nPf\u2026 [+2239 chars]"}, {"source": {"id": null, "name": "Jamaica Observer"}, "author": null, "title": "Pfizer tests extra COVID shot for kids under 5 in setback", "description": "Pfizer said Friday it was changing plans and testing three doses of its COVID-19 vaccine in babies and preschoolers after the usual two shots didn't appear strong enough for some of the children.Pfizer announced the change after a preliminary analysis found t\u2026", "url": "https://www.jamaicaobserver.com/international/pfizer-tests-extra-covid-shot-for-kids-under-5-in-setback_239230?profile=1470", "urlToImage": "https://www.jamaicaobserver.com/apps/pbcsi.dll/storyimage/JO/20211218/ARTICLE/312189992/AR/0/AR-312189992.jpg", "publishedAt": "2021-12-18T07:01:00Z", "content": "Pfizer said Friday it was changing plans and testing three doses of its COVID-19 vaccine in babies and preschoolers after the usual two shots didn't appear strong enough for some of the children.\r\nPf\u2026 [+2269 chars]"}, {"source": {"id": null, "name": "Thegatewaypundit.com"}, "author": "Jim Hoft", "title": "Naomi Wolf: NIAID Is Trying to Sideline the J&J Vaccines Because They Don\u2019t Have a Patent on and Aren\u2019t Making Money Off of Them like Pfizer and Moderna Vaccines (VIDEO)", "description": "Dr. Naomi Wolf, a Rhodes Scholar and former Clinton Administration advisor, joined Steve Bannon on The War Room on Saturday. Earlier this week the Centers for Disease Control and Prevention (CDC) expressed their preference for Pfizer-BioNTech and Moderna\u2019s mR\u2026", "url": "https://www.thegatewaypundit.com/2021/12/naomi-wolf-niaid-trying-sideline-jj-vaccines-dont-patent-arent-making-money-off-like-pfizer-moderna-vaccines-video/", "urlToImage": "https://www.thegatewaypundit.com/wp-content/uploads/naomi-wolf-war-room.jpg", "publishedAt": "2021-12-18T16:30:48Z", "content": "Dr. Naomi Wolf, a Rhodes Scholar and former Clinton Administration advisor, joined Steve Bannon on The War Room on Saturday.\r\nEarlier this week the Centers for Disease Control and Prevention (CDC) ex\u2026 [+802 chars]"}, {"source": {"id": "independent", "name": "Independent"}, "author": "Eleanor Sly", "title": "How effective are the Pfizer, AstraZeneca and Moderna vaccines against Omicron?", "description": "Booster jabs provide up to 70% omicron protection, study finds", "url": "https://www.independent.co.uk/news/health/omicron-vaccine-booster-pfizer-astrazeneca-moderna-b1978612.html", "urlToImage": "https://static.independent.co.uk/2021/12/09/16/GettyImages-89747046%20%281%29.jpg?width=1200&auto=webp&quality=75", "publishedAt": "2021-12-18T11:47:43Z", "content": "The Omicron variant of Covid-19 has begun to spread in the UK, with Boris Johnson warning of a tidal wave of infections hitting these shores if the public do not observe social restrictions and get t\u2026 [+7514 chars]"}, {"source": {"id": null, "name": "Daily Mail"}, "author": "Dailymail.com, Associated", "title": "Pfizer tests extra COVID shot for kids under 5 in setback", "description": "Pfizer said Friday it's going to test three doses of its COVID vaccine in young children under five years old, after two jabs failed to produce the expected immunity in babies and preschoolers.", "url": "https://www.dailymail.co.uk/news/article-10322175/Pfizer-study-tests-extra-COVID-vaccine-dose-kids-5.html", "urlToImage": "https://i.dailymail.co.uk/1s/2021/12/17/19/wire-51934761-1639770883-696_636x382.jpg", "publishedAt": "2021-12-18T05:21:57Z", "content": "Pfizer said Friday it's going to test three doses of its COVID vaccine in young children under five years old, after two jabs failed to produce the expected immunity in babies and preschoolers.\r\nTwo \u2026 [+2241 chars]"}, {"source": {"id": null, "name": "bdnews24.com"}, "author": null, "title": "Pfizer trial of low-dose shot fails for young children", "description": "A low dose of the Pfizer-BioNTech coronavirus vaccine did not produce a potent immune response in children aged 2 to just under 5 years of age, the companies announced Friday, a discouraging setback that threatens to keep the vaccine from younger children for\u2026", "url": "https://bdnews24.com/health/2021/12/18/pfizer-trial-of-low-dose-shot-fails-for-young-children", "urlToImage": "https://d30fl32nd2baj9.cloudfront.net/media/2021/12/18/pfizer-vaccine-children-181221-01-smr.jpg/BINARY/pfizer-vaccine-children-181221-01-smr.jpg", "publishedAt": "2021-12-18T07:30:04Z", "content": "In ongoing clinical trials, the companies\r\ntested 3 micrograms of the vaccine one-tenth of the adult dose in children\r\n6 months to less than 5 years of age. After two doses, children between 6\r\nmonth\u2026 [+2693 chars]"}, {"source": {"id": null, "name": "Business Standard"}, "author": "BS Web Team", "title": "LIVE: India Omicron count crosses 100, Pfizer says Covid may stay till 2024", "description": "The Centre has advised people to avoid non-essential travel and mass gatherings and keep New Year celebrations at low intensity.", "url": "https://www.business-standard.com/article/current-affairs/live-india-omicron-count-crosses-100-pfizer-says-covid-may-stay-till-2024-121121800130_1.html", "urlToImage": "https://bsmedia.business-standard.com/_media/bs/img/article/2021-12/05/full/1638664968-8717.jpg", "publishedAt": "2021-12-18T01:45:00Z", "content": "Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the count\u2026 [+1029 chars]"}, {"source": {"id": null, "name": "Business Standard"}, "author": "IANS", "title": "Covid: Pfizer vax for 2 to 4 year-olds fails to produce expected immunity", "description": "The Covid vaccine developed for small children aged 2 to 4-year-olds by US drug maker Pfizer generates weaker immune response than expected, the company has announced", "url": "https://www.business-standard.com/article/current-affairs/covid-pfizer-vax-for-2-to-4-year-olds-fails-to-produce-expected-immunity-121121800718_1.html", "urlToImage": "https://bsmedia.business-standard.com/_media/bs/img/article/2021-05/24/full/1621857595-3349.jpg", "publishedAt": "2021-12-18T14:30:00Z", "content": "The Covid vaccine developed for small children aged 2 to 4-year-olds by US drug maker Pfizer generates weaker immune response than expected, the company has announced.\r\nThe company said a routine rev\u2026 [+3961 chars]"}, {"source": {"id": null, "name": "bdnews24.com"}, "author": null, "title": "Pfizer says pandemic could extend to 2024, vaccine data for younger children delayed", "description": "Pfizer Inc on Friday forecast that the COVID-19 pandemic would not be behind us until 2024 and said a lower-dose version of its vaccine for 2- to 4-year-olds generated a weaker immune response than expected, potentially delaying authorisation.", "url": "https://bdnews24.com/coronavirus-pandemic/2021/12/18/pfizer-says-pandemic-could-extend-to-2024-vaccine-data-for-younger-children-delayed", "urlToImage": "https://d30fl32nd2baj9.cloudfront.net/media/2020/11/09/pfizer-vaccine-091120-01.jpg/ALTERNATES/w640/pfizer-vaccine-091120-01.jpg", "publishedAt": "2021-12-18T04:48:52Z", "content": "Pfizer Chief Scientific Officer Mikael Dolsten\r\nsaid in a presentation to investors that the company expects some regions to\r\ncontinue to see pandemic levels of COVID-19 cases over the next year or t\u2026 [+2936 chars]"}]}, "2021-12-17": {"status": "ok", "totalResults": 137, "articles": [{"source": {"id": "reuters", "name": "Reuters"}, "author": "Reuters Editorial", "title": "CDC panel recommends Pfizer, Moderna over J&J shot - Reuters", "description": "A panel of outside advisers to the U.S. Centers for Disease Control and Prevention on Thursday voted to recommend Americans choose to receive one of the other two authorized COVID-19 vaccines over Johnson & Johnson's shot, due to rare but sometimes fatal case\u2026", "url": "https://www.reuters.com/video/watch/idPBOo?now=true", "urlToImage": "https://ajo.prod.reuters.tv/api/v2/img/61bbd0a4e4b09631b0e445ba-1639698596092?location=LANDSCAPE", "publishedAt": "2021-12-17T00:11:20Z", "content": "Posted \r\nA panel of outside advisers to the U.S. Centers for Disease Control and Prevention on Thursday voted to recommend Americans choose to receive one of the other two authorized COVID-19 vaccine\u2026 [+92 chars]"}, {"source": {"id": "reuters", "name": "Reuters"}, "author": "Reuters Editorial", "title": "Pfizer says vaccine data for younger children delayed - Reuters", "description": "Pfizer on Friday forecast that the COVID-19 pandemic would not be behind us until 2024 and said a lower-dose version of its vaccine for 2-4 year olds generated a weaker immune response than expected, potentially delaying authorization.", "url": "https://www.reuters.com/video/watch/idPBG6?now=true", "urlToImage": "https://ajo.prod.reuters.tv/api/v2/img/61bcfe7fe4b09631b0e4463a-1639775871185?location=LANDSCAPE", "publishedAt": "2021-12-17T22:52:14Z", "content": "Posted \r\nPfizer on Friday forecast that the COVID-19 pandemic would not be behind us until 2024 and said a lower-dose version of its vaccine for 2-4 year olds generated a weaker immune response than \u2026 [+44 chars]"}, {"source": {"id": null, "name": "Zacks.com"}, "author": "Zacks Equity Research", "title": "Pfizer (PFE) COVID Pill Paxlovid Gets CHMP Support in Europe", "description": "The CHMP supports the use of Pfizer's (PFE) oral COVID-19 drug, Paxlovid, to treat high-risk patients even though it has not received conditional authorization from the European Commission.", "url": "http://www.zacks.com/stock/news/1840655/pfizer-pfe-covid-pill-paxlovid-gets-chmp-support-in-europe?cid=CS-ENTREPRENEUR-FT-analyst_blog|company_news_-_medical_sector-1840655", "urlToImage": "https://assets.entrepreneur.com/providers/zacks/hero-image-zacks-403463.jpeg", "publishedAt": "2021-12-17T15:43:00Z", "content": "Pfizer PFE announced that the Committee for Medicinal Products for Human Use (\"CHMP\") of the European Medicines Agency (\"EMA\") has advised the use of its oral COVID-19 drug, Paxlovid. The drug can be\u2026 [+5089 chars]"}, {"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "EU to place order with Pfizer for COVID shots adapted to Omicron - Reuters", "description": "European Union governments have agreed to order over 180 million doses of an adapted version against Omicron of the COVID-19 vaccine developed by BioNTech <a href=\"https://www.reuters.com/companies/22UAy.DE\" target=\"_blank\">(22UAy.DE)</a> and Pfizer <a href=\"\u2026", "url": "https://www.reuters.com/world/europe/eu-place-order-with-pfizer-covid-shots-adapted-omicron-2021-12-17/", "urlToImage": "https://www.reuters.com/resizer/fFoeyW05UVpMCcBqIXpYU3vyX-s=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/U27WJ3QH6FO2JOJJK456YGVODI.jpg", "publishedAt": "2021-12-17T10:25:00Z", "content": "People pose with syringe with needle in front of displayed Pfizer logo in this illustration taken, December 11, 2021. REUTERS/Dado RuvicBRUSSELS, Dec 17 (Reuters) - European Union governments have ag\u2026 [+846 chars]"}, {"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "Japan PM Kishida speaks with Pfizer CEO on speeding vaccine boosters - media - Reuters", "description": "Japanese Prime Minister Fumio Kishida on Friday spoke with the country's biggest supplier of COVID-19 vaccines amid media reports he will seek to speed up the booster shot programme.", "url": "https://www.reuters.com/markets/asia/japan-pm-kishida-speaks-with-pfizer-ceo-speeding-vaccine-boosters-media-2021-12-17/", "urlToImage": "https://www.reuters.com/pf/resources/images/reuters/reuters-default.png?d=66", "publishedAt": "2021-12-17T07:15:00Z", "content": "TOKYO, Dec 17 (Reuters) - Japanese Prime Minister Fumio Kishida on Friday spoke with the country's biggest supplier of COVID-19 vaccines amid media reports he will seek to speed up the booster shot p\u2026 [+1450 chars]"}, {"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "CDC recommends Moderna, Pfizer COVID-19 vaccines over J&J's - Reuters", "description": "The U.S. Centers for Disease Control and Prevention on Thursday recommended Americans choose to receive one of two other authorised COVID-19 vaccines over Johnson & Johnson's <a href=\"https://www.reuters.com/companies/JNJ.N\" target=\"_blank\">(JNJ.N)</a> shot, \u2026", "url": "https://www.reuters.com/markets/stocks/cdc-recommends-moderna-pfizer-covid-19-vaccines-over-jjs-2021-12-17/", "urlToImage": "https://www.reuters.com/pf/resources/images/reuters/reuters-default.png?d=66", "publishedAt": "2021-12-17T15:36:00Z", "content": "Dec 17 (Reuters) - The U.S. Centers for Disease Control and Prevention on Thursday recommended Americans choose to receive one of two other authorised COVID-19 vaccines over Johnson &amp; Johnson's (\u2026 [+3206 chars]"}, {"source": {"id": null, "name": "NPR"}, "author": "Scott Neuman", "title": "Pfizer plan to test a third dose of its COVID vaccine on infants and young children", "description": "Pfizer and BioNTech, which produced the first COVID-19 vaccine authorized in the U.S., say they will expand ongoing trials to include a third dose for children as young as 6 months old.", "url": "https://www.npr.org/sections/coronavirus-live-updates/2021/12/17/1065200225/pfizer-third-dose-covid-vaccine-infants-young-children", "urlToImage": "https://media.npr.org/assets/img/2021/12/17/ap21336608878733_wide-aeb3401da28bfdc580b68efa00815e55e2735760.jpg?s=1400", "publishedAt": "2021-12-17T18:32:19Z", "content": "An information sign is displayed as a child arrives with her parent to receive the Pfizer COVID-19 vaccine for children 5 to 11-years-old at London Middle School in Wheeling, Ill., last month.\r\nNam Y\u2026 [+2190 chars]"}, {"source": {"id": "time", "name": "Time"}, "author": "LAURAN NEERGAARD and MIKE STOBBE / AP", "title": "U.S. Government Recommends Americans Get the Pfizer-BioNTech or Moderna COVID-19 Shots Instead of J&J\u2019s", "description": "Most Americans should be given the Pfizer or Moderna vaccines instead of the Johnson & Johnson shot that can cause rare but serious blood clots, U.S. health advisers recommended Thursday. The strange clotting problem has caused nine confirmed deaths after J&J\u2026", "url": "https://time.com/6129590/pfizer-moderna-vs-jandj/", "urlToImage": "https://api.time.com/wp-content/uploads/2021/12/jj-vaccine-2021.jpg?quality=85&w=1024&h=628&crop=1", "publishedAt": "2021-12-17T00:16:42Z", "content": "Most Americans should be given the Pfizer or Moderna vaccines instead of the Johnson &amp; Johnson shot that can cause rare but serious blood clots, U.S. health advisers recommended Thursday.\r\nThe st\u2026 [+5364 chars]"}, {"source": {"id": "bloomberg", "name": "Bloomberg"}, "author": null, "title": "CDC Backs Pfizer, Moderna Covid Vaccines (Podcast)", "description": "Understand every aspect of the global economy \u2013 and know how to make your next move.", "url": "https://www.bloomberg.com/news/audio/2021-12-17/cdc-backs-pfizer-moderna-covid-vaccines-podcast", "urlToImage": null, "publishedAt": "2021-12-17T02:27:40Z", "content": "Rachel Chang, Bloomberg's team leader for Asia consumer and healthcare, discusses the CDC's backing for Pfizer and Moderna's vaccines over J&amp;J's with Ed Baxter on Bloomberg Daybreak Asia.\r\nDec 17\u2026 [+5 chars]"}, {"source": {"id": "bloomberg", "name": "Bloomberg"}, "author": "Isabel Reynolds", "title": "Japan's Kishida Presses Pfizer CEO for Vaccines as Omicron Looms", "description": "Japanese Prime Minister Fumio Kishida called the CEO of Pfizer Inc. to seek faster delivery of coronavirus vaccines, TV Asahi reported Friday, as the country braces for the spread of the omicron variant.", "url": "https://www.bloomberg.com/news/articles/2021-12-17/japan-s-kishida-presses-pfizer-ceo-for-vaccines-as-omicron-looms", "urlToImage": "https://assets.bwbx.io/images/users/iqjWHBFdfxIU/i_.rCmyoAky8/v1/1200x800.jpg", "publishedAt": "2021-12-17T00:59:13Z", "content": "Japanese Prime Minister Fumio Kishida called the CEO of \r\nPfizer Inc. to seek faster delivery of coronavirus vaccines, TV Asahi reported Friday, as the country braces for the spread of the omicron va\u2026 [+1904 chars]"}, {"source": {"id": null, "name": "WebMD"}, "author": "https://www.facebook.com/WebMD", "title": "Pfizer COVID Vaccine for Younger Children Hits Snag", "description": "Pfizer\u2019s COVID-19 vaccine for children ages 2 to 5 years old fizzled in clinical trials, the company said on Friday, signaling a further delay in getting a vaccine to preschoolers just as Omicron bears down on the U.S.", "url": "https://www.webmd.com/vaccines/covid-19-vaccine/news/20211217/pfizer-covid-vaccine-younger-children-snag", "urlToImage": "https://img.webmd.com/dtmcms/live/webmd/consumer_assets/site_images/article_thumbnails/other/vaccine_covid19_other/1800x1200_vaccine_1_other.jpg", "publishedAt": "2021-12-17T21:44:14Z", "content": "[MUSIC PLAYING]\r\nSPEAKER: How does a COVID-19\r\nmRNA vaccine work?\r\nCOVID vaccines are now\r\navailable.\r\nSome of the COVID-19 vaccines\r\nare mRNA vaccines, but what does\r\nthis mean?\r\nmRNA vaccines are\r\n\u2026 [+2094 chars]"}, {"source": {"id": null, "name": "Motley Fool"}, "author": "newsfeedback@fool.com (Eric Volkman)", "title": "Why Pfizer and Johnson & Johnson Fell on Friday", "description": "One prominent investment bank expressed a distinct lack of enthusiasm for the two stocks.", "url": "https://www.fool.com/investing/2021/12/17/why-pfizer-and-johnson-johnson-fell-on-friday/", "urlToImage": "https://g.foolcdn.com/editorial/images/658036/elderly-customer-at-a-pharmacy.jpg", "publishedAt": "2021-12-17T23:40:50Z", "content": "What happened\r\nTwo prominent U.S. coronavirus stocks ended the week on a down note. Pfizer(NYSE:PFE) and Johnson &amp; Johnson(NYSE:JNJ) both fell on the day by nearly 3%. This followed a prominent i\u2026 [+1822 chars]"}, {"source": {"id": "bloomberg", "name": "Bloomberg"}, "author": "Riley Griffin", "title": "When Can Kids Under 5 Get Vaccinated? Pfizer Shifts Trial to Three Doses", "description": "Pfizer Inc. and BioNTech SE plan to study a three-dose regimen of their Covid-19 vaccine in young children 6 months to 4 years old, the companies said in a statement.", "url": "https://www.bloomberg.com/news/articles/2021-12-17/pfizer-to-study-three-shot-regimen-in-kids-6-months-to-4-years", "urlToImage": "https://assets.bwbx.io/images/users/iqjWHBFdfxIU/i8Ge1i0Puxd0/v1/1200x800.jpg", "publishedAt": "2021-12-17T14:18:57Z", "content": "Pfizer Inc. and \r\nBioNTech SE plan to study a three-dose regimen of their Covid-19 vaccine in young children 6 months to 4 years old, the companies said in a statement.\u00a0\r\nThe vaccine partners amended\u2026 [+1264 chars]"}, {"source": {"id": null, "name": "Motley Fool"}, "author": "newsfeedback@fool.com (George Budwell)", "title": "Here's Why Shares of Bristol Myers Squibb, Eli Lilly, and Pfizer Rocketed Higher This Week", "description": "These three big-pharma stocks exploded higher this week.", "url": "https://www.fool.com/investing/2021/12/17/heres-why-shares-of-bristol-myers-squibb-eli-lilly/", "urlToImage": "https://g.foolcdn.com/editorial/images/657887/toy-rocket.jpg", "publishedAt": "2021-12-17T11:44:00Z", "content": "What happened\r\nBig-pharma stocks have generally had an outstanding week thus far. Through Thursday's closing bell, Bristol Myers Squibb(NYSE:BMY) shares have tracked higher by a respectable 8.2%, Pfi\u2026 [+2372 chars]"}, {"source": {"id": null, "name": "Seeking Alpha"}, "author": "SA Transcripts", "title": "Pfizer (PFE) Investor Presentation - Slideshow", "description": "The following slide deck was published by Pfizer Inc.", "url": "https://seekingalpha.com/article/4475801-pfizer-pfe-investor-presentation-slideshow", "urlToImage": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png", "publishedAt": "2021-12-17T22:15:48Z", "content": "The following slide deck was published by Pfizer Inc. in conjunction with this event.\r\n\n\r\nView as PDF\r\nClick to Enlarge\r\n117"}, {"source": {"id": "the-times-of-india", "name": "The Times of India"}, "author": "AP", "title": "US CDC recommends Pfizer, Moderna COVID-19 shots over J&J's", "description": "Until now the U.S. has treated all three COVID-19 vaccines available to Americans as an equal choice, since large studies found they all offered strong protection and early supplies were limited. J&J's vaccine initially was welcomed as a single-dose option th\u2026", "url": "https://economictimes.indiatimes.com/news/international/world-news/us-cdc-recommend-pfizer-moderna-covid-19-shots-over-jjs/articleshow/88329758.cms", "urlToImage": "https://img.etimg.com/thumb/msid-88329797,width-1070,height-580,imgsize-45344,overlay-economictimes/photo.jpg", "publishedAt": "2021-12-17T01:16:04Z", "content": "Most Americans should be given the or Moderna vaccines instead of the Johnson &amp; Johnson shot that can cause rare but serious blood clots, U.S. health officials said Thursday.\r\nThe strange clottin\u2026 [+5388 chars]"}, {"source": {"id": null, "name": "The Guardian"}, "author": "Peter Beaumont", "title": "T-cells in people who have had Pfizer Covid jab stay robust against severe illness", "description": "Research in South Africa raises hopes that similar responses may be present with other vaccines<ul><li>Coronavirus \u2013 latest updates</li><li>See all our coronavirus coverage</li></ul>South African researchers examining how the body\u2019s immune system responds to \u2026", "url": "https://amp.theguardian.com/world/2021/dec/17/t-cells-pfizer-covid-jab-robust-against-severe-illness-south-africa-research", "urlToImage": "https://i.guim.co.uk/img/media/96c6408976ab22b83ab5a503af13e81237f5262f/0_236_3543_2126/master/3543.jpg?width=1200&height=630&quality=85&auto=format&fit=crop&overlay-align=bottom%2Cleft&overlay-width=100p&overlay-base64=L2ltZy9zdGF0aWMvb3ZlcmxheXMvdGctZGVmYXVsdC5wbmc&enable=upscale&s=d03c866375bd163b14d25a0c6193b2d4", "publishedAt": "2021-12-17T16:50:57Z", "content": "South African researchers examining how the bodys immune system responds to the Omicron variant have identified that T-cells in people who have had the Pfizer vaccine continue to be robust in potenti\u2026 [+4000 chars]"}, {"source": {"id": null, "name": "Forbes"}, "author": "Trefis Team, Contributor, \n Trefis Team, Contributor\n https://www.forbes.com/sites/greatspeculations/people/trefis/", "title": "Will Pfizer Stock See Higher Levels After A Large 18% Rise In A Month?", "description": "The stock price of Pfizer (NYSE: PFE) has outperformed the broader indices. While the S&P500 index has seen a rise of 1% over the last month or so, PFE stock is up a solid 19%. This also compares with -10% returns for its peer \u2013 Merck, and 5% growth for Johns\u2026", "url": "https://www.forbes.com/sites/greatspeculations/2021/12/17/will-pfizer-stock-see-higher-levels-after-a-large-18-rise-in-a-month/", "urlToImage": "https://thumbor.forbes.com/thumbor/fit-in/1200x0/filters%3Aformat%28jpg%29/https%3A%2F%2Fspecials-images.forbesimg.com%2Fimageserve%2F5fc9f88165fd2c07cd02256e%2F0x0.jpg", "publishedAt": "2021-12-17T12:00:35Z", "content": "The logo of US multinational pharmaceutical company Pfizer, is pictured at a factory in Puurs, where ... [+] Covid-19 vaccines are being produced for Britain, on December 3, 2020. - Britain on Decemb\u2026 [+12559 chars]"}, {"source": {"id": null, "name": "Forbes"}, "author": "Mason Bissada, Forbes Staff, \n Mason Bissada, Forbes Staff\n https://www.forbes.com/sites/masonbissada/", "title": "Pfizer Requests Full Approval For Covid-19 Vaccine For 12- To 15-Year-Olds", "description": "The pharmaceutical company said in November its vaccine gave the age group 100% long-term protection against the virus.", "url": "https://www.forbes.com/sites/masonbissada/2021/12/16/pfizer-requests-full-approval-for-covid-19-vaccine-for-12to-15-year-olds/", "urlToImage": "https://thumbor.forbes.com/thumbor/fit-in/1200x0/filters%3Aformat%28jpg%29/https%3A%2F%2Fspecials-images.forbesimg.com%2Fimageserve%2F61bbeb234f4c89e82741ffb0%2F0x0.jpg", "publishedAt": "2021-12-17T01:43:52Z", "content": "Pfizer and BioNTech announced Thursday they have asked the Food and Drug Administration to fully approve their Covid-19 vaccine for children ages 12 to 15, citing data that showed the shot gave 100% \u2026 [+3059 chars]"}, {"source": {"id": null, "name": "Snopes.com"}, "author": "Dan Evon", "title": "Did Pfizer CEO Say COVID-19 Vaccines Contain Microchips?", "description": "A 2018 video featuring Albert Bourla had nothing to do with COVID-19 or vaccines.", "url": "https://www.snopes.com/fact-check/pfizer-bourla-vaccine-microchip/", "urlToImage": "https://www.snopes.com/tachyon/2021/12/world-economic-forum.jpg", "publishedAt": "2021-12-17T18:24:00Z", "content": "Snopes is still fighting an infodemic of rumors and misinformation surrounding the COVID-19 pandemic, and you can help. Find out what weve learned and how to inoculate yourself against COVID-19 misin\u2026 [+6107 chars]"}]}, "2021-12-16": {"status": "ok", "totalResults": 98, "articles": [{"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "New Zealand approves Pfizer vaccine for children aged 5-11 years - Reuters", "description": "New Zealand's health regulator Medsafe has granted provisional approval for the Pfizer Inc <a href=\"https://www.reuters.com/companies/PFE.N\" target=\"_blank\">(PFE.N)</a> COVID-19 vaccine for children aged 5 to 11 years old, the health ministry said in a statem\u2026", "url": "https://www.reuters.com/world/asia-pacific/new-zealand-approves-pfizer-vaccine-children-aged-5-11-years-2021-12-16/", "urlToImage": "https://www.reuters.com/resizer/pySIyOfuU2gCA_JQhapeN-v53DU=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/LIIKYWVBYVILXMO7PE3OIDLKBA.jpg", "publishedAt": "2021-12-16T00:21:00Z", "content": "A vial labelled with the Pfizer-BioNTech coronavirus disease (COVID-19) vaccine is seen in this illustration picture taken March 19, 2021. REUTERS/Dado Ruvic/IllustrationWELLINGTON, Dec 16 (Reuters) \u2026 [+661 chars]"}, {"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "Japan adds Moderna shot to COVID vaccine booster arsenal, joining Pfizer - Reuters", "description": "Japan on Thursday officially approved Moderna Inc's <a href=\"https://www.reuters.com/companies/MRNA.O\" target=\"_blank\">(MRNA.O)</a> COVID-19 vaccine for its booster shot programme that began this month.", "url": "https://www.reuters.com/world/asia-pacific/japan-adds-moderna-shot-covid-vaccine-booster-arsenal-joining-pfizer-2021-12-16/", "urlToImage": "https://www.reuters.com/resizer/DNWCKjP-UTc21x4Fij5lqVdfy-U=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/LXZ7Q7HUERO4LJ6MQSEN5X7GLE.jpg", "publishedAt": "2021-12-16T03:19:00Z", "content": "TOKYO, Dec 16 (Reuters) - Japan on Thursday officially approved Moderna Inc's (MRNA.O) COVID-19 vaccine for its booster shot programme that began this month.\r\nThe move followed a recommendation from \u2026 [+1316 chars]"}, {"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "Pfizer files for full FDA approval of COVID-19 vaccine in adolescents - Reuters", "description": "Pfizer Inc <a href=\"https://www.reuters.com/companies/PFE.N\" target=\"_blank\">(PFE.N)</a> and its German partner BioNTech SE  said on Thursday they have filed for full approval of their COVID-19 vaccine with the U.S. Food and Drug Administration to include ado\u2026", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-files-full-fda-approval-covid-19-vaccine-adolescents-2021-12-16/", "urlToImage": "https://www.reuters.com/resizer/cwGkwK-smqTh4lr2uCTbyuSdIHw=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/YMX4DCRRGRNANNKVGSPMYL3K6U.jpg", "publishedAt": "2021-12-16T22:54:00Z", "content": "Dec 16 (Reuters) - Pfizer Inc (PFE.N) and its German partner BioNTech SE said on Thursday they have filed for full approval of their COVID-19 vaccine with the U.S. Food and Drug Administration to inc\u2026 [+1165 chars]"}, {"source": {"id": null, "name": "CP24 Toronto's Breaking News"}, "author": "Lauran Neergaard And Mike Stobbe", "title": "CDC panel recommends Pfizer, Moderna vaccines over Johnson & Johnson shot - CP24 Toronto's Breaking News", "description": "<ol><li>CDC panel recommends Pfizer, Moderna vaccines over Johnson & Johnson shot\u00a0\u00a0CP24 Toronto's Breaking News\r\n</li><li>CDC recommends Moderna, Pfizer COVID-19 vaccines over J&J's\u00a0\u00a0National Post\r\n</li><li>Pfizer, Moderna Covid Shots Preferred Over J&J's, CD\u2026", "url": "https://www.cp24.com/world/cdc-panel-recommends-pfizer-moderna-vaccines-over-johnson-johnson-shot-1.5710521", "urlToImage": "https://www.cp24.com/polopoly_fs/1.5704853.1639399008!/httpImage/image.jpg_gen/derivatives/landscape_620/image.jpg", "publishedAt": "2021-12-16T20:56:47Z", "content": "Most Americans should be given the Pfizer or Moderna vaccines instead of the Johnson &amp; Johnson shot that can cause rare but serious blood clots, U.S. health officials said Thursday.\r\nThe strange \u2026 [+5281 chars]"}, {"source": {"id": null, "name": "HuffPost"}, "author": "AP", "title": "CDC Panel Recommends Pfizer, Moderna Vaccines Over J&J Shot", "description": "U.S. health advisers are recommending that most Americans get the Pfizer or Moderna vaccines instead of the Johnson & Johnson shot.", "url": "https://www.huffpost.com/entry/cdc-johnson-johnson-pfizer_n_61bbb1cfe4b0bf370338955c", "urlToImage": "https://img.huffingtonpost.com/asset/61bbb1d1280000b98d7ece6f.jpeg?ops=1778_1000", "publishedAt": "2021-12-16T21:43:20Z", "content": "Most Americans should be given the Pfizer or Moderna vaccines instead of the Johnson &amp; Johnson shot that can cause rare but serious blood clots, U.S. health advisers recommended Thursday.\r\nThe st\u2026 [+3898 chars]"}, {"source": {"id": "abc-news", "name": "ABC News"}, "author": "Cheyenne Haslett", "title": "CDC committee recommends opting for Pfizer or Moderna over J&J when there's a choice", "description": "The rare blood clots are not a new safety concern, and the vaccine has already become far less common in the US.", "url": "https://abcnews.go.com/Politics/cdc-committee-recommends-opting-pfizer-moderna-jj-choice/story?id=81797560", "urlToImage": "https://s.abcnews.com/images/Health/connecticut-covid-01-gty-llr-211207_1638927273426_hpMain_16x9_992.jpg", "publishedAt": "2021-12-16T21:15:53Z", "content": "The CDC's advisory committee recommended Thursday that people who have a choice should get an mRNA vaccine, either Pfizer or Moderna, over the single-shot Johnson &amp; Johnson vaccine after a review\u2026 [+5774 chars]"}, {"source": {"id": "usa-today", "name": "USA Today"}, "author": "USA TODAY, Elizabeth Weise, USA TODAY", "title": "CDC panel recommends Pfizer, Moderna COVID vaccines over Johnson & Johnson for people 18 and older", "description": "A CDC panel recommended the Pfizer and Moderna\u00a0COVID-19 vaccines be preferred over J&J's due to the chance of rare but dangerous blood clots.", "url": "https://www.usatoday.com/story/news/health/2021/12/16/cdc-panel-recommends-pfizer-moderna-covid-vaccines-over-johnson-johnson/8929073002/", "urlToImage": "https://www.gannett-cdn.com/-mm-/b2b05a4ab25f4fca0316459e1c7404c537a89702/c=0-0-1365-768/local/-/media/2021/12/14/USATODAY/usatsports/imageForEntry27-1pA.jpg?auto=webp&format=pjpg&width=1200", "publishedAt": "2021-12-16T20:43:10Z", "content": "A CDC panel voted Thursday to\u00a0recommend the Pfizer and Moderna\u00a0COVID-19 vaccines be preferred for adults\u00a0over the Johnson &amp; Johnson vaccine due to a small number of very rare but dangerous blood \u2026 [+1368 chars]"}, {"source": {"id": null, "name": "CNET"}, "author": "Jessica Rendall", "title": "CDC committee recommends Moderna, Pfizer vaccines over Johnson & Johnson's - CNET", "description": "A panel that advises the CDC says the agency should adopt the recommendation because of a rare but dangerous blood-clotting disorder that's been linked to the J&J vaccine.", "url": "https://www.cnet.com/health/medical/cdc-committee-recommends-moderna-pfizer-vaccines-over-johnson-johnsons/", "urlToImage": "https://www.cnet.com/a/img/DIokPAs8y4IzuE2lt70Pd09OPeg=/1200x630/2021/12/16/e86b83cb-e165-43a8-8b87-d4e55ca8a78e/gettyimages-1312932254-1.jpg", "publishedAt": "2021-12-16T23:03:01Z", "content": "Getty Images\r\nA committee of scientists and doctors that give guidance to the US Centers for Disease Control and Prevention voted Thursday to recommend Pfizer's and Moderna's COVID-19 vaccines over J\u2026 [+2860 chars]"}, {"source": {"id": "bloomberg", "name": "Bloomberg"}, "author": "Tracy Withers", "title": "New Zealand Provisionally Approves Pfizer Vaccine for Ages 5-11", "description": "New Zealand\u2019s medicines regulator has provisionally approved the use of the Pfizer Covid-19 vaccine for children aged five to 11.", "url": "https://www.bloomberg.com/news/articles/2021-12-16/new-zealand-provisionally-approves-pfizer-vaccine-for-ages-5-11", "urlToImage": "https://assets.bwbx.io/images/users/iqjWHBFdfxIU/iN8.lELke3bU/v0/1200x800.jpg", "publishedAt": "2021-12-16T00:28:00Z", "content": "New Zealands medicines regulator has provisionally approved the use of the Pfizer Covid-19 vaccine for children aged five to 11.\r\nThe provisional approval is for two doses of the pediatric vaccine gi\u2026 [+162 chars]"}, {"source": {"id": null, "name": "Motley Fool"}, "author": "newsfeedback@fool.com (Eric Volkman)", "title": "Why Moderna and Pfizer Beat the Market Today", "description": "An influential advisory committee burnishes the reputations of the two companies' coronavirus vaccines, while one gets a glowing write-up about its COVID-19 pill.", "url": "https://www.fool.com/investing/2021/12/16/why-moderna-and-pfizer-beat-the-market-today/", "urlToImage": "https://g.foolcdn.com/editorial/images/657886/pregnant-woman-receiving-a-vaccine-jab.jpg", "publishedAt": "2021-12-16T23:10:00Z", "content": "What happened\r\nModerna(NASDAQ:MRNA) and Pfizer(NYSE:PFE), makers of two of the three coronavirus vaccines authorized for use in the U.S., both outpaced the sagging S&amp;P 500 index on Thursday. Mode\u2026 [+1957 chars]"}, {"source": {"id": "bloomberg", "name": "Bloomberg"}, "author": "James Paton", "title": "Pfizer Will Dominate $20 Billion Covid-Pill Market in 2022, Analysis Shows", "description": "Large-scale generic-drug production\u00a0likely won\u2019t come until 2023, data firm says", "url": "https://www.bloomberg.com/news/articles/2021-12-16/pfizer-pfe-will-dominate-20-billion-covid-pill-market-in-2022-analysis-shows", "urlToImage": "https://assets.bwbx.io/s3/javelin/public/javelin/images/social-default-a4f15fa7ee.jpg", "publishedAt": "2021-12-16T17:06:16Z", "content": "Pfizer Inc. is set to dominate a $20 billion market for Covid pills next year as richer nations rush to purchase supplies, while less affluent countries will have to wait until early 2023 for generic\u2026 [+6410 chars]"}, {"source": {"id": "bloomberg", "name": "Bloomberg"}, "author": "Corinne Gretler, Naomi Kresge", "title": "Pfizer Covid Pill Can Be Used to Treat Adults, EU Regulator Says", "description": "A European Union advisory committee said Pfizer Inc.\u2019s experimental antiviral pill against Covid-19 can be used to treat adults, opening up another potential tool as the region prepares for the possibility of a wave of infections from the omicron variant.", "url": "https://www.bloomberg.com/news/articles/2021-12-16/pfizer-covid-pill-can-be-used-to-treat-adults-eu-regulator-says", "urlToImage": "https://assets.bwbx.io/images/users/iqjWHBFdfxIU/ilD.HvfJkruY/v0/1200x801.jpg", "publishedAt": "2021-12-16T15:55:13Z", "content": "A European Union advisory committee said \r\nPfizer Inc.s experimental antiviral pill against Covid-19 can be used to treat adults, opening up another potential tool as the region prepares for the poss\u2026 [+476 chars]"}, {"source": {"id": null, "name": "The Guardian"}, "author": "Guardian staff and agencies", "title": "CDC advisers recommend Pfizer and Moderna vaccines over Johnson & Johnson", "description": "The panel cited the risk of rare but sometimes fatal cases of blood clotting as well as a lower level of effectiveness against Covid in the J&J shotA panel of outside advisers to the Centers for Disease Control and Prevention (CDC) on Thursday voted to recomm\u2026", "url": "https://amp.theguardian.com/world/2021/dec/16/cdc-recommends-pfizer-moderna-covid-vaccines", "urlToImage": "https://i.guim.co.uk/img/media/6e3691e2c807c7d650dd1f54edf96269ad0905e9/0_138_5760_3456/master/5760.jpg?width=1200&height=630&quality=85&auto=format&fit=crop&overlay-align=bottom%2Cleft&overlay-width=100p&overlay-base64=L2ltZy9zdGF0aWMvb3ZlcmxheXMvdGctZGVmYXVsdC5wbmc&enable=upscale&s=bb5c6f06e8e13f6fd5a6ee801e00be8a", "publishedAt": "2021-12-16T21:41:03Z", "content": "A panel of outside advisers to the Centers for Disease Control and Prevention (CDC) on Thursday voted to recommend directing Americans towards the mRNA vaccines for protection against Covid-19 meanin\u2026 [+2256 chars]"}, {"source": {"id": null, "name": "SlashGear"}, "author": "Brittany A. Roston", "title": "CDC advisers recommend Pfizer, Moderna vaccines over Johnson & Johnson", "description": "When possible, advisers with the US Centers for Disease Control and Prevention say the public should choose Pfizer or Moderna\u2019s COVID-19 vaccines over the Johnson & Johnson version. The agency has published a lengthy presentation from the Advisory Committee o\u2026", "url": "https://www.slashgear.com/cdc-advisers-recommend-pfizer-moderna-vaccines-over-johnson-johnson-16702992/", "urlToImage": "https://cdn.slashgear.com/wp-content/uploads/2021/12/CDC-johnson-covid-vaccine-change-recommendation.jpg", "publishedAt": "2021-12-16T22:26:33Z", "content": "When possible, advisers with the US Centers for Disease Control and Prevention say the public should choose Pfizer or Moderna\u2019s COVID-19 vaccines over the Johnson &amp; Johnson version. The agency ha\u2026 [+3830 chars]"}, {"source": {"id": null, "name": "The Indian Express"}, "author": "Reuters", "title": "Covid-19: New Zealand approves Pfizer vaccine for children aged 5-11 years", "description": "The provisional approval is for two doses of the paediatric Pfizer Covid-19 vaccine, given at least 21 days apart, New Zealand\u2019s health regulator  said.", "url": "https://indianexpress.com/article/world/new-zealand-approves-pfizer-vaccine-for-children-aged-5-11-years-7675416/", "urlToImage": "https://images.indianexpress.com/2021/11/2021-11-01T011127Z_871970238_RC2A7O9F52KN_RTRMADP_3_PFIZER-RESULTS.jpg", "publishedAt": "2021-12-16T03:54:13Z", "content": "New Zealands health regulator Medsafe has granted provisional approval for the Pfizer Inc Covid-19 vaccine for children aged 5 to 11 years old, the health ministry said in a statement.The provisional\u2026 [+280 chars]"}, {"source": {"id": null, "name": "Forbes"}, "author": "Marisa Dellatto, Forbes Staff, \n Marisa Dellatto, Forbes Staff\n https://www.forbes.com/sites/marisadellatto/", "title": "Moderna, Pfizer Covid Vaccines Should Be Given Over Johnson & Johnson\u2019s, CDC Advisory Board Says", "description": "The CDC has not yet decided if it will accept the recommendation and remove the shot from the market.", "url": "https://www.forbes.com/sites/marisadellatto/2021/12/16/moderna-pfizer-covid-vaccines-should-be-given-over-johnson--johnsons-cdc-advisory-board-says/", "urlToImage": "https://thumbor.forbes.com/thumbor/fit-in/1200x0/filters%3Aformat%28jpg%29/https%3A%2F%2Fspecials-images.forbesimg.com%2Fimageserve%2F61bbc1c67f7a2a18cd91fb68%2F0x0.jpg%3FcropX1%3D0%26cropX2%3D3244%26cropY1%3D0%26cropY2%3D1825", "publishedAt": "2021-12-16T22:49:31Z", "content": "A Centers For Disease Control and Prevention advisory board recommended Thursday that Moderna and Pfizers Covid-19 vaccines should be administered rather than Johnson &amp; Johnsons one-dose shot, ci\u2026 [+2152 chars]"}, {"source": {"id": null, "name": "Designtaxi.com"}, "author": "Alexa Heah", "title": "Pfizer Says New COVID-19 Pill Could Help Treat Rapidly-Spreading Omicron", "description": "Image ID 210332358 \u00a9 via Esther19775 | Dreamstime.com\n\nIn mid-November, Pfizer announced it was seeking approval from the US Food and Drug Administration (FDA) for its COVID-19 treatment pill, which could potentially help treat patients at a higher risk of de\u2026", "url": "https://designtaxi.com/news/417049/Pfizer-Says-New-COVID-19-Pill-Could-Help-Treat-Rapidly-Spreading-Omicron/", "urlToImage": "https://editorial.designtaxi.com/editorial-images/news-PfizerPillVariant161221/Pfizer-Pill-Variant-1.jpeg", "publishedAt": "2021-12-16T05:10:10Z", "content": "Image ID 210332358 \u00a9 via Esther19775 | Dreamstime.comIn mid-November, Pfizer announced it was seeking approval from the US Food and Drug Administration (FDA) for its COVID-19 treatment pill, which co\u2026 [+2547 chars]"}, {"source": {"id": null, "name": "Fox Business"}, "author": "Paul Best", "title": "CDC recommends Pfizer and Moderna vaccines over Johnson & Johnson due to rare blood clotting issue - Fox Business", "description": "The CDC now recommends that Americans take the mRNA vaccines made by Pfizer and Moderna instead of the one-shot Johnson & Johnson vaccine due to\u00a0rare but serious blood clots.", "url": "https://www.foxbusiness.com/economy/cdc-advisory-panel-recommends-pfizer-and-modern-vaccines-over-johnson-johnson", "urlToImage": "https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2021/07/0/0/Johnson-Johnson-Vaccine-Delta.jpg?ve=1&tl=1", "publishedAt": "2021-12-16T20:59:28Z", "content": "The CDC now recommends that Americans take the mRNA vaccines made by Pfizer and Moderna instead of the one-shot Johnson &amp; Johnson vaccine due to\u00a0rare but serious blood clots.\r\nThe agency's Adviso\u2026 [+3870 chars]"}, {"source": {"id": "national-review", "name": "National Review"}, "author": "Brittany Bernstein, Brittany Bernstein", "title": "CDC Panel Recommends Pfizer, Moderna Vaccines over J&J Due to Rare Blood Clot Cases", "description": "The vote serves to discourage vaccine providers and American adults from using the one-dose vaccine.", "url": "https://www.nationalreview.com/news/cdc-panel-recommends-pfizer-moderna-vaccines-over-jj-due-to-rare-blood-clot-cases/", "urlToImage": "https://www.nationalreview.com/wp-content/uploads/2021/05/vaccine.jpg?fit=2057%2C1200", "publishedAt": "2021-12-16T22:11:15Z", "content": "A healthcare worker prepares a dose of the Johnson &amp; Johnson vaccine in New York, May 12, 2021.(Carlo Allegri/Reuters)\r\nA CDC advisory panel on Thursday voted to recommend that adults 18 and over\u2026 [+2344 chars]"}, {"source": {"id": "cbs-news", "name": "CBS News"}, "author": "CBS News", "title": "South African study says 2 doses of Pfizer vaccine 70% effective against Omicron hospitalization", "description": "A new study out of South Africa claims that two doses of Pfizer's COVID vaccine give up to 70% protection against hospitalization from the Omicron variant, despite an increase in children being hospitalized by the new variant. Debora Patta speaks with a pedia\u2026", "url": "https://www.cbsnews.com/video/south-african-study-says-two-doses-of-pfizer-vaccine-70percent-effective-against-omicron-hospitalization/", "urlToImage": "https://cbsnews2.cbsistatic.com/hub/i/r/2021/12/15/0c14c571-9409-4358-9342-a0986f2f4f8a/thumbnail/1200x630/1c7a68f2c92000536bb1c8e91795df07/1215-ctm-southafricaomicronvaxkids-patta-856412-640x360.jpg", "publishedAt": "2021-12-16T03:35:40Z", "content": "Watch CBSN Live\r\nCopyright \u00a9 2021 CBS Interactive Inc. All rights reserved.\r\nGet browser notifications for breaking news, live events, and exclusive reporting.\r\nNot NowTurn On"}]}, "2021-12-15": {"status": "ok", "totalResults": 58, "articles": [{"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "Pfizer set to oust AstraZeneca as top supplier of COVID-19 shots to poor nations - Reuters", "description": "Pfizer <a href=\"https://www.reuters.com/companies/PFE.N\" target=\"_blank\">(PFE.N)</a> and BioNtech <a href=\"https://www.reuters.com/companies/22UAy.DE\" target=\"_blank\">(22UAy.DE)</a> are set to displace AstraZeneca <a href=\"https://www.reuters.com/companies/AZ\u2026", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-set-oust-astrazeneca-top-supplier-covid-19-shots-poor-nations-2021-12-15/", "urlToImage": "https://www.reuters.com/resizer/zqVKXHnosclneKBBNjva9dTGYBU=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/RVB4EWSAT5PKHCFJME7AYIOIOQ.jpg", "publishedAt": "2021-12-15T06:03:00Z", "content": "BRUSSELS, Dec 15 (Reuters) - Pfizer (PFE.N) and BioNtech (22UAy.DE) are set to displace AstraZeneca (AZN.L) as the main suppliers of COVID-19 vaccines to the global COVAX programme at the start of 20\u2026 [+4223 chars]"}, {"source": {"id": null, "name": "Zacks.com"}, "author": "Zacks Equity Research", "title": "The Zacks Analyst Blog Highlights: Pfizer, Arena Pharma, Merck, Jazz Pharm and Sanofi", "description": "The Zacks Analyst Blog Highlights: Pfizer, Arena Pharma, Merck, Jazz Pharm and Sanofi", "url": "http://www.zacks.com/stock/news/1839444/the-zacks-analyst-blog-highlights-pfizer-arena-pharma-merck-jazz-pharm-and-sanofi?cid=CS-ENTREPRENEUR-FT-press_releases-1839444", "urlToImage": "https://assets.entrepreneur.com/providers/zacks/hero-image-zacks-402829.jpeg", "publishedAt": "2021-12-15T10:00:00Z", "content": "For Immediate Release\r\nChicago, IL December 15, 2021 Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and even\u2026 [+6118 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "The Hill", "title": "Pfizer requests EMERGENCY authorization for 'effective' Covid antiviral pill as deaths near 800,000", "description": "Ryan Grim and Robby Soave weigh in on the Senate debt ceiling vote, as well as Pfizer's efforts to earn FDA approval for their antiviral Covid treatment...", "url": "https://news.yahoo.com/pfizer-requests-emergency-authorization-effective-134000505.html", "urlToImage": "https://s.yimg.com/hd/cp-video-transcode/prod/2021-12/15/61b9f2d124ffa931eb944a22/61b9f2d124ffa931eb944a23_o_U_v2.jpg", "publishedAt": "2021-12-15T13:40:00Z", "content": "The study, published in the Nature Medicine journal, compared the risks of myocarditis, pericarditis and cardiac arrhythmia following a first and second dose of COVID-19 vaccines from AstraZeneca-Oxf\u2026 [+309 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "CBS News Videos", "title": "South African study says two doses of Pfizer vaccine 70% effective against Omicron hospitalization", "description": "A new study out of South Africa claims that two doses of Pfizer's COVID vaccine give up to 70% protection against hospitalization from the Omicron variant...", "url": "https://news.yahoo.com/south-african-study-says-double-131839618.html", "urlToImage": "https://s.yimg.com/hd/cp-video-transcode/prod/2021-12/15/61b9eddb24ffa931eb94386e/61b9eddb24ffa931eb94386f_o_U_v2.jpg", "publishedAt": "2021-12-15T13:18:39Z", "content": "Scientists say they finally have an explanation for a mystifying, bright blue light that came from deep in space. Three years ago, astronomers were stunned to see a bright blue flash that came out of\u2026 [+360 chars]"}, {"source": {"id": null, "name": "Theonion.com"}, "author": "ji39f8deollek3", "title": "Pfizer Granted Emergency Use For Pill That Kills You Before Covid Can", "description": "WASHINGTON\u2014Stressing that the \u201crevolutionary treatment\u201d could change the way we fight the novel coronavirus, drug manufacturer Pfizer was granted emergency use authorization Wednesday for a pill that kills you before Covid can. \u201cAfter several months of testin\u2026", "url": "https://www.theonion.com/pfizer-granted-emergency-use-for-pill-that-kills-you-be-1848214138", "urlToImage": "https://i.kinja-img.com/gawker-media/image/upload/c_fill,f_auto,fl_progressive,g_center,h_675,pg_1,q_80,w_1200/fee9c5e72e74900965511976af843be8.jpg", "publishedAt": "2021-12-15T15:55:00Z", "content": "WASHINGTONStressing that the revolutionary treatment could change the way we fight the novel coronavirus, drug manufacturer Pfizer was granted emergency use authorization Wednesday for a pill that ki\u2026 [+1086 chars]"}, {"source": {"id": null, "name": "Motley Fool"}, "author": "newsfeedback@fool.com (Joe Tenebruso)", "title": "Why Pfizer Stock Jumped Today", "description": "Even more gains could lie ahead for the vaccine maker's investors.", "url": "https://www.fool.com/investing/2021/12/15/why-pfizer-stock-jumped-today/", "urlToImage": "https://g.foolcdn.com/editorial/images/657690/buy-gettyimages-986757634.jpg", "publishedAt": "2021-12-15T21:04:47Z", "content": "What happened\r\nShares of\u00a0Pfizer(NYSE:PFE) rose on Wednesday, following positive analyst commentary.\r\nAs of 3:30 p.m. ET, the drugmaker's stock price was up more than 5%.\u00a0\r\nSo what\u00a0\r\nOn Monday, UBS an\u2026 [+1600 chars]"}, {"source": {"id": "bloomberg", "name": "Bloomberg"}, "author": "Janice Kew, Antony Sguazzin", "title": "Pfizer Shots And Prior Infection May Protect Better Against Omicron, South African Scientists Say", "description": "A two dose course of Pfizer Inc. and BioNTech SE\u2019s Covid-19 shot as well as a previous infection with the disease may give stronger protection against the omicron variant, scientists from South Africa\u2019s Africa Health Research Institute said.", "url": "https://www.bloomberg.com/news/articles/2021-12-15/pfizer-prior-infection-may-see-better-covid-shield-ahri-says", "urlToImage": "https://assets.bwbx.io/images/users/iqjWHBFdfxIU/ime4J9y9QFxg/v0/1200x800.jpg", "publishedAt": "2021-12-15T18:14:20Z", "content": "A two dose course of \r\nPfizer Inc. and \r\nBioNTech SEs Covid-19 shot as well as a previous infection with the disease may give stronger protection against the omicron variant, scientists from South Af\u2026 [+759 chars]"}, {"source": {"id": null, "name": "Forbes"}, "author": "Robert Hart, Forbes Staff, \n Robert Hart, Forbes Staff\n https://www.forbes.com/sites/roberthart/", "title": "Pfizer, Moderna Vaccines Less Effective Against Delta In Elderly And Protection Wanes Rapidly Four Months After Second Covid Shot, Study Finds", "description": "The mRNA shots were around 20% effective at preventing infection with delta in males over age 65 months five through seven after completing vaccination.", "url": "https://www.forbes.com/sites/roberthart/2021/12/15/pfizer-moderna-vaccines-less-effective-against-delta-in-elderly-and-protection-wanes-rapidly-four-months-after-second-covid-shot-study-finds/", "urlToImage": "https://thumbor.forbes.com/thumbor/fit-in/1200x0/filters%3Aformat%28jpg%29/https%3A%2F%2Fspecials-images.forbesimg.com%2Fimageserve%2F61ba13a4011ae60a27cce11f%2F0x0.jpg%3FcropX1%3D0%26cropX2%3D5524%26cropY1%3D229%26cropY2%3D3337", "publishedAt": "2021-12-15T16:17:31Z", "content": "Pfizer and Modernas Covid-19 vaccines are much less effective at preventing infection of senior citizens with the delta coronavirus variant and protection fades rapidly four months after the final ja\u2026 [+2824 chars]"}, {"source": {"id": "independent", "name": "Independent"}, "author": "Francesco Guarascio", "title": "Pfizer set to oust AstraZeneca as top supplier of Covid-19 shots to poor nations", "description": "UNICEF and WHO warn about insufficient supply of auto-disable syringes", "url": "https://www.independent.co.uk/news/health/pfizer-astrazeneca-supplier-covid19-poor-b1976406.html", "urlToImage": "https://static.independent.co.uk/2021/12/14/16/6d8dd759c7035de31ae7c5577063190dY29udGVudHNlYXJjaGFwaSwxNjM5NTgzNzYx-2.64080164.jpg?width=1200&auto=webp&quality=75", "publishedAt": "2021-12-15T14:01:12Z", "content": "Pfizer and BioNtech are set to displace AstraZeneca as the main suppliers of Covid-19 vaccines to the global COVAX programme at the start of 2022, a shift that shows the increasing importance of thei\u2026 [+3890 chars]"}, {"source": {"id": "cbs-news", "name": "CBS News"}, "author": "CBS News", "title": "South African study says two doses of Pfizer vaccine 70% effective against Omicron hospitalization", "description": "A new study out of South Africa claims that two doses of Pfizer's COVID vaccine give up to 70% protection against hospitalization from the Omicron variant, despite an increase in children being hospitalized by the new variant. Debora Patta speaks with a pedia\u2026", "url": "https://www.cbsnews.com/video/south-african-study-says-two-doses-of-pfizer-vaccine-70-effective-against-omicron-hospitalization/", "urlToImage": "https://cbsnews2.cbsistatic.com/hub/i/r/2021/12/15/0c14c571-9409-4358-9342-a0986f2f4f8a/thumbnail/1200x630/1c7a68f2c92000536bb1c8e91795df07/1215-ctm-southafricaomicronvaxkids-patta-856412-640x360.jpg", "publishedAt": "2021-12-15T13:27:34Z", "content": "Watch CBSN Live\r\nCopyright \u00a9 2021 CBS Interactive Inc. All rights reserved.\r\nGet browser notifications for breaking news, live events, and exclusive reporting.\r\nNot NowTurn On"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "Research and Markets", "title": "European Drug Discovery Industry to 2030 - Featuring Bayer, Novartis and Pfizer Among Others", "description": "Dublin, Dec. 15, 2021 (GLOBE NEWSWIRE) -- The \"Europe Drug Discovery Market 2020-2030 by Drug Type, Service, Process, Technology, Therapeutic Area, End User,...", "url": "https://finance.yahoo.com/news/european-drug-discovery-industry-2030-091300201.html", "urlToImage": "https://s.yimg.com/uu/api/res/1.2/HP.E8HUfnyGeLtMAKwLgAQ--~B/aD01ODt3PTQ4MDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/93d5b27580f67db722dd7c112e43e8bc", "publishedAt": "2021-12-15T09:13:00Z", "content": "Dublin, Dec. 15, 2021 (GLOBE NEWSWIRE) -- The \"Europe Drug Discovery Market 2020-2030 by Drug Type, Service, Process, Technology, Therapeutic Area, End User, and Country: Trend Forecast and Growth Op\u2026 [+7547 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "Ya\u0451l Bizouati-Kennedy", "title": "Pfizer Stock Rises as Study Links COVID Pill to 89% Reduction of Hospitalization, Death", "description": "Pfizer released results of a recent study on Dec. 14, stating that its COVID-19 oral antiviral pill -- Paxlovid -- reduced risk of hospitalization or death...", "url": "https://finance.yahoo.com/news/pfizer-stock-rises-study-links-163125739.html", "urlToImage": "https://s.yimg.com/ny/api/res/1.2/vcWWs8ULpWOYoSCj6_eICA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzU-/https://s.yimg.com/uu/api/res/1.2/SBgxV33XseCek_XNCVPPSA--~B/aD0xMDgwO3c9MTkyMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/gobankingrates_644/5d2e7dc9f73c16aaf68a844c68dab3ce", "publishedAt": "2021-12-15T16:31:25Z", "content": "Spencer Platt / Getty Images\r\nPfizer released results of a recent study on Dec. 14, stating that its COVID-19 oral antiviral pill Paxlovid reduced risk of hospitalization or death by 89% within three\u2026 [+3499 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "Francesco Guarascio", "title": "Pfizer set to oust AstraZeneca as top supplier of COVID-19 shots to poor nations", "description": "Pfizer and BioNtech are set to displace AstraZeneca as the main suppliers of COVID-19 vaccines to the global COVAX programme at the start of 2022, a shift...", "url": "https://news.yahoo.com/pfizer-set-oust-astrazeneca-top-060325628.html", "urlToImage": "https://s.yimg.com/uu/api/res/1.2/LvRqFqTnSbDXOXMO9IqPmA--~B/aD00OTQ7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/16d1e69b70a7746388246ff8d1255535", "publishedAt": "2021-12-15T06:03:25Z", "content": "By Francesco Guarascio\r\nBRUSSELS (Reuters) - Pfizer and BioNtech are set to displace AstraZeneca as the main suppliers of COVID-19 vaccines to the global COVAX programme at the start of 2022, a shift\u2026 [+4039 chars]"}, {"source": {"id": null, "name": "Moneycontrol"}, "author": null, "title": "Pfizer set to oust AstraZeneca as top supplier of COVID-19 shots to poor nations", "description": "The expected change comes with headaches for receiving countries that lack sufficient cold storage capacity to handle the Pfizer vaccine, and amid risks of a shortage of syringes needed to administer that shot.", "url": "https://www.moneycontrol.com/news/trends/health-trends/pfizer-set-to-oust-astrazeneca-as-top-supplier-of-covid-19-shots-to-poor-nations-7827751.html", "urlToImage": "https://images.moneycontrol.com/static-mcnews/2021/12/pfizer-astrazeneca-770x433.png", "publishedAt": "2021-12-15T06:23:52Z", "content": "Pfizer and BioNtech are set to displace AstraZeneca as the main suppliers of COVID-19 vaccines to the global COVAX programme at the start of 2022, a shift that shows the increasing importance of thei\u2026 [+3812 chars]"}, {"source": {"id": null, "name": "AllAfrica - Top Africa News"}, "author": "VOA", "title": "South Africa: Pfizer Vaccine Provides Protection Against Hospitalisation in Omicron Patients - New Studies", "description": "[VOA] A new study out of South Africa shows that Pfizer's two-dose COVID-19 vaccine provides a high degree of protection against hospitalization from the fast-spreading omicron variant.", "url": "https://allafrica.com/stories/202112150036.html", "urlToImage": "https://cdn08.allafrica.com/download/pic/main/main/csiid/00591463:1339f9991956e22b0818911cd9097902:arc614x376:w1200.jpg", "publishedAt": "2021-12-15T05:57:35Z", "content": "A new study out of South Africa shows that Pfizer's two-dose COVID-19 vaccine provides a high degree of protection against hospitalization from the fast-spreading omicron variant.\r\nThe real-world stu\u2026 [+4168 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "PR Newswire", "title": "Global Targeted Therapeutics Market Report 2021-2026 Featuring Major Players - Amgen, AstraZeneca, Boehringer Ingelheim, BMS, F. Hoffmann-La Roche, Pfizer, Novartis, Merck & Co., and Takeda", "description": "The \"Global Targeted Therapeutics Market 2021-2026\" report has been added to ResearchAndMarkets.com's offering.", "url": "https://finance.yahoo.com/news/global-targeted-therapeutics-market-report-170000380.html", "urlToImage": "https://s.yimg.com/uu/api/res/1.2/wDGPSO44TROYKbQSONxNmQ--~B/aD00Mjt3PTQwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/prnewswire.com/e75ef6f3096d7cb6f5dd43ba82eca2fe", "publishedAt": "2021-12-15T17:00:00Z", "content": "DUBLIN, Dec. 15, 2021 /PRNewswire/ -- The \"Global Targeted Therapeutics Market 2021-2026\" report has been added to ResearchAndMarkets.com's offering.\r\nResearch and Markets Logo\r\nThe global market for\u2026 [+6228 chars]"}, {"source": {"id": null, "name": "Newkerala.com"}, "author": "Naveen", "title": "Pfizer, Moderna, J and Js Covid vax less effective against Omicron: Study - newkerala.com - New Kerala", "description": "<ol><li>Pfizer, Moderna, J and Js Covid vax less effective against Omicron: Study - newkerala.com\u00a0\u00a0New Kerala\r\n</li><li>J&J Shot Loses Antibody Protection Against Omicron In Study\u00a0\u00a0NDTV\r\n</li><li>Matter of time before Omicron variant becomes dominant strain i\u2026", "url": "https://www.newkerala.com/news/2021/176522.htm", "urlToImage": null, "publishedAt": "2021-12-15T21:25:12Z", "content": "New York, Dec 15: Vaccines developed by US drugmakers Pfizer, Moderna, Johnson and Johnson against Covid-19 have proved to be less effective against the new super mutant Omicron variant that has now \u2026 [+2686 chars]"}, {"source": {"id": null, "name": "BloombergQuint"}, "author": "Janice Kew, Antony Sguazzin", "title": "Pfizer Shots And Prior Infection May Protect Better Against Omicron, South African Scientists Say - BloombergQuint", "description": "<ol><li>Pfizer Shots And Prior Infection May Protect Better Against Omicron, South African Scientists Say\u00a0\u00a0BloombergQuint\r\n</li><li>US study suggests Covid-19 vaccines may be ineffective against Omicron without booster\u00a0\u00a0Times of India\r\n</li><li>Omicron Is Mil\u2026", "url": "https://www.bloombergquint.com/business/pfizer-prior-infection-may-see-better-covid-shield-ahri-says", "urlToImage": "https://gumlet.assettype.com/bloombergquint%2F2018-08%2F3a8e2237-2edb-4494-bcf2-231993fb6108%2FBLOOMBERG_LOGO.png?rect=0%2C56%2C1920%2C1008&w=1200&auto=format%2Ccompress&ogImage=true", "publishedAt": "2021-12-15T18:44:08Z", "content": "(Bloomberg) -- A two-dose course of Pfizer Inc. and BioNTech SEs Covid-19 shot as well as a previous infection with the disease may give stronger protection against the omicron variant, scientists fr\u2026 [+2142 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "Research and Markets", "title": "Insights on the Over-The-Counter Consumer Health Products Global Market to 2026 - Featuring Abbott Laboratories, Bayer and Pfizer Among Others", "description": "Dublin, Dec. 15, 2021 (GLOBE NEWSWIRE) -- The \"Over- The -Counter Consumer Health Products Market Research Report by Indications, Distribution Channel, and...", "url": "https://finance.yahoo.com/news/insights-over-counter-consumer-health-112800409.html", "urlToImage": "https://s.yimg.com/uu/api/res/1.2/HP.E8HUfnyGeLtMAKwLgAQ--~B/aD01ODt3PTQ4MDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/93d5b27580f67db722dd7c112e43e8bc", "publishedAt": "2021-12-15T11:28:00Z", "content": "Dublin, Dec. 15, 2021 (GLOBE NEWSWIRE) -- The \"Over- The -Counter Consumer Health Products Market Research Report by Indications, Distribution Channel, and Region - Global Forecast to 2026 - Cumulati\u2026 [+8612 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "PR Newswire", "title": "Global Inflammatory Bowel Disease (IBD) Market 2021-2026 Featuring Johnson & Johnson, AbbVie, Takeda, Pfizer, Roche, Celgene, GlaxoSmithKline, Novartis, UCB and Eli Lilly & Co", "description": "The \"Global Inflammatory Bowel Disease (IBD) Market - Analysis By Disease Indication (Crohn's Disease, Ulcerative Colitis), Drug Class, Distribution Channel,...", "url": "https://finance.yahoo.com/news/global-inflammatory-bowel-disease-ibd-213000545.html", "urlToImage": "https://s.yimg.com/uu/api/res/1.2/wDGPSO44TROYKbQSONxNmQ--~B/aD00Mjt3PTQwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/prnewswire.com/e75ef6f3096d7cb6f5dd43ba82eca2fe", "publishedAt": "2021-12-15T21:30:00Z", "content": "DUBLIN, Dec. 15, 2021 /PRNewswire/ -- The \"Global Inflammatory Bowel Disease (IBD) Market - Analysis By Disease Indication (Crohn's Disease, Ulcerative Colitis), Drug Class, Distribution Channel, By \u2026 [+4803 chars]"}]}, "2021-12-14": {"status": "ok", "totalResults": 189, "articles": [{"source": {"id": null, "name": "New York Times"}, "author": "Remy Tumin", "title": "Pfizer, Antarctica, James Webb Telescope: Your Tuesday Evening Briefing", "description": "Here\u2019s what you need to know at the end of the day.", "url": "https://www.nytimes.com/2021/12/14/briefing/pfizer-antarctica-james-webb-telescope.html", "urlToImage": "https://static01.nyt.com/images/2021/12/14/multimedia/14evening-briefing-01-promo/14evening-briefing-01-facebookJumbo.jpg", "publishedAt": "2021-12-14T23:07:44Z", "content": "10. And finally, hot ho-ho-home markets.\r\nPartly because of the pandemic, partly because of the small-town appeal (and prices) and partly because of the vibe, real estate in Santa-centric towns is bo\u2026 [+755 chars]"}, {"source": {"id": null, "name": "New York Times"}, "author": "The New York Times", "title": "Pfizer Pill Protects Against Severe Disease, Including From Omicron, Study Says", "description": "The company said the pill reduced the risk of hospitalization and death by 89 percent if given within three days of the onset of symptoms. It\u2019s been one year since the first vaccine dose in the U.S.", "url": "https://www.nytimes.com/live/2021/12/14/world/covid-omicron-vaccines", "urlToImage": "https://static01.nyt.com/images/2021/12/14/us/14virus-brief-vaccination-promo/14virus-brief-vaccination-promo-facebookJumbo.jpg", "publishedAt": "2021-12-14T12:00:59Z", "content": "A highly anticipated study of Pfizers Covid pill confirmed that it helps stave off severe disease, the company announced on Tuesday.\r\nPfizer also said its antiviral pill worked in laboratory studies \u2026 [+4003 chars]"}, {"source": {"id": "reuters", "name": "Reuters"}, "author": "Reuters Editorial", "title": "Pfizer vaccine less effective against hospitalization: study - Reuters", "description": "Two doses of Pfizer-BioNTech's COVID-19 vaccine appear to have given 70% protection against hospitalization in South Africa in recent weeks, according to a major real-world study which suggests weaker efficacy against the new Omicron variant. Soraya Ali repor\u2026", "url": "https://www.reuters.com/video/watch/idOVF80NJ3N", "urlToImage": "https://static.reuters.com/resources/r/?d=20211214&i=OVF80NJ3N&r=OVF80NJ3N&t=2", "publishedAt": "2021-12-14T17:51:52Z", "content": "Posted \r\nTwo doses of Pfizer-BioNTech's COVID-19 vaccine appear to have given 70% protection against hospitalization in South Africa in recent weeks, according to a major real-world study which sugge\u2026 [+71 chars]"}, {"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "Pfizer vaccine protecting against hospitalisation during Omicron wave - study - Reuters", "description": "Two doses of Pfizer-BioNTech's COVID-19 vaccine appear to have given 70% protection against hospitalisation in South Africa in recent weeks, a major real-world study on the potential impact of Omicron showed on Tuesday, as the country battles a spike in infec\u2026", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-vaccine-protecting-against-hospitalisation-during-omicron-wave-study-2021-12-14/", "urlToImage": "https://www.reuters.com/resizer/0o67-UJ5isqUSocj2LzQrtgmFHU=/728x381/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/ZGQTHP6LK5OBJGQQ3OEWNLNXTY.jpg", "publishedAt": "2021-12-14T09:14:00Z", "content": "JOHANNESBURG, Dec 14 (Reuters) - Two doses of Pfizer-BioNTech's COVID-19 vaccine appear to have given 70% protection against hospitalisation in South Africa in recent weeks, a major real-world study \u2026 [+2466 chars]"}, {"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "Swiss to start Pfizer/BioNTech jab for children aged 5-11 in January - Reuters", "description": "Swiss health authorities will start administering the COVID-19 vaccination from Pfizer <a href=\"https://www.reuters.com/companies/PFE.N\" target=\"_blank\">(PFE.N)</a> and BioNTech <a href=\"https://www.reuters.com/companies/22UAy.DE\" target=\"_blank\">(22UAy.DE)</\u2026", "url": "https://www.reuters.com/world/europe/swiss-start-pfizerbiontech-jab-children-aged-5-11-january-2021-12-14/", "urlToImage": "https://www.reuters.com/resizer/qW0LWALO_2OCSHBEdLMCzbbHMdw=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/CBK2MELTPNJ7JJUIUGWP2A7564.jpg", "publishedAt": "2021-12-14T13:28:00Z", "content": "Shoppers are seen under Christmas illuminations, amid the spread of the coronavirus disease (COVID-19), on the Bahnhofstrasse street in Zurich, Switzerland December 11, 2021. REUTERS/Arnd WiegmannZUR\u2026 [+1086 chars]"}, {"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "Biden: U.S. has ordered enough Pfizer anti-viral pills to treat 10 million Americans - Reuters", "description": "U.S. President Joe Biden said on Tuesday he is encouraged by data released by Pfizer Inc <a href=\"https://www.reuters.com/companies/PFE.N\" target=\"_blank\">(PFE.N)</a> on its COVID-19 anti-viral medicine and his administration has ordered enough of the pills t\u2026", "url": "https://www.reuters.com/world/us/biden-us-has-ordered-enough-pfizer-anti-viral-pills-treat-10-million-americans-2021-12-14/", "urlToImage": "https://www.reuters.com/resizer/xo2BngNMVGyDfM3L-IaQeQ8APVE=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/2MGQF64MONKWBBDTYJHGC4OKGM.jpg", "publishedAt": "2021-12-14T20:46:00Z", "content": "U.S. President Joe Biden speaks prior to signing an executive order intended to reduce bureaucracy around government services for the public, in the Oval Office at the White House in Washington, U.S.\u2026 [+748 chars]"}, {"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "Pfizer says COVID-19 pill near 90% effective in final analysis - Reuters", "description": "Pfizer Inc <a href=\"https://www.reuters.com/companies/PFE.N\" target=\"_blank\">(PFE.N)</a> on Tuesday said final analysis of its antiviral COVID-19 pill still showed near 90% efficacy in preventing hospitalizations and deaths in high-risk patients, and recent l\u2026", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-says-covid-19-pill-near-90-effective-final-analysis-2021-12-14/", "urlToImage": "https://www.reuters.com/resizer/6ajCUtrS6UDOyJ4bG5tJuu6YRLg=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/QDROFKF225L55I36I7TMPUEFZA.jpg", "publishedAt": "2021-12-14T11:54:00Z", "content": "NEW YORK, Dec 14 (Reuters) - Pfizer Inc (PFE.N) on Tuesday said final analysis of its antiviral COVID-19 pill still showed near 90% efficacy in preventing hospitalizations and deaths in high-risk pat\u2026 [+3516 chars]"}, {"source": {"id": null, "name": "The Guardian"}, "author": "Richard Luscombe", "title": "Pfizer says pill is effective in protecting against severe disease from Covid", "description": "Experimental antiviral pill Paxlovid is also effective against the Omicron variant, company announcesA pill manufactured by the prominent Covid-19 vaccine provider Pfizer is highly effective in protecting against severe disease from coronavirus, the company s\u2026", "url": "https://amp.theguardian.com/world/2021/dec/14/pfizer-covid-pill-effective-protecting-against-severe-disease-omicron", "urlToImage": "https://i.guim.co.uk/img/media/9e4197db69f2ccb31b06e256d6efbba16a3689f6/0_0_2200_1321/master/2200.jpg?width=1200&height=630&quality=85&auto=format&fit=crop&overlay-align=bottom%2Cleft&overlay-width=100p&overlay-base64=L2ltZy9zdGF0aWMvb3ZlcmxheXMvdGctZGVmYXVsdC5wbmc&enable=upscale&s=20c118090d0e6d3ba936c2a6a2d941e6", "publishedAt": "2021-12-14T15:22:23Z", "content": "A pill manufactured by the prominent Covid-19 vaccine provider Pfizer is highly effective in protecting against severe disease from coronavirus, the company said on Tuesday.\r\nThe experimental antivir\u2026 [+3333 chars]"}, {"source": {"id": null, "name": "Healthday.com"}, "author": "Robert Preidt", "title": "Omicron Resists Pfizer Vaccine But Causes Less Severe Disease: Study - The Suburban Newspaper", "description": "<ol><li>Omicron Resists Pfizer Vaccine But Causes Less Severe Disease: Study\u00a0\u00a0The Suburban Newspaper\r\n</li><li>Data indicates Omicron is milder, better at evading vaccines\u00a0\u00a0CTV News\r\n</li><li>Why omicron is overtaking delta \u2014 and what that means for our fight\u2026", "url": "https://consumer.healthday.com/b-12-14-omicron-resists-vaccines-more-but-causes-less-severe-disease-study-2656024787.html", "urlToImage": "https://bloximages.newyork1.vip.townnews.com/thesuburban.com/content/tncms/assets/v3/editorial/9/cb/9cb8ecd0-4148-58de-971a-1905816207c3/61b8ca3538e2e.image.jpg?crop=600%2C315%2C0%2C15&resize=600%2C315&order=crop%2Cresize", "publishedAt": "2021-12-14T15:43:15Z", "content": "TUESDAY, Dec. 14, 2021 (HealthDay News) -- Compared to previous coronavirus variants, Omicron appears to cause less severe illness, but is more resistant to the Pfizer vaccine, researchers at South A\u2026 [+2331 chars]"}, {"source": {"id": null, "name": "CP24 Toronto's Breaking News"}, "author": "Andrew Meldrum", "title": "Pfizer coronavirus vaccine provides 70 per cent protection against hospitalization by Omicron variant - CP24 Toronto's Breaking News", "description": "<ol><li>Pfizer coronavirus vaccine provides 70 per cent protection against hospitalization by Omicron variant\u00a0\u00a0CP24 Toronto's Breaking News\r\n</li><li>LIVE: The WHO gives an update as Omicron variant spreads\u00a0\u00a0Reuters\r\n</li><li>Why omicron is overtaking delta \u2014\u2026", "url": "https://www.cp24.com/world/pfizer-vaccine-protects-70-per-cent-against-hospitalization-from-omicron-1.5706309", "urlToImage": "https://www.cp24.com/polopoly_fs/1.5478753.1624274569!/httpImage/image.jpg_gen/derivatives/landscape_620/image.jpg", "publishedAt": "2021-12-14T11:24:00Z", "content": "JOHANNESBURG (AP) -- The omicron variant appears to cause less severe disease than previous versions of the coronavirus, and the Pfizer vaccine seems to offer less defense against infection from it b\u2026 [+4586 chars]"}, {"source": {"id": null, "name": "Marginalrevolution.com"}, "author": "Tyler Cowen", "title": "Will China ever get Pfizer?", "description": "As Covid-19 started spreading in Wuhan early last year, Chinese billionaire Guo Guangchang\u2019s drugmaker appeared to have scored a big win: A partnership with Germany\u2019s\u00a0BioNTech SE, which went on to produce with\u00a0Pfizer Inc.\u00a0one of the world\u2019s most successful va\u2026", "url": "https://marginalrevolution.com/marginalrevolution/2021/12/will-china-ever-get-pfizer.html", "urlToImage": "https://marginalrevolution.com/wp-content/uploads/2016/10/MR-logo-thumbnail.png", "publishedAt": "2021-12-14T18:35:00Z", "content": "As Covid-19 started spreading in Wuhan early last year, Chinese billionaire Guo Guangchangs drugmaker appeared to have scored a big win: A partnership with Germanys\u00a0BioNTech SE, which went on to prod\u2026 [+691 chars]"}, {"source": {"id": "associated-press", "name": "Associated Press"}, "author": "Matthew Perrone", "title": "Pfizer Confirms COVID Pill's Results, Potency Versus Omicron", "description": "WASHINGTON (AP) \u2014 Pfizer said Tuesday that its experimental COVID-19 pill appears effective against the omicron variant.  The company also said full results of its 2,250-person study confirmed the pill's promising early results against the virus: The drug red\u2026", "url": "https://apnews.com/article/coronavirus-pandemic-science-business-health-1662719827498fa2b1a4f168c7723688", "urlToImage": "https://storage.googleapis.com/afs-prod/media/d7cf4607f2e74468a1fee27fb57f1560/2000.jpeg", "publishedAt": "2021-12-14T12:35:58Z", "content": "WASHINGTON (AP) Pfizer said Tuesday that its experimental COVID-19 pill appears effective against the omicron variant. \r\nThe company also said full results of its 2,250-person study confirmed the pil\u2026 [+3249 chars]"}, {"source": {"id": null, "name": "NPR"}, "author": "Scott Hensley", "title": "Pfizer data shows that its COVID-19 pill is effective against severe disease", "description": "The research finds that the medicine, called Paxlovid, was effective in preventing hospitalization and death when taken by people with mild to moderate illness within a few days of symptoms.", "url": "https://www.npr.org/sections/health-shots/2021/12/14/1064030639/pfizer-covid-19-pill-paxlovid-data", "urlToImage": "https://media.npr.org/assets/img/2021/12/14/gettyimages-1349260353_wide-32fb9407b30bce6e04eba60d86fb13f4234e774d.jpg?s=1400", "publishedAt": "2021-12-14T12:41:01Z", "content": "A COVID-19 pop-up testing sits stands on a Manhattan street in October in New York City. On Tuesday, Pfizer released promising data about a pill to treat COVID-19.\r\nSpencer Platt/Getty Images\r\nPfizer\u2026 [+1595 chars]"}, {"source": {"id": "al-jazeera-english", "name": "Al Jazeera English"}, "author": "Al Jazeera", "title": "Pfizer jab protects against hospitalisation with Omicron: Study", "description": "South Africa study finds two doses of Pfizer's COVID shot appear to provide 70% protection against hospitalisation.", "url": "https://www.aljazeera.com/news/2021/12/14/pfizer-jab-protecting-against-hospitalisation-during-omicron-wave", "urlToImage": "https://www.aljazeera.com/wp-content/uploads/2021/12/2021-11-25T112539Z_665301519_RC2N1R9ISHXV_RTRMADP_3_HEALTH-CORONAVIRUS-AFRICA.jpg?resize=1200%2C630", "publishedAt": "2021-12-14T12:08:25Z", "content": "Two doses of Pfizer-BioNTechs COVID-19 vaccine appear to provide 70 percent protection against hospitalisation from the Omicron coronavirus variant, according to an extensive real-world study in Sout\u2026 [+3070 chars]"}, {"source": {"id": "bloomberg", "name": "Bloomberg"}, "author": "Janice Kew", "title": "Pfizer Stops 70% Omicron Hospitalizations in S. Africa Study", "description": "A two-shot course of Pfizer Inc.\u2019s vaccination may offer 70% protection against being hospitalized with the Covid-19 omicron variant, South Africa\u2019s largest medical-insurance provider Discovery Ltd. said.", "url": "https://www.bloomberg.com/news/articles/2021-12-14/pfizer-stops-70-omicron-hospitalizations-in-south-african-study", "urlToImage": "https://assets.bwbx.io/images/users/iqjWHBFdfxIU/isTZdmqb_XQI/v1/1200x800.jpg", "publishedAt": "2021-12-14T09:44:04Z", "content": "A two-shot course of \r\nPfizer Inc.s vaccination may offer 70% protection against being hospitalized with the Covid-19 omicron variant, South Africas largest medical-insurance provider \r\nDiscovery Ltd\u2026 [+1224 chars]"}, {"source": {"id": "bloomberg", "name": "Bloomberg"}, "author": "Robert Langreth", "title": "Pfizer Covid Pill Stops Hospitalizations, Not Milder Symptoms", "description": "New study data showed Pfizer Inc.\u2019s experimental Covid-19 pill was highly effective at keeping patients out of the hospital, but less adept at erasing milder symptoms often associated with breakthrough infections.", "url": "https://www.bloomberg.com/news/articles/2021-12-14/pfizer-covid-pill-stops-hospitalizations-not-milder-symptoms", "urlToImage": "https://assets.bwbx.io/images/users/iqjWHBFdfxIU/iZ.dsa1OA.ZE/v1/1200x801.jpg", "publishedAt": "2021-12-14T11:45:00Z", "content": "New study data showed \r\nPfizer Inc.s experimental Covid-19 pill was highly effective at keeping patients out of the hospital, but less adept at erasing milder symptoms often associated with breakthro\u2026 [+338 chars]"}, {"source": {"id": "al-jazeera-english", "name": "Al Jazeera English"}, "author": "Al Jazeera", "title": "Pfizer says its COVID pill near 90% effective in clinical trials", "description": "Company says it can have 180,000 treatment courses ready to ship this year.", "url": "https://www.aljazeera.com/news/2021/12/14/pfizer-covid-19-pill-near-90-percent-effective-in-clinical-trial", "urlToImage": "https://www.aljazeera.com/wp-content/uploads/2021/12/000_9RR8X8.jpg?resize=1024%2C630", "publishedAt": "2021-12-14T14:18:08Z", "content": "Pfizer Inc has said the final analysis of its antiviral COVID-19 pill showed close to 90 percent efficacy in preventing hospitalisations and deaths in high-risk patients with recent lab data suggesti\u2026 [+2719 chars]"}, {"source": {"id": null, "name": "WebMD"}, "author": "HealthDay", "title": "Pfizer: Final Data Shows COVID Pill Stays Strong Against Severe Illness", "description": "The latest results reinforce earlier reports that Pfizer\u2019s drug cuts hospitalizations and deaths when taken within three to five days of the start of symptoms.", "url": "https://www.webmd.com/lung/news/20211214/pfizer-says-final-data-shows-covid-pill-stays-strong-against-severe-illness", "urlToImage": "https://img.webmd.com/dtmcms/live/webmd/consumer_assets/site_images/article_thumbnails/other/pharmacist_filling_prescription_pill_bottle_other/1800x1200_pharmacist_filling_prescription_pill_bottle_other.jpg", "publishedAt": "2021-12-14T15:05:44Z", "content": "TUESDAY, Dec. 14, 2021 (HealthDay News) -- Pfizer Inc. announced Tuesday that a final analysis shows its experimental antiviral pill Paxlovid sharply reduced hospitalizations and deaths among people \u2026 [+2663 chars]"}, {"source": {"id": null, "name": "New York Times"}, "author": "Carl Zimmer and Rebecca Robbins", "title": "Pfizer Says Its Covid Pill Will Protect Against Severe Disease, Even From Omicron", "description": "The company said the pill, Paxlovid, reduced the risk of hospitalization and death by 89 percent if given within three days of the onset of symptoms.", "url": "https://www.nytimes.com/2021/12/14/health/pfizer-covid-pill-paxlovid.html", "urlToImage": "https://static01.nyt.com/images/2021/12/03/14virus-briefing-Pfizer/14virus-briefing-Pfizer-facebookJumbo-v2.jpg", "publishedAt": "2021-12-14T11:45:03Z", "content": "Mikael Dolsten, the chief scientific officer of Pfizer, was exuberant about the results after having overseen the development of the drug since the spring of 2020, with more than 200 company scientis\u2026 [+2361 chars]"}, {"source": {"id": "axios", "name": "Axios"}, "author": "Tina Reed", "title": "Pfizer says new data confirms COVID pill efficacy", "description": "Pfizer released new data Tuesday morning confirming Paxlovid, its oral antiviral pill for COVID, reduced the risk of hospitalization or death by 89% in high-risk adults.Driving the news: The company said it shared the Phase 2/3 data with the FDA as part of it\u2026", "url": "https://www.axios.com/pfizer-covid-pill-paxlovid-efficacy-22730d78-9587-4586-9cc8-8431c4cc0880.html", "urlToImage": "https://images.axios.com/-E8bGeWgXtUvV_BPiHyl91Doovo=/0x185:6048x3587/1366x768/2021/12/14/1639483422553.jpg", "publishedAt": "2021-12-14T12:06:48Z", "content": "Pfizer released new data Tuesday morning confirming Paxlovid, its oral antiviral pill for COVID, reduced the risk of hospitalization or death by 89% in high-risk adults.\r\nDriving the news: The compan\u2026 [+1010 chars]"}]}, "2021-12-13": {"status": "ok", "totalResults": 55, "articles": [{"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "Pfizer to acquire Arena Pharmaceuticals in $6.7 bln deal - Reuters", "description": "Pfizer Inc <a href=\"https://www.reuters.com/companies/PFE.N\" target=\"_blank\">(PFE.N)</a> has agreed to acquire Arena Pharmaceuticals <a href=\"https://www.reuters.com/companies/ARNA.O\" target=\"_blank\">(ARNA.O)</a> in a $6.7 billion all-cash deal to expand its \u2026", "url": "https://www.reuters.com/markets/deals/pfizer-acquire-arena-pharmaceuticals-67-bln-deal-2021-12-13/", "urlToImage": "https://www.reuters.com/resizer/KgX0WtFBM-zpivynlZiuO-HO5qg=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/HLQD2IA4QBJSVG5SMQV3K4RARU.jpg", "publishedAt": "2021-12-13T11:20:00Z", "content": "Pfizer logo seen outside their building in Manhattan, New York City, New York, U.S., March 2, 2021. REUTERS/Carlo AllegriDec 13 (Reuters) - Pfizer Inc (PFE.N) has agreed to acquire Arena Pharmaceutic\u2026 [+889 chars]"}, {"source": {"id": "business-insider", "name": "Business Insider"}, "author": "insider@insider.com (Carla Moz\u00e9e)", "title": "Arena Pharmaceuticals soars 97% as Pfizer to spend $6.7 billion to buy ulcerative colitis drug developer", "description": "Arena's stock surge comes after the price this year had dropped by 35%.", "url": "https://markets.businessinsider.com/news/stocks/arena-pharmaceuticals-stock-price-pfizer-purchase-acquisition-plan-arna-2021-12", "urlToImage": "https://images2.markets.businessinsider.com/619f6d74ee9795001883e392?format=jpeg", "publishedAt": "2021-12-13T14:31:13Z", "content": "Carlo Allegri/Reuters\r\nShares of Arena Pharmaceuticals almost doubled in price Monday after Pfizer said it's reached a $6.7 billion deal to buy the Boston-based developer of medicines targeting immun\u2026 [+1497 chars]"}, {"source": {"id": "bloomberg", "name": "Bloomberg"}, "author": "James Paton", "title": "Pfizer to Purchase Arena at 100% Premium in $6.7 Billion Deal", "description": "Pfizer Inc. agreed to buy Arena Pharmaceuticals Inc. in a deal valued at about $6.7 billion, gaining potential therapies targeting immuno-inflammatory diseases.", "url": "https://www.bloomberg.com/news/articles/2021-12-13/pfizer-to-acquire-arena-in-deal-valued-at-6-7-billion", "urlToImage": "https://assets.bwbx.io/images/users/iqjWHBFdfxIU/imFZGzAOhrFE/v0/1200x800.jpg", "publishedAt": "2021-12-13T12:07:46Z", "content": "Pfizer Inc. agreed to buy \r\nArena Pharmaceuticals Inc. in a deal valued at about $6.7 billion, gaining potential therapies targeting immuno-inflammatory diseases.\r\nThe U.S. drugmaker will pay $100 a \u2026 [+941 chars]"}, {"source": {"id": null, "name": "Motley Fool"}, "author": "newsfeedback@fool.com (Keith Speights)", "title": "How Much Will COVID Boosters for Teens Impact Pfizer and BioNTech?", "description": "Probably not very much.", "url": "https://www.fool.com/investing/2021/12/13/how-much-will-covid-boosters-for-teens-impact-pfiz/", "urlToImage": "https://g.foolcdn.com/editorial/images/656787/gettyimages-1307014774.jpg", "publishedAt": "2021-12-13T16:45:00Z", "content": "Pfizer( PFE 5.14% ) and BioNTech( BNTX 4.99% ) received expanded U.S. Emergency Use Authorization (EUA) of booster doses of their COVID-19 vaccine to teens ages 16 and 17 last week. In this Motley Fo\u2026 [+1866 chars]"}, {"source": {"id": null, "name": "TheStreet"}, "author": "Scott Rutt", "title": "Cramer's Mad Money Recap 12/13: Bank of America, Ford, Pfizer", "description": "Jim Cramer says a strong, diversified portfolio will serve you well into 2022.", "url": "https://www.thestreet.com/jim-cramer/cramers-mad-money-recap-dec-13-2021", "urlToImage": "https://www.thestreet.com/.image/t_share/MTY4NjQ5NTQ2OTI3Nzc3Njg3/not-all-low-volatility-funds-equal-says-intech-ceo.jpg", "publishedAt": "2021-12-13T19:27:00Z", "content": "Don't stray too far from the beaten path, Jim Cramer told his Mad Money viewers Monday. There may not be very many winners in this market, but the winners are likely to keep on winning.\r\nTypically, a\u2026 [+6612 chars]"}, {"source": {"id": "independent", "name": "Independent"}, "author": "Nina Massey", "title": "Pfizer and AstraZeneca jabs \u2018induce fewer antibodies against Omicron\u2019", "description": "Researchers have said there is currently no evidence of increased potential to cause severe disease.", "url": "https://www.independent.co.uk/news/uk/astrazeneca-pfizer-omicron-antibodies-university-of-oxford-b1974976.html", "urlToImage": "https://static.independent.co.uk/2021/12/13/11/94dfc158cbf1416e55209f325a153386Y29udGVudHNlYXJjaGFwaSwxNjM5NDgwODg5-2.63932995.jpg?width=1200&auto=webp&quality=75", "publishedAt": "2021-12-13T13:15:30Z", "content": "Two doses of the Pfizer and AstraZeneca Covid-19 vaccines induce lower levels of antibodies against Omicron a new study suggests.\r\nResearchers said the findings indicate the new variant has the poten\u2026 [+3175 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "Reuters", "title": "Pfizer to buy Arena Pharmaceuticals for $6.7 billion", "description": "Pfizer will take over all outstanding shares of Arena for $100 per share, representing a 100.2% premium to Arena's last closing price.  Arena is developing...", "url": "https://finance.yahoo.com/news/pfizer-buy-arena-pharmaceuticals-6-112905695.html", "urlToImage": "https://s.yimg.com/uu/api/res/1.2/Kmx3htSmvM9TgCW63cvjEw--~B/aD01MzM7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters-finance.com/b850f0d83569433c9aa21c77674829fa", "publishedAt": "2021-12-13T11:29:05Z", "content": "(Reuters) - Pfizer Inc has agreed to acquire Arena Pharmaceuticals in a $6.7 billion all-cash deal to expand its cancer and inflammatory disease treatment pipeline, the companies said on Monday.\r\nPfi\u2026 [+637 chars]"}, {"source": {"id": null, "name": "Business Wire"}, "author": null, "title": "Pfizer to Acquire Arena Pharmaceuticals", "description": "NEW YORK & PARK CITY, Utah--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that the companies have entered into a definitive agreement under which Pfizer will acquire Arena, a clinical stage company dev\u2026", "url": "https://www.businesswire.com/news/home/20211213005204/en/Pfizer-to-Acquire-Arena-Pharmaceuticals", "urlToImage": "https://mms.businesswire.com/media/20211213005204/en/1045874/23/Pfizer_Logo_Color_RGB_APPROVED.jpg", "publishedAt": "2021-12-13T11:50:35Z", "content": "NEW YORK &amp; PARK CITY, Utah--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that the companies have entered into a definitive agreement und\u2026 [+14110 chars]"}, {"source": {"id": null, "name": "Investor's Business Daily"}, "author": "Investor's Business Daily", "title": "Pfizer Stock Up, Arena Stock Soars On Merger - Investor's Business Daily", "description": "<ol><li>Pfizer Stock Up, Arena Stock Soars On Merger\u00a0\u00a0Investor's Business Daily\r\n</li><li>Pfizer bets on Arena Pharmaceuticals' promising bowel disease treatment in $6.7 billion deal\u00a0\u00a0CNBC\r\n</li><li>Pfizer to acquire Arena Pharmaceuticals for $6.7 billion\u00a0\u00a0Ya\u2026", "url": "https://www.investors.com/news/technology/pfizer-stock-up-arena-stock-soars-on-merger/", "urlToImage": "https://www.investors.com/wp-content/uploads/2021/12/IT01-arenapharma-01-news.jpg", "publishedAt": "2021-12-13T15:56:00Z", "content": "Covid vaccine maker Pfizer (PFE) said Monday it plans to acquire Arena Pharmaceuticals (ARNA) for $100 a share, in a deal worth an estimated $6.7 billion. The news sent Arena stock rocketing and gave\u2026 [+2145 chars]"}, {"source": {"id": "independent", "name": "Independent"}, "author": "Eleanor Sly", "title": "Vaccines and omicron: What we know about how variant responds to Pfizer, AstraZeneca and Moderna jabs", "description": "New jabs to target latest strain could be produced by March 2022", "url": "https://www.independent.co.uk/news/health/omicron-vaccine-jab-pfizer-astrazeneca-moderna-b1974863.html", "urlToImage": "https://static.independent.co.uk/2021/12/09/16/GettyImages-89747046%20%281%29.jpg?width=1200&auto=webp&quality=75", "publishedAt": "2021-12-13T09:48:27Z", "content": "The omicron variant of Covid-19 has begun to spread in the UK, with Boris Johnson warning of a tidal wave of infections hitting these shores if the public do not observe social restrictions and get t\u2026 [+7169 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "James Paton and Riley Griffin", "title": "Pfizer to Purchase Arena at 100% Premium in $6.7 Billion Deal", "description": "(Bloomberg) -- Pfizer Inc. agreed to buy Arena Pharmaceuticals Inc. in a deal valued at about $6.7 billion that brings potential therapies targeting immuno...", "url": "https://finance.yahoo.com/news/pfizer-purchase-arena-100-premium-120746456.html", "urlToImage": "https://s.yimg.com/ny/api/res/1.2/KYbPCc_2pDZKU55Re0BLiw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://s.yimg.com/uu/api/res/1.2/1yeqk97B_8wqhnzOeFKooQ--~B/aD0xMzM0O3c9MjAwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/bloomberg_markets_842/e3aa4001712ff1a45b601607745d6d2c", "publishedAt": "2021-12-13T12:07:46Z", "content": "(Bloomberg) -- Pfizer Inc. agreed to buy Arena Pharmaceuticals Inc. in a deal valued at about $6.7 billion that brings potential therapies targeting immuno-inflammatory diseases.\r\nMost Read from Bloo\u2026 [+1988 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "John Csiszar", "title": "How Pfizer and Moderna Are Faring a Year Into Mass COVID-19 Vaccinations", "description": "Pfizer and Moderna were the first two companies to get emergency approval for COVID-19 vaccinations, which they began distributing in earnest at the...", "url": "https://finance.yahoo.com/news/pfizer-moderna-faring-mass-covid-233127713.html", "urlToImage": "https://s.yimg.com/ny/api/res/1.2/jFPIwkxajTME43xlgmSv_g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzU-/https://s.yimg.com/uu/api/res/1.2/jvbWsRItuvYnIOej7VAmtw--~B/aD0xMDgwO3c9MTkyMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/gobankingrates_644/4c92cd07b99923bc023b257c9096e377", "publishedAt": "2021-12-13T23:31:27Z", "content": "Spencer Platt / Getty Images\r\nPfizer and Moderna were the first two companies to get emergency approval for COVID-19 vaccinations, which they began distributing in earnest at the beginning of 2021. A\u2026 [+3381 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "PR Newswire", "title": "Shareholder Alert: Ademi LLP investigates whether Arena Pharmaceuticals, Inc. has obtained a Fair Price in its transaction with Pfizer Inc.", "description": "Ademi LLP is investigating Arena (Nasdaq: ARNA), for possible breaches of fiduciary duty and other violations of law in its transaction Pfizer.", "url": "https://finance.yahoo.com/news/shareholder-alert-ademi-llp-investigates-222200944.html", "urlToImage": "https://s.yimg.com/uu/api/res/1.2/aNtqK.M_4mlFIhoU1.T7bA--~B/aD0xNTA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/47b59738751d31639b8bc7e27514ae1e", "publishedAt": "2021-12-13T22:22:00Z", "content": "MILWAUKEE, Dec. 13, 2021 /PRNewswire/ -- Ademi LLP is investigating Arena (Nasdaq: ARNA), for possible breaches of fiduciary duty and other violations of law in its transaction Pfizer.\r\nAdemiLogo (PR\u2026 [+1691 chars]"}, {"source": {"id": null, "name": "FierceBiotech"}, "author": "Annalee Armstrong", "title": "UPDATE: Pfizer books Arena for immuno-inflammatory portfolio in $6.7B deal", "description": "Arena Pharmaceuticals has been in need of a new R&D show since a phase 2 pain drug flopped earlier this year, and, now, the biotech has landed the biggest ticket in town: Pfizer. The Big Pharma will add Arena to its bill in a deal valued at $6.7 billion, brin\u2026", "url": "https://www.fiercebiotech.com/biotech/pfizer-books-arena-for-immuno-inflammatory-portfolio-6-7b-deal", "urlToImage": "https://qtxasset.com/fiercebiotech/1639404752/PfizerHQsignone.jpg/PfizerHQsignone.jpg?VersionId=BIDLjv1NUH1fwnsUt_Se17qfoQybA9ED", "publishedAt": "2021-12-13T14:12:49Z", "content": "Arena Pharmaceuticals has been in need of a new R&amp;D show since a phase 2 pain drug flopped earlier this year, and, now, the biotech has landed the biggest ticket in town: Pfizer.\r\nThe Big Pharma \u2026 [+5867 chars]"}, {"source": {"id": null, "name": "Sputnik International"}, "author": "Sputnik International", "title": "Omicron Strain Could Reduce Effectiveness of Pfizer Shots by More Than 30 Times - Study", "description": "BEIJING (Sputnik) - The Pfizer/BioNTech vaccine could be over 30 times less effective against the Omicron strain of the coronavirus than other variants, a new study reveals.", "url": "https://sputniknews.com/20211213/omicron-strain-could-reduce-effectiveness-of-pfizer-shots-by-more-than-30-times---study-1091473377.html", "urlToImage": "https://cdnn1.img.sputniknews.com/images/sharing/article/eng/1091473377.jpg?10911336251639360501", "publishedAt": "2021-12-13T01:55:00Z", "content": "Registration was successful!Please follow the link from the email sent to \r\nThe new COVID variant was initially detected in South Africa and Botswana and sparked major concerns due to its high number\u2026 [+4176 chars]"}, {"source": {"id": null, "name": "Shtfplan.com"}, "author": "Mac Slavo", "title": "Pfizer Documents Reveal A Whole SLEW Of Side Effects From The COVID Shot", "description": "Documents released by the Food and Drug Administration (FDA) reveal that drugmaker Pfizer recorded nearly 160,000 adverse reactions to its Covid-19 vaccine in the initial months of its rollout. And the FDA still went ahead and authorized the drug for use.\nThe\u2026", "url": "https://www.shtfplan.com/headline-news/pfizer-documents-reveal-a-whole-slew-of-side-effects-from-the-covid-shot", "urlToImage": "https://www.shtfplan.com/wp-content/uploads/2021/07/covidvaccine-e1626440798888.jpg", "publishedAt": "2021-12-13T18:30:22Z", "content": "Documents released by the Food and Drug Administration (FDA) reveal that drugmaker Pfizer recorded nearly 160,000 adverse reactions to its Covid-19 vaccine in the initial months of its rollout. And t\u2026 [+2713 chars]"}, {"source": {"id": null, "name": "Boston Herald"}, "author": "Associated Press", "title": "Pfizer to pay $6.7B in cash for Arena Pharmaceuticals", "description": "NEW YORK (AP) \u2014 Pfizer is spending $6.7 billion to buy a drugmaker that is developing treatments for inflammatory conditions like Chrohn\u2019s disease but has no products on the market.", "url": "https://www.bostonherald.com/2021/12/13/pfizer-to-pay-6-7b-in-cash-for-arena-pharmaceuticals/", "urlToImage": "https://www.bostonherald.com/wp-content/uploads/2021/12/Pfizer_Results_51310.jpg?w=1024&h=682", "publishedAt": "2021-12-13T14:13:30Z", "content": "The Associated Press\r\nNEW YORK (AP) Pfizer is spending $6.7 billion to buy a drugmaker that is developing treatments for inflammatory conditions like Chrohns disease but has no products on the market\u2026 [+917 chars]"}, {"source": {"id": null, "name": "CNBC"}, "author": "Reuters", "title": "Pfizer to acquire Arena Pharmaceuticals in $6.7 billion deal", "description": "Pfizer has entered into a definitive agreement to acquire Arena Pharmaceuticals in a $6.7 billion deal, a regulatory filing showed on Monday.", "url": "https://www.cnbc.com/2021/12/13/pfizer-to-acquire-arena-pharmaceuticals-in-6point7-billion-deal-.html", "urlToImage": "https://image.cnbcfm.com/api/v1/image/106788033-16049416212020-11-09t165323z_136326159_rc2szj9nfzx8_rtrmadp_0_health-coronavirus-vaccines-pfizer.jpeg?v=1604941677", "publishedAt": "2021-12-13T11:45:00Z", "content": "Pfizer has entered into a definitive agreement to acquire Arena Pharmaceuticals in a $6.7 billion deal, a regulatory filing showed on Monday.\r\nPfizer will take over all outstanding shares of Arena fo\u2026 [+562 chars]"}, {"source": {"id": null, "name": "Barron's"}, "author": "Joe Woelfel", "title": "Buy Pfizer Stock Because Its Covid Pill Will Be a Big Seller, UBS Says", "description": "UBS expects antiviral pill Paxlovid to reach sales of at least $14 billion next year.", "url": "https://www.barrons.com/articles/pfizer-stock-price-upgrade-buy-covid-antirviral-pill-51639395479", "urlToImage": "https://images.barrons.com/im-427528/social", "publishedAt": "2021-12-13T14:46:00Z", "content": "Shares of \r\nPfizer\r\nwere upgraded to Buy from Neutral at UBS, with the firm writing that it expects antiviral pill Paxlovid to reach sales of at least $14 billion next year, or 40% above Wall Street \u2026 [+1139 chars]"}, {"source": {"id": null, "name": "Barron's"}, "author": "Callum Keown", "title": "Pfizer to Buy Arena Pharmaceuticals in $6.7 Billion Deal. Arena Stock Soars.", "description": "Pfizer agrees to buy U.S. biotech company Arena Pharmaceuticals in a deal valued at about $6.7 billion.", "url": "https://www.barrons.com/articles/pfizer-pfe-arena-pharmaceuticals-arna-acquisition-stock-51639396154", "urlToImage": "https://images.barrons.com/im-334275/social", "publishedAt": "2021-12-13T11:50:00Z", "content": "The U.S. pharma giant said the acquisition would expand its cancer and inflammatory disease drug pipeline.Shares in Arena Pharmaceuticals (ticker: ARNA) surged 93% to $96.45 in premarket trading, whi\u2026 [+973 chars]"}]}, "2021-12-12": {"status": "ok", "totalResults": 27, "articles": [{"source": {"id": "the-wall-street-journal", "name": "The Wall Street Journal"}, "author": "Dov Lieber", "title": "Pfizer Booster Shots Are Effective Against Omicron Variant, Israeli Study Says - The Wall Street Journal", "description": "<ol><li>Pfizer Booster Shots Are Effective Against Omicron Variant, Israeli Study Says\u00a0\u00a0The Wall Street Journal\r\n</li><li>'Three shots of Pfizer COVID vaccine 4x less effective against Omicron'\u00a0\u00a0The Jerusalem Post\r\n</li><li>Booster shots up to 75% effective a\u2026", "url": "https://www.wsj.com/articles/pfizer-booster-shots-are-effective-against-omicron-variant-israeli-study-says-11639317136", "urlToImage": "https://images.wsj.net/im-450677/social", "publishedAt": "2021-12-12T13:52:00Z", "content": "TEL AVIVA booster shot of Pfizer Inc. and BioNTech SE s Covid-19 vaccine provides good protection against severe illness from the Omicron variant, while those without a third shot are highly vulnerab\u2026 [+222 chars]"}, {"source": {"id": "rt", "name": "RT"}, "author": "RT", "title": "Pfizer documents reveal variety of vaccine side effects", "description": "Documents released by the Food and Drug Administration (FDA) reveal that drugmaker Pfizer recorded nearly 160,000 adverse reactions to its Covid-19 vaccine in the initial months of its rollout. Read Full Article at RT.com", "url": "https://www.rt.com/usa/543001-pfizer-vaccine-side-effects/", "urlToImage": "https://cdni.rt.com/files/2021.12/article/61b661c585f54071355978bd.JPG", "publishedAt": "2021-12-12T21:17:07Z", "content": "The documents were obtained by a group of doctors, professors, and journalists calling themselves Public Health and Medical Professionals for Transparency, who filed a Freedom of Information Act (FOI\u2026 [+2269 chars]"}, {"source": {"id": null, "name": "Daily Mail"}, "author": "David Averre, Reuters", "title": "Three shots of Pfizer vaccine DOES protect against Omicron, Israeli study shows", "description": "Gili Regev-Yochay, director of the Infectious Diseases Unit at Sheba Medical Centre which conducted the research, said a booster provides 'significant protection' against Omicron.", "url": "https://www.dailymail.co.uk/news/article-10302089/Three-shots-Pfizer-vaccine-DOES-protect-against-Omicron-Israeli-study-shows.html", "urlToImage": "https://i.dailymail.co.uk/1s/2021/12/12/20/51699021-0-image-a-6_1639339536399.jpg", "publishedAt": "2021-12-12T20:16:23Z", "content": "Israeli researchers have found that a three-shot course of the Pfizer/BioNTech COVID-19 vaccine provides significant protection against the new Omicron variant.\r\nThe study, carried out by Sheba Medic\u2026 [+5473 chars]"}, {"source": {"id": null, "name": "CNBC"}, "author": "Reuters", "title": "Israeli study finds Pfizer Covid booster protects against omicron variant", "description": "Israeli researchers said they found that a three-shot course of the Pfizer-BioNTech vaccine provided significant protection against the new omicron variant.", "url": "https://www.cnbc.com/2021/12/12/israeli-study-finds-pfizer-covid-booster-protects-against-omicron-variant.html", "urlToImage": "https://image.cnbcfm.com/api/v1/image/106984847-16387957942021-12-05t225115z_715541588_rc2g8r9ppg6q_rtrmadp_0_health-coronavirus-usa-children.jpeg?v=1638795846", "publishedAt": "2021-12-12T13:37:00Z", "content": "Israeli researchers said on Saturday they found that a three-shot course of the Pfizer-BioNTech Covid-19 vaccine provided significant protection against the new omicron variant.\r\nThe findings were si\u2026 [+1260 chars]"}, {"source": {"id": "newsweek", "name": "Newsweek"}, "author": "Thomas Kika", "title": "Protection From Omicron Jumps 100-Fold With Pfizer Booster Shot: Israeli Researchers", "description": "Compared to a two-dose track with the Pfizer vaccine, researchers found that getting a third booster reduces the chance of infection from Omicron significantly.", "url": "https://www.newsweek.com/protection-omicron-jumps-100-fold-pfizer-booster-shot-israeli-researchers-1658584", "urlToImage": "https://d.newsweek.com/en/full/1949929/israeli-research-omicron-vaccine-booster.jpg", "publishedAt": "2021-12-12T20:35:14Z", "content": "As the international medical community continues to study the Omicron variant, new research out of Israel suggests that available vaccines may be helpful.\r\nThe findings of a study carried out by Isra\u2026 [+2822 chars]"}, {"source": {"id": null, "name": "The Indian Express"}, "author": "Reuters", "title": "Israeli study finds Pfizer Covid-19 booster protects against Omicron", "description": "The findings were similar to those presented by BioNTech and Pfizer earlier in the week, which were an early signal that booster shots could be key to protect against infection from the newly identified variant.", "url": "https://indianexpress.com/article/world/israeli-study-finds-pfizer-covid-19-booster-protects-against-omicron-7668554/", "urlToImage": "https://images.indianexpress.com/2021/12/Pfizer-1.jpg", "publishedAt": "2021-12-12T04:25:37Z", "content": "The findings were similar to those presented by BioNTech and Pfizer earlier in the week, which were an early signal that booster shots could be key to protect against infection from the newly identif\u2026 [+1082 chars]"}, {"source": {"id": null, "name": "Business Wire"}, "author": null, "title": "Pfizer and Sangamo Announce Updated Phase 1/2 Results Showing Sustained Bleeding Control in Highest Dose Cohort Through Two Years Following Hemophilia A Gene Therapy", "description": "NEW YORK & BRISBANE, Calif.--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicines company, today announced updated follow-up data from the Phase 1/2 Alta study of giroctocogene fitelparvovec, an investiga\u2026", "url": "https://www.businesswire.com/news/home/20211212005051/en/Pfizer-and-Sangamo-Announce-Updated-Phase-12-Results-Showing-Sustained-Bleeding-Control-in-Highest-Dose-Cohort-Through-Two-Years-Following-Hemophilia-A-Gene-Therapy", "urlToImage": "https://mms.businesswire.com/media/20211212005051/en/736004/23/Sangamo_logoTM.jpg", "publishedAt": "2021-12-12T21:39:20Z", "content": "NEW YORK &amp; BRISBANE, Calif.--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) andSangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicines company, today announced updated follow-up data from the Ph\u2026 [+15109 chars]"}, {"source": {"id": null, "name": "New York Post"}, "author": "Sam Raskin", "title": "Pfizer booster provides \u2018significant protection\u2019 against Omicron, study says", "description": "A third dose of Pfizer's COVID-19 vaccine provides \"significant protection\" against the Omicron variant of COVID-19, Israel researchers said Saturday.", "url": "https://nypost.com/2021/12/12/pfizer-covid-19-booster-protects-against-omicron-variant-study/", "urlToImage": "https://nypost.com/wp-content/uploads/sites/2/2021/12/ca-vaccination-168.jpg?quality=90&strip=all&w=1024", "publishedAt": "2021-12-12T14:06:58Z", "content": "A third dose of Pfizer\u2019s COVID-19 vaccine provides \u201csignificant protection\u201d against the Omicron variant of COVID-19, Israel researchers said Saturday. \r\nThe study, conducted by Sheba Medical Center a\u2026 [+2209 chars]"}, {"source": {"id": null, "name": "Seeking Alpha"}, "author": "Jonathan M Block", "title": "Israeli study bolsters efficacy of Pfizer/BioNTech COVID booster against Omicron", "description": "Three doses of the Pfizer/BioNTech COVID-19 provides protection against the Omicron variant, according to a new study from Israel.", "url": "https://seekingalpha.com/news/3779360-israeli-study-bolsters-effiicacy-of-pfizerbiontech-covid-booster-against-omicron", "urlToImage": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1304330723/large_image_1304330723.jpg", "publishedAt": "2021-12-12T17:23:25Z", "content": "narvikk/iStock via Getty Images"}, {"source": {"id": null, "name": "The Punch"}, "author": "Godfrey George", "title": "Omicron: Fourth dose needed to deal with new strain, says Pfizer", "description": "The Chief Executive of pharmaceutical giant, Pfizer, Dr Albert Bourla, has confirmed that a fourth COVID-19 jab will be needed to deal with Omicron. He warned that it would likely be required within a matter of months. Bourla has for weeks been floating the i\u2026", "url": "https://punchng.com/omicron-fourth-dose-needed-to-deal-with-new-strain-says-pfizer/", "urlToImage": "https://cdn.punchng.com/wp-content/uploads/2019/06/17163448/pfizer-logo.jpg", "publishedAt": "2021-12-12T00:03:24Z", "content": "The Chief Executive of pharmaceutical giant, Pfizer, Dr Albert Bourla, has confirmed that a fourth COVID-19 jab will be needed to deal with Omicron.\r\nHe warned that it would likely be required within\u2026 [+2321 chars]"}, {"source": {"id": null, "name": "Cracknewz.com"}, "author": "Neha", "title": "Pfizer CEO says fourth vaccine dose might be needed sooner than expected", "description": "", "url": "https://www.cracknewz.com/2021/12/pfizer-ceo-says-fourth-vaccine-dose.html", "urlToImage": null, "publishedAt": "2021-12-12T14:59:31Z", "content": "As people around the world line up to get their third-dose \u201cbooster\u201d shot of mRNA vaccines against COVID-19 due to waning protection from the first round, the CEO of Pfizer, Albert Bourla, has alread\u2026 [+3275 chars]"}, {"source": {"id": null, "name": "Cracknewz.com"}, "author": "Neha", "title": "Japan Health Ministry issues HEART WARNING for Pfizer and Moderna covid vaccines", "description": "", "url": "https://www.cracknewz.com/2021/12/japan-health-ministry-issues-heart.html", "urlToImage": null, "publishedAt": "2021-12-12T13:51:25Z", "content": "The Japan Health Ministry has been receiving several reports of\u00a0young people developing severe heart inflammation\u00a0after taking the Pfizer or Modern mRNA vaccines. The public health officials recently\u2026 [+3714 chars]"}, {"source": {"id": null, "name": "Zerohedge.com"}, "author": "Mike Rivero", "title": "Pfizer Jab Is Only 23% Effective Against Omicron, South African Study Finds", "description": "A few days ago, researchers in South Africa shared data from a preliminary study showing that the Pfizer vaccine is less effective at blocking the omicron variant than earlier variants like beta and delta. Now, the team is telling us exactly how much less eff\u2026", "url": "https://www.zerohedge.com/covid-19/pfizer-jab-only-23-against-omicron-south-african-study-finds", "urlToImage": "https://assets.zerohedge.com/s3fs-public/styles/16_9_max_700/public/2021-12/pfizer15.jpg?itok=YtSrbZHa", "publishedAt": "2021-12-12T13:34:33Z", "content": "A few days ago, researchers in South Africa shared data from a preliminary study showing that the Pfizer vaccine is less effective at blocking the omicron variant than earlier variants like beta and \u2026 [+3514 chars]"}, {"source": {"id": null, "name": "Cracknewz.com"}, "author": "Neha", "title": "BioNTech says three additional Pfizer covid vaccine doses needed to fight Omicron: total of SIX to be required for \u201cfull\u201d vaccination", "description": "", "url": "https://www.cracknewz.com/2021/12/biontech-says-three-additional-pfizer.html", "urlToImage": null, "publishedAt": "2021-12-12T14:12:58Z", "content": "Ugur Sahin, the CEO of BioNTech (Pfizer\u2019s \u201cvaccine\u201d partner), has\u00a0announced plans\u00a0to start selling a three-dose injection regimen specifically for the \u201cOmicron\u201d (Moronic) variant of the Wuhan coronav\u2026 [+3353 chars]"}, {"source": {"id": null, "name": "The Star Online"}, "author": "The Star Online", "title": "Israeli study finds Pfizer Covid-19 booster protects against Omicron", "description": "JERUSALEM (Reuters): Israeli researchers said on Saturday (Dec 12) that they found that a three-shot course of the Pfizer / BioNTech Covid-19 vaccine provided significant protection against the new Omicron variant. Read full story", "url": "https://www.thestar.com.my/news/world/2021/12/12/israeli-study-finds-pfizer-covid-19-booster-protects-against-omicron", "urlToImage": "https://apicms.thestar.com.my/uploads/images/2021/12/12/1403154.jpg", "publishedAt": "2021-12-12T02:57:00Z", "content": "JERUSALEM (Reuters): Israeli researchers said on Saturday (Dec 12) that they found that a three-shot course of the Pfizer / BioNTech Covid-19 vaccine provided significant protection against the new O\u2026 [+1317 chars]"}, {"source": {"id": null, "name": "bdnews24.com"}, "author": null, "title": "Israeli study finds Pfizer COVID-19 booster protects against omicron", "description": "Israeli researchers said on Saturday they found that a three-shot course of the Pfizer/BioNTech, COVID-19 vaccine provided significant protection against the new omicron variant.", "url": "https://bdnews24.com/coronavirus-pandemic/2021/12/12/israeli-study-finds-pfizer-covid-19-booster-protects-against-omicron", "urlToImage": "https://d30fl32nd2baj9.cloudfront.net/media/2021/09/21/pfizer-vaccine-kids-smr-210921-01.jpg/BINARY/pfizer-vaccine-kids-smr-210921-01.jpg", "publishedAt": "2021-12-12T03:17:05Z", "content": "The findings were similar to those presented by BioNTech and Pfizer earlier in the week, which were an early signal that booster shots could be key to protect against infection from the newly identif\u2026 [+1081 chars]"}, {"source": {"id": null, "name": "Freerepublic.com"}, "author": "Time", "title": "Pfizer Course Has 23% Efficacy Vs. Omicron in South African Study", "description": "A two-shot course of Pfizer Inc.\u2019s vaccine has just 22.5% efficacy against symptomatic infection with the omicron variant, but can thwart severe disease, according to laboratory experiments in South Africa.", "url": "https://freerepublic.com/focus/f-news/4020441/posts", "urlToImage": null, "publishedAt": "2021-12-12T03:34:36Z", "content": "Skip to comments.\r\nPfizer Course Has 23% Efficacy Vs. Omicron in South African StudyTime ^\r\n | 12/11/21\r\nPosted on 12/11/2021 7:34:36 PM PST by BusterDog\r\nA two-shot course of Pfizer Inc.s vaccine ha\u2026 [+1901 chars]"}, {"source": {"id": null, "name": "Freerepublic.com"}, "author": "Nation and State", "title": "Pfizer Jab Is Only 23% Effective Against Omicron, South African Study Finds", "description": "A few days ago, researchers in South Africa shared data from a preliminary study showing that the Pfizer vaccine is less effective at blocking the omicron variant than earlier variants like beta and delta. Now, the team is telling us exactly how much less eff\u2026", "url": "https://freerepublic.com/focus/f-chat/4020458/posts", "urlToImage": null, "publishedAt": "2021-12-12T05:32:44Z", "content": "Skip to comments.\r\nPfizer Jab Is Only 23% Effective Against Omicron, South African Study FindsNation and State ^\r\n | 12/11/2021\r\n | Tyler Durden\r\nPosted on 12/11/2021 9:32:44 PM PST by SeekAndFind\r\nA\u2026 [+4336 chars]"}, {"source": {"id": "the-hill", "name": "The Hill"}, "author": "Caroline Vakil", "title": "Israeli study supports Pfizer findings that booster provides strong protection against omicron", "description": "An Israeli study appears to support findings from Pfizer and BioNTech that\u00a0three doses of their vaccine, including a booster as well as\u00a0an initial two-shot regimen, provide\u00a0strong protection against the omicron vari...", "url": "https://thehill.com/policy/healthcare/585443-israeli-study-supports-pfizer-findings-that-booster-provides-strong", "urlToImage": "https://thehill.com/sites/default/files/article_images/coronavirus_vaccine_092421getty_companies.jpg", "publishedAt": "2021-12-12T01:19:30Z", "content": "An Israeli study appears to support findings from Pfizer and BioNTech that\u00a0three doses of their vaccine, including a booster as well as\u00a0an initial two-shot regimen, provide\u00a0strong protection against \u2026 [+2142 chars]"}, {"source": {"id": null, "name": "The Times of Israel"}, "author": null, "title": "Israeli study finds 2 Pfizer shots fail to neutralize Omicron, but booster effective", "description": "This data is \u2018very worrisome,' says study head, but those who received a third dose of the vaccine have cause for \u2018optimism'", "url": "https://www.timesofisrael.com/israeli-study-finds-2-pfizer-shots-fail-to-neutralize-omicron-but-booster-effective/", "urlToImage": "https://static.timesofisrael.com/www/uploads/2021/12/F211129DC02-1-1024x640.jpg", "publishedAt": "2021-12-12T08:17:29Z", "content": "People who were vaccinated with Pfizer shots six months ago or more have almost no neutralizing ability against the Omicron variant, while those who received boosters are in reasonably good shape, an\u2026 [+2730 chars]"}]}, "2021-12-11": {"status": "ok", "totalResults": 13, "articles": [{"source": {"id": null, "name": "Ctvnews.ca"}, "author": null, "title": "Pfizer booster shot protects against Omicron: Israeli study - CTV News", "description": "<ol><li>Pfizer booster shot protects against Omicron: Israeli study\u00a0\u00a0CTV News\r\n</li><li>Boosters give up to 75 percent protection from mild Omicron: UK\u00a0\u00a0Al Jazeera English\r\n</li><li>Pfizer Course Has 23% Efficacy Vs. Omicron in South African Study\u00a0\u00a0TIME\r\n</li\u2026", "url": "https://www.ctvnews.ca/health/coronavirus/israeli-study-finds-pfizer-covid-19-booster-protects-against-omicron-1.5703809", "urlToImage": "https://www.ctvnews.ca/polopoly_fs/1.5703811.1639255201!/httpImage/image.jpg_gen/derivatives/landscape_620/image.jpg", "publishedAt": "2021-12-11T20:40:30Z", "content": "JERUSALEM -- \r\nIsraeli researchers said on Saturday they found that a three-shot course of the Pfizer/BioNTech COVID-19 vaccine provided significant protection against the new Omicron variant.\r\nThe f\u2026 [+1276 chars]"}, {"source": {"id": "time", "name": "Time"}, "author": "Antony Sguazzin / Bloomberg", "title": "Pfizer Course Has 23% Efficacy Vs. Omicron in South African Study", "description": "The research considered blood plasma samples from 12 participants", "url": "https://time.com/6127710/omicron-pfizer/", "urlToImage": "https://api.time.com/wp-content/uploads/2021/12/Pfizer.jpg?quality=85&w=1024&h=628&crop=1", "publishedAt": "2021-12-11T17:58:51Z", "content": "Bloomberg \u2014 A two-shot course of Pfizer Inc.\u2019s vaccine has just 22.5% efficacy against symptomatic infection with the omicron variant, but can thwart severe disease, according to laboratory experimen\u2026 [+1307 chars]"}, {"source": {"id": "bloomberg", "name": "Bloomberg"}, "author": "Antony Sguazzin", "title": "Pfizer Course Has 23% Efficacy Vs. Omicron in S. African Study", "description": "A two-shot course of Pfizer Inc.\u2019s vaccine has just 22.5% efficacy against symptomatic infection with the omicron variant, but can thwart severe disease, according to laboratory experiments in South Africa.", "url": "https://www.bloomberg.com/news/articles/2021-12-11/pfizer-course-has-23-efficacy-vs-omicron-in-s-african-study", "urlToImage": "https://assets.bwbx.io/images/users/iqjWHBFdfxIU/iR1WCOedPmAo/v0/1200x738.jpg", "publishedAt": "2021-12-11T16:41:24Z", "content": "A two-shot course of \r\nPfizer Inc.s vaccine has just 22.5% efficacy against symptomatic infection with the omicron variant, but can thwart severe disease, according to laboratory experiments in South\u2026 [+138 chars]"}, {"source": {"id": "cbs-news", "name": "CBS News"}, "author": "CBS News", "title": "One year after first Pfizer vaccination, COVID case continue to rise", "description": "It has been exactly one year since the Food and Drug Administration authorized the Pfizer vaccine -- the first of three COVID-19 vaccines now in use in the United States. During that time, more than 480 million shots have been administered. But even with thos\u2026", "url": "https://www.cbsnews.com/video/one-year-after-first-pfizer-vaccination-covid-case-continue-to-rise/", "urlToImage": "https://cbsnews3.cbsistatic.com/hub/i/r/2021/12/11/f559d80a-0d64-4aab-9d0b-c1c7b21f4638/thumbnail/1200x630/e67d99bc6094ad80dcdc0393a3aa33b1/1211-satmo-covidlatest-853661-640x360.jpg", "publishedAt": "2021-12-11T13:32:38Z", "content": "Watch CBSN Live\r\nCopyright \u00a9 2021 CBS Interactive Inc. All rights reserved.\r\nGet browser notifications for breaking news, live events, and exclusive reporting.\r\nNot NowTurn On"}, {"source": {"id": null, "name": "Sputnik International"}, "author": "Sputnik International", "title": "Pfizer Booster Gives Some Protection Against Omicron, Two Shots Not Enough - Study", "description": "TEL AVIV (Sputnik) - Two shots of the Pfizer vaccine against COVID-19 are not enough to protect people against the Omicron strain, while the booster shot's protection is much lower than with respect to other variants, a new study conducted at Israel\u2019s Sheba M\u2026", "url": "https://sputniknews.com/20211211/pfizer-booster-gives-some-protection-against-omicron-two-shots-not-enough---study-1091449420.html", "urlToImage": "https://cdnn1.img.sputniknews.com/images/sharing/article/eng/1091449420.jpg?10913416961639261802", "publishedAt": "2021-12-11T22:30:00Z", "content": "Registration was successful!Please follow the link from the email sent to \r\nhttps://sputniknews.com/20211211/pfizer-booster-gives-some-protection-against-omicron-two-shots-not-enough---study-10914494\u2026 [+3038 chars]"}, {"source": {"id": "the-times-of-india", "name": "The Times of India"}, "author": "ANI", "title": "Swiss medical agency approves Pfizer vaccine for children over 5", "description": "Europe News: ZURICH: The Swiss Agency for Therapeutic Products, Swissmedic on Friday approved the use of the Pfizer vaccine for children aged 5-11.", "url": "https://timesofindia.indiatimes.com/world/europe/swiss-medical-agency-approves-pfizer-vaccine-for-children-over-5/articleshow/88219632.cms", "urlToImage": "https://static.toiimg.com/thumb/msid-88219657,width-1070,height-580,imgsize-22902,resizemode-75,overlay-toi_sw,pt-32,y_pad-40/photo.jpg", "publishedAt": "2021-12-11T04:56:41Z", "content": "Swiss medical agency approves Pfizer vaccine for children over 5"}, {"source": {"id": null, "name": "Scoopyweb.com"}, "author": "unewsy", "title": "Vast majority of Britons have NO PROTECTION against Omicron: After 100 days two AstraZeneca doses offer virtually zero defence while two Pfizer jabs provide just 37% protection against new variant \u2013 but boosters cut risk of falling ill by 75%", "description": "Millions of Britons have effectively no protection against the Omicron Covid variant, health experts have warned as the public was urged to get their booster jabs - despite chaos on the NHS booking site meaning some can't get jabs until Christmas Eve.", "url": "http://www.scoopyweb.com/2021/12/vast-majority-of-britons-have-no.html", "urlToImage": "https://lh5.googleusercontent.com/proxy/7HVZkb3pPM9s5TfIFsXL4fDgb2SzXevFD5ceVvCWgJTL5WJ-bkjVecOOJCg4xr90jCJ-QRd4Skp4WRI5kGAIqitm4nv6GeOrVniblXA7akYBOb-k18QQ5Yxh8GKIW8wJ4bWqIGbO=w1200-h630-p-k-no-nu", "publishedAt": "2021-12-11T12:55:15Z", "content": "Millions of Britons have effectively no protection against the\u00a0Omicron\u00a0Covid variant, health experts have warned as the public was urged to get their booster jabs - despite chaos on the NHS booking s\u2026 [+28397 chars]"}, {"source": {"id": null, "name": "Freerepublic.com"}, "author": "IBT Times", "title": "552 Fully Vaccinated Oregon Residents Died Of COVID-19, Half Received Pfizer Vaccine", "description": "More than 500 residents in Oregon have now died of COVID-19 despite being fully vaccinated against the virus as health officials continue to report over 2,000 new infections daily. Since the beginning of the pandemic, health authorities in Oregon have recorde\u2026", "url": "https://freerepublic.com/focus/f-chat/4020313/posts", "urlToImage": null, "publishedAt": "2021-12-11T15:46:04Z", "content": "Skip to comments.\r\n552 Fully Vaccinated Oregon Residents Died Of COVID-19, Half Received Pfizer VaccineIBT Times ^\r\n | 12/06/2021\r\n | Danielle Ong\r\nPosted on 12/11/2021 7:46:04 AM PST by Jan_Sobieski\u2026 [+2192 chars]"}, {"source": {"id": null, "name": "Freerepublic.com"}, "author": "NWT", "title": "33-Year-Old New Zealand Nurse Diagnosed With Pericarditis Following Pfizer COVID-19 Jab; 7th Person Admitted in One Day Suffering Heart Problem After Shot", "description": "We\u2019re told by pharmaceutical companies, mainstream media, and politicians on both sides of the aisle that adverse reactions to the COVID-19 injections are rare. But anyone with common sense knows that\u2019s a lie. Serious medical complications, such as myocarditi\u2026", "url": "https://freerepublic.com/focus/f-news/4020197/posts", "urlToImage": null, "publishedAt": "2021-12-11T02:36:17Z", "content": "Skip to comments.\r\n33-Year-Old New Zealand Nurse Diagnosed With Pericarditis Following Pfizer COVID-19 Jab; 7th Person Admitted in One Day Suffering Heart Problem After Shot\r\nNWT ^\r\n | 12/10/2021\r\nPo\u2026 [+2685 chars]"}, {"source": {"id": null, "name": "Ynetnews"}, "author": "Reuters", "title": "Israeli study finds Pfizer COVID-19 booster protects against Omicron", "description": "Joint study conducted by Sheba Medical Center, Health Ministry adds credence to Pfizer research proving that the booster could be key to protecting against newly identified Omicron variant", "url": "https://www.ynetnews.com/health_science/article/bk28kqm5t", "urlToImage": "https://ynet-images1.yit.co.il/picserver5/crop_images/2021/11/27/ryorNmxKF/ryorNmxKF_0_170_3000_1688_0_large.jpg", "publishedAt": "2021-12-11T21:03:46Z", "content": "<ul><li>facebook</li><li>print</li><li>send to friend</li><li>comment</li></ul>\r\nIsraeli researchers said on Saturday they found that a three-shot course of the Pfizer/BioNTech COVID-19 vaccine provi\u2026 [+1420 chars]"}, {"source": {"id": null, "name": "Slashdot.org"}, "author": "feedfeeder", "title": "Israeli study finds Pfizer COVID-19 booster protects against Omicron - Reuters", "description": "Israeli study finds Pfizer COVID-19 booster protects against OmicronReuters 'Three shots of Pfizer COVID vaccine 4x less effective against Omicron'The Jerusalem Post Omicron Cases, Vaccines and Boosters News: Covid-19 Live UpdatesThe New York Times Booster sh\u2026", "url": "https://slashdot.org/firehose.pl?op=view&amp;id=156420875", "urlToImage": null, "publishedAt": "2021-12-11T23:12:57Z", "content": "The Fine Print: The following comments are owned by whoever posted them. We are not responsible for them in any way."}, {"source": {"id": "the-irish-times", "name": "The Irish Times"}, "author": null, "title": "Pfizer booster provides significant protection against Omicron variant \u2013 study", "description": "Israeli research compared blood samples between two-dose group and booster group", "url": "https://www.irishtimes.com/news/world/pfizer-booster-provides-significant-protection-against-omicron-variant-study-1.4753298", "urlToImage": "https://www.irishtimes.com/image-creator/?id=1.4753297&origw=960", "publishedAt": "2021-12-11T20:44:10Z", "content": "Israeli researchers said on Saturday they found that a three-shot course of the Pfizer/BioNTech Covid-19 vaccine provided significant protection against the new Omicron variant.\r\nThe findings were si\u2026 [+190 chars]"}, {"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "Israeli study finds Pfizer COVID-19 booster protects against Omicron", "description": "Israeli researchers said on Saturday they found that a three-shot course of the Pfizer/BioNTech <a href=\"https://www.reuters.com/companies/PFE.N\" target=\"_blank\">(PFE.N)</a>, <a href=\"https://www.reuters.com/companies/22UAy.DE\" target=\"_blank\">(22UAy.DE)</a> \u2026", "url": "https://www.reuters.com/world/middle-east/israeli-study-finds-pfizer-covid-19-booster-protects-against-omicron-2021-12-11/", "urlToImage": "https://www.reuters.com/resizer/_PpvTEOu1ldeGiWGRMkDndiUy5g=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/GZ24RWTXMZNJRBJFMYXAJDC2S4.jpg", "publishedAt": "2021-12-11T20:42:00Z", "content": "JERUSALEM, Dec 11 (Reuters) - Israeli researchers said on Saturday they found that a three-shot course of the Pfizer/BioNTech (PFE.N), (22UAy.DE) COVID-19 vaccine provided significant protection agai\u2026 [+1529 chars]"}]}, "2021-12-10": {"status": "ok", "totalResults": 43, "articles": [{"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "South Africa to offer Pfizer and J&J vaccine booster doses - Reuters", "description": "South Africa is preparing to offer people booster doses of the Pfizer <a href=\"https://www.reuters.com/companies/PFE.N\" target=\"_blank\">(PFE.N)</a> and Johnson & Johnson <a href=\"https://www.reuters.com/companies/JNJ.N\" target=\"_blank\">(JNJ.N)</a> COVID-19 va\u2026", "url": "https://www.reuters.com/world/africa/south-africa-offer-pfizer-jj-vaccine-booster-doses-2021-12-10/", "urlToImage": "https://www.reuters.com/resizer/BFOBNMhYnz9KGAb-ldlOoIsXYRk=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/6BVOZWSNURNNLFN7XWB75LZTDA.jpg", "publishedAt": "2021-12-10T07:20:00Z", "content": "A healthcare worker administers the Pfizer coronavirus disease (COVID-19) vaccine to a man, amidst the spread of the SARS-CoV-2 variant Omicron, in Johannesburg, South Africa, December 9, 2021. REUTE\u2026 [+645 chars]"}, {"source": {"id": null, "name": "The Indian Express"}, "author": "The Conversation", "title": "Safety, side effects, allergies and doses. Pfizer vaccine for 5-11 year olds explained", "description": "Meanwhile, more than five million US children aged five-11 have had one dose and more than two million have had a second dose.", "url": "https://indianexpress.com/article/world/australia-pfizer-vaccine-children-safety-side-effects-allergies-7666018/", "urlToImage": "https://images.indianexpress.com/2021/12/vaccine-1200-1.jpg", "publishedAt": "2021-12-10T10:18:29Z", "content": "Australian children aged five-11 will start to receive the PfizerCovid-19 vaccine from January 10, after it cleared the final regulatory step and was recommended for use in this age group by the Aust\u2026 [+5226 chars]"}, {"source": {"id": null, "name": "SlashGear"}, "author": "Brittany A. Roston", "title": "FDA and CDC green light Pfizer COVID-19 booster for older teenagers", "description": "Teenagers ages 16 and 17 in the United States are now eligible for the Pfizer COVID-19 booster shot, the US FDA and CDC have announced. The FDA revealed its Emergency Use Authorization (EUA) expansion on December 9, noting that eligible teenagers must have re\u2026", "url": "https://www.slashgear.com/fda-and-cdc-green-light-pfizer-covid-19-booster-for-older-teenagers-09701744/", "urlToImage": "https://cdn.slashgear.com/wp-content/uploads/2021/12/FDA-CDC-Pfizer-Booster-Teens.jpg", "publishedAt": "2021-12-10T00:10:19Z", "content": "Teenagers ages 16 and 17 in the United States are now eligible for the Pfizer COVID-19 booster shot, the US FDA and CDC have announced. The FDA revealed its Emergency Use Authorization (EUA) expansio\u2026 [+4169 chars]"}, {"source": {"id": null, "name": "TheBlaze"}, "author": "Alex Nitzberg", "title": "US expands Pfizer COVID-19 vaccine booster eligibility to include 16- and 17-year-olds", "description": "The U.S. has given the green light for 16- and 17-year-olds to get a booster dose of the Pfizer-BioNTech COVID-19 vaccine.The U.S. Food and Drug Administration expanded the emergency use authorization for the vaccine to allow a booster shot for 16- and 17-yea\u2026", "url": "https://www.theblaze.com/news/us-expands-pfizer-covid-19-vaccine-booster-eligibility-to-include-those-ages-16-and-17", "urlToImage": "https://assets.rebelmouse.io/eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJpbWFnZSI6Imh0dHBzOi8vYXNzZXRzLnJibC5tcy8yODIwMDExOS9vcmlnaW4uanBnIiwiZXhwaXJlc19hdCI6MTY4NzQxNjMzNH0.RgLc_K_lmYwk98rmO4loa8Q1GojZX3NFCAbCvoGooaQ/img.jpg?width=1200&coordinates=0%2C85%2C0%2C86&height=600", "publishedAt": "2021-12-10T04:35:22Z", "content": "The U.S. has given the green light for 16- and 17-year-olds to get a booster dose of the Pfizer-BioNTech COVID-19 vaccine.\r\nThe U.S. Food and Drug Administration expanded the emergency use authorizat\u2026 [+1856 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "AFP Videographics", "title": "Biden: 'Encouraging news from Pfizer' over Omicron variant", "description": "Ahead of a meeting with his White House Covid-19 Response Team, US President Joe Biden says that preliminary lab data shows that three doses of the Pfizer...", "url": "https://news.yahoo.com/biden-encouraging-news-pfizer-over-043757765.html", "urlToImage": "https://s.yimg.com/ny/api/res/1.2/skK8vojxolOkV2yH3Fq2qw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzU-/https://s.yimg.com/hd/cp-video-transcode/prod/2021-12/10/61b2dacecec8b12ed24ff843/61b2dacecec8b12ed24ff844_o_U_v2.jpg", "publishedAt": "2021-12-10T04:37:57Z", "content": "A Los Angeles-bound flight from Washington, D.C. was diverted to Oklahoma City after a\"combative passenger\" assaulted a flight attendant and an air marshal aboard the plane Thursday evening, local po\u2026 [+299 chars]"}, {"source": {"id": null, "name": "Business Wire"}, "author": null, "title": "Pfizer Declares First-Quarter 2022 Dividend", "description": "NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced that its board of directors declared an increase in the quarterly cash dividend on the company\u2019s common stock to $0.40 for the first-quarter 2022 dividend, payable March 4, 2022, to holders of\u2026", "url": "https://www.businesswire.com/news/home/20211210005405/en/Pfizer-Declares-First-Quarter-2022-Dividend", "urlToImage": "https://mms.businesswire.com/media/20211210005405/en/1045874/23/Pfizer_Logo_Color_RGB_APPROVED.jpg", "publishedAt": "2021-12-10T17:07:48Z", "content": "NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced that its board of directors declared an increase in the quarterly cash dividend on the companys common stock to $0.40 for the first-\u2026 [+3186 chars]"}, {"source": {"id": null, "name": "Moneycontrol"}, "author": null, "title": "Booster shot of Pfizer COVID vaccine can cut mortality from Delta variant by 90%: Study", "description": "The research, published in The New England Journal of Medicine on Thursday, included data from participants 50 years of age or older who had received two doses of Pfizer vaccine at least five months earlier.", "url": "https://www.moneycontrol.com/news/trends/health-trends/booster-shot-of-pfizer-covid-vaccine-can-cut-mortality-from-delta-variant-by-90-study-7812411.html", "urlToImage": "https://images.moneycontrol.com/static-mcnews/2021/09/pfizer-770x433.jpg", "publishedAt": "2021-12-10T10:45:22Z", "content": "The third dose of the Pfizer COVID-19 vaccine can reduce mortality due to the Delta variant of the SARS-CoV-2 virus by 90 per cent, according to a study conducted in Israel.\r\nThe research, published \u2026 [+1992 chars]"}, {"source": {"id": null, "name": "Globalresearch.ca"}, "author": "Emily Mangiaracina", "title": "\u2018Unbiased\u2019 News Source? Reuters Chairman Is Top Investor and Board Member of Pfizer", "description": "All Global Research articles\u00a0can be read in 51 languages by activating the \u201cTranslate Website\u201d\u00a0drop down menu on the top banner of our home page (Desktop version). To receive Global Research\u2019s Daily Newsletter (selected articles),\u00a0click here. Visit and follow\u2026", "url": "https://www.globalresearch.ca/unbiased-news-source-reuters-chairman-top-investor-board-member-pfizer/5764305", "urlToImage": "https://www.globalresearch.ca/wp-content/uploads/2021/12/James-Smith-Reuters-1-810x500.jpg", "publishedAt": "2021-12-10T15:20:28Z", "content": "All Global Research articles\u00a0can be read in 51 languages by activating the Translate Website\u00a0drop down menu on the top banner of our home page (Desktop version).\r\nTo receive Global Researchs Daily Ne\u2026 [+3587 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "Arvinas Inc.", "title": "Arvinas and Pfizer Announce PROTAC\u00ae Protein Degrader ARV-471 Continues to Demonstrate Encouraging Clinical Benefit Rate in Patients with Locally Advanced or Metastatic ER+/HER2- Breast Cancer", "description": "\u2013 ARV-471 continues to show a favorable tolerability profile and robust ER degradation in updated phase 1 dose escalation data presented at San Antonio...", "url": "https://finance.yahoo.com/news/arvinas-pfizer-announce-protac-protein-131000635.html", "urlToImage": "https://s.yimg.com/uu/api/res/1.2/THk8GpbFdRBalzjrkr1Fkw--~B/aD0yNTI7dz02OTY7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/92323019a5a4213cf6ded7f6af366081", "publishedAt": "2021-12-10T13:10:00Z", "content": "ARV-471 continues to show a favorable tolerability profile and robust ER degradation in updated phase 1 dose escalation data presented at San Antonio Breast Cancer Symposium \r\n ARV-471 is expected to\u2026 [+22042 chars]"}, {"source": {"id": null, "name": "Globalresearch.ca"}, "author": "Ethan Huff", "title": "Beyond Belief: FDA Adds Another 20 Years to Timeline for Full Release of Pfizer COVID Vaccine Data \u2013 Not Until 2096 Now", "description": "All Global Research articles\u00a0can be read in 51 languages by activating the \u201cTranslate Website\u201d\u00a0drop down menu on the top banner of our home page (Desktop version).\nTo receive Global Research\u2019s Daily Newsletter (selected articles),\u00a0click here.\nVisit \u2026\nThe post\u2026", "url": "https://www.globalresearch.ca/fda-adds-another-20-years-timeline-full-release-pfizer-covid-vaccine-data-not-until-2096-now/5764309", "urlToImage": "https://www.globalresearch.ca/wp-content/uploads/2021/12/Coronavirus-Covid-19-Pfizer-Vaccine-Syringe-Vial.jpg", "publishedAt": "2021-12-10T15:23:56Z", "content": "All Global Research articles\u00a0can be read in 51 languages by activating the Translate Website\u00a0drop down menu on the top banner of our home page (Desktop version).\r\nTo receive Global Researchs Daily Ne\u2026 [+3971 chars]"}, {"source": {"id": null, "name": "Globalresearch.ca"}, "author": "Guy Hatchard", "title": "New Zealand: Pfizer \u201cConfidential Document\u201d Concedes that There Is a Large Increase in Types of Adverse Event Reaction to Its Vaccine", "description": "All Global Research articles\u00a0can be read in 51 languages by activating the \u201cTranslate Website\u201d\u00a0drop down menu on the top banner of our home page (Desktop version).\nTo receive Global Research\u2019s Daily Newsletter (selected articles),\u00a0click here.\nVisit \u2026\nThe post\u2026", "url": "https://www.globalresearch.ca/pfizer-document-concedes-large-increase-types-adverse-event-reaction-vaccine/5764294", "urlToImage": "https://www.globalresearch.ca/wp-content/uploads/2020/12/allergic-reactions-Pfizer-vaccine-feature-800x417.jpg", "publishedAt": "2021-12-10T15:22:50Z", "content": "All Global Research articles\u00a0can be read in 51 languages by activating the Translate Website\u00a0drop down menu on the top banner of our home page (Desktop version).\r\nTo receive Global Researchs Daily Ne\u2026 [+14591 chars]"}, {"source": {"id": null, "name": "CNA"}, "author": null, "title": "Singapore approves Pfizer-BioNTech COVID-19 vaccine for children aged 5 to 11; first shots by end-2021", "description": "SINGAPORE: The Health Sciences Authority (HSA) has extended the authorisation of the Pfizer-BioNTech/Comirnaty COVID-19 vaccine for use in children aged between five and 11, with inoculations set to begin before the end of the year.\r\n\r\n\u201cThe vaccination regime\u2026", "url": "https://www.channelnewsasia.com/singapore/moh-covid-19-vaccination-children-singapore-2372631", "urlToImage": "https://onecms-res.cloudinary.com/image/upload/s--NjGSjPaw--/fl_relative%2Cg_south_east%2Cl_one-cms:core:watermark:afp_watermark%2Cw_0.1/f_auto%2Cq_auto/c_fill%2Cg_auto%2Ch_676%2Cw_1200/v1/one-cms/core/33bac94ffa8cc3f4612e21b6bc7170888ac8a2bc.jpg?itok=FOKCPTSV", "publishedAt": "2021-12-10T16:14:00Z", "content": "SINGAPORE: The Health Sciences Authority (HSA) has extended the authorisation of the Pfizer-BioNTech/Comirnaty COVID-19 vaccine for use in children aged between five and 11, with inoculations set to \u2026 [+1852 chars]"}, {"source": {"id": null, "name": "Seeking Alpha"}, "author": "Dulan Lokuwithana", "title": "Pfizer wins European approval for Cibinqo in atopic dermatitis", "description": "Pfizer (PFE) announced that the European Commission ((EC)) approved its Janus kinase 1 (JAK1) inhibitor Cibinqo (abrocitinib) for patients with moderate-to-severe atopic...", "url": "https://seekingalpha.com/news/3779174-pfizer-wins-european-approval-for-cibinqo-in-atopic-dermatitis", "urlToImage": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1227739745/large_image_1227739745.jpg", "publishedAt": "2021-12-10T14:46:02Z", "content": "Jeenah Moon/Getty Images News"}, {"source": {"id": "news24", "name": "News24"}, "author": "Zakiyah Ebrahim", "title": "News24.com | Covid-19 vaccines: Latest on when Pfizer and J&J booster shots will likely be rolled out", "description": "The rollout of booster shots of the Pfizer and J&J vaccines is expected to kick off within a couple of weeks, the department of health said on Friday.", "url": "https://www.news24.com/health24/Medical/Infectious-diseases/Coronavirus/covid-19-vaccines-latest-on-when-pfizer-and-jj-booster-shots-will-likely-be-rolled-out-20211210", "urlToImage": "https://cdn.24.co.za/files/Cms/General/d/411/6b7f635b5e814377aa83a58f803c0d70.jpg", "publishedAt": "2021-12-10T10:09:46Z", "content": "<ul><li>Booster doses for adults who received the two-dose Pfizer vaccine have been approved.</li><li>This will likely become available to people in the new year.</li><li>Those who received the J&amp\u2026 [+4449 chars]"}, {"source": {"id": null, "name": "The Punch"}, "author": "Ademola Olonilua", "title": "Pfizer partners American Cancer Society to subsidise medication cost by 50%", "description": "Pharmaceutical company, Pfizer, has partnered with the American Cancer Society, as well as the Clinton Health Access Initiative to close the patient affordability gap and increase patient access to oncology treatments. In a statement signed by the Country Man\u2026", "url": "https://punchng.com/pfizer-partners-american-cancer-society-to-subsidise-medication-cost-by-50/", "urlToImage": "https://cdn.punchng.com/wp-content/uploads/2019/06/17163448/pfizer-logo.jpg", "publishedAt": "2021-12-10T20:58:46Z", "content": "Pharmaceutical company, Pfizer, has partnered with the American Cancer Society, as well as the Clinton Health Access Initiative to close the patient affordability gap and increase patient access to o\u2026 [+2498 chars]"}, {"source": {"id": null, "name": "Stationgossip.com"}, "author": "orraz", "title": "FDA Authorizes Pfizer Covid Booster Shot For 16 and 17 Year Olds One Day After Pfizer Pushes Third Jab as Protection Against Omicron Variant", "description": "Your Daily Station of Entertainment !!", "url": "http://www.stationgossip.com/2021/12/fda-authorizes-pfizer-covid-booster.html", "urlToImage": "https://lh3.googleusercontent.com/proxy/N5QFM8pujPkrlwd-mcPVvNszJztfw_pAuHa5OHhhPu6Sjj6C34dBMyEyx7IaD3G_rc_ZL7XI03PzlsozLpncpf1sxEV8q-taPfSarcDN0N0fPXchXyiw2CVkdjv2V9khGYu2g3sk3kzUkYpIbn5P0ozMxAuXmiHpIQ=w1200-h630-p-k-no-nu", "publishedAt": "2021-12-10T16:20:10Z", "content": "The FDA on Thursday authorized the Pfizer Covid booster shot for 16 and 17 year olds just in time for the Omicron variant.\r\nThe announcement comes just one day after Pfizer said protection against th\u2026 [+787 chars]"}, {"source": {"id": null, "name": "Seeking Alpha"}, "author": "Mamta Mayani", "title": "Pfizer, Arvinas' ARV-471 shows encouraging clinical benefit rate in breast cancer patients", "description": "Arvinas (ARVN) and Pfizer (PFE) announce an update on Phase 1 dose escalation data of ARV-471, a PROTAC estrogen receptor ((ER)) degrader, being co-developed for the treatment of...", "url": "https://seekingalpha.com/news/3779116-pfizer-arvinas-arv-471-shows-encouraging-clinical-benefit-rate-in-breast-cancer-patients", "urlToImage": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/897593850/large_image_897593850.jpg", "publishedAt": "2021-12-10T13:23:24Z", "content": "Vasyl Dolmatov/iStock via Getty Images"}, {"source": {"id": null, "name": "Investmentwatchblog.com"}, "author": "alexmark", "title": "FOIA Release of Pfizer Vax Data Pushed Back from 2076 to 2096", "description": null, "url": "https://www.investmentwatchblog.com/foia-release-of-pfizer-vax-data-pushed-back-from-2076-to-2096/", "urlToImage": null, "publishedAt": "2021-12-10T14:02:13Z", "content": "by Chris Black\r\nThese people are mocking you.\r\nThe vaccines are safe and effective, Pfizer is a legit good-company, and the government has nothing to hide, right?\r\nWrong.\r\nAnyway, you will have to wa\u2026 [+461 chars]"}, {"source": {"id": null, "name": "Jamaica Observer"}, "author": null, "title": "US expands Pfizer COVID boosters for children", "description": "WASHINGTON, United States (AP) - United States health authorities said yesterday that 16 and 17 year olds should get a booster dose of Pfizer's COVID-19 vaccine once they're six months past their last shot.The US and many other nations already were urging adu\u2026", "url": "https://www.jamaicaobserver.com/international/us-expands-pfizer-covid-boosters-for-children_238531?profile=1470", "urlToImage": "https://www.jamaicaobserver.com/apps/pbcsi.dll/storyimage/JO/20211210/ARTICLE/312109958/AR/0/AR-312109958.jpg", "publishedAt": "2021-12-10T06:21:37Z", "content": "WASHINGTON, United States (AP) \u2014 United States health authorities said yesterday that 16 and 17 year olds should get a booster dose of Pfizer's COVID-19 vaccine once they're six months past their las\u2026 [+3212 chars]"}, {"source": {"id": null, "name": "Americanthinker.com"}, "author": null, "title": "Why does Pfizer want its vaccine research protected?", "description": "Go look at the VAERS COVID Vaccine Mortality Report to know why Pfizer wants FDA protection for its vaccine research along with 75 years of document secrecy. While there are all sorts of ways to interpret the VAERS data, and it\u2019s entirely possi...", "url": "https://www.americanthinker.com/blog/2021/12/why_does_pfizer_want_its_vaccine_research_protected.html", "urlToImage": "https://www.americanthinker.com/images/bucket/2021-12/234401.jpg", "publishedAt": "2021-12-10T06:00:00Z", "content": "Go look at the VAERS COVID Vaccine Mortality Report to know why Pfizer wants FDA protection for its vaccine research along with 75 years of document secrecy. While there are all sorts of ways to inte\u2026 [+3769 chars]"}]}, "2021-12-09": {"status": "ok", "totalResults": 154, "articles": [{"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "U.S. FDA authorizes Pfizer/BioNTech booster for 16- and 17-year-olds - Reuters", "description": "The U.S. Food and Drug Administration on Thursday authorized booster shots of the COVID-19 vaccine from Pfizer Inc <a href=\"https://www.reuters.com/companies/PFE.N\" target=\"_blank\">(PFE.N)</a> and BioNTech SE  those aged 16 and 17, as public health officials \u2026", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-authorizes-pfizerbiontech-booster-16-17-year-olds-2021-12-09/", "urlToImage": "https://www.reuters.com/resizer/bkUwY5mw95BseoxbGI5hQWv6hk4=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/QECPI4VTXNLM7AYMJK7B3PPZ4Q.jpg", "publishedAt": "2021-12-09T16:45:00Z", "content": "Dec 9 (Reuters) - The U.S. Food and Drug Administration on Thursday authorized booster shots of the COVID-19 vaccine from Pfizer Inc (PFE.N) and BioNTech SE those aged 16 and 17, as public health off\u2026 [+1888 chars]"}, {"source": {"id": null, "name": "CNET"}, "author": "Jessica Rendall", "title": "FDA authorizes Pfizer boosters for 16- and 17-year-olds - CNET", "description": "The CDC still needs to sign off on the boosters for teens.", "url": "https://www.cnet.com/health/medical/fda-authorizes-pfizer-boosters-for-16-and-17-year-olds/", "urlToImage": "https://www.cnet.com/a/img/uHrXnopQHI-c7JDO-hz2calChRE=/1200x630/2021/11/24/646991f4-5a1a-4e6d-83ea-cc96bc1948fc/covid-19-vaccines-3rd-booster-shot-syringes-winter-2021-cnet-025.jpg", "publishedAt": "2021-12-09T17:49:00Z", "content": "Sarah Tew/CNET\r\nThe US Food and Drug Administration on Thursday\u00a0authorized boosters of Pfizer's COVID-19 vaccine for teens ages 16 and 17\u00a0at least six months after their second dose of Pfizer.\u00a0\r\nThe \u2026 [+1365 chars]"}, {"source": {"id": null, "name": "National Post"}, "author": "Bloomberg News", "title": "Pfizer CEO sees need for fourth shot faster than expected to protect against Omicron - National Post", "description": "<ol><li>Pfizer CEO sees need for fourth shot faster than expected to protect against Omicron\u00a0\u00a0National Post\r\n</li><li>Global National: Dec. 8, 2021 | Pfizer says 3rd vaccine dose raises defence against Omicron variant\u00a0\u00a0Global News\r\n</li><li>Pfizer-BioNTech pu\u2026", "url": "https://nationalpost.com/news/pfizer-ceo-recommends-four-shots-of-vaccine-to-boost-immunity-against-omicron", "urlToImage": "https://smartcdn.prod.postmedia.digital/nationalpost/wp-content/uploads/2021/11/vaccine.jpg", "publishedAt": "2021-12-09T17:50:34Z", "content": "Albert Bourla had said a fourth shot would be needed a year after the third dose, but 'we may need it faster' \r\nBoxes of the Pfizer Covid-19 vaccine to be administered to children from 5-11 years old\u2026 [+8952 chars]"}, {"source": {"id": null, "name": "Calgary Herald"}, "author": "Newsroom Staff", "title": "COVID-19 Update: 333 new cases, one death | Pfizer working on Omicron shot | Quebec to send rapid tests home with students - Calgary Herald", "description": "<ol><li>COVID-19 Update: 333 new cases, one death | Pfizer working on Omicron shot | Quebec to send rapid tests home with students\u00a0\u00a0Calgary Herald\r\n</li><li>COVID-19: Alberta reports six new cases of Omicron variant\u00a0\u00a0Edmonton Journal\r\n</li><li>COVID-19 in Alb\u2026", "url": "https://calgaryherald.com/news/local-news/covid-19-update-alberta-now-at-17-omicron-cases-10-in-calgary-zone-province-to-expand-monitoring-of-wastewater", "urlToImage": "https://smartcdn.prod.postmedia.digital/calgaryherald/wp-content/uploads/2021/12/Snowblast024.jpg", "publishedAt": "2021-12-09T23:15:00Z", "content": "Watch this page throughout the day for updates on COVID-19 in Calgary \r\nNewsroom Staff\r\nDowntown Calgary got a blast of snow sending commuters and maintence workers scrambling in Calgary on Wednesday\u2026 [+16488 chars]"}, {"source": {"id": null, "name": "New York Times"}, "author": "Sharon LaFraniere", "title": "Pfizer Says Its Booster Is Effective Against Omicron", "description": "The company\u2019s finding is based on only a small study of blood samples in a laboratory, but others are sure to follow.", "url": "https://www.nytimes.com/2021/12/08/health/pfizer-booster-omicron.html", "urlToImage": "https://static01.nyt.com/images/2021/12/08/us/politics/08DC-PFIZER-1/08DC-PFIZER-1-facebookJumbo.jpg", "publishedAt": "2021-12-09T00:17:06Z", "content": "You have to start somewhere, said Kathrin U. Jansen, a senior vice president and the head of vaccine research and development at Pfizer, while awaiting the results of more complex studies and real-wo\u2026 [+2150 chars]"}, {"source": {"id": "bloomberg", "name": "Bloomberg"}, "author": null, "title": "Third Pfizer-BioNTech Dose Is Key to Fight Omicron (Podcast)", "description": "Understand every aspect of the global economy \u2013 and know how to make your next move.", "url": "https://www.bloomberg.com/news/audio/2021-12-09/third-pfizer-biontech-dose-is-key-to-fight-omicron-podcast", "urlToImage": null, "publishedAt": "2021-12-09T03:19:01Z", "content": "Jason Gale, Bloomberg's Senior Editor, discusses the latest on the omicron variant and vaccines' impact with Bryan Curtis and Rishaad Salamat on Bloomberg Daybreak Asia.\r\nDec 09, 2021"}, {"source": {"id": null, "name": "WebMD"}, "author": "https://www.facebook.com/WebMD", "title": "FDA Authorizes Pfizer Boosters for 16 and 17 year-olds", "description": "The FDA said it was basing its emergency authorization of boosters for 16 and 17 year olds on data from 200 individuals who were ages 18 to 55 years of age when they received a booster dose.  They are requiring Pfizer to collect data on safety in post-authori\u2026", "url": "https://www.webmd.com/vaccines/covid-19-vaccine/news/20211209/fda-oks-boosters-for-teens", "urlToImage": "https://img.webmd.com/dtmcms/live/webmd/consumer_assets/site_images/article_thumbnails/reference_guide/meningitis_vaccination_ref_guide/650x350_meningitis_vaccination_ref_guide.jpg", "publishedAt": "2021-12-09T18:37:17Z", "content": "Dec. 9, 2021 -- The FDA has authorized booster doses of Pfizers COVID-19 vaccine, clearing the way for millions of teenagers to get a third dose of vaccine starting 6 months after their second dose.\r\u2026 [+2087 chars]"}, {"source": {"id": null, "name": "New York Times"}, "author": "Sharon LaFraniere and Noah Weiland", "title": "F.D.A. Authorizes Pfizer Boosters for 16- and 17-Year-Olds", "description": "The move clears the way for millions of teenagers to receive an additional shot, with a top regulator citing evidence that the effectiveness of two doses is waning in the age group.", "url": "https://www.nytimes.com/2021/12/09/us/politics/pfizer-boosters-16-17-year-olds.html", "urlToImage": "https://static01.nyt.com/images/2021/12/09/us/politics/09dc-pfizer-1/09dc-pfizer-1-facebookJumbo.jpg", "publishedAt": "2021-12-09T23:34:10Z", "content": "According to federal data, about 5.5 million 16- and 17-year-olds two-thirds of that age group have received at least one dose of Pfizers vaccine. More than 4.7 million have received two doses. Rough\u2026 [+2301 chars]"}, {"source": {"id": null, "name": "Quartz India"}, "author": "Annalisa Merelli", "title": "Should we trust what Pfizer tells us about its vaccine and omicron?", "description": "Relying on drugmakers' data on efficacy risks compromising the public trust in official approvals", "url": "https://qz.com/2100229/how-to-evaluate-pfizers-claim-its-booster-works-against-omicron/", "urlToImage": "https://cms.qz.com/wp-content/uploads/2021/12/2021-12-02T212845Z_590510391_RC243R9VECCC_RTRMADP_3_HEALTH-CORONAVIRUS-VARIANT-USA-e1639008963140.jpg?quality=75&strip=all&w=1200&h=630&crop=1", "publishedAt": "2021-12-09T18:53:24Z", "content": "As the world continues to gather information about covid-19s omicron variant, Pfizer has some good news: Early evidence indicates three doses of vaccine show significantly more\u00a0protection against omi\u2026 [+2959 chars]"}, {"source": {"id": "business-insider", "name": "Business Insider"}, "author": "jepstein@insider.com (Jake Epstein,Andrew Dunn)", "title": "The FDA says 16- and 17-year-olds can now get a Pfizer vaccine booster shot", "description": "The FDA authorized the Pfizer COVID-19 booster shot for all adults in the United States in November.", "url": "https://www.businessinsider.com/fda-authorizes-pfizer-booster-coronavirus-shot-teenagers-2021-12", "urlToImage": "https://i.insider.com/604276ca44d8e300117b9541?width=1200&format=jpeg", "publishedAt": "2021-12-09T16:37:07Z", "content": "The US Food &amp; Drug Administration on Thursday said it is authorizing Pfizer's COVID-19 booster shot for 16- and 17-year-olds.\r\nThis story is developing. Please check back for updates."}, {"source": {"id": null, "name": "The Indian Express"}, "author": "AP", "title": "FDA expands Pfizer COVID booster, opens extra dose to age 16", "description": "The Pfizer vaccine is the only option in the US for anyone younger than 18, either for initial vaccination or for use as a booster.", "url": "https://indianexpress.com/article/world/fda-expands-pfizer-covid-booster-opens-extra-dose-to-age-16-7664828/", "urlToImage": "https://images.indianexpress.com/2021/12/Pfizer-1.jpg", "publishedAt": "2021-12-09T16:54:17Z", "content": "The US is expanding COVID-19 boosters, ruling that 16- and 17-year-olds can get a third dose of Pfizer\u2019s vaccine.The US and many other nations already were urging adults to get booster shots to pump \u2026 [+1996 chars]"}, {"source": {"id": "the-times-of-india", "name": "The Times of India"}, "author": "Reuters", "title": "U.S. FDA authorizes Pfizer/BioNTech booster for 16- and 17-year-olds", "description": "Regulators from the U.S. Centers for Disease Control and Prevention (CDC) likely need to sign off on the shots before the teenagers can begin receiving the doses. Around 4.7 million 16- and 17-year-olds in the United States are fully vaccinated and more than \u2026", "url": "https://economictimes.indiatimes.com/news/international/world-news/u-s-fda-authorizes-pfizer/biontech-booster-for-16-and-17-year-olds/articleshow/88193500.cms", "urlToImage": "https://img.etimg.com/thumb/msid-88193494,width-1070,height-580,imgsize-794879,overlay-economictimes/photo.jpg", "publishedAt": "2021-12-09T17:26:37Z", "content": "The U.S. Food and Drug Administration on Thursday authorized booster shots of the COVID-19 vaccine from Inc and BioNTech SE those aged 16 and 17, as public health officials have urged Americans to ge\u2026 [+1575 chars]"}, {"source": {"id": null, "name": "Forbes"}, "author": "Alex Knapp, Forbes Staff, \n Alex Knapp, Forbes Staff\n https://www.forbes.com/sites/alexknapp/", "title": "FDA Greenlights Booster Shots Of Pfizer/BioNTech\u2019s Covid Vaccine For 16 And 17-Year-Olds", "description": "Pfizer and BioNTech will also apply to the FDA to expand the approval of their companies' vaccine to include the third dose.", "url": "https://www.forbes.com/sites/alexknapp/2021/12/09/fda-greenlights-booster-shots-of-pfizerbiontechs-covid-vaccine-for-16-and-17-year-olds/", "urlToImage": "https://thumbor.forbes.com/thumbor/fit-in/1200x0/filters%3Aformat%28jpg%29/https%3A%2F%2Fspecials-images.forbesimg.com%2Fimageserve%2F61b16a0ac42674add98fdd64%2F0x0.jpg", "publishedAt": "2021-12-09T16:31:54Z", "content": "AFP via Getty Images\r\nOn Thursday, the FDA announced that it is expanding the emergency use authorization of the Covid vaccine developed by Pfizer &amp; BioNTech to allow for booster shots in 16 and \u2026 [+1269 chars]"}, {"source": {"id": "axios", "name": "Axios"}, "author": "Rebecca Falconer", "title": "FDA authorizes Pfizer COVID booster for teens ages 16 to 17", "description": "The Food and Drug Administration expanded its emergency use authorization for Pfizer-BioNTech's COVID-19 vaccine booster shots to include those aged 16 and 17.Why it matters: The move could expand access to the boosters at a time when there's increasing conce\u2026", "url": "https://www.axios.com/fda-authorizes-pfizer-covid-vaccine-booster-teens-00358128-bf37-452f-9239-1cb0602e2db9.html", "urlToImage": "https://images.axios.com/YNJ-9A2lBfdt7iReP0eli76gYUg=/0x0:7642x4299/1366x768/2021/12/09/1639037834230.jpg", "publishedAt": "2021-12-09T16:22:33Z", "content": "The Food and Drug Administration on Thursday expanded its emergency use authorization for Pfizer-BioNTech's COVID-19 vaccine booster shots to include those aged 16 and 17.\r\nWhy it matters: The move c\u2026 [+1743 chars]"}, {"source": {"id": null, "name": "WBAL TV Baltimore"}, "author": null, "title": "FDA expands Pfizer COVID-19 booster to 16 and 17 year olds - WBAL Baltimore", "description": "<ol><li>FDA expands Pfizer COVID-19 booster to 16 and 17 year olds\u00a0\u00a0WBAL Baltimore\r\n</li><li>FDA authorizes Pfizer's COVID-19 booster for teens age 16 and up\u00a0\u00a0CBS News\r\n</li><li>CDC study: Veterans with two mRNA doses saw dip in antibody response after four m\u2026", "url": "https://www.wbaltv.com/article/fda-expands-pfizer-covid-19-booster-16-and-17-year-olds/38473671", "urlToImage": "https://kubrick.htvapps.com/htv-prod-media.s3.amazonaws.com/images/covid-19-vaccine-1622285336.jpg?crop=1.00xw:0.824xh;0,0.0258xh&resize=1200:*", "publishedAt": "2021-12-09T16:54:00Z", "content": "U.S. health authorities said Thursday that 16- and 17-year-olds should get a booster dose of Pfizer's COVID-19 vaccine once they're six months past their last shot.\r\nThe U.S. and many other nations a\u2026 [+3293 chars]"}, {"source": {"id": "rt", "name": "RT"}, "author": "RT", "title": "Disclosing Pfizer vaccine data \u2018may now take until 2096\u2019", "description": "The US Food and Drug Administration is cooperating with a Freedom of Information Act request for clinical data associated with Pfizer\u2019s Covid-19 vaccine, but may require 75 years to do so \u2013 even longer than a prior estimate. Read Full Article at RT.com", "url": "https://www.rt.com/usa/542616-fda-years-declassify-pfizer/", "urlToImage": "https://cdni.rt.com/files/2021.12/article/61b14d542030273c932a422c.JPG", "publishedAt": "2021-12-09T01:59:49Z", "content": "The FDA has insisted it cannot commit to a faster release of the medical data associated with the approval of the Pfizer-BioNTech coronavirus vaccine, according to a legal brief filed on Tuesday in r\u2026 [+1640 chars]"}, {"source": {"id": null, "name": "Moneycontrol"}, "author": null, "title": "BioNTech, Pfizer vaccine neutralises Omicron with three shots", "description": "In the first official statement from vaccine manufacturers on the likely efficacy of their shot against Omicron, BioNTech and Pfizer said that two vaccine doses resulted in significantly lower neutralising antibodies but that a third dose of their vaccine inc\u2026", "url": "https://www.moneycontrol.com/news/world/biontech-pfizer-vaccine-neutralises-omicron-with-three-shots-7806111.html", "urlToImage": "https://images.moneycontrol.com/static-mcnews/2021/09/pfizer-770x433.jpg", "publishedAt": "2021-12-09T03:15:49Z", "content": "BioNTech and Pfizer said on Wednesday a three-shot course of their COVID-19 vaccine was able to neutralise the new Omicron variant in a laboratory test and they could deliver an Omicron-based vaccine\u2026 [+1220 chars]"}, {"source": {"id": null, "name": "fox8.com"}, "author": "Peter Sullivan, The Hill via Nexstar Media Wire", "title": "Pfizer CEO says fourth vaccine shot may eventually be needed - WJW FOX 8 News Cleveland", "description": "<ol><li>Pfizer CEO says fourth vaccine shot may eventually be needed\u00a0\u00a0WJW FOX 8 News Cleveland\r\n</li><li>Coronavirus live updates: Omicron variant could require fourth vaccine dose\u00a0\u00a0The Washington Post\r\n</li><li>Mounting evidence highlights the importance of \u2026", "url": "https://fox8.com/news/coronavirus/pfizer-ceo-says-fourth-vaccine-shot-may-eventually-be-needed/", "urlToImage": "https://fox8.com/wp-content/uploads/sites/12/2021/12/AP21253766386353.jpg?w=1280", "publishedAt": "2021-12-09T15:36:10Z", "content": "(The Hill) \u2014 Pfizer CEO Albert Bourla\u00a0on Wednesday said that a fourth\u00a0dose of the COVID-19 vaccine may eventually be needed amid concerns about the omicron variant.\r\nBourla\u00a0told CNBC\u00a0that he previous\u2026 [+1464 chars]"}, {"source": {"id": "independent", "name": "Independent"}, "author": "Eleanor Sly", "title": "Vaccines and omicron: What we know about how variant responds to Pfizer, AstraZeneca and Moderna jabs", "description": "Vaccines to target omicron could be produced by March 2022", "url": "https://www.independent.co.uk/news/health/omicron-vaccine-jab-pfizer-astrazeneca-moderna-b1973045.html", "urlToImage": "https://static.independent.co.uk/2021/12/09/16/GettyImages-89747046%20%281%29.jpg?width=1200&auto=webp&quality=75", "publishedAt": "2021-12-09T19:52:06Z", "content": "The latest variant of Covid-19 has begun to spread in the UK, with the number of confirmed cases nearly doubling between Wednesday and Thursday.\r\nA total of 817 cases of the omicron variant of Covid \u2026 [+6288 chars]"}, {"source": {"id": "cbs-news", "name": "CBS News"}, "author": "Alexander Alexander", "title": "FDA greenlights Pfizer booster shots for Americans as young as 16", "description": "Less than a third of Americans 16 to 17 years old will initially be eligible to receive the additional dose.", "url": "https://www.cbsnews.com/news/fda-pfizer-covid-vaccine-booster-shots-age-16/", "urlToImage": "https://cbsnews1.cbsistatic.com/hub/i/r/2021/09/23/8c128fec-6552-4f8b-a085-937fee43742f/thumbnail/1200x630g8/2cf7af29f4cb588cdd9a5c62eba09987/2021-09-23t095602z-1017402233-rc2lvp9taqdy-rtrmadp-3-health-coronavirus-eu-pfizer.jpg", "publishedAt": "2021-12-09T16:26:48Z", "content": "The Food and Drug Administration has greenlighted a request from Pfizer and BioNTech to allow Americans as young as 16 to get a booster shot of their COVID-19 vaccine, the agency announced on Thursda\u2026 [+5488 chars]"}]}, "2021-12-08": {"status": "ok", "totalResults": 231, "articles": [{"source": {"id": null, "name": "New York Times"}, "author": "The New York Times", "title": "Early Study Shows Pfizer Vaccine Gives Some Protection Against Omicron", "description": "A South African lab experiment found the variant may dull the power of vaccines but hinted that booster shots might help. Here\u2019s the latest.", "url": "https://www.nytimes.com/live/2021/12/08/world/omicron-variant-covid", "urlToImage": "https://static01.nyt.com/images/2021/12/07/multimedia/07virus-briefing-pfizer/07virus-briefing-pfizer-facebookJumbo-v3.jpg", "publishedAt": "2021-12-08T10:14:29Z", "content": "A report out of South Africa offered a first glimpse at how vaccinated people might fare against the fast-spreading Omicron variant of the coronavirus.\r\nLaboratory experiments found that Omicron seem\u2026 [+5189 chars]"}, {"source": {"id": "bbc-news", "name": "BBC News"}, "author": "https://www.facebook.com/bbcnews", "title": "Covid: Pfizer says booster shot promising against Omicron", "description": "The company says a third dose of its vaccine could improve protection against the new variant.", "url": "https://www.bbc.co.uk/news/world-59582006", "urlToImage": "https://ichef.bbci.co.uk/news/1024/branded_news/537B/production/_122017312_072023140-1.jpg", "publishedAt": "2021-12-08T13:42:27Z", "content": "Three doses provide a similar level of antibodies against Omicron to that of two doses with other variants, the companies said after a small study."}, {"source": {"id": "reuters", "name": "Reuters"}, "author": "Reuters Editorial", "title": "Booster works against Omicron - Pfizer/BioNTech - Reuters.com", "description": "BioNTech and Pfizer said on Wednesday a three-shot course of their COVID-19 vaccine was able to neutralize the new Omicron variant in a laboratory test and they could deliver an Omicron-based vaccine in March 2022 if needed.", "url": "https://www.reuters.com/video/watch/idPEoc?now=true", "urlToImage": "https://ajo.prod.reuters.tv/api/v2/img/61b0d22de4b09631b0e441d2-1638978093385?location=LANDSCAPE", "publishedAt": "2021-12-08T16:40:09Z", "content": "Posted \r\nBioNTech and Pfizer said on Wednesday a three-shot course of their COVID-19 vaccine was able to neutralize the new Omicron variant in a laboratory test and they could deliver an Omicron-base\u2026 [+33 chars]"}, {"source": {"id": "reuters", "name": "Reuters"}, "author": "Reuters Editorial", "title": "Booster works against Omicron - Pfizer/BioNTech - Reuters.com", "description": "BioNTech and Pfizer said on Wednesday a three-shot course of their COVID-19 vaccine was able to neutralize the new Omicron variant in a laboratory test and they could deliver a vaccine targeted at it in March 2022 if needed. Francis Maguire reports.", "url": "https://www.reuters.com/video/watch/idOVF76N0JV", "urlToImage": "https://static.reuters.com/resources/r/?d=20211208&i=OVF76N0JV&r=OVF76N0JV&t=2", "publishedAt": "2021-12-08T16:09:37Z", "content": "Posted \r\nBioNTech and Pfizer said on Wednesday a three-shot course of their COVID-19 vaccine was able to neutralize the new Omicron variant in a laboratory test and they could deliver a vaccine targe\u2026 [+58 chars]"}, {"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "Futures rise after positive vaccine update from Pfizer - Reuters", "description": "U.S. stock index futures rose on Wednesday after drugmakers Pfizer and BioNTech said a three-shot course of their COVID-19 vaccine was shown to have a neutralizing effect against the new Omicron coronavirus variant in a laboratory test.", "url": "https://www.reuters.com/markets/europe/futures-rise-after-positive-vaccine-update-pfizer-2021-12-08/", "urlToImage": "https://www.reuters.com/pf/resources/images/reuters/reuters-default.png?d=60", "publishedAt": "2021-12-08T12:23:00Z", "content": "Dec 8 (Reuters) - U.S. stock index futures rose on Wednesday after drugmakers Pfizer and BioNTech said a three-shot course of their COVID-19 vaccine was shown to have a neutralizing effect against th\u2026 [+1778 chars]"}, {"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "Britain marks one year since giving first Pfizer COVID-19 shot - Reuters UK", "description": "Britain on Wednesday marked a year since the first person in the world was given a Pfizer-BioNTech COVID-19 vaccine outside of clinical trials, calling for people to receive booster shots as soon as they are eligible.", "url": "https://www.reuters.com/world/uk/britain-marks-one-year-since-giving-first-pfizer-covid-19-shot-2021-12-08/", "urlToImage": "https://www.reuters.com/resizer/bigXgSIWMWvkrxpvYXYK-eQZA40=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/2O7FXQ5ZVZP4LH3ONE64IMCCZA.jpg", "publishedAt": "2021-12-08T00:16:00Z", "content": "LONDON, Dec 8 (Reuters) - Britain on Wednesday marked a year since the first person in the world was given a Pfizer-BioNTech COVID-19 vaccine outside of clinical trials, calling for people to receive\u2026 [+1920 chars]"}, {"source": {"id": "reuters", "name": "Reuters"}, "author": "Chuck Mikolajczak", "title": "TREASURIES-U.S. yields rise as Pfizer vaccine update dents Omicron worry - Reuters.com", "description": "The benchmark U.S. 10-year Treasury yield rose for a third straight day on Wednesday, as drugmakers Pfizer and BioNtech announced positive results for their COVID-19 vaccine in a laboratory test against the new Omicron variant.", "url": "https://www.reuters.com/article/usa-bonds-idUSL1N2ST19S", "urlToImage": "https://s1.reutersmedia.net/resources_v2/images/rcom-default.png?w=800", "publishedAt": "2021-12-08T15:36:00Z", "content": "NEW YORK, Dec 8 (Reuters) - The benchmark U.S. 10-year Treasury yield rose for a third straight day on Wednesday, as drugmakers Pfizer and BioNtech announced positive results for their COVID-19 vacci\u2026 [+2789 chars]"}, {"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "BioNTech, Pfizer say test shows 3 doses of vaccine neutralise Omicron - Reuters", "description": "BioNTech  and Pfizer <a href=\"https://www.reuters.com/companies/PFE.N\" target=\"_blank\">(PFE.N)</a> said on Wednesday a three-shot course of their COVID-19 vaccine was shown to generate a neutralising effect against the new Omicron variant in a laboratory test.", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/biontech-pfizer-say-test-shows-3-doses-vaccine-neutralise-omicron-2021-12-08/", "urlToImage": "https://www.reuters.com/resizer/AO74kgZXcbvT_EDNQsnkti5YS3Y=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/6AE3OV5UEFIMVKNGINVA5YXYEM.jpg", "publishedAt": "2021-12-08T12:16:00Z", "content": "A vial labelled with the Pfizer-BioNTech coronavirus disease (COVID-19) vaccine is seen in this illustration picture taken March 19, 2021. REUTERS/Dado RuvicDec 8 (Reuters) - BioNTech and Pfizer (PFE\u2026 [+746 chars]"}, {"source": {"id": "business-insider", "name": "Business Insider"}, "author": "sbaker@businessinsider.com (Sin\u00e9ad Baker)", "title": "Pfizer says 3 of its shots work against Omicron, but that 2 are significantly less effective", "description": "Pfizer and BioNTech observed a 25-fold reduction in neutralizing antibodies after two doses of vaccine, but those levels were restored after three.", "url": "https://www.businessinsider.com/omicron-variant-pfizer-says-3-shots-work-2-less-effective-2021-12", "urlToImage": "https://i.insider.com/61b0a1b606b6770018c48883?width=1200&format=jpeg", "publishedAt": "2021-12-08T12:19:58Z", "content": "Although there is a marked reduction in the level of protective antibodies against Omicron after two doses of vaccine, a third dose seems to bring those levels back up, Pfizer and BioNTech said on We\u2026 [+1863 chars]"}, {"source": {"id": null, "name": "CP24 Toronto's Breaking News"}, "author": "Lauran Neergaard", "title": "Pfizer says COVID-19 vaccine booster offers protection against Omicron - CP24 Toronto's Breaking News", "description": "<ol><li>Pfizer says COVID-19 vaccine booster offers protection against Omicron\u00a0\u00a0CP24 Toronto's Breaking News\r\n</li><li>Global National: Dec. 8, 2021 | Pfizer says 3rd vaccine dose raises defence against Omicron variant\u00a0\u00a0Global News\r\n</li><li>Pfizer-BioNTech p\u2026", "url": "https://www.cp24.com/world/pfizer-says-covid-19-vaccine-booster-offers-protection-against-omicron-1.5699039", "urlToImage": "https://www.cp24.com/polopoly_fs/1.5699040.1638992621!/httpImage/image.jpg_gen/derivatives/landscape_620/image.jpg", "publishedAt": "2021-12-08T19:44:26Z", "content": "Pfizer said Wednesday that a booster of its COVID-19 vaccine may offer important protection against the new omicron variant even though the initial two doses appear significantly less effective.\r\nPfi\u2026 [+5034 chars]"}, {"source": {"id": null, "name": "Toronto Sun"}, "author": "Reuters", "title": "Study suggests Pfizer COVID-19 vaccine only partially protects against Omicron - Toronto Sun", "description": "The Omicron variant of the coronavirus can partially evade the protection from two doses of Pfizer Inc and partner BioNTech\u2019s COVID-19 vaccine, the research\u2026", "url": "https://torontosun.com/health/pfizer-covid-19-vaccine-partially-protective-against-omicron-reports", "urlToImage": "https://smartcdn.prod.postmedia.digital/torontosun/wp-content/uploads/2021/11/HEALTH-CORONAVIRUS_USA-CDC-scaled-e1637532679997.jpg?quality=100&strip=all", "publishedAt": "2021-12-08T00:45:00Z", "content": "A syringe is filled with a dose of Pfizer's COVID-19 vaccine at a pop-up community vaccination center at the Gateway World Christian Center in Valley Stream, New York, U.S., Feb. 23, 2021. Photo by B\u2026 [+5767 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "The Canadian Press", "title": "Pfizer says COVID booster offers protection against omicron - Yahoo Canada Finance", "description": "<ol><li>Pfizer says COVID booster offers protection against omicron\u00a0\u00a0Yahoo Canada Finance\r\n</li><li>Global National: Dec. 8, 2021 | Pfizer says 3rd vaccine dose raises defence against Omicron variant\u00a0\u00a0Global News\r\n</li><li>Pfizer-BioNTech pushing 3-dose COVID\u2026", "url": "https://ca.finance.yahoo.com/news/pfizer-says-covid-booster-offers-123554063.html", "urlToImage": "https://s.yimg.com/uu/api/res/1.2/EoJy2kgFXtceMWqaBaeYRg--~B/aD01MzM7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/cp.org/5bf690d418027fbc086d9fbfe2809df5", "publishedAt": "2021-12-08T17:29:00Z", "content": "Pfizer said Wednesday that a booster of its COVID-19 vaccine may offer important protection against the new omicron variant even though the initial two doses appear significantly less effective.\r\nPfi\u2026 [+5265 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "CBS News Videos", "title": "Pfizer says 3 doses of coronavirus vaccine can neutralize Omicron variant", "description": "Pfizer says preliminary research shows that a booster dose of its existing COVID-19 vaccine raises effectiveness when battling the Omicron variant. CBS News'...", "url": "https://news.yahoo.com/pfizer-says-3-doses-coronavirus-142639490.html", "urlToImage": "https://s.yimg.com/hd/cp-video-transcode/prod/2021-12/08/61b0c5a378856f75e6010885/61b0c5a378856f75e6010886_o_U_v2.jpg", "publishedAt": "2021-12-08T14:26:39Z", "content": "Entertainment Tonight Videos\r\nFormer 'Real Housewives' stars Tamra Judge and Teddi Mellencamp chat with ET's Denny Directo at iHeartRadio 102.7 KIIS FM's Jingle Ball 2021. The ladies dish all about t\u2026 [+320 chars]"}, {"source": {"id": null, "name": "MarketWatch"}, "author": "Mark DeCambre", "title": "Bond Report: U.S. Treasury yields steady after Pfizer/BioNTech omicron report", "description": "Yields for U.S. government debt on Wednesday were trading mixed as investors digested news suggesting the omicron variant of coronavirus that causes COVID-19 may not impact the economy as much as feared.", "url": "https://www.marketwatch.com/story/u-s-treasury-yields-steady-after-pfizer-biontech-omicron-report-11638967792", "urlToImage": "https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png", "publishedAt": "2021-12-08T12:49:00Z", "content": "Yields for U.S. government debt on Wednesday were trading mixed as investors digested news suggesting the omicron variant of coronavirus that causes COVID-19 may not impact the economy as much as fea\u2026 [+1892 chars]"}, {"source": {"id": "al-jazeera-english", "name": "Al Jazeera English"}, "author": "Al Jazeera", "title": "Pfizer says COVID booster \u2018effective\u2019 against Omicron variant", "description": "Lab tests show three-shot course of Pfizer-BioNTech vaccine neutralises Omicron, while two shots appear less effective.", "url": "https://www.aljazeera.com/news/2021/12/8/pfizer-booster-covid-vaccine-omicron-effective", "urlToImage": "https://www.aljazeera.com/wp-content/uploads/2021/12/AP21342448804833.jpg?resize=1200%2C630", "publishedAt": "2021-12-08T14:55:31Z", "content": "Pfizer has said a booster dose of its COVID-19 vaccine was able to neutralise the new Omicron variant in lab studies,\u00a0even though the initial two doses appear significantly less effective.\r\nThe annou\u2026 [+2430 chars]"}, {"source": {"id": "bloomberg", "name": "Bloomberg"}, "author": null, "title": "Third Dose of Pfizer-BioNTech Key to Omicron (Audio)", "description": "Understand every aspect of the global economy \u2013 and know how to make your next move.", "url": "https://www.bloomberg.com/news/audio/2021-12-08/third-dose-of-pfizer-biontech-key-to-omicron-audio", "urlToImage": null, "publishedAt": "2021-12-08T19:36:44Z", "content": "Dr. Anthony Harris, Chief Innovation Officer at WorkCare, discusses vaccine efficacy for the omicron variant with Carol Massar and Tim Stenovec. \r\nDec 08, 2021"}, {"source": {"id": "bloomberg", "name": "Bloomberg"}, "author": "Fiona Rutherford", "title": "Pfizer Booster for More Teens Moves Closer to FDA Clearance", "description": "", "url": "https://www.bloomberg.com/news/articles/2021-12-08/pfizer-booster-for-more-teens-moves-closer-to-fda-clearance", "urlToImage": "https://assets.bwbx.io/images/users/iqjWHBFdfxIU/ir06zuCPMEjo/v0/1200x800.jpg", "publishedAt": "2021-12-08T22:04:46Z", "content": "Food and Drug Administration authorization of \r\nPfizer Inc. \u00a0booster vaccines for more teens took a step forward when the agency said further study by an advisory committee wasnt necessary.\u00a0\r\nThird d\u2026 [+1423 chars]"}, {"source": {"id": null, "name": "WebMD"}, "author": "https://www.facebook.com/WebMD", "title": "Pfizer Says Vaccine Booster Should Protect Against Omicron", "description": "Blood samples obtained from people a month after they'd gotten their booster shots showed a level of antibodies against Omicron that were equal to those seen against other variants after two doses.", "url": "https://www.webmd.com/vaccines/covid-19-vaccine/news/20211208/pfizer-covid-booster-omicron", "urlToImage": "https://img.webmd.com/dtmcms/live/webmd/consumer_assets/site_images/article_thumbnails/news/2020/12_2020/pfizer_vaccine/1800x1200_pfizer_vaccine.jpg", "publishedAt": "2021-12-08T22:46:15Z", "content": "[MUSIC PLAYING]\r\nSPEAKER: How does a COVID-19\r\nmRNA vaccine work?\r\nCOVID vaccines are now\r\navailable.\r\nSome of the COVID-19 vaccines\r\nare mRNA vaccines, but what does\r\nthis mean?\r\nmRNA vaccines are\r\n\u2026 [+2094 chars]"}, {"source": {"id": null, "name": "Pfizer.com"}, "author": null, "title": "Pfizer and BioNTech Provide Update on Omicron Variant - Pfizer", "description": "Preliminary laboratory studies demonstrate that three doses of the Pfizer-BioNTech COVID-19 Vaccine neutralize the Omicron variant (B.1.1.529 lineage) while two doses show significantly reduced neutralization titers Data indicate that a third dose of BNT162b2\u2026", "url": "https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-provide-update-omicron-variant", "urlToImage": null, "publishedAt": "2021-12-08T11:58:10Z", "content": "<ul><li>Preliminary laboratory studies demonstrate that three doses of the Pfizer-BioNTech COVID-19 Vaccine neutralize the Omicron variant (B.1.1.529 lineage) while two doses show significantly reduc\u2026 [+27774 chars]"}, {"source": {"id": null, "name": "Telegraph.co.uk"}, "author": "Joe Pinkstone", "title": "Omicron significantly reduces Covid antibodies generated by Pfizer vaccine, study finds", "description": "First data from very small research group suggests people who have had coronavirus would have more protection", "url": "https://www.telegraph.co.uk/news/2021/12/08/omicron-significantly-reduces-covid-antibodies-generated-pfizer/", "urlToImage": "https://www.telegraph.co.uk/content/dam/news/2021/12/07/TELEMMGLPICT000280034471_trans_NvBQzQNjv4Bq1EFwp94ofGImOIvvi5f16fcd23UqRwUae9Ng8w1oDOQ.jpeg?impolicy=logo-overlay", "publishedAt": "2021-12-08T00:16:21Z", "content": "People who have previously had Covid or been vaccinated have far less protection against omicron than they do for other variants, according to the first data of its kind.\r\nScientists from South Afric\u2026 [+1782 chars]"}]}, "2021-12-07": {"status": "ok", "totalResults": 51, "articles": [{"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "Pfizer COVID-19 vaccine partially protective against Omicron - Bloomberg News - Reuters", "description": "The Omicron variant of the coronavirus can partially evade the protection from Pfizer Inc <a href=\"https://www.reuters.com/companies/PFE.N\" target=\"_blank\">(PFE.N)</a> and partner BioNTech's  COVID-19 vaccine, Bloomberg News reported on Tuesday, citing the re\u2026", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-covid-19-vaccine-partially-protective-against-omicron-bloomberg-news-2021-12-07/", "urlToImage": "https://www.reuters.com/resizer/hV4nC8d2xxB4F9E_FL0qk50pvJg=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/R3VFM7EHYRP3VONKX5CMDLSMTU.jpg", "publishedAt": "2021-12-07T21:07:00Z", "content": "Vials of the Pfizer-BioNTech vaccine are pictured in a vaccination centre in Geneva, Switzerland, February 3, 2021. REUTERS/Denis BalibouseDec 7 (Reuters) - The Omicron variant of the coronavirus can\u2026 [+1071 chars]"}, {"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "Pfizer, ex-employee reach accord over COVID-19 vaccine secrets - Reuters", "description": "Pfizer Inc <a href=\"https://www.reuters.com/companies/PFE.N\" target=\"_blank\">(PFE.N)</a> has reached a truce with a former longtime employee it sued two weeks ago for allegedly stealing confidential documents related to its COVID-19 vaccine and other drugs.", "url": "https://www.reuters.com/legal/government/pfizer-ex-employee-reach-accord-over-covid-19-vaccine-secrets-2021-12-07/", "urlToImage": "https://www.reuters.com/pf/resources/images/reuters/reuters-default.png?d=60", "publishedAt": "2021-12-07T22:14:00Z", "content": "The company and law firm names shown above are generated automatically based on the text of the article. We are improving this feature as we continue to test and develop in beta. We welcome feedback,\u2026 [+1483 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "Joe Pinkstone", "title": "Omicron significantly reduces Covid antibodies generated by Pfizer vaccine, study finds", "description": "People who have previously had Covid or been vaccinated have far less protection against omicron than they do for other variants, according to the first data...", "url": "https://news.yahoo.com/omicron-significantly-reduces-covid-antibodies-235058967.html", "urlToImage": "https://s.yimg.com/ny/api/res/1.2/K3_zcYDmldSBW5SydoXrhQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD03NTA-/https://s.yimg.com/uu/api/res/1.2/FDLMucLiIEvb4MLexZrN4w--~B/aD0xNDM3O3c9MjMwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/the_telegraph_258/7d9890d6008c634d18c8e701dfdb766a", "publishedAt": "2021-12-07T23:50:58Z", "content": "Health workers giving out Covid vaccines in Gaza on Tuesday - BLOOMBERG\r\nPeople who have previously had Covid or been vaccinated have far less protection against omicron than they do for other varian\u2026 [+3384 chars]"}, {"source": {"id": null, "name": "Motley Fool"}, "author": "newsfeedback@fool.com (Kody Kester)", "title": "What This Label Expansion Means for Pfizer", "description": "The European Commission recently approved Pfizer's Xeljanz to treat patients with ankylosing spondylitis.", "url": "https://www.fool.com/investing/2021/12/07/what-this-label-expansion-means-for-pfizer/", "urlToImage": "https://g.foolcdn.com/editorial/images/655523/a-senior-woman-receives-a-vaccination-to-protect-against-covid-19.jpg", "publishedAt": "2021-12-07T16:50:00Z", "content": "Last month, Pfizer(NYSE:PFE) announced that the European Commission (E.C.) had authorized the company's Xeljanz immunology drug to treat adult ankylosing spondylitis -- a kind of arthritis affecting \u2026 [+4091 chars]"}, {"source": {"id": null, "name": "The Indian Express"}, "author": "Reuters", "title": "Mixing Pfizer, AstraZ Covid-19 shots with Moderna gives better immune response: UK study", "description": "If the AstraZeneca-Oxford vaccine is followed by a Moderna or Novavax shot, higher antibodies and T-cell responses were induced versus two doses of AstraZeneca-Oxford, according to researchers at the University of Oxford.", "url": "https://indianexpress.com/article/world/mixing-pfizer-astrazeneca-moderna-covid-19-vaccine-immune-response-study-7660092/", "urlToImage": "https://images.indianexpress.com/2021/12/2021-12-06T065942Z_1051280657_RC2S7R9118QG_RTRMADP_3_HEALTH-CORONAVIRUS-VARIANT-HOTSPOT.jpg", "publishedAt": "2021-12-07T04:19:07Z", "content": "A major British study into mixing Covid-19 vaccines has found that people had a better immune response when they received a first dose of AstraZeneca or Pfizer-BioNTech shots followed by Moderna nine\u2026 [+3085 chars]"}, {"source": {"id": null, "name": "Democracy Now!"}, "author": "webdev@democracynow.org (Democracy Now!)", "title": "As World Confronts Omicron Variant, Top 8 Pfizer & Moderna Investors Make $10 Billion in a Week", "description": "The eight top Pfizer and Moderna shareholders made over $10 billion last week when  their stock holdings skyrocketed after the discovery of the new Omicron variant. This comes as global public health advocates warn the world will keep seeing more coronavirus \u2026", "url": "https://www.democracynow.org/2021/12/7/pfizer_and_moderna_shareholders_profit", "urlToImage": "https://www.democracynow.org/images/story/49/60649/full_hd/SEG2-PandemicProfits-2.jpg", "publishedAt": "2021-12-07T13:13:38Z", "content": "Dear Friend,\r\n This year Democracy Now! is celebrating our 25th anniversarythats 25 years of bringing you fearless, independent journalism. Since our first broadcast in 1996, Democracy Now! has refus\u2026 [+1184 chars]"}, {"source": {"id": "business-insider", "name": "Business Insider"}, "author": "Aria Bendix, Andrew Dunn", "title": "Omicron may resist Pfizer vaccine more than other variants: preprint - Business Insider", "description": "Two small studies that have yet to be published give the first look at how Omicron may impact immunity.", "url": "https://www.businessinsider.com/omicron-resist-pfizer-vaccine-lab-data-2021-12", "urlToImage": "https://i.insider.com/61afd0666531110019cf03a5?width=1200&format=jpeg", "publishedAt": "2021-12-07T14:52:36Z", "content": "The Omicron variant substantially reduced antibody levels generated by the Pfizer-BioNTech COVID-19 vaccine, according to preliminary results from a South African study that's still awaiting peer rev\u2026 [+5177 chars]"}, {"source": {"id": "cbs-news", "name": "CBS News"}, "author": "CBS News", "title": "Pfizer shot offers partial protection against Omicron variant, study finds", "description": "Pfizer's COVID-19 vaccine offers some protection against the Omicron variant \"but not complete\" protection, according to an early study by South African scientists. Nikki Battiste shares the latest.", "url": "https://www.cbsnews.com/video/pfizer-shot-offers-partial-protection-against-omicron-variant-study-finds/", "urlToImage": "https://cbsnews2.cbsistatic.com/hub/i/r/2021/12/07/5bde9754-daae-4969-bb72-0f9122ffc986/thumbnail/1200x630/3425d1b5d7a4a924a7fe3fd0a390b2d1/cbsn-fusion-pfizer-shot-offers-partial-protection-against-omicron-variant-study-finds-thumbnail-850947-640x360.jpg", "publishedAt": "2021-12-07T23:48:52Z", "content": "Watch CBSN Live\r\nCopyright \u00a9 2021 CBS Interactive Inc. All rights reserved.\r\nGet browser notifications for breaking news, live events, and exclusive reporting.\r\nNot NowTurn On"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "Reuters", "title": "Pfizer COVID-19 vaccine partially protective against Omicron - Bloomberg News", "description": "Its evasion is not complete and a booster shot could provide additional protection, according to the report, citing Alex Sigal, head of the lab.  The Omicron...", "url": "https://news.yahoo.com/pfizer-covid-19-vaccine-partially-210542703.html", "urlToImage": "https://s.yimg.com/uu/api/res/1.2/TIRPiLeEc5I5b0f04rTOEA--~B/aD01MzM7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/60f78910457d169469367d728f3c8f79", "publishedAt": "2021-12-07T21:05:42Z", "content": "(Reuters) - The Omicron variant of the coronavirus can partially evade the protection from Pfizer Inc and partner BioNTech's COVID-19 vaccine, Bloomberg News reported on Tuesday, citing the research \u2026 [+800 chars]"}, {"source": {"id": null, "name": "MMA Mania"}, "author": "Jesse Holland", "title": "Rogan Calls CNN \u2018The Right Arm Of Pfizer\u2019", "description": "UFC mouthpiece and Spotify podcaster Joe Rogan slams CNN for its propaganda and biased ideology following the exit of Chris Cuomo.", "url": "https://www.mmamania.com/2021/12/7/22822188/ufc-joe-rogan-calls-cnn-the-right-arm-pfizer-slams-propagandists-following-chris-cuomo-exit", "urlToImage": "https://cdn.vox-cdn.com/thumbor/mKAiIZa5yzgEkl0N3R4LbyJN8o0=/0x0:3000x1688/1600x900/cdn.vox-cdn.com/uploads/chorus_image/image/70239570/1233899520.0.jpg", "publishedAt": "2021-12-07T15:23:07Z", "content": "Photo by Louis Grasse/PxImages/Icon Sportswire via Getty Images\r\n\n \n\n UFC color commentator and podcasting dynamo Joe Rogan misses the old days of CNN, back when the cable news network delivered obje\u2026 [+2021 chars]"}, {"source": {"id": "abc-news-au", "name": "ABC News (AU)"}, "author": "Dan Conifer", "title": "Emails reveal Pfizer was 'enthusiastic' to engage with Australia about COVID-19 vaccine", "description": "Documents obtained\u00a0under freedom of information laws shed new light on Pfizer\u00a0and the government's dealings at a critical time for negotiations last year.", "url": "https://www.abc.net.au/news/2021-12-07/new-emails-reveal-how-enthusiastic-pfizer-to-engage-australia/100680842", "urlToImage": "https://live-production.wcms.abc-cdn.net.au/04f0a5a4f816c350327fc9168bd61cb8?impolicy=wcms_crop_resize&cropH=2813&cropW=5000&xPos=0&yPos=23&width=862&height=485", "publishedAt": "2021-12-07T11:57:05Z", "content": "New emails reveal how \"enthusiastic\" Pfizer was to engage with Australia about its COVID-19 vaccine, months before the federal government agreed to buy any doses.\r\nKey points:\r\n<ul><li>In late June 2\u2026 [+5446 chars]"}, {"source": {"id": null, "name": "Business Wire"}, "author": null, "title": "Pfizer Invites Public to Register for Webcast of Analyst and Investor Call to Discuss Pfizer-BioNTech COVID-19 Vaccine and Pfizer\u2019s Novel COVID-19 Oral Antiviral Treatment Candidate", "description": "NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) invites investors and the general public to access a live webcast of a presentation and conference call with investment analysts at 8:30 a.m. EST on Friday, December 17, 2021. Pfizer Vaccines and Hospital lea\u2026", "url": "https://www.businesswire.com/news/home/20211207005083/en/Pfizer-Invites-Public-to-Register-for-Webcast-of-Analyst-and-Investor-Call-to-Discuss-Pfizer-BioNTech-COVID-19-Vaccine-and-Pfizer%E2%80%99s-Novel-COVID-19-Oral-Antiviral-Treatment-Candidate", "urlToImage": "https://mms.businesswire.com/media/20211207005083/en/1045874/23/Pfizer_Logo_Color_RGB_APPROVED.jpg", "publishedAt": "2021-12-07T15:09:16Z", "content": "NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) invites investors and the general public to access a live webcast of a presentation and conference call with investment analysts at 8:30 a.m. EST on\u2026 [+3713 chars]"}, {"source": {"id": "cnn", "name": "CNN"}, "author": "Maggie Fox, CNN", "title": "Omicron coronavirus variant partly evades Pfizer vaccine's protection, study shows", "description": "The Omicron coronavirus variant partly escapes the protection offered by the Pfizer vaccine, but people who have been previously infected and then vaccinated are likely to be well protected, researchers working in South Africa reported Tuesday.", "url": "https://www.cnn.com/2021/12/07/health/omicron-variant-pfizer-vaccine-south-africa-study/index.html", "urlToImage": "https://cdn.cnn.com/cnnnext/dam/assets/211207174255-pfizer-vaccine-south-africa-113021-restricted-super-tease.jpg", "publishedAt": "2021-12-07T23:22:06Z", "content": "(CNN)The Omicron coronavirus variant partly escapes the protection offered by the Pfizer vaccine, but people who have been previously infected and then vaccinated are likely to be well protected, res\u2026 [+4043 chars]"}, {"source": {"id": null, "name": "ZDNet"}, "author": "Aimee Chanthadavong", "title": "AWS and Pfizer team up to develop cloud solutions to speed up medical development", "description": "Pfizer is developing prototype solutions that incorporate a slew of AWS capabilities including machine learning, analytics, data warehousing, storage, and security.", "url": "https://www.zdnet.com/article/aws-and-pfizer-team-up-to-develop-cloud-solutions-to-speed-up-medical-development/", "urlToImage": "https://www.zdnet.com/a/img/resize/b8d18eab920a4ee336bf0de05c2550b2bc2353a6/2013/08/26/77b82875-0e21-11e3-90a0-0291187ef9b6/drugs-innovation-research-pfizer-news-co_fENM2.jpg?width=770&height=578&fit=crop&auto=webp", "publishedAt": "2021-12-07T23:53:11Z", "content": "Amazon Web Services (AWS) and Pfizer have joined forces to create cloud-based solutions to speed up how new medicines are developed, manufactured, and distributed for testing in clinical trials.\r\nThe\u2026 [+4108 chars]"}, {"source": {"id": null, "name": "Globalresearch.ca"}, "author": "Megan Redshaw", "title": "120 Teens Hospitalized, 3 Dead Following Pfizer Vaccine Rollout for 15- to 17-Year-Olds in Vietnam", "description": "All Global Research articles\u00a0can be read in 51 languages by activating the \u201cTranslate Website\u201d\u00a0drop down menu on the top banner of our home page (Desktop version).\nTo receive Global Research\u2019s Daily Newsletter (selected articles),\u00a0click here.\nVisit \u2026\nThe post\u2026", "url": "https://www.globalresearch.ca/120-teens-hospitalized-3-dead-following-pfizer-vaccine-rollout-15-17-year-olds-vietnam/5763913", "urlToImage": "https://www.globalresearch.ca/wp-content/uploads/2021/12/Covid-vaccine-Vietnam-teen-deaths-feature-800x417.jpg", "publishedAt": "2021-12-07T16:02:58Z", "content": "All Global Research articles\u00a0can be read in 51 languages by activating the Translate Website\u00a0drop down menu on the top banner of our home page (Desktop version).\r\nTo receive Global Researchs Daily Ne\u2026 [+3592 chars]"}, {"source": {"id": null, "name": "CNA"}, "author": null, "title": "Mixing Pfizer, AstraZeneca COVID-19 shots with Moderna gives better immune response: UK study", "description": "LONDON: A major British study into mixing COVID-19 vaccines has found that people had a better immune response when they received a first dose of AstraZeneca or Pfizer-BioNTech shots followed by Moderna nine weeks later, according to the results on Monday (De\u2026", "url": "https://www.channelnewsasia.com/world/mixing-pfizer-astrazeneca-covid-19-shots-moderna-gives-better-immune-response-uk-study-2362776", "urlToImage": "https://onecms-res.cloudinary.com/image/upload/s--lO9NJAbQ--/fl_relative%2Cg_south_east%2Cl_one-cms:core:watermark:reuters%2Cw_0.1/f_auto%2Cq_auto/c_fill%2Cg_auto%2Ch_676%2Cw_1200/v1/one-cms/core/2021-12-06t235303z_2_lynxmpehb512y_rtroptp_3_health-coronavirus-vaccine.jpg?itok=n11J8aZF", "publishedAt": "2021-12-07T00:27:15Z", "content": "LONDON: A major British study into mixing COVID-19 vaccines has found that people had a better immune response when they received a first dose of AstraZeneca or Pfizer-BioNTech shots followed by Mode\u2026 [+2100 chars]"}, {"source": {"id": null, "name": "CNA"}, "author": null, "title": "Study suggests Pfizer COVID-19 vaccine only partially protects against Omicron", "description": "DURBAN: The Omicron variant of the coronavirus can partially evade the protection from Pfizer and partner BioNTech's COVID-19 vaccine, the research head of a laboratory at Africa Health Research Institute in South Africa said on Tuesday (Dec 7).\r\n\r\nAlex Sigal\u2026", "url": "https://www.channelnewsasia.com/world/study-suggests-pfizer-covid-19-vaccine-only-partially-protects-against-omicron-2365041", "urlToImage": "https://onecms-res.cloudinary.com/image/upload/s--bZy-tf8M--/fl_relative%2Cg_south_east%2Cl_one-cms:core:watermark:reuters%2Cw_0.1/f_auto%2Cq_auto/c_fill%2Cg_auto%2Ch_676%2Cw_1200/v1/one-cms/core/2021-12-07t220933z_4_lynxmpehb6155_rtroptp_3_health-coronavirus-newzealand.jpg?itok=jXCLy9Gd", "publishedAt": "2021-12-07T22:51:00Z", "content": "DURBAN: The Omicron variant of the coronavirus can partially evade the protection from Pfizer and partner BioNTech's COVID-19 vaccine, the research head of a laboratory at Africa Health Research Inst\u2026 [+854 chars]"}, {"source": {"id": "business-insider", "name": "Business Insider"}, "author": "insider@insider.com (Allana Akhtar)", "title": "Pfizer should have helped low-income countries better distribute COVID-19 vaccines, CEO said", "description": "Albert Bourla told The Wall Street Journal he would have worked with low-income countries to improve infrastructure and better distribute doses.", "url": "https://www.businessinsider.com/pfizer-could-have-improved-vaccine-distribution-equity-ceo-said-2021-12", "urlToImage": "https://i.insider.com/61af76e16531110019cee136?width=1200&format=jpeg", "publishedAt": "2021-12-07T16:28:33Z", "content": "Pfizer CEO Albert Bourla acknowledged the pharmaceutical giant could have worked better to ensure low-income countries got enough COVID-19 vaccines.\r\nBourla said low-income countries have asked Pfize\u2026 [+2260 chars]"}, {"source": {"id": null, "name": "Business Wire"}, "author": null, "title": "Psoriatic Arthritis Treatment Global Market Report 2021 Featuring AbbVie, Amgen, J&J, BMS, Celgene, Novartis, Eli Lilly And Co, Pfizer, UCB Biosciences, and Hoffmann La Roche - ResearchAndMarkets.com", "description": "DUBLIN--(BUSINESS WIRE)--The \"Psoriatic Arthritis Treatment Global Market Report 2021: COVID-19 Growth and Change to 2030\" report has been added to ResearchAndMarkets.com's offering. The global psoriatic arthritis treatment market is expected to grow from $7.\u2026", "url": "https://www.businesswire.com/news/home/20211207005933/en/Psoriatic-Arthritis-Treatment-Global-Market-Report-2021-Featuring-AbbVie-Amgen-JJ-BMS-Celgene-Novartis-Eli-Lilly-And-Co-Pfizer-UCB-Biosciences-and-Hoffmann-La-Roche---ResearchAndMarkets.com", "urlToImage": "http://www.businesswire.com/images/bwlogo_square.png", "publishedAt": "2021-12-07T17:55:38Z", "content": "DUBLIN--(BUSINESS WIRE)--The \"Psoriatic Arthritis Treatment Global Market Report 2021: COVID-19 Growth and Change to 2030\" report has been added to ResearchAndMarkets.com's offering.\r\nThe global psor\u2026 [+5464 chars]"}, {"source": {"id": null, "name": "PharmaLive"}, "author": "Pushkala Aripaka", "title": "Mixing Pfizer, AstraZeneca COVID-19 shots with Moderna gives better immune response \u2013 UK study - PharmaLive", "description": "<ol><li>Mixing Pfizer, AstraZeneca COVID-19 shots with Moderna gives better immune response \u2013 UK study\u00a0\u00a0PharmaLive\r\n</li><li>Moderna or Novavax after AstraZeneca jab confers high Covid immunity, study finds\u00a0\u00a0The Guardian\r\n</li><li>Study: Mixing J&J Booster Ra\u2026", "url": "https://www.pharmalive.com/mixing-pfizer-astrazeneca-covid-19-shots-with-moderna-gives-better-immune-response-uk-study/", "urlToImage": "https://www.pharmalive.com/wp-content/uploads/2021/12/Mixing-Pfizer-AstraZ-COVID-19-shots-with-Moderna-gives-better-immune-response-UK-study-Reuters-12-6-21.jpg", "publishedAt": "2021-12-07T07:33:24Z", "content": "Mixing Pfizer, AstraZ COVID-19 shots with Moderna gives better immune response UK study(Reuters) \u2013 A major British study into mixing COVID-19 vaccines has found that people had a better immune respon\u2026 [+3578 chars]"}]}, "2021-12-06": {"status": "ok", "totalResults": 56, "articles": [{"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "Mixing Pfizer, AstraZ COVID-19 shots with Moderna gives better immune response -UK study - Reuters", "description": "A major British study into mixing COVID-19 vaccines has found that people had a better immune response when they received a first dose of AstraZeneca or Pfizer-BioNTech shots followed by Moderna nine weeks later, according to the results on Monday.", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/mixing-pfizer-astraz-covid-19-shots-with-moderna-gives-better-immune-response-uk-2021-12-06/", "urlToImage": "https://www.reuters.com/resizer/2hWWuQQtDAfsE2_em2jdEEeltMw=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/P3XCTOZZEJKGRERRQ6XNXOCXUU.jpg", "publishedAt": "2021-12-06T23:40:00Z", "content": "Dec 6 (Reuters) - A major British study into mixing COVID-19 vaccines has found that people had a better immune response when they received a first dose of AstraZeneca or Pfizer-BioNTech shots follow\u2026 [+3422 chars]"}, {"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "South Africa's Biovac to start making Pfizer-BioNTech COVID-19 vaccine in early 2022 - exec - Reuters", "description": "South Africa's Biovac Institute will start making Pfizer-BioNTech's <a href=\"https://www.reuters.com/companies/PFE.N\" target=\"_blank\">(PFE.N)</a>, <a href=\"https://www.reuters.com/companies/22UAy.DE\" target=\"_blank\">(22UAy.DE)</a> COVID-19 vaccine early next \u2026", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/south-africas-biovac-start-making-pfizer-biontech-covid-19-vaccine-early-2022-2021-12-06/", "urlToImage": "https://www.reuters.com/resizer/1cSn2jGxJGJONEa4AmZW9bIygxI=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/WTRFASBFQFOYDJKN4755OTK5KY.jpg", "publishedAt": "2021-12-06T13:59:00Z", "content": "KIGALI, Dec 6 (Reuters) - South Africa's Biovac Institute will start making Pfizer-BioNTech's (PFE.N), (22UAy.DE) COVID-19 vaccine early next year after receiving the drug substance from facilities i\u2026 [+1633 chars]"}, {"source": {"id": "bloomberg", "name": "Bloomberg"}, "author": "Irina Anghel", "title": "Mixing Covid Vaccines Is Effective in Study on Pfizer, Astra", "description": "Mixing other vaccines with those from AstraZeneca Plc or Pfizer Inc. offers at least as effective protection against Covid-19 as giving two doses of the same shots, a U.K. study found.", "url": "https://www.bloomberg.com/news/articles/2021-12-06/mixing-covid-vaccines-is-effective-in-study-on-pfizer-astra", "urlToImage": "https://assets.bwbx.io/images/users/iqjWHBFdfxIU/i9O8xVfPiHs8/v0/1200x800.jpg", "publishedAt": "2021-12-06T23:30:00Z", "content": "Mixing other vaccines with those from \r\nAstraZeneca Plc or \r\nPfizer Inc. offers at least as effective protection against Covid-19 as giving two doses of the same shots, a U.K. study found.\u00a0\r\nThe Univ\u2026 [+2114 chars]"}, {"source": {"id": null, "name": "Motley Fool"}, "author": "newsfeedback@fool.com (George Budwell)", "title": "Why Shares of Pfizer, Ocugen, and Vaxart Are Losing Ground Today", "description": "The initial data on omicron suggests that the pandemic has entered a new, less deadly phase.", "url": "https://www.fool.com/investing/2021/12/06/why-shares-of-pfizer-ocugen-and-vaxart-are-losing/", "urlToImage": "https://g.foolcdn.com/editorial/images/656256/covid-vax.jpg", "publishedAt": "2021-12-06T18:45:40Z", "content": "What happened\r\nShares of the COVID-19 vaccine makers Pfizer(NYSE:PFE), Ocugen(NASDAQ:OCGN), and Vaxart(NASDAQ:VXRT) are all moving in the wrong direction today. Specifically, Pfizer's stock is down b\u2026 [+2263 chars]"}, {"source": {"id": "rt", "name": "RT"}, "author": "RT", "title": "Pfizer accused of \u2018sabotaging\u2019 AstraZeneca jab", "description": "US drugmaker Pfizer is denying any wrongdoing after a British TV documentary showed a presentation on its behalf had criticized the rival Covid-19 vaccine AstraZeneca as potentially dangerous and unsafe. Read Full Article at RT.com", "url": "https://www.rt.com/uk/542389-pfizer-astrazeneca-undermine-documentary/", "urlToImage": "https://cdni.rt.com/files/2021.12/article/61ae8cb585f5404afe76c337.JPG", "publishedAt": "2021-12-06T22:31:21Z", "content": "Teasers for a Channel 4 Dispatches investigative report, shown Monday, say that a Pfizer presentation described AstraZeneca\u2019s vaccine against Covid-19 as unsafe for patients with compromised immune s\u2026 [+1693 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "Pushkala Aripaka and Lucy Marks", "title": "Mixing Pfizer, AstraZ COVID-19 shots with Moderna gives better immune response - UK study - Yahoo News", "description": "<ol><li>Mixing Pfizer, AstraZ COVID-19 shots with Moderna gives better immune response - UK study\u00a0\u00a0Yahoo News\r\n</li><li>Mix-and-match J&J Covid booster raised immune response after Pfizer vaccine, study finds\u00a0\u00a0CNN\r\n</li><li>Researchers say any approved vaccin\u2026", "url": "https://uk.news.yahoo.com/mixing-pfizer-astraz-covid-19-234026305.html", "urlToImage": "https://s.yimg.com/uu/api/res/1.2/f4FnVunWZPfnoeUaEHGIyg--~B/aD01MTE7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/ea129a6d834bdf23e30712a3ac307f4c", "publishedAt": "2021-12-06T23:40:26Z", "content": "By Pushkala Aripaka and Lucy Marks\r\n(Reuters) - A major British study into mixing COVID-19 vaccines has found that people had a better immune response when they received a first dose of AstraZeneca o\u2026 [+3234 chars]"}, {"source": {"id": "the-wall-street-journal", "name": "The Wall Street Journal"}, "author": null, "title": "WSJ CEO Council: Leaders from Tesla, Intel, Reddit, Pfizer and More Discuss Challenges Facing Business - The Wall Street Journal", "description": "The Wall Street Journal is gathering prominent leaders in business and politics to discuss how CEOs can best navigate the current political and economic climate.", "url": "https://www.wsj.com/livecoverage/wsj-ceo-council-tesla-intel-reddit-pfizer", "urlToImage": "https://images.wsj.net/im-446301/social", "publishedAt": "2021-12-06T10:37:00Z", "content": "The Wall Street Journal is gathering prominent leaders in business and politics, including several members of President Bidens cabinet, at its CEO Council summit on Monday and Tuesday for discussions\u2026 [+1537 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "Pushkala Aripaka and Lucy Marks", "title": "Mixing Pfizer, AstraZ COVID-19 shots with Moderna gives better immune response - UK study", "description": "A major British study into mixing COVID-19 vaccines has found that people had a better immune response when they received a first dose of AstraZeneca or...", "url": "https://news.yahoo.com/mixing-pfizer-astraz-covid-19-234026305.html", "urlToImage": "https://s.yimg.com/uu/api/res/1.2/vIfC1kmKmg2Aubar6WYayg--~B/aD01MTE7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/e4b1ef0bc078f01a9ebe28e90aaf929c", "publishedAt": "2021-12-06T23:40:26Z", "content": "By Pushkala Aripaka and Lucy Marks\r\n(Reuters) - A major British study into mixing COVID-19 vaccines has found that people had a better immune response when they received a first dose of AstraZeneca o\u2026 [+3234 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "PR Newswire", "title": "Worldwide Benign Prostatic Hyperplasia Treatment Industry to 2026 - Featuring GlaxoSmithKline, Pfizer and Sanofi Among Others", "description": "The \"Benign Prostatic Hyperplasia Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026\" report has been added to...", "url": "https://finance.yahoo.com/news/worldwide-benign-prostatic-hyperplasia-treatment-214500039.html", "urlToImage": "https://s.yimg.com/uu/api/res/1.2/wDGPSO44TROYKbQSONxNmQ--~B/aD00Mjt3PTQwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/prnewswire.com/e75ef6f3096d7cb6f5dd43ba82eca2fe", "publishedAt": "2021-12-06T21:45:00Z", "content": "DUBLIN, Dec. 6, 2021 /PRNewswire/ -- The \"Benign Prostatic Hyperplasia Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026\" report has been added to Rese\u2026 [+6531 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "PR Newswire", "title": "Worldwide Liposomal Doxorubicin Industry to 2026 - Featuring Baxter International, Cipla and Pfizer Among Others", "description": "The \"Liposomal Doxorubicin Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026\" report has been added to...", "url": "https://finance.yahoo.com/news/worldwide-liposomal-doxorubicin-industry-2026-191500819.html", "urlToImage": "https://s.yimg.com/uu/api/res/1.2/wDGPSO44TROYKbQSONxNmQ--~B/aD00Mjt3PTQwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/prnewswire.com/e75ef6f3096d7cb6f5dd43ba82eca2fe", "publishedAt": "2021-12-06T19:15:00Z", "content": "DUBLIN, Dec. 6, 2021 /PRNewswire/ -- The \"Liposomal Doxorubicin Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026\" report has been added to ResearchAndMarkets.co\u2026 [+5691 chars]"}, {"source": {"id": null, "name": "CNET"}, "author": "Jessica Dolcourt", "title": "Where can I get a booster shot? Quickly find Moderna and Pfizer vaccines near you - CNET", "description": "Texting a single number can save you a ton of time and hassle -- and you might even get a free Lyft or Uber ride in the process.", "url": "https://www.cnet.com/health/where-can-i-get-a-booster-shot-quickly-find-moderna-and-pfizer-vaccines-near-you/", "urlToImage": "https://www.cnet.com/a/img/fy-bL2dzhG4DqpoY_-Q7S38Gqi4=/1200x630/2021/11/24/5def0981-0b4a-497f-91d7-65d0323be6e8/covid-19-masks-n95-cnet-2021-012.jpg", "publishedAt": "2021-12-06T21:35:02Z", "content": "COVID-19 vaccine booster shots are available in 80,000 locations.\r\nSarah Tew/CNET\r\nFor the most up-to-date news and information about the coronavirus pandemic, visit the WHO and CDC websites.\r\nBringi\u2026 [+4373 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": null, "title": "Mixing Pfizer, AstraZ COVID-19 shots with Moderna gives better immune response - UK study - Yahoo News UK", "description": "Mixing Pfizer, AstraZ COVID-19 shots with Moderna gives better immune response - UK study\u00a0\u00a0Yahoo News UKView Full Coverage on Google News", "url": "https://consent.yahoo.com/v2/collectConsent?sessionId=1_cc-session_e79d32e6-cec9-4add-a94f-8e7d751d3fb9", "urlToImage": null, "publishedAt": "2021-12-06T23:40:26Z", "content": "Yahoo is part of the Yahoo family of brands.\r\nBy clicking \"Accept all\" you agree that Yahoo and our partners will store and/or access information on your device through the use of cookies and similar\u2026 [+689 chars]"}, {"source": {"id": null, "name": "The Boston Globe"}, "author": "Carl Zimmer", "title": "J&J booster works well for people who had Pfizer originally, study finds", "description": "People who received Pfizer-BioNTech vaccines may get as much benefit from a Johnson & Johnson booster shot as a Pfizer one. That\u2019s the finding of a small study released Sunday.", "url": "https://www.bostonglobe.com/2021/12/05/nation/jj-booster-works-well-people-who-had-pfizer-originally-study-finds/", "urlToImage": "https://bostonglobe-prod.cdn.arcpublishing.com/resizer/TaTn3qJJm7G4hq0qE94vGHOsNBA=/506x0/cloudfront-us-east-1.images.arcpublishing.com/bostonglobe/PFIVB7OKCHVYHYSDRTATW6C3RU.jpg", "publishedAt": "2021-12-06T02:23:06Z", "content": "People who received Pfizer-BioNTech vaccines may get as much benefit from a Johnson &amp; Johnson booster shot as a Pfizer one. Thats the finding of a small study released Sunday.\r\nResearchers at the\u2026 [+2289 chars]"}, {"source": {"id": null, "name": "Sputnik International"}, "author": "Sputnik International", "title": "Two Infants Hospitalised in Brazil After Getting Pfizer Shots by Mistake, Reports Say", "description": "BUENOS AIRES (Sputnik) - Two newborns in Brazil were given coronavirus vaccine shots by mistake and had to be hospitalised, the Brazilian media reports.", "url": "https://sputniknews.com/20211206/two-infants-hospitalised-in-brazil-after-getting-pfizer-shots-by-mistake-reports-say-1091272174.html", "urlToImage": "https://cdnn1.img.sputniknews.com/images/sharing/article/eng/1091272174.jpg?10902672951638765315", "publishedAt": "2021-12-06T04:34:07Z", "content": "Registration was successful!Please follow the link from the email sent to \r\nhttps://sputniknews.com/20211206/two-infants-hospitalised-in-brazil-after-getting-pfizer-shots-by-mistake-reports-say-10912\u2026 [+2144 chars]"}, {"source": {"id": null, "name": "Globalresearch.ca"}, "author": "Megan Redshaw", "title": "5-Year-Old Died 4 Days after Pfizer Shot, CDC VAERS Data Show", "description": "All Global Research articles\u00a0can be read in 51 languages by activating the \u201cTranslate Website\u201d\u00a0drop down menu on the top banner of our home page (Desktop version). To receive Global Research\u2019s Daily Newsletter (selected articles),\u00a0click here. Visit and follow\u2026", "url": "https://www.globalresearch.ca/5-year-old-died-4-days-pfizer-shot-cdc-vaers-data-show/5763620", "urlToImage": "https://www.globalresearch.ca/wp-content/uploads/2021/12/Covid-vaccine-VAERS-120321-feature-800x417.jpg", "publishedAt": "2021-12-06T05:14:46Z", "content": "All Global Research articles\u00a0can be read in 51 languages by activating the Translate Website\u00a0drop down menu on the top banner of our home page (Desktop version).\r\nTo receive Global Researchs Daily Ne\u2026 [+9952 chars]"}, {"source": {"id": null, "name": "Devdiscourse"}, "author": "Reuters", "title": "Mixing Pfizer, AstraZ COVID-19 shots with Moderna gives better immune response -UK study - Devdiscourse", "description": "A major British study into mixing COVID-19 vaccines has found that people had a better immune response when they received a first dose of AstraZeneca or Pfizer-BioNTech shots followed by Moderna nine weeks later, according to the results on Monday.  \"We found\u2026", "url": "https://www.devdiscourse.com/article/health/1837011-mixing-pfizer-astraz-covid-19-shots-with-moderna-gives-better-immune-response--uk-study", "urlToImage": "https://www.devdiscourse.com/remote.axd?https://devdiscourse.blob.core.windows.net/imagegallery/27_06_2019_18_22_44_8556925.png?width=920&format=jpeg", "publishedAt": "2021-12-06T23:30:42Z", "content": "A major British study into mixing COVID-19 vaccines has found that people had a better immune response when they received a first dose of AstraZeneca or Pfizer-BioNTech shots followed by Moderna nine\u2026 [+3408 chars]"}, {"source": {"id": null, "name": "Trust.org"}, "author": "Thomson Reuters Foundation", "title": "Mixing Pfizer, AstraZ COVID-19 shots with Moderna gives ... - Thomson Reuters Foundation", "description": "<ol><li>Mixing Pfizer, AstraZ COVID-19 shots with Moderna gives ...\u00a0\u00a0Thomson Reuters Foundation\r\n</li><li>Researchers say any approved vaccine will work as booster\u00a0\u00a0KRIS 6 News\r\n</li><li>Study shows COVID booster shots work\u00a0\u00a0News-Medical.net\r\n</li><li>Moderna\u2026", "url": "https://news.trust.org/item/20211206232742-o7inz/", "urlToImage": "https://d8zcwdvc14g2e.cloudfront.net/contentAsset/image/b8c49d62-dcf2-4d21-8e51-cd450b89fcc5/image/byInode/1/filter/Resize,Jpeg/jpeg_q/70/resize_w/1100", "publishedAt": "2021-12-06T23:30:00Z", "content": "By Pushkala Aripaka and Lucy Marks\r\nDec 6 (Reuters) - A major British study into mixing COVID-19 vaccines has found that people had a better immune response when they received a first dose of AstraZe\u2026 [+3512 chars]"}, {"source": {"id": null, "name": "Globalresearch.ca"}, "author": "Seth Hancock", "title": "Congressman Introduces Bill to Force FDA to Release Pfizer Documents Within 100 Days, Instead of 55 Years", "description": "All Global Research articles\u00a0can be read in 51 languages by activating the \u201cTranslate Website\u201d\u00a0drop down menu on the top banner of our home page (Desktop version).\nTo receive Global Research\u2019s Daily Newsletter (selected articles),\u00a0click here.\nVisit \u2026\nThe post\u2026", "url": "https://www.globalresearch.ca/congressman-introduces-bill-force-fda-release-pfizer-documents-100-days-instead-55-years/5763710", "urlToImage": "https://www.globalresearch.ca/wp-content/uploads/2021/12/Rep-Norman-demands-FDA-Pfizer-data-feature-800x417.jpg", "publishedAt": "2021-12-06T14:38:37Z", "content": "All Global Research articles\u00a0can be read in 51 languages by activating the Translate Website\u00a0drop down menu on the top banner of our home page (Desktop version).\r\nTo receive Global Researchs Daily Ne\u2026 [+6768 chars]"}, {"source": {"id": "cnn", "name": "CNN"}, "author": "Maggie Fox, CNN", "title": "Mix-and-match J&J Covid booster raised immune response after Pfizer vaccine, study finds", "description": "Using the Johnson & Johnson vaccine as a booster for people initially immunized with the Pfizer/BioNTech vaccine produces a strong immune response and may do more to elicit protection against severe disease, researchers reported Sunday.", "url": "https://www.cnn.com/2021/12/05/health/covid-vaccine-johnson-pfizer-booster-mix/index.html", "urlToImage": "https://cdn.cnn.com/cnnnext/dam/assets/211111052048-johnson--johnson-janssen-covid-19-vaccine-california-032521-file-super-tease.jpg", "publishedAt": "2021-12-06T03:16:55Z", "content": "(CNN)Using the Johnson &amp; Johnson vaccine as a booster for people initially immunized with the Pfizer/BioNTech vaccine produces a strong immune response and may do more to elicit protection agains\u2026 [+2171 chars]"}, {"source": {"id": null, "name": "CNA"}, "author": null, "title": "South Africa's Biovac to start making Pfizer-BioNTech COVID-19 vaccine in early 2022", "description": "KIGALI: South Africa's Biovac Institute will start making Pfizer-BioNTech's COVID-19 vaccine early next year after receiving the drug substance from facilities in Europe, a Pfizer executive said on Monday (Dec 6).\r\n\r\nThat earlier than the forecast start at ar\u2026", "url": "https://www.channelnewsasia.com/business/south-africas-biovac-start-making-pfizer-biontech-covid-19-vaccine-early-2022-2361996", "urlToImage": "https://onecms-res.cloudinary.com/image/upload/s--BMeg4VXM--/fl_relative%2Cg_south_east%2Cl_one-cms:core:watermark:reuters%2Cw_0.1/f_auto%2Cq_auto/c_fill%2Cg_auto%2Ch_676%2Cw_1200/v1/one-cms/core/2021-12-06t135809z_1_lynxmpehb50la_rtroptp_3_health-coronavirus-usa-children.jpg?itok=1spx8HWR", "publishedAt": "2021-12-06T13:59:00Z", "content": "KIGALI: South Africa's Biovac Institute will start making Pfizer-BioNTech's COVID-19 vaccine early next year after receiving the drug substance from facilities in Europe, a Pfizer executive said on M\u2026 [+1301 chars]"}]}, "2021-12-05": {"status": "ok", "totalResults": 22, "articles": [{"source": {"id": null, "name": "The Guardian"}, "author": "Jon Ungoed-Thomas", "title": "\u2018Wall of secrecy\u2019 in Pfizer contracts as company accused of profiteering", "description": "US company faces scrutiny over Covid profits after UK agrees to secrecy clause<ul><li>Coronavirus \u2013 latest updates</li><li>See all our coronavirus coverage</li></ul>Ministers have agreed a secrecy clause in any dispute with the drugs manufacturer Pfizer over \u2026", "url": "https://amp.theguardian.com/uk-news/2021/dec/05/wall-of-secrecy-in-pfizer-contracts-as-company-accused-of-profiteering", "urlToImage": "https://i.guim.co.uk/img/media/f48fdea9871e0b96394a999a0bd48e3b49971b44/0_118_5483_3290/master/5483.jpg?width=1200&height=630&quality=85&auto=format&fit=crop&overlay-align=bottom%2Cleft&overlay-width=100p&overlay-base64=L2ltZy9zdGF0aWMvb3ZlcmxheXMvdG8tZGVmYXVsdC5wbmc&enable=upscale&s=eb3b4edcf499e6758ace0de6e27423df", "publishedAt": "2021-12-05T06:30:47Z", "content": "Ministers have agreed a secrecy clause in any dispute with the drugs manufacturer Pfizer over Britains Covid vaccine supply. Large portions of the governments contracts with the company over the supp\u2026 [+4720 chars]"}, {"source": {"id": null, "name": "New York Times"}, "author": "Carl Zimmer", "title": "J.&J. Booster Worked for People Who Got Pfizer Shots in Study", "description": "", "url": "https://www.nytimes.com/2021/12/05/health/jj-booster-pfizer-study.html", "urlToImage": "https://static01.nyt.com/images/2021/12/05/multimedia/05virus-briefing-JJ-boosters-alt/05virus-briefing-JJ-boosters-alt-facebookJumbo.jpg", "publishedAt": "2021-12-05T22:55:16Z", "content": "People who received Pfizer-BioNTech vaccines may get as much benefit from a Johnson &amp; Johnson booster shot as a Pfizer one. Thats the finding of a small study released on Sunday.\r\nResearchers at \u2026 [+1288 chars]"}, {"source": {"id": null, "name": "The Guardian"}, "author": "Paul Karp", "title": "\u2018Provisional approval\u2019: Australian children aged five to 11 set to receive Pfizer Covid vaccine from mid-January", "description": "Subject to final approvals, 2.3 million children in age cohort could have first jab before school returns in 2022<ul><li>Get our free news app; get our morning email briefing</li></ul>Australian children aged five to 11 could receive the Pfizer vaccine agains\u2026", "url": "https://amp.theguardian.com/society/2021/dec/05/australian-children-aged-five-to-11-set-to-receive-pfizer-covid-vaccine-from-mid-january", "urlToImage": "https://i.guim.co.uk/img/media/8de38ca47901c8114400d7067e2d8ce32c30e4b6/0_64_4915_2949/master/4915.jpg?width=1200&height=630&quality=85&auto=format&fit=crop&overlay-align=bottom%2Cleft&overlay-width=100p&overlay-base64=L2ltZy9zdGF0aWMvb3ZlcmxheXMvdGctZGVmYXVsdC5wbmc&enable=upscale&s=e6218722ff3080965f87ac32156b8c56", "publishedAt": "2021-12-05T00:17:06Z", "content": "Australian children aged five to 11 could receive the Pfizer vaccine against Covid as soon as 10 January, following provisional approval by the countrys drugs regulator.\r\nThe Therapeutic Goods Admini\u2026 [+2606 chars]"}, {"source": {"id": null, "name": "WWLP.com"}, "author": "Michael Bartiromo, Nexstar Media Wire", "title": "Moderna or Pfizer? Head-to-head study finds one is slightly more effective, Harvard researchers say - WWLP.com", "description": "Moderna or Pfizer? Head-to-head study finds one is slightly more effective, Harvard researchers say\u00a0\u00a0WWLP.comView Full Coverage on Google News", "url": "https://www.wwlp.com/news/health/coronavirus/moderna-or-pfizer-head-to-head-study-finds-one-is-slightly-more-effective-harvard-researchers-say/", "urlToImage": "https://www.wwlp.com/wp-content/uploads/sites/26/2021/12/ModernaPfizerGettyImages-1234603091.jpg?w=1280", "publishedAt": "2021-12-05T17:36:15Z", "content": "(NEXSTAR) A head-to-head study of the Moderna and Pfizer vaccines has determined the former to be slightly more effective against COVID-19, at least as far as the alpha and delta variants are concern\u2026 [+1852 chars]"}, {"source": {"id": null, "name": "Globalresearch.ca"}, "author": "The Election Wizard", "title": "Bombshell Document Dump on Pfizer Vaccine Data", "description": "All Global Research articles\u00a0can be read in 51 languages by activating the \u201cTranslate Website\u201d\u00a0drop down menu on the top banner of our home page (Desktop version). To receive Global Research\u2019s Daily Newsletter (selected articles),\u00a0click here. Visit and follow\u2026", "url": "https://www.globalresearch.ca/bombshell-document-dump-pfizer-vaccine-data/5763397", "urlToImage": "https://www.globalresearch.ca/wp-content/uploads/2021/11/Covid-19-Coronavirus-Pfizer-Syringe-Vaccine-Vial.jpg", "publishedAt": "2021-12-05T23:03:53Z", "content": "This document provides an integrated analysis of the cumulative post-authorization safety data, including U.S. and foreign post-authorization adverse event reports received through 28 February 2021.\r\u2026 [+1114 chars]"}, {"source": {"id": null, "name": "RochesterFirst"}, "author": "Michael Bartiromo, Nexstar Media Wire", "title": "Moderna or Pfizer? Head-to-head study finds one is slightly more effective, Harvard researchers say - RochesterFirst", "description": "<ol><li>Moderna or Pfizer? Head-to-head study finds one is slightly more effective, Harvard researchers say\u00a0\u00a0RochesterFirst\r\n</li><li>Mix-and-match J&J Covid booster raised immune response after Pfizer vaccine, study finds\u00a0\u00a0CNN\r\n</li><li>Researchers say any a\u2026", "url": "https://www.rochesterfirst.com/coronavirus/moderna-or-pfizer-head-to-head-study-finds-one-is-slightly-more-effective-harvard-researchers-say/", "urlToImage": "https://www.rochesterfirst.com/wp-content/uploads/sites/66/2021/12/GettyImages-1231116335.jpg?w=1280", "publishedAt": "2021-12-05T00:06:20Z", "content": "(NEXSTAR) A head-to-head study of the Moderna and Pfizer vaccines has determined the former to be slightly more effective against COVID-19, at least as far as the alpha and delta variants are concern\u2026 [+1851 chars]"}, {"source": {"id": null, "name": "Israelnationalnews.com"}, "author": "Arutz Sheva Staff", "title": "Pfizer CEO: Israel is a beacon of hope in this pandemic", "description": "Albert Bourla talks about his good relations with Netanyahu and Bennett and answers parents who are worried over the COVID vaccine.", "url": "https://www.israelnationalnews.com/News/News.aspx/318091", "urlToImage": "https://u.a7.org/pictures/1040/1040424.jpg", "publishedAt": "2021-12-05T01:55:00Z", "content": "Albert Bourla, CEO of Pfizer, is not alarmed by the new Omicron variant of COVID-19 and reveals what he thinks about the way Israel is handling the crisis.\r\nIn an interview with the Yediot Aharonot n\u2026 [+3164 chars]"}, {"source": {"id": null, "name": "Cracknewz.com"}, "author": "Neha", "title": "3 children dead, 120 hospitalized\u2026 Pfizer Vaccine batch suspended\u2026", "description": "", "url": "https://www.cracknewz.com/2021/12/ghislaine-maxwell-kept-degrading-58.html", "urlToImage": null, "publishedAt": "2021-12-05T12:54:00Z", "content": "Since November 30, the central province has been vaccinating children aged 15-17 with the Pfizer Covid-19 vaccine. However, over 120 of the children were admitted to hospitals after exhibiting sympto\u2026 [+1431 chars]"}, {"source": {"id": null, "name": "ArkLaTexHomepage"}, "author": "Michael Bartiromo, Nexstar Media Wire", "title": "Moderna or Pfizer? Head-to-head study finds one is slightly more effective, Harvard researchers say - ArkLaTexHomepage", "description": "<ol><li>Moderna or Pfizer? Head-to-head study finds one is slightly more effective, Harvard researchers say\u00a0\u00a0ArkLaTexHomepage\r\n</li><li>COVID-19: Study suggests mixing and matching vaccine boosters proves effective\u00a0\u00a0Global News\r\n</li><li>Study Finds Most Covi\u2026", "url": "https://www.arklatexhomepage.com/health/coronavirus/moderna-or-pfizer-head-to-head-study-finds-one-is-slightly-more-effective-harvard-researchers-say/", "urlToImage": "https://www.arklatexhomepage.com/wp-content/uploads/sites/5/2021/12/ModernaPfizerGettyImages-1234603091.jpg?w=1280", "publishedAt": "2021-12-05T03:19:53Z", "content": "(NEXSTAR) A head-to-head study of the Moderna and Pfizer vaccines has determined the former to be slightly more effective against COVID-19, at least as far as the alpha and delta variants are concern\u2026 [+1970 chars]"}, {"source": {"id": null, "name": "TheJournal.ie"}, "author": "AFP", "title": "Australia approves Pfizer Covid-19 vaccine for children aged 5-11", "description": "\u201cIt is about keeping our kids safe, keeping our families safe, keeping all Australians safe,\u201d Australia\u2019s Health Minister said.", "url": "https://www.thejournal.ie/australia-covid-vaccines-pfizer-5620841-Dec2021/", "urlToImage": "https://img2.thejournal.ie/article/5620841/river/?height=400&version=5620874", "publishedAt": "2021-12-05T12:40:51Z", "content": "AUSTRALIA HAS CLEARED the first Covid-19 vaccine for children aged five to 11, with the next stage of its vaccine rollout expected to start in early 2022.\r\nHealth Minister Greg Hunt said medical regu\u2026 [+1600 chars]"}, {"source": {"id": null, "name": "City A.M."}, "author": "Amy O'Brien", "title": "Pfizer accused of funding anti-AstraZeneca information", "description": "US drugmaker Pfizer, the world\u2019s dominant Covid vaccine maker, has been accused of funding educational presentations that said its UK rival AstraZeneca was ineffective and even dangerous for some members of the population. A Channel 4 Dispatches investigation\u2026", "url": "https://www.cityam.com/pfizer-accused-of-funding-anti-astrazeneca-information/", "urlToImage": "https://www.cityam.com/wp-content/uploads/2021/10/City-AM-OG-1.jpg", "publishedAt": "2021-12-05T13:42:08Z", "content": "Sunday 05 December 2021 1:42 pm\r\nPfizer CEO Albert Bourla talks during a press conference after a visit at Pfizer vaccine plant in Puurs\r\nUS drugmaker Pfizer, the world\u2019s dominant Covid vaccine maker\u2026 [+2871 chars]"}, {"source": {"id": null, "name": "Vaccineimpact.com"}, "author": "Mike Rivero", "title": "2,809 Dead Babies in VAERS Following COVID Shots as New Documents Prove Pfizer, the FDA, and the CDC Knew the Shots Were Not Safe for Pregnant Women", "description": "The latest data dump into the U.S. Government\u2019s Vaccine Adverse Events Reporting System (VAERS) happened yesterday (12/3/21) and covers data through 11/26/2021. There are now 927,740 cases reported to VAERS following COVID-19 shots for the past 11 months, out\u2026", "url": "https://vaccineimpact.com/2021/2809-dead-babies-in-vaers-following-covid-shots-as-new-documents-prove-pfizer-the-fda-and-the-cdc-knew-the-shots-were-not-safe-for-pregnant-women/", "urlToImage": null, "publishedAt": "2021-12-05T14:23:19Z", "content": "by Brian ShilhavyEditor, Health Impact News\r\nThe latest data dump into the U.S. Governments\u00a0Vaccine Adverse Events Reporting System\u00a0(VAERS) happened yesterday (12/3/21) and covers data through 11/26/\u2026 [+18642 chars]"}, {"source": {"id": null, "name": "Freerepublic.com"}, "author": "The National Pulse", "title": "CONFLICT: Reuters Chairman is Pfizer Investor and Board Member.", "description": "The chairman and former Chief Executive Officer (CEO) of the Reuters news agency \u2013 James C. Smith \u2013 is a top investor and board member for pharmaceuticals giant Pfizer. He was elected to the board in 2014, as well as joining Pfizer\u2019s Corporate Governance and \u2026", "url": "https://freerepublic.com/focus/f-bloggers/4018528/posts", "urlToImage": null, "publishedAt": "2021-12-05T21:38:19Z", "content": "Skip to comments.\r\nCONFLICT: Reuters Chairman is Pfizer Investor and Board Member.The National Pulse ^\r\n | 12/1/21\r\n | Kay Smythe\r\nPosted on 12/05/2021 1:38:19 PM PST by Roman_War_Criminal\r\nThe chair\u2026 [+2107 chars]"}, {"source": {"id": null, "name": "bdnews24.com"}, "author": null, "title": "Australia regulator approves Pfizer vaccine for children 5-11", "description": "Australia's medicine regulator on Sunday provisionally approved the Pfizer Inc coronavirus vaccine for children between the ages of 5 and 11, with the health minister saying the rollout could begin from Jan10.", "url": "https://bdnews24.com/world/asia-pacific/2021/12/05/australia-regulator-approves-pfizer-vaccine-for-children-5-11", "urlToImage": "https://d30fl32nd2baj9.cloudfront.net/media/2021/10/29/australia-vaccine-291021-smr.jpg/BINARY/australia-vaccine-291021-smr.jpg", "publishedAt": "2021-12-05T04:40:06Z", "content": "The Therapeutics Goods Administration \"have made a careful, thorough assessment, determined that it is safe and effective and that it is in the interests of children and Australians for children 5 to\u2026 [+2086 chars]"}, {"source": {"id": null, "name": "Business Standard"}, "author": "IANS", "title": "Pfizer faces scrutiny over scale of its Covid profits, says report", "description": "Pfizer has to date pledged 40m doses out of global production to Covax", "url": "https://www.business-standard.com/article/international/pfizer-faces-scrutiny-over-scale-of-its-covid-profits-says-report-121120500724_1.html", "urlToImage": "https://bsmedia.business-standard.com/_media/bs/img/article/2021-02/25/full/1614255646-8333.jpg", "publishedAt": "2021-12-05T15:14:00Z", "content": "Pfizer has won plaudits for its Covid vaccine delivery programme, but the US multinational faces growing scrutiny over the scale of its profits and the proportion of doses it has delivered to low-inc\u2026 [+4581 chars]"}, {"source": {"id": null, "name": "Freerepublic.com"}, "author": "CNN", "title": "Pfizer revenue and profits soar on its Covid vaccine business: Vaccine business alone was responsible for more than 60% of the company's sales", "description": "New York (CNN Business): Pfizer reported that earnings and sales more than doubled in the past quarter, and it raised its outlook for results the full year, thanks greatly to its Covid-19 vaccine. The company reported adjusted earnings of $7.7 billion, up 133\u2026", "url": "https://freerepublic.com/focus/f-chat/4018478/posts", "urlToImage": null, "publishedAt": "2021-12-05T17:41:07Z", "content": "Skip to comments.\r\nPfizer revenue and profits soar on its Covid vaccine business: Vaccine business alone was responsible for more than 60% of the company's salesCNN ^\r\n | November 2021\r\n | Chris Isid\u2026 [+3467 chars]"}, {"source": {"id": null, "name": "Slashdot.org"}, "author": "feedfeeder", "title": "Omicron and COVID booster shot: Find out fast if your pharmacy has Pfizer or Moderna - CNET", "description": "Omicron and COVID booster shot: Find out fast if your pharmacy has Pfizer or ModernaCNET COVID-19 Booster Vaccine: A Timeline for Third Dose Effectiveness and ImmunityGoodHousekeeping.com What to expect from booster reactionsKOLD COVID booster shot and omicro\u2026", "url": "https://slashdot.org/firehose.pl?op=view&amp;id=156240673", "urlToImage": null, "publishedAt": "2021-12-05T05:32:13Z", "content": "The Fine Print: The following comments are owned by whoever posted them. We are not responsible for them in any way."}, {"source": {"id": null, "name": "Slashdot.org"}, "author": "Anonymous Coward", "title": "Over 42,000 Adverse Reaction Reports Revealed In First Batch Of Pfizer Vax Docs", "description": "As first reported by Kyle Becker, there were a total of 42,086 case reports for adverse reactions (25,379 medically confirmed, 16,707 non-medically confirmed), spanning 158,893 total events. More than 25,000 of the events were classified as \"Nervous system di\u2026", "url": "https://slashdot.org/submission/15085467/over-42000-adverse-reaction-reports-revealed-in-first-batch-of-pfizer-vax-docs", "urlToImage": null, "publishedAt": "2021-12-05T02:35:52Z", "content": "As first reported by Kyle Becker, there were a total of 42,086 case reports for adverse reactions (25,379 medically confirmed, 16,707 non-medically confirmed), spanning 158,893 total events. More tha\u2026 [+222 chars]"}, {"source": {"id": "the-irish-times", "name": "The Irish Times"}, "author": null, "title": "Australian regulator approves Pfizer vaccine for children aged 5-11", "description": "Rollout of Covid jabs for children could begin in early January, health minister says", "url": "https://www.irishtimes.com/news/world/asia-pacific/australian-regulator-approves-pfizer-vaccine-for-children-aged-5-11-1.4747183", "urlToImage": "https://www.irishtimes.com/image-creator/?id=1.4747182&origw=1440", "publishedAt": "2021-12-05T08:59:30Z", "content": "Australias medicine regulator on Sunday provisionally approved the Pfizer coronavirus vaccine for children between the ages of five and 11, with the health minister saying the rollout could begin fro\u2026 [+282 chars]"}, {"source": {"id": null, "name": "Slashdot.org"}, "author": "feedfeeder", "title": "Moderna or Pfizer? Head-to-head study finds one is slightly more effective, Harvard researchers say - fox4kc.com", "description": "Moderna or Pfizer? Head-to-head study finds one is slightly more effective, Harvard researchers sayfox4kc.com...", "url": "https://slashdot.org/firehose.pl?op=view&amp;id=156240009", "urlToImage": null, "publishedAt": "2021-12-05T04:12:10Z", "content": "Thus mathematics may be defined as the subject in which we never know\r\nwhat we are talking about, nor whether what we are saying is true.\r\n-- Bertrand Russell"}]}, "2021-12-04": {"status": "ok", "totalResults": 14, "articles": [{"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "Australia's medicine regulator approves Pfizer vaccine for children 5-11 - Reuters", "description": "Australia's medicine regulator provisionally approved on Sunday the Pfizer Inc  coronavirus vaccine for children between the ages of 5 and 11, with the health minister saying the rollout could begin from Jan. 10.", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/australias-medicine-regulator-approves-pfizer-vaccine-children-5-11-2021-12-04/", "urlToImage": "https://www.reuters.com/resizer/RvUfhvsalZtMT3LGTX3k_lkNOOg=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/S35QHTUSCBPIDBFCGZBRGOZUM4.jpg", "publishedAt": "2021-12-04T23:07:00Z", "content": "MELBOURNE, Dec 5 (Reuters) - Australia's medicine regulator provisionally approved on Sunday the Pfizer Inc coronavirus vaccine for children between the ages of 5 and 11, with the health minister say\u2026 [+2016 chars]"}, {"source": {"id": "business-insider", "name": "Business Insider"}, "author": "ydzhanova@businessinsider.com (Yelena Dzhanova)", "title": "Pfizer said it expects to have more data by end of year on whether COVID-19 vaccine can be administered to children under 5", "description": "Dr. Anthony Fauci has predicted that parents won't have to wait much longer for kids under 5\u00a0to receive a vaccine.", "url": "https://www.businessinsider.com/pfizer-vaccine-data-kids-under-5-years-end-2021-12", "urlToImage": "https://i.insider.com/619f6d74ee9795001883e392?width=1200&format=jpeg", "publishedAt": "2021-12-04T15:40:56Z", "content": "Pfizer CEO Albert Bourla on Friday said the company expects to know more about the effectiveness of its vaccines in children under 5\u00a0by the end of the year.\u00a0\r\n\"We have a study in children six months \u2026 [+2165 chars]"}, {"source": {"id": null, "name": "WDAF FOX4 Kansas City"}, "author": "Michael Bartiromo, Nexstar Media Wire", "title": "Moderna or Pfizer? Head-to-head study finds one is slightly more effective, Harvard researchers say - fox4kc.com", "description": "Moderna or Pfizer? Head-to-head study finds one is slightly more effective, Harvard researchers say\u00a0\u00a0fox4kc.comView Full Coverage on Google News", "url": "https://fox4kc.com/news/moderna-or-pfizer-head-to-head-study-finds-one-is-slightly-more-effective-harvard-researchers-say/", "urlToImage": "https://fox4kc.com/wp-content/uploads/sites/16/2021/12/ModernaPfizerGettyImages-1234603091.jpg?w=1280", "publishedAt": "2021-12-04T22:06:58Z", "content": "(NEXSTAR) A head-to-head study of the Moderna and Pfizer vaccines has determined the former to be slightly more effective against COVID-19, at least as far as the alpha and delta variants are concern\u2026 [+1874 chars]"}, {"source": {"id": "abc-news-au", "name": "ABC News (AU)"}, "author": "Michael Doyle", "title": "TGA approves Pfizer COVID-19 vaccine for 5-11-year-olds", "description": "The\u00a0Therapeutic Goods Administration provisionally approves the Pfizer vaccine for children aged between five and 11 years of age.", "url": "https://www.abc.net.au/news/2021-12-05/tga-approves-pfizer-covid-19-vaccine-for-5-11-year-olds/100675138", "urlToImage": "https://live-production.wcms.abc-cdn.net.au/761bdb8c386110a2b34083c817b0091f?impolicy=wcms_crop_resize&cropH=2813&cropW=5000&xPos=0&yPos=260&width=862&height=485", "publishedAt": "2021-12-04T21:16:56Z", "content": "Australia's Therapeutic Goods Administration (TGA) has provisionally approved the Pfizer vaccine for children aged between five and 11 years of age.\u00a0\r\nFederal Health Minister Greg Hunt said the gover\u2026 [+672 chars]"}, {"source": {"id": null, "name": "Daily Mail"}, "author": "Australian Associated", "title": "Covid-19 Australia: Pfizer vaccines could be approved for children as young as five before Christmas", "description": "Federal Minister Greg Hunt has said the medical regulator should make the call on if Pifzer Covid-19 shots for children will get the go ahead before Christmas.", "url": "https://www.dailymail.co.uk/news/article-10274143/Covid-19-Australia-Pfizer-vaccines-approved-children-young-five-Christmas.html", "urlToImage": "https://i.dailymail.co.uk/1s/2021/12/04/05/51324773-0-image-a-53_1638596693919.jpg", "publishedAt": "2021-12-04T05:50:14Z", "content": "Federal Health Minister Greg Hunt said the Therapeutic Goods Administration and Australian Technical Advisory Group on Immunisation should make a call on Pfizer pediatric doses before year's end.\r\nIt\u2026 [+1614 chars]"}, {"source": {"id": null, "name": "FOX 31 Denver"}, "author": "Michael Bartiromo, Nexstar Media Wire", "title": "Moderna or Pfizer? Head-to-head study finds one is slightly more effective, Harvard researchers say - FOX31 Denver", "description": "Moderna or Pfizer? Head-to-head study finds one is slightly more effective, Harvard researchers say\u00a0\u00a0FOX31 DenverView Full Coverage on Google News", "url": "https://kdvr.com/news/coronavirus/covid-19-vaccine/moderna-or-pfizer-head-to-head-study-finds-one-is-slightly-more-effective-harvard-researchers-say/", "urlToImage": "https://kdvr.com/wp-content/uploads/sites/11/2021/12/ModernaPfizerGettyImages-1234603091.jpg?w=1280", "publishedAt": "2021-12-04T15:34:40Z", "content": "(NEXSTAR) A head-to-head study of the Moderna and Pfizer vaccines has determined the former to be slightly more effective against COVID-19, at least as far as the alpha and delta variants are concern\u2026 [+1874 chars]"}, {"source": {"id": null, "name": "Freerepublic.com"}, "author": "National File", "title": "Pfizer Documents Reveal Over 1,200 Vaccine Deaths Over 90-Day Trial Period", "description": "The Food and Drug Administration (FDA) has released the first batch of documents related to Pfizer\u2019s COVID-19 vaccine program after a federal judge ordered that they must comply with a massive FOIA request.The request was filed by the Public Health and Medica\u2026", "url": "https://freerepublic.com/focus/f-news/4018121/posts", "urlToImage": null, "publishedAt": "2021-12-04T01:23:19Z", "content": "Skip to comments.\r\nPfizer Documents Reveal Over 1,200 Vaccine Deaths Over 90-Day Trial PeriodNational File ^\r\n | 12/02/2021\r\n | Cullen McCue\r\nPosted on 12/03/2021 5:23:19 PM PST by Jan_Sobieski\r\nThe \u2026 [+2835 chars]"}, {"source": {"id": "the-hill", "name": "The Hill"}, "author": "Lexi Lonas", "title": "Pfizer CEO says vaccine data for those under 5 could be available by end of year", "description": "Pfizer's CEO on Friday said data about the effectiveness of its coronavirus vaccine in those under the age of five could be available by the end of\u00a0the year.CEO Albert Bourla ...", "url": "https://thehill.com/policy/healthcare/584322-pfizer-ceo-says-vaccine-data-for-those-under-5-could-be-available-by-end-of", "urlToImage": "https://thehill.com/sites/default/files/pfizervaccine_boosters_012621apmaryaltaffer.jpg", "publishedAt": "2021-12-04T03:47:20Z", "content": "Pfizer's CEO on Friday said data about the effectiveness of its coronavirus vaccine in those under the age of five could be available by the end of\u00a0the year.\r\nCEO Albert Bourla spoke with\u00a0NBC News ch\u2026 [+1164 chars]"}, {"source": {"id": null, "name": "Daily Mail"}, "author": "Kevin Airs", "title": "TGA gives provisional approval for the Pfizer vaccines for children aged 5-11", "description": "Jabs for children in 5-11 age group will now start to be rolled out by the government from January 10, subject to final approvals, with doses limited to just one-third of the adult dose.", "url": "https://www.dailymail.co.uk/news/article-10274569/TGA-gives-provisional-approval-Pfizer-vaccines-children-aged-5-11.html", "urlToImage": "https://i.dailymail.co.uk/1s/2021/12/04/05/51324773-0-image-a-53_1638596693919.jpg", "publishedAt": "2021-12-04T11:34:25Z", "content": "The Pfizer vaccine has been provisionally approved for use in children aged 5-11, the Therapeutic Goods Administration confirmed on Saturday.\r\nJabs for children in that age group will now start to be\u2026 [+2326 chars]"}, {"source": {"id": "nbc-news", "name": "NBC News"}, "author": "Berkeley Lovelace Jr.", "title": "Pfizer could have vaccine data for kids under age 5 by year-end, CEO says", "description": "Children under age 5 are the only group in the U.S. not eligible to get a shot.", "url": "https://www.nbcnews.com/health/health-news/pfizer-vaccine-data-kids-age-5-year-end-ceo-says-rcna7602", "urlToImage": "https://media-cldnry.s-nbcnews.com/image/upload/t_nbcnews-fp-1200-630,f_auto,q_auto:best/rockcms/2021-12/211203-pfizer-child-ac-633p-e0280e.jpg", "publishedAt": "2021-12-04T00:49:27Z", "content": "Pfizer could have data on how well its Covid-19 vaccine works in kids under age 5 by the end of the year, according to CEO Albert Bourla.\r\n\"We have a study in children 6 months to 2 years and then an\u2026 [+2465 chars]"}, {"source": {"id": null, "name": "9News"}, "author": "9news Staff", "title": "TGA provisionally approves Pfizer COVID-19 vaccine for five to 11-year-old children", "description": "<p>The Therapeutic Goods Administration (TGA) has provisionally approved the <a href=\"https://www.9news.com.au/pfizer-vaccine\" target=\"\" rel=\"\" title=\"Pfizer\">Pfizer</a> vaccine as safe and effective for use among Australian children aged five to 11-years-old\u2026", "url": "https://www.9news.com.au/national/coronavirus-australia-updates-covid-19-vaccine-for-children-could-be-available-within-weeks/dfaba6ff-0007-4ad5-82b0-975d4e115b4c", "urlToImage": "https://imageresizer.static9.net.au/s7bjOy7-ar9rUkAEbJfIJkIQGNI=/1200x628/smart/https%3A%2F%2Fprod.static9.net.au%2Ffs%2F9669b5df-424a-4b4e-9910-5d343a0dadff", "publishedAt": "2021-12-04T21:22:12Z", "content": "Property News:\u00a0Music promoter Michael Coppel sells Toorak home for more than $30 million - domain.com.au"}, {"source": {"id": "news-com-au", "name": "News.com.au"}, "author": "Sam Clench", "title": "Pfizer Covid vaccines for children aged 5-11 reportedly approved by TGA", "description": "<p>The Therapeutic Goods Administration (TGA) is expected to announce on Sunday that it has provisionally approved Pfizer&rsquo;s Covid-19 vaccine to be administered to children between the ages of five and eleven.</p>", "url": "https://www.news.com.au/lifestyle/health/pfizer-covid-vaccines-for-children-aged-511-reportedly-approved-by-tga/news-story/b18bfb577d6d19734ca8ee6cfedadd5f", "urlToImage": "https://content.api.news/v3/images/bin/dc8097dbee349d8445e44fd132ee25b4", "publishedAt": "2021-12-04T13:10:26Z", "content": "Children aged 5-11 could be vaccinated against Covid before school returns next year, with a key hurdle about to be cleared.The Therapeutic Goods Administration (TGA) is expected to announce on Sunda\u2026 [+3301 chars]"}, {"source": {"id": null, "name": "CNET"}, "author": "Jessica Dolcourt", "title": "Omicron and COVID booster shot: Find out fast if your pharmacy has Pfizer or Moderna", "description": "Texting a single number can save you a bundle of time and hassle -- and maybe get you a free Lyft or Uber ride in the process.", "url": "https://www.cnet.com/health/covid-booster-shot-and-omicron-find-out-fast-if-your-pharmacy-has-pfizer-or-moderna/", "urlToImage": "https://www.cnet.com/a/img/fy-bL2dzhG4DqpoY_-Q7S38Gqi4=/1200x630/2021/11/24/5def0981-0b4a-497f-91d7-65d0323be6e8/covid-19-masks-n95-cnet-2021-012.jpg", "publishedAt": "2021-12-04T19:00:51Z", "content": "COVID-19 vaccine booster shots are available in 80,000 locations.\r\nSarah Tew/CNET\r\nFor the most up-to-date news and information about the coronavirus pandemic, visit the WHO and CDC websites.\r\nMore t\u2026 [+4283 chars]"}, {"source": {"id": null, "name": "KOLR - OzarksFirst.com"}, "author": "Michael Bartiromo, Nexstar Media Wire", "title": "Moderna or Pfizer? Head-to-head study finds one is slightly more effective, Harvard researchers say", "description": "The results of the study were published in the New England Journal of Medicine this week.", "url": "https://www.ozarksfirst.com/life-health/coronavirus/moderna-or-pfizer-head-to-head-study-finds-one-is-slightly-more-effective-harvard-researchers-say/", "urlToImage": "https://www.ozarksfirst.com/wp-content/uploads/sites/65/2021/12/ModernaPfizerGettyImages-1234603091.jpg?w=1280", "publishedAt": "2021-12-04T17:26:18Z", "content": "(NEXSTAR) A head-to-head study of the Moderna and Pfizer vaccines has determined the former to be slightly more effective against COVID-19, at least as far as the alpha and delta variants are concern\u2026 [+1852 chars]"}]}, "2022-01-18": {"status": "ok", "totalResults": 8, "articles": [{"source": {"id": null, "name": "Skift"}, "author": "Skift", "title": "Too Early to Tell if Pfizer Job Cuts Tied to More Virtual Meetings Will Be a Trend", "description": "The vaccine maker\u2019s decision to axe client-facing sales roles, and increase the number of virtual meetings it has with customers, shouldn\u2019t ring alarm bells among the travel industry just yet.\n-Matthew Parsons", "url": "https://skift.com/2022/01/18/too-early-to-tell-if-pfizer-job-cuts-tied-to-more-virtual-meetings-will-be-a-trend/", "urlToImage": "https://skift.com/wp-content/uploads/2022/01/Vaccination-station-Russ-Allison-Loar-Flickr.jpg", "publishedAt": "2022-01-18T13:15:00Z", "content": "Pfizers long-term virtual meetings push has not come as a shock to the corporate travel sector experts have said it could be unique to the pharmaceutical sector, rather signaling a major shift in the\u2026 [+4347 chars]"}, {"source": {"id": "rt", "name": "RT"}, "author": "RT", "title": "Israel finds 4 Pfizer jabs \u2018not good enough\u2019 against Omicron", "description": "A fourth dose of Pfizer\u2019s coronavirus vaccine showed dwindling effectiveness against the Omicron variant, according to a trial conducted in Israel, with one its lead researchers saying the immunization is simply \u201cnot good enough.\u201d Read Full Article at RT.com", "url": "https://www.rt.com/news/546337-pfizer-omicron-booster-trial/", "urlToImage": "https://cdni.rt.com/files/2022.01/article/61e614c985f5407fd4540e08.jpg", "publishedAt": "2022-01-18T01:22:41Z", "content": "A fourth dose of Pfizers coronavirus vaccine showed dwindling effectiveness against the Omicron variant, according to a trial conducted in Israel, with one its lead researchers saying the immunizatio\u2026 [+2484 chars]"}, {"source": {"id": null, "name": "Boston Herald"}, "author": "Boston Herald Wire Services", "title": "Ticker: Canada approves Pfizer COVID drug; Budget writers set revenue estimate", "description": "Canada's health regulator has approved a pill by Pfizer that treats the effects of COVID-19.", "url": "https://www.bostonherald.com/2022/01/17/ticker-canada-approves-pfizer-covid-drug-budget-writers-set-revenue-estimate/", "urlToImage": "https://www.bostonherald.com/wp-content/uploads/2022/01/AP21355638155362.jpg?w=1024&h=682", "publishedAt": "2022-01-18T00:18:34Z", "content": "Canada\u2019s health regulator has approved a pill by Pfizer that treats the effects of COVID-19.\r\nHealth Canada authorized Paxlovid for adult patients with mild or moderate COVID-19 who are also at high \u2026 [+1484 chars]"}, {"source": {"id": null, "name": "Mercola.com"}, "author": "communities@mercola.com (Dr. Joseph Mercola)", "title": "Pfizer to Roll Out Omicron Shot in March", "description": "While a third COVID booster shot started rolling out in late September 2021,1 and people have been bullied into getting it, that booster is no different from the first two doses. It's not specific against Omicron, which is rapidly overtaking other variants an\u2026", "url": "https://articles.mercola.com/sites/articles/archive/2022/01/18/omicron-vaccine.aspx", "urlToImage": "https://media.mercola.com/ImageServer/Public/2022/January/FB/omicron-vaccine-fb.jpg", "publishedAt": "2022-01-18T00:00:00Z", "content": "Mercola proudly supports these charities and organizations. View All \r\nDisclaimer: The entire contents of this website are based upon the opinions of Dr. Mercola, unless otherwise noted. Individual a\u2026 [+1007 chars]"}, {"source": {"id": null, "name": "Zerohedge.com"}, "author": "Mike Rivero", "title": "Pfizer CEO Predicts Life On Earth \"Will Return To Normal\" In The Spring", "description": "Just a few days ago, Bill Gates shared some of his (revised) thoughts on the COVID pandemic and the trajectory that omicron has left us on. Several weeks after warning that omicron's heightened infectiousness might send the pandemic into overdrive, the Micros\u2026", "url": "https://www.zerohedge.com/covid-19/pfizer-ceo-predicts-life-earth-will-return-normal-spring", "urlToImage": "https://assets.zerohedge.com/s3fs-public/styles/16_9_max_700/public/2022-01/bourla.jpg?itok=faG0GIx9", "publishedAt": "2022-01-18T13:22:05Z", "content": "Just a few days ago, Bill Gates shared some of his (revised) thoughts on the COVID pandemic and the trajectory that omicron has left us on. Several weeks after warning that omicron's heightened infec\u2026 [+3121 chars]"}, {"source": {"id": null, "name": "National Observer"}, "author": "Mia Rabson", "title": "Pfizer antiviral approved in Canada but supply issues are expected", "description": "Health Canada approved Pfizer's antiviral treatment for COVID-19 on Monday, January 17, 2022, which could help cut pressure on the health-care system by preventing high-risk patients from ending up in the hospital.", "url": "https://www.nationalobserver.com/2022/01/18/news/pfizer-antiviral-approved-canada-supply-issues-expected", "urlToImage": "https://www.nationalobserver.com/sites/nationalobserver.com/files/img/2022/01/18/2022011710018-61e586f4ec217c9ccd0a91b9jpeg.jpg", "publishedAt": "2022-01-18T14:05:01Z", "content": "Health Canada approved Pfizer's antiviral treatment for COVID-19 Monday which could help cut pressure on the health-care system by preventing high-risk patients from ending up in the hospital.\r\nBut l\u2026 [+4758 chars]"}, {"source": {"id": "bloomberg", "name": "Bloomberg"}, "author": "Farah Elbahrawy", "title": "Stock Markets Today: Treasuries, oil rises, Johnson, Pfizer and omicron - Bloomberg", "description": "Stock Markets Today: Treasuries, oil rises, Johnson, Pfizer and omicron\u00a0\u00a0Bloomberg", "url": "https://www.bloomberg.com/news/newsletters/2022-01-18/stock-markets-today-treasuries-oil-rises-johnson-pfizer-and-omicron", "urlToImage": "https://assets.bwbx.io/images/users/iqjWHBFdfxIU/iMKPFThj7Jjg/v0/1200x899.jpg", "publishedAt": "2022-01-18T06:19:00Z", "content": "Good morning. Treasuries extend losses, Brent is at the highest since 2014, Cummings accuses Johnson of\u00a0lying to Parliament and four Pfizer shots are insufficient against omicron spread. Heres whats \u2026 [+4232 chars]"}, {"source": {"id": null, "name": "Euronews"}, "author": "Tom Bateman", "title": "Seasonal COVID and flu booster vaccines will become the norm after Omicron, say Moderna and Pfizer", "description": "Vaccine maker Moderna predicted that its seasonal COVID and flu boosters would be available in some countries within the next two years.", "url": "https://www.euronews.com/next/2022/01/18/seasonal-covid-and-flu-booster-vaccines-will-become-the-norm-after-omicron-say-moderna-and", "urlToImage": "https://static.euronews.com/articles/stories/06/38/98/78/1000x563_cmsv2_ec636300-8fa4-5af4-a18d-6f44e5f5defa-6389878.jpg", "publishedAt": "2022-01-18T10:45:00Z", "content": "COVID-19 vaccines will be here for the long-term, and could become part of the annual range of booster shots offered, leading vaccine makers predicted on Monday.\r\nCOVID-19 mRNA vaccine manufacturers \u2026 [+1838 chars]"}]}, "2022-01-17": {"status": "ok", "totalResults": 43, "articles": [{"source": {"id": null, "name": "Blogspot.com"}, "author": "noreply@blogger.com (Unknown)", "title": "Pfizer CEO: Virus will be here for years but this may be last wave with restrictions", "description": "<table><tr><td></td></tr><tr><td>Pfizer CEO Albert Bourla speaks during a ceremony in Thessaloniki, Greece, on October 12, 2021. (AP Photo/Giannis Papanikos, File)</td></tr>\r\n</table>Pfizer CEO Albert Bourla said on Monday that while the \"most likely scenario\u2026", "url": "https://techncruncher.blogspot.com/2022/01/pfizer-ceo-virus-will-be-here-for-years.html", "urlToImage": "https://blogger.googleusercontent.com/img/a/AVvXsEgUefMIyfEcwpuSCNpU86bk5fTPur3_mU3uNNiZ2vhxIp1MeFV1evQxacQdJue9uBaqPlGInuhvR3is7Pza8vpXaGQ40suLvVxg4YXlSBLqBLlXNrwg1hXBNXMFBLjud5lA7ePKN1EhFJigxWqTEYuEIO71eQEiJS_Bp3C75anrIc5w6e93l9lgCIVnAA=w1200-h630-p-k-no-nu", "publishedAt": "2022-01-17T12:33:00Z", "content": "Pfizer CEO Albert Bourla said on Monday that while the \"most likely scenario\" is that the coronavirus will circulate for many years, he believes the current wave of infections will be the last to req\u2026 [+1964 chars]"}, {"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "Pfizer to boost COVID-19 pill production with French deal - Reuters", "description": "Pfizer <a href=\"https://www.reuters.com/companies/PFE.N\" target=\"_blank\">(PFE.N)</a> will add a production facility for its antiviral COVID-19 pill in France as part of a plan to invest 520 million euros ($594 million) in the country over the next five years,\u2026", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-boost-covid-19-pill-production-with-french-deal-2022-01-17/", "urlToImage": "https://www.reuters.com/resizer/6ajCUtrS6UDOyJ4bG5tJuu6YRLg=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/QDROFKF225L55I36I7TMPUEFZA.jpg", "publishedAt": "2022-01-17T11:27:00Z", "content": "PARIS, Jan 17 (Reuters) - Pfizer (PFE.N) will add a production facility for its antiviral COVID-19 pill in France as part of a plan to invest 520 million euros ($594 million) in the country over the \u2026 [+1922 chars]"}, {"source": {"id": null, "name": "Novascotia.ca"}, "author": "Communications Nova Scotia", "title": "COVID-19 Boosters for Nova Scotians 18 and Older; More Pfizer Appointments Added - Government of Nova Scotia", "description": "<ol><li>COVID-19 Boosters for Nova Scotians 18 and Older; More Pfizer Appointments Added\u00a0\u00a0Government of Nova Scotia\r\n</li><li>Nova Scotia opens up COVID-19 vaccine booster doses to 18+\u00a0\u00a0CBC.ca\r\n</li><li>Nova Scotia opens COVID-19 booster appointments for peop\u2026", "url": "https://novascotia.ca/news/release/?id=20220117001", "urlToImage": null, "publishedAt": "2022-01-17T13:59:00Z", "content": "The Province has expanded eligibility for COVID-19 booster doses to include anyone 18 years of age and older. \r\nBooster doses are administered at least 168 days after the primary series. People who r\u2026 [+1401 chars]"}, {"source": {"id": "bloomberg", "name": "Bloomberg"}, "author": "Marthe Fourcade", "title": "Pfizer CEO Sees Return to Normal Life 'Soon'", "description": "Life may soon return to normal after two years of pandemic disruption, Pfizer Inc.\u2019s chief executive officer said in an interview with Le Figaro.", "url": "https://www.bloomberg.com/news/articles/2022-01-17/pfizer-s-bourla-sees-return-to-normal-life-in-figaro-interview", "urlToImage": "https://assets.bwbx.io/images/users/iqjWHBFdfxIU/iP4HakVYC8lU/v0/1200x800.jpg", "publishedAt": "2022-01-17T10:50:53Z", "content": "Life may soon return to normal after two years of pandemic disruption, \r\nPfizer Inc.s chief executive officer said in an interview with Le Figaro.\u00a0\r\nWe will soon be able to resume a normal life, Albe\u2026 [+205 chars]"}, {"source": {"id": null, "name": "New York Times"}, "author": "Michael J. de la Merced", "title": "Unilever in Takeover Fight for Glaxo and Pfizer Consumer Health Business", "description": "Rejected three times, Unilever suggests it will keep fighting to acquire a giant in the world of pain relievers, toothpastes and cold treatments.", "url": "https://www.nytimes.com/2022/01/17/business/dealbook/unilever-glaxo-health-takeover.html", "urlToImage": "https://static01.nyt.com/images/2022/01/17/business/17db-unilever/17db-unilever-facebookJumbo.jpg", "publishedAt": "2022-01-17T16:53:24Z", "content": "A spokeswoman for Elliott declined to comment on Unilevers takeover effort.\r\nIt is unclear whether others will make offers for the joint venture, though the prospect of a bidding war pushed shares in\u2026 [+1485 chars]"}, {"source": {"id": "bloomberg", "name": "Bloomberg"}, "author": "Daniel Avis", "title": "Fourth Pfizer Dose Is Insufficient to Ward Off Omicron, Israeli Trial Suggests", "description": "A fourth dose of the Pfizer-BioNTech vaccine was insufficient to prevent infection with the omicron variant of Covid-19, according to preliminary data from a trial in Israel released Monday.", "url": "https://www.bloomberg.com/news/articles/2022-01-17/israel-trial-suggests-4th-dose-not-warding-off-omicron-infection", "urlToImage": "https://assets.bwbx.io/images/users/iqjWHBFdfxIU/i2lOXtz3iknU/v1/1200x800.jpg", "publishedAt": "2022-01-17T17:48:27Z", "content": "A fourth dose of the Pfizer-BioNTech vaccine was insufficient to prevent infection with the omicron variant of Covid-19, according to preliminary data from a trial in Israel released Monday.\r\nTwo wee\u2026 [+163 chars]"}, {"source": {"id": "the-times-of-india", "name": "The Times of India"}, "author": "AFP", "title": "Unilever still eyes GSK-Pfizer unit after \u00a350 bn bid rebuffed", "description": "GSK said on Saturday that it had received three unsolicited offers from Unilever for GSK Consumer Healthcare, but they were all rejected as the company said the unit was undervalued.", "url": "https://economictimes.indiatimes.com/news/international/business/unilever-still-eyes-gsk-pfizer-unit-after-50-bn-bid-rebuffed/articleshow/88948502.cms", "urlToImage": "https://img.etimg.com/thumb/msid-88948579,width-1070,height-580,imgsize-115732,overlay-economictimes/photo.jpg", "publishedAt": "2022-01-17T08:28:40Z", "content": "Consumer goods giant on Monday revealed ongoing interest in a consumer health care unit jointly owned with pharmaceutical groups GlaxoSmithKline and after a bid of \u00a350 billion ($68 billion) was refus\u2026 [+819 chars]"}, {"source": {"id": null, "name": "New York Times"}, "author": "Michael J. de la Merced", "title": "Unilever Pursues Glaxo and Pfizer Consumer Health Venture", "description": "Rejected three times, Unilever suggests it will keep fighting to acquire a giant in the world of pain relievers, toothpastes and cold treatments.", "url": "https://www.nytimes.com/2022/01/17/business/dealbook/unilever-glaxo-pfizer.html", "urlToImage": "https://static01.nyt.com/images/2022/01/17/business/17db-unilever/17db-unilever-facebookJumbo.jpg", "publishedAt": "2022-01-17T17:10:52Z", "content": "A spokeswoman for Elliott declined to comment on Unilevers takeover effort.\r\nIt is unclear whether others will make offers for the joint venture, though the prospect of a bidding war pushed shares in\u2026 [+1486 chars]"}, {"source": {"id": null, "name": "Fox Business"}, "author": "Edmund DeMarche", "title": "COVID-19: Pfizer head sees a return to \u2018normal life\u2019 in the spring - Fox Business", "description": "Albert Bourla, the CEO of Pfizer, said in an interview published late Sunday that he believes there will be a \u201creturn to normal life\u201d sometime in the spring after over two years of dealing with the COVID-19 pandemic, according to a report.", "url": "https://www.foxbusiness.com/economy/covid-19-pfizer-head-sees-a-return-to-normal-life-in-the-spring", "urlToImage": "https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2022/01/0/0/pfizer.jpg?ve=1&tl=1", "publishedAt": "2022-01-17T10:26:48Z", "content": "Albert Bourla, the CEO of Pfizer, said in an interview published late Sunday that he believes there will be a \"return to normal life\" sometime in the spring after over two years of dealing with the C\u2026 [+1577 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "AFP", "title": "Unilever pursues GSK-Pfizer unit after huge bid rebuffed", "description": "Consumer goods giant Unilever on Monday revealed ongoing interest in a consumer health care unit owned by pharmaceutical groups GlaxoSmithKline and Pfizer...", "url": "https://news.yahoo.com/unilever-pursues-gsk-pfizer-unit-083706528.html", "urlToImage": "https://s.yimg.com/uu/api/res/1.2/YIPjonJRHR4BM9EaDqKS0g--~B/aD01MTI7dz03Njg7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/afp.com/c59190ee43a2fdeb907811a50d7a6bed", "publishedAt": "2022-01-17T08:37:06Z", "content": "Consumer goods giant Unilever on Monday revealed ongoing interest in a consumer health care unit owned by pharmaceutical groups GlaxoSmithKline and Pfizer after a bid of \u00a350 billion ($68 billion) was\u2026 [+2647 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "Reuters", "title": "Pfizer to boost COVID-19 pill production with French deal", "description": "Pfizer will add a production facility for its antiviral COVID-19 pill in France as part of a plan to invest 520 million euros ($594 million) in the country...", "url": "https://news.yahoo.com/pfizer-boost-covid-19-pill-112759669.html", "urlToImage": "https://s.yimg.com/uu/api/res/1.2/jfo2tFnzN95V7bw6CoT2Fg--~B/aD01MzQ7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/8edd0b981703546334fe533cd39cd71f", "publishedAt": "2022-01-17T11:27:59Z", "content": "PARIS (Reuters) - Pfizer will add a production facility for its antiviral COVID-19 pill in France as part of a plan to invest 520 million euros ($594 million) in the country over the next five years,\u2026 [+1744 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "CNW Group", "title": "Pfizer Receives Health Canada Authorization for COVID-19 Oral Treatment", "description": "Pfizer Canada announced today that Health Canada has authorized the use of PAXLOVID\u2122 (nirmatrelvir tablets and ritonavir tablets) for the treatment of mild...", "url": "https://finance.yahoo.com/news/pfizer-receives-health-canada-authorization-154500968.html", "urlToImage": "https://s.yimg.com/uu/api/res/1.2/vZWAXBOGGfhOVeSeBeDH5Q--~B/aD0xNjU7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/cnwgroup.com/381a26cb604bebf7fc7ccfc7b2b0fdf2", "publishedAt": "2022-01-17T15:45:00Z", "content": "<ul><li>PAXLOVID (nirmatrelvir tablets and ritonavir tablets) is authorized for use in high-risk adults (18 years of age and older)\r\n</li><li>Pfizer is ready to start immediate delivery in Canada, in\u2026 [+3714 chars]"}, {"source": {"id": null, "name": "The Boston Globe"}, "author": "The Associated Press", "title": "Pfizer COVID-19 drug approved by Canada", "description": "Canada\u2019s health regulator has approved Paxlovid, a pill by Pfizer that treats the effects of COVID-19.", "url": "https://www.bostonglobe.com/2022/01/17/world/pfizer-covid-19-drug-approved-by-canada/", "urlToImage": "https://bostonglobe-prod.cdn.arcpublishing.com/resizer/rnkNIgKYYkXBTAB1Ifs6ZpmHkvc=/506x0/cloudfront-us-east-1.images.arcpublishing.com/bostonglobe/WF3ODKIQSQ5IXS5D5YFHEDWX4M.jpg", "publishedAt": "2022-01-17T18:35:29Z", "content": "Late last month, US health regulators authorized the pill that patients will be able to take at home to ward off the worst effects of the virus. At the time, Pfizer said it had 180,000 treatment cour\u2026 [+816 chars]"}, {"source": {"id": null, "name": "Japan Today"}, "author": null, "title": "Canada approves Pfizer COVID drug", "description": "Canada\u2019s health regulator has approved a pill by Pfizer that treats the effects of COVID-19.  Health Canada authorized Paxlovid for adult patients with mild or moderate COVID-19 who are also at high risk of becoming more seriously ill. Health Canada did not a\u2026", "url": "https://japantoday.com/category/world/canada-approves-pfizer-covid-drug", "urlToImage": null, "publishedAt": "2022-01-17T21:58:58Z", "content": "Canadas health regulator has approved a pill by Pfizer that treats the effects of COVID-19. \r\nHealth Canada authorized Paxlovid for adult patients with mild or moderate COVID-19 who are also at high \u2026 [+1448 chars]"}, {"source": {"id": null, "name": "The Boston Globe"}, "author": "Daniel Avis", "title": "Fourth Pfizer dose is insufficient to ward off Omicron, Israeli trial suggests", "description": "Israel started rolling out the fourth dose of the vaccine to those over 60 and the immunocompromised in late December amid a surge in cases.", "url": "https://www.bostonglobe.com/2022/01/17/nation/fourth-pfizer-dose-is-insufficient-ward-off-omicron-israeli-trial-suggests/", "urlToImage": "https://bostonglobe-prod.cdn.arcpublishing.com/resizer/LveUmq78BKVp4xL1wg9LiYUx8wk=/506x0/cloudfront-us-east-1.images.arcpublishing.com/bostonglobe/ZJTBMMOAQEBX23JLSXOE3BD2MY.jpg", "publishedAt": "2022-01-17T22:07:14Z", "content": "A fourth dose of the Pfizer-BioNTech vaccine was insufficient to prevent infection with the omicron variant of COVID-19, according to preliminary data from a trial in Israel released Monday.\r\nTwo wee\u2026 [+1311 chars]"}, {"source": {"id": "abc-news", "name": "ABC News"}, "author": "The Associated Press", "title": "Canada approves Pfizer COVID drug", "description": "Canada\u2019s health regulator has approved a pill by Pfizer that treats the effects of COVID-19", "url": "https://abcnews.go.com/International/wireStory/canada-approves-pfizer-covid-drug-82311737", "urlToImage": "https://s.abcnews.com/images/GMA/220117_gma_ramos_hpMain_16x9_992.jpg", "publishedAt": "2022-01-17T18:21:06Z", "content": "TORONTO -- Canadas health regulator has approved a pill by Pfizer that treats the effects of COVID-19.\r\nHealth Canada authorized Paxlovid for adult patients with mild or moderate COVID-19 who are als\u2026 [+1302 chars]"}, {"source": {"id": null, "name": "Rumble.com"}, "author": "Mike Rivero", "title": "PFIZER ADMITS VACCINES DON'T WORK IN STUNNING INTERVIEW", "description": "!function(r,u,m,b,l,e){r._Rumble=b,r[b]||(r[b]=function(){(r[b]._=r[b]._||[]).push(arguments);if(r[b]._.length==1){l=u.createElement(m),e=u.getElementsByTagName(m)[0],l.async=1,l.src=\"https://rumble.com/embedJS/u4\"+(arguments[1].video?'.'+arguments[1].video:'\u2026", "url": "https://rumble.com/vsopes-pfizer-admits-vaccines-dont-work-in-stunning-interview.html", "urlToImage": "https://sp.rmbl.ws/s8/1/K/k/Z/3/KkZ3c.qR4e-small-PFIZER-ADMITS-VACCINES-DONT.jpg", "publishedAt": "2022-01-17T20:13:25Z", "content": "Copyright \u00a9 2022 Rumble. All Rights Reserved."}, {"source": {"id": null, "name": "Slashdot.org"}, "author": "BeauHD", "title": "Fourth Pfizer Dose Is Insufficient to Ward Off Omicron, Israeli Trial Suggests", "description": "A fourth dose of the Pfizer-BioNTech vaccine was insufficient to prevent infection with the omicron variant of Covid-19, according to preliminary data from a trial in Israel released Monday. Bloomberg reports: Two weeks after the start of the trial of 154 med\u2026", "url": "https://science.slashdot.org/story/22/01/17/213242/fourth-pfizer-dose-is-insufficient-to-ward-off-omicron-israeli-trial-suggests", "urlToImage": "https://a.fsdn.com/sd/topics/medicine_64.png?refresh=now", "publishedAt": "2022-01-17T22:40:00Z", "content": "Two weeks after the start of the trial of 154 medical personnel at the Sheba Medical Center in Tel Aviv, researchers found the vaccine successfully raised antibody levels. But that only offered a par\u2026 [+794 chars]"}, {"source": {"id": null, "name": "Mercola.com"}, "author": "communities@mercola.com (Dr. Joseph Mercola)", "title": "Pfizer to Roll Out Omicron Shot in March", "description": "While a third COVID booster shot started rolling out in late September 2021,1 and people have been bullied into getting it, that booster is no different from the first two doses. It's not specific against Omicron, which is rapidly overtaking other variants an\u2026", "url": "https://articles.mercola.com/sites/articles/archive/2022/01/18/omicron-vaccine.aspx", "urlToImage": "https://media.mercola.com/ImageServer/Public/2022/January/FB/omicron-vaccine-fb.jpg", "publishedAt": "2022-01-18T00:00:00Z", "content": "Mercola proudly supports these charities and organizations. View All \r\nDisclaimer: The entire contents of this website are based upon the opinions of Dr. Mercola, unless otherwise noted. Individual a\u2026 [+1007 chars]"}, {"source": {"id": "news-com-au", "name": "News.com.au"}, "author": "Frank Chung", "title": "Booster vaccine: TGA confirms first cases of myocarditis, pericarditis after Pfizer, Moderna | news.com.au \u2014 Australia's leading news site - NEWS.com.au", "description": "<ol><li>Booster vaccine: TGA confirms first cases of myocarditis, pericarditis after Pfizer, Moderna | news.com.au \u2014 Australia's leading news site\u00a0\u00a0NEWS.com.au\r\n</li><li>Omicron: Three 'serious side effects' of the Covid booster \u2013 seek medical help 'urgently'\u2026", "url": "https://www.news.com.au/lifestyle/health/health-problems/tga-confirms-first-cases-of-myocarditis-linked-to-booster-shots/news-story/a0211e1242c66366e21d83a54aa7a298", "urlToImage": "https://content.api.news/v3/images/bin/4fec9f32c0b012a4394ee971b1965512", "publishedAt": "2022-01-17T01:43:48Z", "content": "Australias medicines regulator has confirmed the first cases of rare heart inflammation after booster vaccines.Australia\u2019s medicines regulator has confirmed the first cases of rare heart inflammation\u2026 [+6350 chars]"}]}, "2022-01-16": {"status": "ok", "totalResults": 3, "articles": [{"source": {"id": null, "name": "Thegatewaypundit.com"}, "author": "Jim Hoft", "title": "Autopsy Reveals Death of 26-Year-Old Man Who Developed Myocarditis was Due to Pfizer Vaccine", "description": "Joseph Keating, 26 years old from Dakota, died of myocarditis on Nov. 12, 2021 four days after receiving his third Pfizer shot. His family members said he was experiencing rare and mild symptoms including increased heart rate,\u00a0fatigue, muscle soreness. Accord\u2026", "url": "https://www.thegatewaypundit.com/2022/01/autopsy-reveals-death-26-year-old-man-developed-myocarditis-due-pfizer-vaccine/", "urlToImage": "https://www.thegatewaypundit.com/wp-content/uploads/E8821663-2034-48F8-B486-5D451E4C53B4.jpeg", "publishedAt": "2022-01-16T13:30:44Z", "content": "Joseph Keating, 26 years old from Dakota, died of myocarditis on Nov. 12, 2021 four days after receiving his third Pfizer shot.His family members said he was experiencing rare and mild symptoms inclu\u2026 [+3021 chars]"}, {"source": {"id": null, "name": "Lewrockwell.com"}, "author": "Llewellyn H. Rockwell, Jr.", "title": "Autopsy Confirms 26-Year-Old\u2019s Death From Myocarditis Directly Caused by Pfizer Covid Vaxx", "description": "Click Here: Children\u2019s Health Defense \u00a0\nThe post Autopsy Confirms 26-Year-Old\u2019s Death From Myocarditis Directly Caused by Pfizer Covid Vaxx appeared first on LewRockwell.", "url": "https://www.lewrockwell.com/lrc-blog/autopsy-confirms-26-year-olds-death-from-myocarditis-directly-caused-by-pfizer-covid-vaxx/", "urlToImage": "https://lrc-cdn.s3.amazonaws.com/assets/2021/02/LRC-share.jpg", "publishedAt": "2022-01-16T15:48:07Z", "content": "https://www.lewrockwell.com/lrc-blog/autopsy-confirms-26-year-olds-death-from-myocarditis-directly-caused-by-pfizer-covid-vaxx/\r\nTags:"}, {"source": {"id": null, "name": "Freerepublic.com"}, "author": "Semi-News/Semi-Satire", "title": "Pfizer CEO Admits Vaccine Is Failing [semi-satire]", "description": "Pfizer CEO Albert Bourla appeared in a video with Yahoo Finance's Anjalee Khemlani to discuss covid vaccines, boosters, and Omicron. During the discussion Bourla observed that \"we know that the two doses of the vaccine offer very limited protection, if any.\" \u2026", "url": "https://freerepublic.com/focus/f-bloggers/4030061/posts", "urlToImage": null, "publishedAt": "2022-01-16T18:48:05Z", "content": "Skip to comments.\r\nPfizer CEO Admits Vaccine Is Failing [semi-satire]Semi-News/Semi-Satire ^\r\n | 16 January 2022\r\n | John Semmens\r\nPosted on 01/16/2022 10:48:05 AM PST by John Semmens\r\nPfizer CEO Alb\u2026 [+4334 chars]"}]}, "2022-01-15": {"status": "ok", "totalResults": 6, "articles": [{"source": {"id": null, "name": "NBCSports.com"}, "author": "Mike Florio", "title": "Bart Scott tells Josh Allen to use Viagra to improve circulation; Pfizer advises otherwise", "description": "At a time when one specific Pfizer product has gotten the bulk of public attention, its signature blue pill has been mentioned a time or two in the past few days, as it relates to playing football in cold weather.ESPN\u2019s Bart Scott, a former NFL linebacker, re\u2026", "url": "https://profootballtalk.nbcsports.com/2022/01/15/bart-scott-tells-josh-allen-to-use-viagra-to-improve-circulation-pfizer-advises-otherwise/", "urlToImage": "https://profootballtalk.nbcsports.com/wp-content/uploads/sites/25/2022/01/GettyImages-544227235-e1642256190204.jpg", "publishedAt": "2022-01-15T14:20:01Z", "content": "At a time when one specific Pfizer product has gotten the bulk of public attention, its signature blue pill has been mentioned a time or two in the past few days, as it relates to playing football in\u2026 [+736 chars]"}, {"source": {"id": null, "name": "Lewrockwell.com"}, "author": "No Author", "title": "Before the Children of Pfizer", "description": "Warning: The following piece is about war crimes against children. As I have been saying privately for two years and writing publicly for a few months, we are in a Silent War. Western governments and their oligarch owners have declared war on free peoples and\u2026", "url": "https://www.lewrockwell.com/2022/01/no_author/before-the-children-of-pfizer/", "urlToImage": "https://lrc-cdn.s3.amazonaws.com/assets/2021/02/LRC-share.jpg", "publishedAt": "2022-01-15T04:01:00Z", "content": "Warning: The following piece is about war crimes against children.\r\nAs I have been saying privately for two years and writing publicly for a few months, we are in a Silent War. Western governments an\u2026 [+4182 chars]"}, {"source": {"id": null, "name": "Substack.com"}, "author": "Mike Rivero", "title": "What can a single catastrophic reaction tell us about the Pfizer vaccine?", "description": "So we cannot extrapolate from anecdotes. We cannot generalize from them. Nor can we conclude much from them at all. Right?\nActually, this is wrong, and I\u2019m going to show why in this post. In fact, a single case can do a lot more than people realize.\nFirst of \u2026", "url": "https://wearyprof.substack.com/p/what-can-a-single-catastrophic-reaction", "urlToImage": null, "publishedAt": "2022-01-15T14:02:01Z", "content": "It might seem axiomatic that we cant draw conclusions from one case. Single cases are nothing more than anecdotes, right? Anecdotes are selected from the wild, and they make it through the overwhelmi\u2026 [+4947 chars]"}, {"source": {"id": null, "name": "Freerepublic.com"}, "author": "National Catholic Register", "title": "Pfizer and the Vatican", "description": "Pfizer and the VaticanSources say Pope Francis met privately twice last year with Pfizer CEO Albert Bourla VATICAN CITY \u2014 The Register has learned that Pope Francis privately held undisclosed meetings with the CEO of Pfizer last year as questions arise over t\u2026", "url": "https://freerepublic.com/focus/f-religion/4029795/posts", "urlToImage": null, "publishedAt": "2022-01-15T17:26:30Z", "content": "Skip to comments.\r\nPfizer and the VaticanNational Catholic Register ^\r\n | January 15, 2022\r\n | Edward Pentin\r\nPosted on 01/15/2022 9:26:30 AM PST by ebb tide\r\nSources say Pope Francis met privately t\u2026 [+1762 chars]"}, {"source": {"id": null, "name": "Freerepublic.com"}, "author": "Gloria TV", "title": "Pfizer: Francis Held Two Secret Meetings", "description": "Pfizer: Francis Held Two Secret MeetingsFrancis held in 2021 two secret meetings with Albert Bourla, the Pfizer CEO, Edward Pentin learned (NcRegister.com, January 15).The Vatican has mandated Covid-vaccines, although they are inefficient in preventing the Co\u2026", "url": "https://freerepublic.com/focus/f-religion/4029789/posts", "urlToImage": null, "publishedAt": "2022-01-15T17:14:57Z", "content": "Skip to comments.\r\nPfizer: Francis Held Two Secret MeetingsGloria TV ^\r\n | January 15, 2022\r\n | Gloria TV\r\nPosted on 01/15/2022 9:14:57 AM PST by ebb tide\r\nFrancis held in 2021 two secret meetings wi\u2026 [+2378 chars]"}, {"source": {"id": null, "name": "Freerepublic.com"}, "author": "substack.com", "title": "What can a single catastrophic reaction tell us about the Pfizer vaccine?\nA lot more than you think...", "description": "It might seem axiomatic that we can\u2019t draw conclusions from one case. Single cases are nothing more than anecdotes, right? Anecdotes are selected from the wild, and they make it through the overwhelming din of informational noise because they:a) are sensation\u2026", "url": "https://freerepublic.com/focus/f-chat/4029684/posts", "urlToImage": null, "publishedAt": "2022-01-15T06:13:16Z", "content": "It might seem axiomatic that we cant draw conclusions from one case. Single cases are nothing more than anecdotes, right? Anecdotes are selected from the wild, and they make it through the overwhelmi\u2026 [+4929 chars]"}]}, "2022-01-14": {"status": "ok", "totalResults": 16, "articles": [{"source": {"id": null, "name": "Globalresearch.ca"}, "author": "Dr. Gary G. Kohls", "title": "Why Pfizer Can Never be Trusted. Lawsuits Relating to 16 Pfizer Drugs", "description": "All Global Research articles\u00a0can be read in 51 languages by activating the \u201cTranslate Website\u201d\u00a0drop down menu on the top banner of our home page (Desktop version).\nTo receive Global Research\u2019s Daily Newsletter (selected articles),\u00a0click here.\nVisit \u2026\nThe post\u2026", "url": "https://www.globalresearch.ca/why-pfizer-can-never-trusted/5767125", "urlToImage": "https://www.globalresearch.ca/wp-content/uploads/2021/09/pfizer_0.jpg", "publishedAt": "2022-01-14T15:35:12Z", "content": "All Global Research articles\u00a0can be read in 51 languages by activating the Translate Website\u00a0drop down menu on the top banner of our home page (Desktop version).\r\nTo receive Global Researchs Daily Ne\u2026 [+9326 chars]"}, {"source": {"id": null, "name": "Japan Today"}, "author": null, "title": "Pfizer seeks approval for oral COVID-19 pill in Japan", "description": "Pfizer Japan Inc said Friday it has applied to the Japanese health ministry for approval of its COVID-19 pill which, if granted, would make it the second oral drug for mild coronavirus cases available in the country. The new drug application for Paxlovid, a c\u2026", "url": "https://japantoday.com/category/national/pfizer-seeks-approval-for-oral-covid-19-pill-in-japan", "urlToImage": null, "publishedAt": "2022-01-14T21:27:37Z", "content": "Pfizer Japan Inc said Friday it has applied to the Japanese health ministry for approval of its COVID-19 pill which, if granted, would make it the second oral drug for mild coronavirus cases availabl\u2026 [+1396 chars]"}, {"source": {"id": null, "name": "Globalresearch.ca"}, "author": "Corey Lynn", "title": "Pfizer/FDA Corruption, Lethal Batches, and Autopsies Reveal COVID-19 Jab Genocide", "description": "All Global Research articles\u00a0can be read in 51 languages by activating the \u201cTranslate Website\u201d\u00a0drop down menu on the top banner of our home page (Desktop version).\nTo receive Global Research\u2019s Daily Newsletter (selected articles),\u00a0click here.\nVisit \u2026\nThe post\u2026", "url": "https://www.globalresearch.ca/pfizer-fda-corruption-lethal-batches-autopsies-reveal-covid-19-jab-genocide/5767123", "urlToImage": "https://www.globalresearch.ca/wp-content/uploads/2021/12/pfizer-covid-19.jpg", "publishedAt": "2022-01-14T15:41:29Z", "content": "All Global Research articles\u00a0can be read in 51 languages by activating the Translate Website\u00a0drop down menu on the top banner of our home page (Desktop version).\r\nTo receive Global Researchs Daily Ne\u2026 [+21325 chars]"}, {"source": {"id": null, "name": "Seeking Alpha"}, "author": "Dulan Lokuwithana", "title": "Pfizer granted FDA approval for CIBINQO in atopic dermatitis", "description": "Pfizer (PFE) announced the FDA approval of its Janus kinase 1 (JAK1) inhibitor CIBINQO (abrocitinib) as a treatment for adults with refractory, moderate-to-severe atopic...", "url": "https://seekingalpha.com/news/3788420-pfizer-granted-fda-approval-for-cibinqo-in-atopic-dermatitis", "urlToImage": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1227739745/medium_image_1227739745.jpg", "publishedAt": "2022-01-14T21:14:03Z", "content": "Jeenah Moon/Getty Images News"}, {"source": {"id": null, "name": "Womensystems.com"}, "author": "mayaleo", "title": "Investigation Launched After 13-Year-Old Brazilian Girl Dies \u2013 Mother Blames Pfizer Vaccine", "description": "Women Entertainment Sysytem", "url": "http://www.womensystems.com/2022/01/investigation-launched-after-13-year.html", "urlToImage": "https://lh3.googleusercontent.com/proxy/BvtUSL_g71wIK4sS9-LX-Lh1w27VnEwqKPHsfP1Jgv2Vd4atTZvjzm80_E2RptPl-u_rA6a_mzR6D1gXhonMBiCRh4B7OzAU1EmetGP5gew-r8faCbcjhcQKgJWg3WNhV83Pr50SFR6HHRh3ygUsLM3W_dHxEL3K=w1200-h630-p-k-no-nu", "publishedAt": "2022-01-14T16:29:03Z", "content": "Vanessa Martins Figueiredo, 13 years old from\u00a0Ararangu\u00e1, Brazil, died last Monday reportedly due to the Pfizer vaccine complications.\r\nVanessa received her first dose of Pfizer vaccine last November \u2026 [+3305 chars]"}, {"source": {"id": null, "name": "Lifesite"}, "author": "Mike Rivero", "title": "\u2018No words can describe the pain\u2019: Mom shares how 5 days after second Pfizer shot, her baby died", "description": "An Australian mother shared this month that five days after she received a second dose of the Pfizer shot her full-term unborn baby girl died from a brain hemorrhage.\nStephanie Whitmore said she is sharing her story because she \u201cwas all for\u201d the COVID shot, b\u2026", "url": "https://www.lifesitenews.com/news/no-words-can-describe-the-pain-mom-shares-how-5-days-after-second-pfizer-shot-her-baby-died/", "urlToImage": "https://www.lifesitenews.com/wp-content/uploads/2022/01/image-2-1.jpg", "publishedAt": "2022-01-14T14:52:40Z", "content": "(LifeSiteNews) \u00a0An Australian mother shared this month that five days after she received a second dose of the Pfizer shot her full-term unborn baby girl died from a brain hemorrhage.\r\nStephanie Whitm\u2026 [+4011 chars]"}, {"source": {"id": null, "name": "Daily Mail"}, "author": "Mansur Shaheen U.S.", "title": "CDC reduces recommended time between second shot of Pfizer vaccine and booster from to five months", "description": "The CDC has dropped the recommended time between receiving the second dose of the Pfizer vaccine and receiving the booster shot from six months to five months in the wake of Omicron.", "url": "https://www.dailymail.co.uk/health/article-10403775/CDC-reduces-recommended-time-second-shot-Pfizer-vaccine-booster-five-months.html", "urlToImage": "https://i.dailymail.co.uk/1s/2022/01/14/19/52941705-0-image-a-79_1642189231973.jpg", "publishedAt": "2022-01-14T19:51:50Z", "content": "The Centers for Disease Control and Prevention (CDC) has cut the recommended time between receival of the second shot of the Pfizer-BioNTech Covid vaccine and a booster shot to five months, down from\u2026 [+4304 chars]"}, {"source": {"id": null, "name": "Freerepublic.com"}, "author": "NewsBusters", "title": "Reuters \u2018Fact Check\u2019 Shields Pfizer CEO, Fails to Disclose Reuters Chairman Is on Pfizer Board", "description": "Reuters rushed to spin Pfizer CEO Albert Bourla\u2019s recent comments on his company\u2019s vaccine in a so-called \u201cFact Check\u201d and failed to disclose that a senior executive in the Reuters apparatus happens to sit on Pfizer\u2019s board of directors. Reuters attempted to \u2026", "url": "https://freerepublic.com/focus/f-bloggers/4029574/posts", "urlToImage": null, "publishedAt": "2022-01-14T21:54:51Z", "content": "Skip to comments.\r\nReuters Fact Check Shields Pfizer CEO, Fails to Disclose Reuters Chairman Is on Pfizer BoardNewsBusters ^\r\n | 1/14/2022\r\n | Joseph Vazquez\r\nPosted on 01/14/2022 1:54:51 PM PST by J\u2026 [+2652 chars]"}, {"source": {"id": null, "name": "The Japan Times"}, "author": null, "title": "Pfizer seeks approval for oral COVID-19 pill in Japan", "description": "The country has already agreeing to procure enough of the drug, Paxlovid, for 2 million people", "url": "https://www.japantimes.co.jp/news/2022/01/14/national/pfizer-oral-drug-approval/", "urlToImage": "https://cdn-japantimes.com/wp-content/uploads/2022/01/np_file_135177-870x489.jpeg", "publishedAt": "2022-01-14T06:11:45Z", "content": "Pfizer Japan Inc. said Friday it has applied to the health ministry for approval of its COVID-19 pill which, if granted, would make it the second oral drug for mild coronavirus cases available in the\u2026 [+1407 chars]"}, {"source": {"id": null, "name": "Freerepublic.com"}, "author": "The National Catholic Register", "title": "Cardinal Parolin Appears to Deny Conscience Right Exemption from Vatican\u2019s Pfizer Vaccine", "description": "Responding to a query about his Dec. 23 ruling mandating vaccination for all Vatican employees and visitors who haven\u2019t recently recovered from COVID-19, the Vatican secretary of state indicated religious exemptions are not \u2018justified\u2019 with respect to mRNA va\u2026", "url": "https://freerepublic.com/focus/f-religion/4029342/posts", "urlToImage": null, "publishedAt": "2022-01-14T03:00:51Z", "content": "Skip to comments.\r\nCardinal Parolin Appears to Deny Conscience Right Exemption from Vaticans Pfizer VaccineThe National Catholic Register ^\r\n | 1/11/22\r\n | Ed Pentin\r\nPosted on 01/13/2022 7:00:51 PM \u2026 [+2501 chars]"}, {"source": {"id": null, "name": "National Observer"}, "author": "Mia Rabson", "title": "Health Canada to rule on Pfizer COVID treatment drug within two weeks", "description": "Health Canada should be ready to make an authorization decision about Pfizer's Paxlovid antiviral treatment for COVID-19 in a week to 10 days, chief medical adviser Dr. Supriya Sharma said on Thursday, January 13, 2022.", "url": "https://www.nationalobserver.com/2022/01/14/news/health-canada-rule-pfizer-covid-treatment-drug", "urlToImage": "https://www.nationalobserver.com/sites/nationalobserver.com/files/img/2022/01/14/20220113110144-61e056d6b5a7443ec1494ef7jpeg.jpg", "publishedAt": "2022-01-14T14:00:18Z", "content": "Health Canada should be ready to make an authorization decision about Pfizer's Paxlovid antiviral treatment for COVID-19 in a week to 10 days, chief medical adviser Dr. Supriya Sharma said Thursday.\r\u2026 [+4410 chars]"}, {"source": {"id": null, "name": "PRNewswire"}, "author": null, "title": "Thinking about trading options or stock in Wynn Resorts, Tesla, American Airlines, Coca-Cola, or Pfizer?", "description": "NEW YORK, Jan. 14, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for WYNN, TSLA, AAL, KO, and PFE. Click a link below then choose between in-depth options trade idea report or a stock score report. Options Report \u2013 Ideal trade ideas\u2026", "url": "https://www.prnewswire.com/news-releases/thinking-about-trading-options-or-stock-in-wynn-resorts-tesla-american-airlines-coca-cola-or-pfizer-301461252.html", "urlToImage": "https://mma.prnewswire.com/media/1333368/InvestorsObserver_Logo.jpg?p=facebook", "publishedAt": "2022-01-14T14:31:00Z", "content": "NEW YORK, Jan. 14, 2022 /PRNewswire/ --\u00a0InvestorsObserver\u00a0issues critical PriceWatch Alerts for WYNN, TSLA, AAL, KO, and PFE.\r\nClick a link below then choose between in-depth options trade idea repor\u2026 [+796 chars]"}, {"source": {"id": null, "name": "Freerepublic.com"}, "author": "Babylon Bee", "title": "Pfizer CEO Condemns SCOTUS Ruling As A \u2018Clear Violation Of Our Constitutional Right To Produce Experimental Drugs And Use The Full Power Of Government To Force The Entire Population To Inject Them Into Their Bodies\u2019", "description": "NEW YORK, NY\u2014Responding to a 6-3 SCOTUS decision strike down President Biden's unconstitutional vaccine mandate, Pfizer's CEO Albert Bourla took to CNN to condemn the ruling, which he says \"violates our God-given constitutional right to produce experimental d\u2026", "url": "https://freerepublic.com/focus/f-bloggers/4029285/posts", "urlToImage": null, "publishedAt": "2022-01-14T00:09:55Z", "content": "Skip to comments.\r\nPfizer CEO Condemns SCOTUS Ruling As A Clear Violation Of Our Constitutional Right To Produce Experimental Drugs And Use The Full Power Of Government To Force The Entire Population\u2026 [+3654 chars]"}, {"source": {"id": null, "name": "Newsbusters.org"}, "author": "Joseph Vazquez Assistant Editor", "title": "Reuters \u2018Fact Check\u2019 Shields Pfizer CEO, Fails to Disclose Reuters Chairman Is on Pfizer Board", "description": "Reuters rushed to spin Pfizer CEO Albert Bourla\u2019s recent comments on his company\u2019s vaccine in a so-called \u201cFact Check\u201d and failed to disclose that a senior executive in the Reuters apparatus happens to sit on Pfizer\u2019s board of directors.", "url": "https://www.newsbusters.org/blogs/business/joseph-vazquez/2022/01/14/reuters-fact-check-shields-pfizer-ceo-fails-disclose", "urlToImage": "https://cdn.newsbusters.org/styles/mobile_thumb_700x400_/s3/2022-01/Bourla.png?itok=qJ5BmyQs", "publishedAt": "2022-01-14T22:02:14Z", "content": "Reuters rushed to spin Pfizer CEO Albert Bourlas recent comments on his companys vaccine in a so-called Fact Check and failed to disclose that a senior executive in the Reuters apparatus happens to s\u2026 [+3125 chars]"}, {"source": {"id": null, "name": "Newsbusters.org"}, "author": "Joseph Vazquez Assistant Editor", "title": "Reuters \u2018Fact Check\u2019 Shields Pfizer CEO, Fails to Disclose Reuters Chairman Is on Pfizer Board", "description": "Reuters rushed to spin Pfizer CEO Albert Bourla\u2019s recent comments on his company\u2019s vaccine in a so-called \u201cFact Check\u201d and failed to disclose that a senior executive in the Reuters apparatus happens to sit on Pfizer\u2019s board of directors.", "url": "https://newsbusters.org/blogs/business/joseph-vazquez/2022/01/14/reuters-fact-check-shields-pfizer-ceo-fails-disclose", "urlToImage": "https://cdn.newsbusters.org/styles/mobile_thumb_700x400_/s3/2022-01/Bourla.png?itok=qJ5BmyQs", "publishedAt": "2022-01-14T22:18:01Z", "content": "Reuters rushed to spin Pfizer CEO Albert Bourlas recent comments on his companys vaccine in a so-called Fact Check and failed to disclose that a senior executive in the Reuters apparatus happens to s\u2026 [+3125 chars]"}, {"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "Pfizer says it applied for Japanese govt approval for oral COVID-19 drug", "description": "U.S. drugmaker Pfizer Inc <a href=\"https://www.reuters.com/companies/PFE.N\" target=\"_blank\">(PFE.N)</a> said on Friday it has applied for Japanese government approval for its oral COVID-19 treatment.", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-says-it-applied-japanese-govt-approval-oral-covid-19-drug-2022-01-14/", "urlToImage": "https://www.reuters.com/resizer/FnOxj617UJi3dYpnzSu50jxsHRw=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/LAPCYEOMSJJDFEZTUCGEKVXJ7E.jpg", "publishedAt": "2022-01-14T02:41:29Z", "content": "A 3D printed Pfizer logo is placed near medicines from the same manufacturer in this illustration taken September 29, 2021. REUTERS/Dado Ruvic/IllustrationTOKYO, Jan 14 (Reuters) - U.S. drugmaker Pfi\u2026 [+1313 chars]"}]}, "2022-01-13": {"status": "ok", "totalResults": 28, "articles": [{"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "South Korea to deploy Pfizer COVID-19 pills as Omicron wave looms - Reuters", "description": "South Korea will begin treating coronavirus patients with Pfizer's <a href=\"https://www.reuters.com/companies/PFE.N\" target=\"_blank\">(PFE.N)</a> antiviral pills on Friday, health officials said, as concern mounts over the spread of the highly contagious Omicr\u2026", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/south-korea-deploy-pfizer-covid-19-pills-omicron-wave-looms-2022-01-13/", "urlToImage": "https://www.reuters.com/resizer/fc0ztE6yBw4tqdZRFg7HKVsxXC8=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/SCDX5HZI6VPXPDNUR4T4L2WJFM.jpg", "publishedAt": "2022-01-13T05:06:00Z", "content": "SEOUL, Jan 13 (Reuters) - South Korea will begin treating coronavirus patients with Pfizer's (PFE.N) antiviral pills on Friday, health officials said, as concern mounts over the spread of the highly \u2026 [+2159 chars]"}, {"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "Africa CDC talking to Pfizer about importing its COVID treatment pill - Reuters", "description": "Africa's top public health body is in talks with Pfizer <a href=\"https://www.reuters.com/companies/PFE.N\" target=\"_blank\">(PFE.N)</a> about bringing its treatment pill for COVID-19 to the continent, its director said on Thursday.", "url": "https://www.reuters.com/world/africa/africa-cdc-talking-pfizer-about-importing-its-covid-treatment-pill-2022-01-13/", "urlToImage": "https://www.reuters.com/resizer/HOVj_tOwqW7UOz3OcFVdO8QYqWk=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/Y6RMUMRRBNM3JHYVFHRW723ZNY.jpg", "publishedAt": "2022-01-13T09:57:00Z", "content": "Paxlovid, a Pfizer's coronavirus disease (COVID-19) pill, is seen manufactured in Ascoli, Italy, in this undated handout photo obtained by Reuters on November 16, 2021. Pfizer/Handout via REUTERS\r\nJa\u2026 [+624 chars]"}, {"source": {"id": null, "name": "Ctvnews.ca"}, "author": null, "title": "COVID-19 antivirals: Pfizer review nears end in Canada - CTV News", "description": "<ol><li>COVID-19 antivirals: Pfizer review nears end in Canada\u00a0\u00a0CTV News\r\n</li><li>Boosting boosters: experts say fourth doses not yet needed for general population\u00a0\u00a0CP24 Toronto's Breaking News\r\n</li><li>Promising COVID treatments working through Health Cana\u2026", "url": "https://www.ctvnews.ca/health/coronavirus/health-canada-in-final-stages-of-reviewing-pfizer-s-antiviral-covid-19-drug-1.5738880", "urlToImage": "https://www.ctvnews.ca/polopoly_fs/1.5333220.1614851941!/httpImage/image.jpg_gen/derivatives/landscape_620/image.jpg", "publishedAt": "2022-01-13T18:48:00Z", "content": "Health Canadas chief medical adviser Dr. Supriya Sharma says the agency is working through the final stages of its review of Pfizers promising antiviral treatment.\r\nPfizer submitted clinical data for\u2026 [+2371 chars]"}, {"source": {"id": null, "name": "Motley Fool"}, "author": "newsfeedback@fool.com (Eric Volkman)", "title": "Why Pfizer and BioNTech Got Thrashed on Thursday", "description": "A fresh Supreme Court ruling does neither stock any favors.", "url": "https://www.fool.com/investing/2022/01/13/why-pfizer-and-biontech-got-thrashed-on-thursday/", "urlToImage": "https://g.foolcdn.com/editorial/images/661294/man-about-to-receive-a-vaccine-shot.jpg", "publishedAt": "2022-01-13T23:17:59Z", "content": "What happened\r\nIn what hardly qualifies as a surprising development, shares of both Pfizer(NYSE:PFE) and BioNTech(NASDAQ:BNTX) fell in price on Thursday. This was on the back of a Supreme Court decis\u2026 [+1523 chars]"}, {"source": {"id": null, "name": "Motley Fool"}, "author": "newsfeedback@fool.com (Keith Speights)", "title": "5 Reasons Why Pfizer Is a Better Stock to Buy Right Now Than Moderna", "description": "It's not even close.", "url": "https://www.fool.com/investing/2022/01/13/5-reasons-pfizer-better-stock-to-buy-than-moderna/", "urlToImage": "https://g.foolcdn.com/editorial/images/660481/vaccine-shot-globe-currency-symbols-and-charts.jpg", "publishedAt": "2022-01-13T10:52:00Z", "content": "Some investors could look at the relative momentum to pick between two stocks. For example, Pfizer(NYSE:PFE) has been a much bigger winner than\u00a0Moderna(NASDAQ:MRNA) over the past several months.\u00a0\r\nOt\u2026 [+4029 chars]"}, {"source": {"id": null, "name": "Snopes.com"}, "author": "Jordan Liles", "title": "Is the \u2018Pfizer Treatment Survey\u2019 Email a Scam or Legit?", "description": "Such emails promised \"$90 or more\" in rewards for answering a few questions. They didn't come from Pfizer.", "url": "https://www.snopes.com/fact-check/pfizer-treatment-survey-scam/", "urlToImage": "https://www.snopes.com/tachyon/2022/01/GettyImages-1285323968-e1642097189366.jpg", "publishedAt": "2022-01-13T19:38:54Z", "content": "Image via David Benito/Getty Images\r\nEmails promoting a \"Pfizer Treatment Survey\" promise \"$90 or more\" to participants.\r\nAt some point during the COVID-19 pandemic, emails about a Pfizer Treatment S\u2026 [+2776 chars]"}, {"source": {"id": null, "name": "Investor's Business Daily"}, "author": "Investor's Business Daily", "title": "Pfizer Continues Its Covid Makeover: What's Next For The Hot Stock? - Investor's Business Daily", "description": "Pfizer Continues Its Covid Makeover: What's Next For The Hot Stock?\u00a0\u00a0Investor's Business Daily", "url": "https://www.investors.com/news/technology/pfizer-stock-what-is-next-as-pfizer-continues-its-covid-makeover/", "urlToImage": "https://www.investors.com/wp-content/uploads/2022/01/Stock-pfizersign-05-adobe.jpg", "publishedAt": "2022-01-13T12:00:00Z", "content": "The pandemic accelerated a transformation that Pfizer (PFE) began years ago when it first tapped BioNTech (BNTX) for a flu shot. Today, Pfizer stock is near record highs as it doubles down on the tec\u2026 [+6753 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "Associated Press Videos", "title": "Pfizer COVID-19 antiviral pills arrive in SKorea", "description": "South Korea on Thursday received its first supply of Pfizer's antiviral COVID-19 pills to treat patients with mild or moderate symptoms. (Jan. 13)", "url": "https://news.yahoo.com/pfizer-covid-19-antiviral-pills-113954088.html", "urlToImage": "https://s.yimg.com/ny/api/res/1.2/RGUd38F0Rz9yfhfKTFzCUw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzU-/https://s.yimg.com/hd/cp-video-transcode/prod/2022-01/13/61e011842a1f5e27b6dfe942/61e011842a1f5e27b6dfe943_o_U_v2.jpg", "publishedAt": "2022-01-13T11:39:54Z", "content": "Scott Olson/GettyDonald Trump abruptly ended an interview with NPR on Tuesday after he was repeatedly called out on his baseless claims of election fraud in the 2020 presidential election.A video of \u2026 [+298 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "Hyonhee Shin", "title": "South Korea to deploy Pfizer COVID-19 pills as Omicron wave looms", "description": "South Korea will begin treating coronavirus patients with Pfizer's antiviral pills on Friday, health officials said, as concern mounts over the spread of the...", "url": "https://news.yahoo.com/south-korea-deploy-pfizer-covid-050636639.html", "urlToImage": "https://s.yimg.com/uu/api/res/1.2/9kbnXCUnvJDWd41FRtLY2A--~B/aD01MzQ7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/36bfa65d9e2f9e9959c570ee2af3208a", "publishedAt": "2022-01-13T05:06:36Z", "content": "By Hyonhee Shin\r\nSEOUL (Reuters) - South Korea will begin treating coronavirus patients with Pfizer's antiviral pills on Friday, health officials said, as concern mounts over the spread of the highly\u2026 [+1987 chars]"}, {"source": {"id": null, "name": "Toronto Star"}, "author": "Star staff and wire services", "title": "Today\u2019s coronavirus news: Africa\u2019s CDC in talks with Pfizer for COVID treatment pill; UAE\u2019s Ajman warns of pay cuts for exposure to COVID-19 twice", "description": "Meanwhile, France will let in travellers from Britain who are vaccinated against COVID-19 without having to self-isolate or to offer a valid reason for the trip.", "url": "https://www.thestar.com/news/canada/2022/01/13/coronavirus-covid-19-updates-toronto-canada-january-13.html", "urlToImage": "https://images.thestar.com/whAVySsQV81Kayn72ZV4detIonM=/1200x800/smart/filters:cb(1642072687262)/https://www.thestar.com/content/dam/thestar/news/canada/2022/01/13/coronavirus-covid-19-updates-toronto-canada-january-13/ee2b44769af147d4abd555a130351a97_ee2b44769af147d4abd555a130351a9.jpg", "publishedAt": "2022-01-13T11:06:00Z", "content": "The latest coronavirus news from Canada and around the world Thursday. This file will be updated throughout the day. Web links to longer stories if available.\r\n6 a.m.: The director of Africa\u2019s Center\u2026 [+7728 chars]"}, {"source": {"id": null, "name": "AllAfrica - Top Africa News"}, "author": "Government of Mauritius", "title": "Mauritius: The United States Donates 203,580 Doses of the Pfizer Vaccines to Mauritius", "description": "[Government of Mauritius] A donation of 203,580 doses of the Pfizer-BioNTech COVID-19 vaccines was presented, this morning, by the U.S. Embassy to Mauritius to the Mauritian authorities, during a ceremony held at Newton Tower, in Port-Louis.", "url": "https://allafrica.com/stories/202201130047.html", "urlToImage": "https://cdn08.allafrica.com/static/images/structure/aa-logo-rgba-no-text-square.png", "publishedAt": "2022-01-13T07:24:23Z", "content": "A donation of 203,580 doses of the Pfizer-BioNTech COVID-19 vaccines was presented, this morning, by the U.S. Embassy to Mauritius to the Mauritian authorities, during a ceremony held at Newton Tower\u2026 [+5849 chars]"}, {"source": {"id": null, "name": "CNA"}, "author": null, "title": "South Korea to deploy Pfizer COVID-19 pills as Omicron wave looms", "description": "SEOUL: South Korea will begin treating coronavirus patients with Pfizer's antiviral pills on Friday (Jan 14), health officials said, as concern mounts over the spread of the highly contagious Omicron variant.\r\n\r\nAt least 21,000 of the pills, called Paxlovid, \u2026", "url": "https://www.channelnewsasia.com/asia/south-korea-pfizer-covid19-pill-omicron-2432681", "urlToImage": "https://onecms-res.cloudinary.com/image/upload/s--TFq3LV5A--/c_crop%2Ch_450%2Cw_800%2Cx_0%2Cy_84/fl_relative%2Cg_south_east%2Cl_one-cms:core:watermark:reuters%2Cw_0.1/f_auto%2Cq_auto/c_fill%2Cg_auto%2Ch_676%2Cw_1200/v1/one-cms/core/2022-01-13t050636z_1_lynxmpei0c054_rtroptp_3_health-coronavirus-southkorea.jpg?itok=3IN2p9bJ", "publishedAt": "2022-01-13T05:19:49Z", "content": "SEOUL: South Korea will begin treating coronavirus patients with Pfizer's antiviral pills on Friday (Jan 14), health officials said, as concern mounts over the spread of the highly contagious Omicron\u2026 [+1429 chars]"}, {"source": {"id": null, "name": "Wnd.com"}, "author": "WND News Services", "title": "Investigation launched after 13-year-old dies after receiving Pfizer COVID vaccine", "description": "(WASHINGTON STANDARD) \u2013 Pfizer, its CEO and anyone at the unconstitutional Food and Drug Administration dragging their feet on the data on these experimental shots are more nervous than a long tailed cat in a room full of rocking chairs. A young 13-year-old g\u2026", "url": "https://www.wnd.com/2022/01/investigation-launched-13-year-old-dies-receiving-pfizer-covid-vaccine/", "urlToImage": "https://www.wnd.com/wp-content/uploads/2016/10/Weeping-angel.jpg", "publishedAt": "2022-01-13T19:54:26Z", "content": "(WASHINGTON STANDARD) Pfizer, its CEO and anyone at the unconstitutional Food and Drug Administration dragging their feet on the data on these experimental shots are more nervous than a long tailed c\u2026 [+1015 chars]"}, {"source": {"id": null, "name": "Seeking Alpha"}, "author": "Dulan Lokuwithana", "title": "Pfizer in talks with Africa CDC to supply COVID-19 pill", "description": "Africa is reportedly in talks with Pfizer (PFE) to acquire the COVID-19 pill developed by the company, the continent\u2019s top public health body said Thursday in a press", "url": "https://seekingalpha.com/news/3787779-pfizer-in-talks-with-africa-cdc-to-supply-covid-19-pill", "urlToImage": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1292440976/medium_image_1292440976.jpg", "publishedAt": "2022-01-13T12:12:39Z", "content": "Alexandros Michailidis/iStock Editorial via Getty Images"}, {"source": {"id": null, "name": "Thegatewaypundit.com"}, "author": "Jim Hoft", "title": "Investigation Launched After 13-Year-Old Brazilian Girl Dies \u2013 Mother Blames Pfizer Vaccine", "description": "Vanessa Martins Figueiredo, 13 years old from\u00a0Ararangu\u00e1, Brazil, died last Monday reportedly due to the Pfizer vaccine complications. Vanessa received her first dose of Pfizer vaccine last November 9th. She began to experience throwing up and paralysis on her\u2026", "url": "https://www.thegatewaypundit.com/2022/01/investigation-launched-13-year-old-brazilian-girl-died-mother-blames-pfizer-vaccine/", "urlToImage": "https://www.thegatewaypundit.com/wp-content/uploads/156DB7CD-C1A1-4212-A44B-97F2895F6832-scaled.jpeg", "publishedAt": "2022-01-13T15:45:49Z", "content": "Vanessa Martins Figueiredo, 13 years old from\u00a0Ararangu\u00e1, Brazil, died last Monday reportedly due to the Pfizer vaccine complications.\r\nVanessa received her first dose of Pfizer vaccine last November \u2026 [+3626 chars]"}, {"source": {"id": null, "name": "Thecovidworld.com"}, "author": "Mike Rivero", "title": "Kansuda Wichaisuek: 25-Year-Old Doctor Dies 1 Month After Receiving Pfizer Booster Shot, Father Seeks Answers", "description": "A healthy 25-year-old doctor in Thailand has died 1 month after receiving the Pfizer booster shot. Kansuda Wichaisuek, also known to her friends and family as \u201cDr. Po\u201d, got her booster on December 7th and became seriously ill ten days later.", "url": "https://thecovidworld.com/kansuda-wichaisuek-25-year-old-doctor-dies-1-month-after-receiving-pfizer-booster-shot-father-seeks-answers/", "urlToImage": "https://thecovidworld.com/wp-content/uploads/2022/01/Kansuda-Wichaisuek.jpg", "publishedAt": "2022-01-13T16:11:41Z", "content": "The COVID World post date: January 12th, 2022\r\nA healthy 25-year-old doctor in Thailand has died 1 month after receiving the Pfizer booster shot. Kansuda Wichaisuek, also known to her friends and fam\u2026 [+1435 chars]"}, {"source": {"id": null, "name": "En-volve.com"}, "author": "IamShado", "title": "Pfizer Quietly Orders Social Media Companies To DELETE Video Where Their CEO ADMITS Jabs Offer \u201cLimited Protection\u201d", "description": "Pfizer has begun quietly ordering social media companies to delete a video where its CEO admits that their jabs offer \u201climited protection\u201d against the virus.", "url": "https://en-volve.com/2022/01/13/pfizer-quietly-orders-social-media-companies-to-delete-video-where-their-ceo-admits-jabs-offer-limited-protection/", "urlToImage": "http://en-volve.com/wp-content/uploads/2022/01/pfizer-deletes-video-678x381.jpg.optimal.jpg", "publishedAt": "2022-01-13T19:43:38Z", "content": "Pfizer has begun quietly ordering social media companies to delete a video where its CEO admits that their jabs offer limited protection against the virus.\r\nIn a recent interview with Yahoo Finances \u2026 [+1515 chars]"}, {"source": {"id": "abc-news", "name": "ABC News"}, "author": "CARLEY PETESCH Associated Press", "title": "Africa CDC in talks with Pfizer for COVID treatment pill", "description": "The director of Africa\u2019s Centers for Disease Control says the organization is talking to Pfizer about bringing its COVID-19 treatment pill to the continent, which has just passed 10 million cases", "url": "https://abcnews.go.com/Health/wireStory/africa-cdc-talks-pfizer-covid-treatment-pill-82240630", "urlToImage": "null", "publishedAt": "2022-01-13T10:59:00Z", "content": "DAKAR, Senegal _ -- The director of Africas Centers for Disease Control said the organization is talking to Pfizer about bringing its COVID-19 treatment pill to the continent, which has just passed 1\u2026 [+1586 chars]"}, {"source": {"id": null, "name": "Toronto Star"}, "author": "The Canadian Press", "title": "Health Canada seven to 10 days from decision on Pfizer antiviral drug", "description": "OTTAWA - Health Canada\u2019s chief medical adviser says a decision on Pfizer\u2019s antiviral treatment for COVID-19 is expected in seven to 10 days.", "url": "https://www.thestar.com/news/canada/2022/01/13/health-canada-seven-to-10-days-from-decision-on-pfizer-antiviral-drug.html", "urlToImage": "https://images.thestar.com/_kzEEVm0V8tObP6J8NwjBJsGJ9k=/1280x1024/smart/filters:cb(1642109898683)/https://www.thestar.com/content/dam/thestar/news/canada/2022/01/13/health-canada-seven-to-10-days-from-decision-on-pfizer-antiviral-drug/20220113110144-61e056d6b5a7443ec1494ef7jpeg.jpg", "publishedAt": "2022-01-13T21:26:35Z", "content": "OTTAWA - Health Canadas chief medical adviser says a decision on Pfizers antiviral treatment for COVID-19 is expected in seven to 10 days.\r\nBut Supriya Sharma says the department reached out to Pfize\u2026 [+942 chars]"}, {"source": {"id": null, "name": "NDTV News"}, "author": null, "title": "South Korea To Deploy Pfizer COVID-19 Pills As Omicron Wave Looms", "description": "South Korea will begin treating coronavirus patients with Pfizer's antiviral pills on Friday, health officials said, as concern mounts over the spread of the highly contagious Omicron variant.", "url": "https://www.ndtv.com/world-news/south-korea-to-deploy-pfizer-covid-19-pills-as-omicron-wave-looms-2705613", "urlToImage": "https://c.ndtvimg.com/2021-12/4luj96r_pfizer-covid-pill-afp_625x300_22_December_21.jpg", "publishedAt": "2022-01-13T07:18:02Z", "content": "The Covid medication will be used to treat more than 1,000 people a day in South Korea. (File)\r\nSeoul: South Korea will begin treating coronavirus patients with Pfizer's antiviral pills on Friday, he\u2026 [+2482 chars]"}]}, "2022-01-12": {"status": "ok", "totalResults": 41, "articles": [{"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "Pfizer study shows COVID-19 booster can be co-administered with pneumonia shot - Reuters", "description": "Pfizer Inc <a href=\"https://www.reuters.com/companies/PFE.N\" target=\"_blank\">(PFE.N)</a> said on Wednesday booster doses of its COVID-19 vaccine produced strong safety and immune responses when co-administered with its pneumonia vaccine in people aged 65 and \u2026", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-study-shows-covid-19-booster-can-be-co-administered-with-pneumonia-shot-2022-01-12/", "urlToImage": "https://www.reuters.com/resizer/bgqVCSYwsS4d71-i3IKFDE3eZYI=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/7AYVU73CLVJB5M5E63CWIECYUA.jpg", "publishedAt": "2022-01-12T12:09:00Z", "content": "A nurses fills up syringes for patients as they receive their coronavirus disease (COVID-19) booster vaccination during a Pfizer-BioNTech vaccination clinic in Southfield, Michigan, U.S., September 2\u2026 [+702 chars]"}, {"source": {"id": null, "name": "Motley Fool"}, "author": "newsfeedback@fool.com (Prosper Junior Bakiny)", "title": "Will Pfizer Hit $100 This Year?", "description": "The pharma giant has been flying high in the past year.", "url": "https://www.fool.com/investing/2022/01/12/will-pfizer-hit-100-this-year/", "urlToImage": "https://g.foolcdn.com/editorial/images/660531/gettyimages-1291715271.jpg", "publishedAt": "2022-01-12T15:30:00Z", "content": "If winners keep winning, as the saying goes, then 2022 should be a great year for Pfizer(NYSE:PFE). The company has consistently delivered blowout financial results in recent quarters, thanks largely\u2026 [+3862 chars]"}, {"source": {"id": null, "name": "Skift"}, "author": "Michael Erman, Reuters", "title": "Business Travel Shakeout Begins as Pfizer Axes Staff on Virtual Meetings Rise", "description": "Pfizer Inc said on Tuesday it is reducing its U.S. sales staff as it expects doctors and other healthcare providers to want fewer face-to-face interactions with sales people after the COVID-19 pandemic ends.", "url": "https://skift.com/2022/01/12/business-travel-shakeout-begins-as-pfizer-axes-staff-on-virtual-meetings-rise/", "urlToImage": "https://skift.com/wp-content/uploads/2022/01/FILE-PHOTO-Pfizer-logo-in-Manhattan-New-York-scaled.jpeg", "publishedAt": "2022-01-12T19:45:00Z", "content": "Pfizer Inc said on Tuesday it is reducing its U.S. sales staff as it expects doctors and other healthcare providers to want fewer face-to-face interactions with sales people after the Covid-19 pandem\u2026 [+1739 chars]"}, {"source": {"id": null, "name": "Snopes.com"}, "author": "Dan MacGuill", "title": "Did Pfizer CEO Say 2-Dose Vaccine Gives Little Protection Against COVID-19?", "description": "Albert Bourla has been a frequent target of disinformation throughout the COVID-19 pandemic, which entered its third year in January 2022.", "url": "https://www.snopes.com/fact-check/pfizer-ceo-vaccine-covid-limited-protection/", "urlToImage": "https://www.snopes.com/tachyon/2022/01/GettyImages-1232477569-albert-bourla.jpg", "publishedAt": "2022-01-12T22:36:00Z", "content": "Image via John Thys/Pool/AFP via Getty Images\r\nIn January 2022, Pfizer CEO Albert Bourla said the company's two-dose vaccine offered limited or no protection against COVID-19. \r\nSnopes is still fight\u2026 [+6618 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "Reuters", "title": "S.Korea authorises Novavax COVID-19 vaccine, imports Pfizer pills", "description": "SEOUL (Reuters) -South Korea is turning to additional pharmaceutical tools as it looks to pre-empt a surge of COVID-19 omicron infections, authorising the...", "url": "https://news.yahoo.com/korea-authorises-novavax-covid-19-043647637.html", "urlToImage": "https://s.yimg.com/uu/api/res/1.2/vGYyOFQHcan9rP3VoJ1yUA--~B/aD00ODk7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/c5001d1371e9d176e0be592b7e7e5528", "publishedAt": "2022-01-12T04:36:47Z", "content": "SEOUL (Reuters) -South Korea is turning to additional pharmaceutical tools as it looks to pre-empt a surge of COVID-19 omicron infections, authorising the use of Novavax Inc's vaccine on Wednesday an\u2026 [+2466 chars]"}, {"source": {"id": null, "name": "Globalresearch.ca"}, "author": "Michael Nevradakis", "title": "Pfizer, J&J Among Pharma Companies Accused of Funding Terrorism in Iraq", "description": "All Global Research articles\u00a0can be read in 51 languages by activating the \u201cTranslate Website\u201d\u00a0drop down menu on the top banner of our home page (Desktop version). To receive Global Research\u2019s Daily Newsletter (selected articles),\u00a0click here. Visit and follow\u2026", "url": "https://www.globalresearch.ca/pfizer-jj-among-pharma-companies-accused-funding-terrorism-iraq/5766912", "urlToImage": "https://www.globalresearch.ca/wp-content/uploads/2022/01/pharma-companies-funded-terrorism-feature-1-800x417.jpg", "publishedAt": "2022-01-12T07:38:27Z", "content": "All Global Research articles\u00a0can be read in 51 languages by activating the Translate Website\u00a0drop down menu on the top banner of our home page (Desktop version).\r\nTo receive Global Researchs Daily Ne\u2026 [+11404 chars]"}, {"source": {"id": null, "name": "PJ Media"}, "author": "Glenn Reynolds", "title": "IT SHOULD BE AVAILABLE ABOUT THE TIME EVERYONE HAS ALREADY HAD IT: Pfizer exec says new COVID-19 va\u2026", "description": "IT SHOULD BE AVAILABLE ABOUT THE TIME EVERYONE HAS ALREADY HAD IT: Pfizer exec says new COVID-19 vaccine against Omicron variant coming soon.", "url": "https://pjmedia.com/instapundit/496479/", "urlToImage": null, "publishedAt": "2022-01-12T00:00:20Z", "content": "As an Amazon Associate,I earn from qualifying purchases."}, {"source": {"id": null, "name": "FiercePharma"}, "author": "Sharon Klahr Coey", "title": "Pfizer offers a soft sell but with a strong message on vaccines in first COVID ad", "description": "About a hundred years ago in 2019, \u201cnormal\u201d was just shy of an insult\u2014a word synonymous with \u201cboring.\u201d Pfizer knows that these days, \u201cnormal\u201d (not counting the dreaded \u201cnew\u201d normal) seems like a fantasy land.", "url": "https://www.fiercepharma.com/marketing/pfizer-offers-a-soft-sell-a-strong-message-vaccines", "urlToImage": "https://qtxasset.com/fiercepharma/1641992616/Vaccine.jpg/Vaccine.jpg?VersionId=kAC7dV_Qqlndb2mXAKCivy606IIit3l5", "publishedAt": "2022-01-12T13:05:02Z", "content": "About a hundred years ago in 2019, normal was just shy of an insulta word synonymous with boring. Pfizer knows that these days, normal (not counting the dreaded new normal) seems like a fantasy land.\u2026 [+2335 chars]"}, {"source": {"id": null, "name": "FiercePharma"}, "author": "Ben Adams", "title": "Pfizer takes the ax to US sales reps amid virtual push: Reuters", "description": "Pfizer is culling hundreds of sales reps in the U.S. as the company shifts into digital drive as the pandemic pushed away in-person meetings.", "url": "https://www.fiercepharma.com/marketing/pfizer-takes-ax-to-u-s-sales-reps-amid-virtual-push-reuters", "urlToImage": "https://qtxasset.com/fiercepharma/1641983914/AlbertBourla.jpg/AlbertBourla.jpg?VersionId=ifZM.srrmLkuzh6aUxJfgqb6xSMIp4MJ", "publishedAt": "2022-01-12T10:39:36Z", "content": "Pfizer is culling hundreds of sales reps in the United States as the company shifts into digital drive as the pandemic pushed away in-person meetings.\r\nPfizer and partner BioNTech are set to make aro\u2026 [+1777 chars]"}, {"source": {"id": null, "name": "Healio"}, "author": null, "title": "Real-world study confirms Pfizer vaccine's effectiveness among adolescents - Healio", "description": "<ol><li>Real-world study confirms Pfizer vaccine's effectiveness among adolescents\u00a0\u00a0Healio\r\n</li><li>If you got Omicron post-vaccination, medical experts advise not to rush out for a booster shot\u00a0\u00a0CBC.ca\r\n</li><li>Kids and COVID-19: Third shot vs. booster sho\u2026", "url": "https://www.healio.com/news/primary-care/20220112/realworld-study-confirms-pfizer-vaccines-effectiveness-among-adolescents", "urlToImage": "https://www.healio.com/~/media/covid19_vaccine_403394450.jpeg", "publishedAt": "2022-01-12T22:10:56Z", "content": "We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.Back to Healio\r\nA real-world study conducted at more tha\u2026 [+2767 chars]"}, {"source": {"id": null, "name": "Globalresearch.ca"}, "author": "Rada Mateescu", "title": "Pfizer Scandal: CEO Albert Bourla Reveals Two COVID Vaccine Shots Offer \u2018Very Limited Protection, If Any\u2019 after Claiming Shot Was \u2018100% Effective\u2019", "description": "All Global Research articles\u00a0can be read in 51 languages by activating the \u201cTranslate Website\u201d\u00a0drop down menu on the top banner of our home page (Desktop version).\nTo receive Global Research\u2019s Daily Newsletter (selected articles),\u00a0click here.\nVisit \u2026\nThe post\u2026", "url": "https://www.globalresearch.ca/pfizer-scandal-ceo-albert-bourla-reveals-two-covid-vaccines-offer-very-limited-protection-if-any-after-claiming-shot-100-effective/5766930", "urlToImage": "https://www.globalresearch.ca/wp-content/uploads/2022/01/albert-bourla.jpg", "publishedAt": "2022-01-12T13:02:19Z", "content": "All Global Research articles\u00a0can be read in 51 languages by activating the Translate Website\u00a0drop down menu on the top banner of our home page (Desktop version).\r\nTo receive Global Researchs Daily Ne\u2026 [+3352 chars]"}, {"source": {"id": null, "name": "Business Wire"}, "author": null, "title": "Positive Top-Line Results of Pfizer\u2019s Phase 3 Study Exploring Coadministration of PREVNAR 20\u2122 With Pfizer-BioNTech COVID-19 Vaccine in Older Adults Released", "description": "NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) today announced positive top-line results from a Phase 3 study (B74710126) describing the safety and immunogenicity of PREVNAR 20\u2122 (Pneumococcal 20-valent Conjugate Vaccine) in 570 adults in the United States \u2026", "url": "https://www.businesswire.com/news/home/20220112005278/en/Positive-Top-Line-Results-of-Pfizer%E2%80%99s-Phase-3-Study-Exploring-Coadministration-of-PREVNAR-20%E2%84%A2-With-Pfizer-BioNTech-COVID-19-Vaccine-in-Older-Adults-Released", "urlToImage": "https://mms.businesswire.com/media/20220112005278/en/1045874/23/Pfizer_Logo_Color_RGB_APPROVED.jpg", "publishedAt": "2022-01-12T11:55:02Z", "content": "NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) today announced positive top-line results from a Phase 3 study (B74710126) describing the safety and immunogenicity of PREVNAR 20 (Pneumococcal 20-va\u2026 [+24808 chars]"}, {"source": {"id": null, "name": "CP24 Toronto's Breaking News"}, "author": "Mia Rabson", "title": "Canada has contracts for up to 100 million Pfizer, Moderna doses in 2022 - CP24 Toronto's Breaking News", "description": "Federal COVID-19 vaccine contracts mean Canada should get enough doses to give two or three more mRNA shots to every Canadian, every year until at least 2024.", "url": "https://www.cp24.com/news/canada-has-contracts-for-up-to-100-million-pfizer-moderna-doses-in-2022-1.5736632", "urlToImage": "https://www.cp24.com/polopoly_fs/1.5600588.1641961334!/httpImage/image.jpg_gen/derivatives/landscape_620/image.jpg", "publishedAt": "2022-01-12T04:22:44Z", "content": "OTTAWA - Federal COVID-19 vaccine contracts mean Canada should get enough doses to give two or three more mRNA shots to every Canadian, every year until at least 2024.\r\nBut even as the National Advis\u2026 [+3919 chars]"}, {"source": {"id": null, "name": "MarketWatch"}, "author": "Jaimy Lee", "title": "Pfizer says its safe and effective to co-administer its Prevnar 20, COVID-19 shots", "description": "Shares of Pfizer Inc. were down 0.1% in premarket trading on Wednesday after the company said administering the Prevnar 20 pneumococcal disease shot at the same time as the COVID-19 vaccine and booster it developed with BioNTech SE produced the same response.\u2026", "url": "https://www.marketwatch.com/story/pfizer-says-its-safe-and-effective-to-co-administer-its-prevnar-20-covid-19-shots-2022-01-12", "urlToImage": "https://s.wsj.net/public/resources/MWimages/MW-GP644_MicroS_ZG_20180906154215.jpg", "publishedAt": "2022-01-12T12:29:46Z", "content": "Shares of Pfizer Inc. \r\n PFE,\r\n +0.80%\r\nwere down 0.1% in premarket trading on Wednesday after the company said administering the Prevnar 20 pneumococcal disease shot at the same time as the COVID-19\u2026 [+467 chars]"}, {"source": {"id": null, "name": "Seeking Alpha"}, "author": "Mamta Mayani", "title": "Pfizer reports positive results from Phase 3 study of PREVNAR 20 with COVID-19 vaccine", "description": "Sean Gallup/Getty Images News Pfizer (NYSE:PFE) announces positive top-line results from a Phase 3 study describing the safety and immunogenicity of PREVNAR 20 (Pneumococcal 20-valent...", "url": "https://seekingalpha.com/news/3787390-pfizer-reports-positive-results-from-phase-3-study-of-prevnar-20-with-covid-19-vaccine", "urlToImage": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1293283810/medium_image_1293283810.jpg", "publishedAt": "2022-01-12T12:01:36Z", "content": "Sean Gallup/Getty Images News"}, {"source": {"id": null, "name": "Childrenshealthdefense.org"}, "author": "Mike Rivero", "title": "Exclusive: Autopsy Confirms 26-Year-Old\u2019s Death From Myocarditis Directly Caused by Pfizer COVID Vaccine", "description": "A 26-year-old South Dakota man who died Nov. 12, 2021, of myocarditis \u2014 four days after his booster dose of Pfizer\u2019s COVID vaccine \u2014 had no idea he was experiencing a rare and supposedly \u201cmild\u201d heart problem after the shot.\nJoseph Keating\u2019s only warning signs\u2026", "url": "https://childrenshealthdefense.org/defender/joseph-keating-autopsy-death-myocarditis-pfizer-covid-vaccine/", "urlToImage": "https://childrenshealthdefense.org/wp-content/uploads/Joseph-Keating-Pfizer-vaccine-myocarditis-feature-1.jpg", "publishedAt": "2022-01-12T17:20:36Z", "content": "Miss a day, miss a lot.Subscribe to The Defender's Top News of the Day. It's free.\r\nA 26-year-old South Dakota man who died Nov. 12, 2021, of myocarditis four days after his booster dose of Pfizers C\u2026 [+15707 chars]"}, {"source": {"id": null, "name": "Seeking Alpha"}, "author": "Mamta Mayani", "title": "South Korea approves Novavax COVID-19 vaccine, imports Pfizer pills - Reuters", "description": "South Korea has authorized the use of Novavax's (NVAX) COVID-19 Vaccine, and is preparing to distribute the first of Pfizer's (PFE) antiviral pills, source Reuters.The health ministry...", "url": "https://seekingalpha.com/news/3787328-south-korea-approves-novavax-covid-19-vaccine-imports-pfizer-pills-reuters", "urlToImage": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1253358164/medium_image_1253358164.jpg", "publishedAt": "2022-01-12T06:43:11Z", "content": "MarsBars/E+ via Getty Images"}, {"source": {"id": null, "name": "Investmentwatchblog.com"}, "author": "alexmark", "title": "Video: Pfizer CEOBourla: \"Two doses of the vaccine offer very limited protection, if any. 3 doses with a booster offer reasonable protection\"", "description": null, "url": "https://www.investmentwatchblog.com/video-pfizer-ceobourla-two-doses-of-the-vaccine-offer-very-limited-protection-if-any-3-doses-with-a-booster-offer-reasonable-protection/", "urlToImage": null, "publishedAt": "2022-01-12T16:05:00Z", "content": "This guy is a crook. Readily admits that 1 and 2 \u2026 and indirectly 3 shots don\u2019t do anything. But says 3 doses WITH a booster (= 4 shots) offer \u201creasonable protection\u201d.\r\nThen has the audacity to procl\u2026 [+268 chars]"}, {"source": {"id": null, "name": "Business Today"}, "author": "Reuters", "title": "COVID-19: South Korea approves Novavax vaccine, imports Pfizer pills", "description": "At least 21,000 of Pfizer's antiviral pills, called Paxlovid, will arrive in South Korea on Thursday, with another 10,000 more expected to arrive by the end of the month, the health ministry said.", "url": "https://www.businesstoday.in/coronavirus/story/covid-19-south-korea-approves-novavax-vaccine-imports-pfizer-pills-318776-2022-01-12", "urlToImage": "https://akm-img-a-in.tosshub.com/businesstoday/images/story/202201/vaccine-reuters-942321-1611376091-1200-sixteen_nine_0-sixteen_nine.jpg", "publishedAt": "2022-01-12T09:06:08Z", "content": "South Korea is turning to additional pharmaceutical tools as it looks to pre-empt a surge of COVID-19 omicron infections, authorising the use of Novavax Inc's vaccine on Wednesday and preparing to di\u2026 [+2335 chars]"}, {"source": {"id": null, "name": "Business Standard"}, "author": "Reuters", "title": "South Korea authorises Novavax Covid-19 vaccine, imports Pfizer pills", "description": "At least 21,000 of Pfizer's antiviral pills, called Paxlovid, will arrive in South Korea on Thursday, with another 10,000 more expected to arrive by the end of the month, the health ministry said", "url": "https://www.business-standard.com/article/current-affairs/south-korea-authorises-novavax-covid-19-vaccine-imports-pfizer-pills-122011200490_1.html", "urlToImage": "https://bsmedia.business-standard.com/_media/bs/img/article/2021-06/17/full/1623925354-5058.jpg", "publishedAt": "2022-01-12T07:18:00Z", "content": "South Korea is turning to additional pharmaceutical tools as it looks to pre-empt a surge of COVID-19 omicron infections, authorising the use of Novavax Inc's vaccine on Wednesday and preparing to di\u2026 [+3787 chars]"}]}, "2022-01-11": {"status": "ok", "totalResults": 52, "articles": [{"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "EXCLUSIVE Pfizer to cut U.S. sales staff as meetings move to virtual - Reuters", "description": "Pfizer Inc <a href=\"https://www.reuters.com/companies/PFE.N\" target=\"_blank\">(PFE.N)</a> said on Tuesday it is reducing its U.S. sales staff as it expects doctors and other healthcare providers to want fewer face-to-face interactions with sales people after t\u2026", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/exclusive-pfizer-cut-us-sales-staff-meetings-move-virtual-2022-01-11/", "urlToImage": "https://www.reuters.com/resizer/T3OtKTL6rc5O5PI-nVZvNSt94Tg=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/6HXNYWZGA5HQ5H7AUJVAYFG5JY.JPG", "publishedAt": "2022-01-11T20:25:00Z", "content": "Jan 11 (Reuters) - Pfizer Inc (PFE.N) said on Tuesday it is reducing its U.S. sales staff as it expects doctors and other healthcare providers to want fewer face-to-face interactions with sales peopl\u2026 [+1685 chars]"}, {"source": {"id": "usa-today", "name": "USA Today"}, "author": "USA TODAY, Celina Tebor, USA TODAY", "title": "Pfizer developing vaccine that targets omicron; Chicago set to resume in-person classes: COVID-19 updates", "description": "Pfizer's CEO Albert Bourla said developing a COVID vaccine specifically designed to target the omicron variant is \"the most likely scenario.\" Updates.", "url": "https://www.usatoday.com/story/news/health/2022/01/11/covid-omicron-variant-pfizer-cases/9165512002/", "urlToImage": "https://www.gannett-cdn.com/presto/2022/01/11/USAT/8952ff16-fe21-438f-a2cc-8df44ba5f30a-GTY_1363878011.jpg?crop=2932,1649,x4,y148&width=1600&height=800&fit=bounds", "publishedAt": "2022-01-11T10:02:22Z", "content": "President Joe Biden urges concern but not alarm as the U.S. set new records for daily reported COVID-19 cases and his administration struggles to ease concerns about testing shortages and closures ca\u2026 [+5180 chars]"}, {"source": {"id": "bloomberg", "name": "Bloomberg"}, "author": null, "title": "Pfizer Begins Making Shot That Targets Omicron (Audio)", "description": "Understand every aspect of the global economy \u2013 and know how to make your next move.", "url": "https://www.bloomberg.com/news/audio/2022-01-11/pfizer-begins-making-shot-that-targets-omicron-audio", "urlToImage": null, "publishedAt": "2022-01-11T11:28:24Z", "content": "Bhakti Hansoti, Johns Hopkins Associate Professor of Emergency Medicine, talks about vaccines with Bloomberg's Nathan Hager.\r\nJan 11, 2022"}, {"source": {"id": "cbs-news", "name": "CBS News"}, "author": "Megan Megan", "title": "Pfizer: Vaccine targeting Omicron will be ready in March", "description": "Drugmaker expects to be able to develop new variant-specific vaccines in roughly 100 days as COVID-19 mutates.", "url": "https://www.cbsnews.com/news/covid-vaccine-pfizer-omicron-variant-march/", "urlToImage": "https://cbsnews1.cbsistatic.com/hub/i/r/2022/01/10/06538182-58cd-4915-a76c-46477f014ccd/thumbnail/1200x630/da8d7a6ff3c85d4f5b097da3ad47621d/gettyimages-1290225107.jpg", "publishedAt": "2022-01-11T12:54:03Z", "content": "Pfizer will have a COVID-19 vaccine that specifically targets the Omicron variant ready by March, the pharmaceutical company's chief executive said Monday.\u00a0\r\nPfizer CEO Albert Bourla said the company\u2026 [+2928 chars]"}, {"source": {"id": "cbs-news", "name": "CBS News"}, "author": "Megan Megan", "title": "Pfizer: Vaccine targeting Omicron will be ready in March", "description": "Drugmaker expects to be able to develop new variant-specific vaccines in roughly 100 days as COVID-19 mutates.", "url": "https://www.cbsnews.com/news/covid-vaccine-pfizer-omicron-variant-march-paxlovid/", "urlToImage": "https://cbsnews1.cbsistatic.com/hub/i/r/2022/01/10/06538182-58cd-4915-a76c-46477f014ccd/thumbnail/1200x630/da8d7a6ff3c85d4f5b097da3ad47621d/gettyimages-1290225107.jpg", "publishedAt": "2022-01-11T21:01:00Z", "content": "Pfizer will have a COVID-19 vaccine that specifically targets the Omicron variant ready by March, the pharmaceutical company's chief executive said Monday.\u00a0\r\nPfizer CEO Albert Bourla said the company\u2026 [+3963 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "Anjalee Khemlani", "title": "Pfizer to make foray into gene editing, expand mRNA tech in 2022", "description": "Pfizer is doubling down on mRNA investments as well as newer technology, including gene editing, to boost its pipeline.", "url": "https://finance.yahoo.com/news/pfizer-to-make-foray-into-gene-editing-expand-m-rna-in-2022-144902650.html", "urlToImage": "https://s.yimg.com/ny/api/res/1.2/0CaB9to1Jyou6TM_7q3Nxg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDI-/https://s.yimg.com/os/creatr-uploaded-images/2020-12/8c4aea10-390d-11eb-bd7f-a2b8871a4f5e", "publishedAt": "2022-01-11T14:49:02Z", "content": "Pfizer (PFE) may be the most recognized COVID-19 vaccine brand, but that's due in part to its collaboration with BioNTech (BNTX). It's why the companies recently announced they're expanding their par\u2026 [+3858 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "Michael Erman", "title": "Exclusive-Pfizer to cut U.S. sales staff as meetings with healthcare providers move to virtual", "description": "(Reuters) -Pfizer Inc said on Tuesday it is reducing its U.S. sales staff as it expects doctors and other healthcare providers to want fewer face-to-face...", "url": "https://finance.yahoo.com/news/exclusive-pfizer-cut-u-sales-202531753.html", "urlToImage": "https://s.yimg.com/uu/api/res/1.2/H8xfCbS0qua9w1sE84ctqQ--~B/aD01MzM7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters-finance.com/260e92dbc878e084c0bf603bdd304ac3", "publishedAt": "2022-01-11T20:25:31Z", "content": "By Michael Erman\r\n(Reuters) -Pfizer Inc said on Tuesday it is reducing its U.S. sales staff as it expects doctors and other healthcare providers to want fewer face-to-face interactions with sales peo\u2026 [+1524 chars]"}, {"source": {"id": null, "name": "Shtfplan.com"}, "author": "Mac Slavo", "title": "Pfizer CEO: Two COVID Shots Aren\u2019t Enough For Mild Omicron", "description": "The person who stands to profit heavily by making you believe what he says wants you to consume his product. Pfizer's CEO, who has previously called those who dislike his \"vaccines\" criminals, says that two shots are not going to be enough for the mild omicro\u2026", "url": "https://www.shtfplan.com/headline-news/pfizer-ceo-two-covid-shots-arent-enough-for-mild-omicron", "urlToImage": "https://www.shtfplan.com/wp-content/uploads/2021/11/globalvaccine-e1636380220889.jpg", "publishedAt": "2022-01-11T21:00:40Z", "content": "The person who stands to profit heavily by making you believe what he says wants you to consume his product. Pfizer\u2019s CEO, who has previously called those who dislike his \u201cvaccines\u201d criminals, says t\u2026 [+3402 chars]"}, {"source": {"id": null, "name": "Fark.com"}, "author": null, "title": "Pfizer CEO announces that their new Omicron vaccine will be ready in March, just in time for the next variant that won't be affected by it [Obvious]", "description": "Pfizer CEO announces that their new Omicron vaccine will be ready in March, just in time for the next variant that won't be affected by it", "url": "https://www.fark.com/comments/12043665/Pfizer-CEO-announces-that-their-new-Omicron-vaccine-will-be-ready-in-March-just-in-time-for-next-variant-that-wont-be-affected-by-it", "urlToImage": "https://usrimg-full.fark.net/m/m-/fark_m-7OTyZLMmOB4fLMXExJhSwoLzs.jpg?AWSAccessKeyId=HBAYEKZHGUB4NAYQBVSQ&Expires=1642395600&Signature=YVIcAAUiYbdQoH%2BNUa%2FNilNR%2Ffw%3D", "publishedAt": "2022-01-11T00:23:06Z", "content": "ocelot:I'm not taking anymore vaccines.3 shots is enough for me.I've had gunshot wounds that didn't hurt that bad the next day,let alone make you sick.\r\nEvery person I've actually known that's gotten\u2026 [+167 chars]"}, {"source": {"id": null, "name": "Shtfplan.com"}, "author": "Mac Slavo", "title": "Former Pfizer VP: COVID \u201cVaccines\u201d Were \u201cAlways Going To Harm People\u201d", "description": "Dr. Michael Yeadon, a former vice president of big pharma company Pfizer, who is being hailed as a \"conspiracy theorist\" by the mainstream shared his latest take on the damning evidence about the mRNA COVID-19 \u201cvaccines.\u201d Dr. Yeadon says these shots are \"toxi\u2026", "url": "https://www.shtfplan.com/headline-news/former-pfizer-vp-covid-vaccines-were-always-going-to-harm-people", "urlToImage": "https://www.shtfplan.com/wp-content/uploads/2021/04/Mike_Yeadon_810_500_75_s_c1-e1617881714277.jpg", "publishedAt": "2022-01-11T16:00:16Z", "content": "Dr. Michael Yeadon, a former vice president of big pharma company Pfizer, who is being hailed as a \u201cconspiracy theorist\u201d by the mainstream shared his latest take on the damning evidence about the mRN\u2026 [+2954 chars]"}, {"source": {"id": null, "name": "Celebitchy.com"}, "author": "Kaiser", "title": "Moderna & Pfizer will have Omicron-targeted boosters available this year", "description": "Embed from Getty Images A few days ago, Moderna CEO Stephane Bancel explained how the company was preparing to develop and provide a second Covid booster shot \u2013 and a fourth shot overall \u2013 to come out this fall. As in, when people are getting their annual flu\u2026", "url": "https://www.celebitchy.com/749010/moderna_pfizer_will_have_omicron-targeted_boosters_available_this_year/", "urlToImage": null, "publishedAt": "2022-01-11T14:40:07Z", "content": "Embed from Getty Images\r\nA few days ago, Moderna CEO Stephane Bancel explained how the company was preparing to develop and provide a second Covid booster shot \u2013 and a fourth shot overall \u2013 to come o\u2026 [+3109 chars]"}, {"source": {"id": null, "name": "ValueWalk"}, "author": "Cristian Bustos", "title": "Pfizer CEO: Two Covid Shots Not Enough Against Omicron", "description": "Pfizer Inc (NYSE:PFE) CEO Albert Bourla said \u201cThe two doses, they\u2019re not enough for Omicron,\u201d in reference to the efficacy of the company\u2019s vaccine against COVID-19. He further added that the ability of the initial two-injection to prevent hospitalization dos\u2026", "url": "https://www.valuewalk.com/pfizer-ceo-two-covid-shots-not-enough-against-omicron/", "urlToImage": "https://valuewalk.b-cdn.net/wp-content/uploads/2020/10/corona_1603286109.jpg", "publishedAt": "2022-01-11T15:36:19Z", "content": "Pfizer Inc (NYSE:PFE) CEO Albert Bourla said The two doses, theyre not enough for Omicron, in reference to the efficacy of the companys vaccine against COVID-19. He further added that the ability of \u2026 [+2477 chars]"}, {"source": {"id": null, "name": "Nomoresilence.world"}, "author": "Mike Rivero", "title": "Sarah Jessica Blattner \u2013 Pfizer 14th May 2021", "description": "She Died Of A Heart Attack On 12th October 2021, Aged Just 14\nSarah tells us about her Adverse Reaction to Pfizer in her Video Story and then sadly dies 5 days later on 12th October 2021.\nHer parents speak out and urged the public not to vaccinate their kids.\u2026", "url": "https://nomoresilence.world/pfizer-biontech/sarah-jessica-blattner-aged-14-pfizer-death/", "urlToImage": "https://nomoresilence.world/wp-content/uploads/2022/01/Sarah-Jessica-Blattner.png", "publishedAt": "2022-01-11T15:41:15Z", "content": "She Died Of A Heart Attack On 12th October 2021, Aged Just 14\r\nSarah tells us about her Adverse Reaction to Pfizer in her Video Story and then sadly dies 5 days later on 12th October 2021.\r\nHer paren\u2026 [+2415 chars]"}, {"source": {"id": null, "name": "CNBC"}, "author": "Reuters", "title": "Pfizer to cut U.S. sales staff as meetings with health-care providers move to virtual", "description": "A source to Reuters that Pfizer was eliminating a few hundred positions.", "url": "https://www.cnbc.com/2022/01/11/pfizer-to-cut-us-sales-staff-as-meetings-move-to-virtual.html", "urlToImage": "https://image.cnbcfm.com/api/v1/image/103702412-GettyImages-494838886.jpg?v=1641932983", "publishedAt": "2022-01-11T20:41:00Z", "content": "Pfizer\u00a0said on Tuesday it is reducing its U.S. sales staff as it expects doctors and other health-care providers to want fewer face-to-face interactions with salespeople after the Covid-19 pandemic e\u2026 [+1433 chars]"}, {"source": {"id": null, "name": "Cracknewz.com"}, "author": "Neha", "title": "Pfizer CEO \u2014 Omicron Vaccine will be ready in 45 days\u2026", "description": "", "url": "https://www.cracknewz.com/2022/01/pfizer-ceo-omicron-vaccine-will-be.html", "urlToImage": "https://lh3.googleusercontent.com/proxy/hmIupnI0Q2GzPMKaJPurCita3kIZbkyqO2oTCB6x9mja6d1AN0zVxl-fwDGWFYFBG4S8hL0wLjxUvywqeGhzFs8nlZ0=w1200-h630-n-k-no-nu", "publishedAt": "2022-01-11T14:45:12Z", "content": "Amid heightened tensions between China, Taiwan's President Tsai Ing-wen on Saturday extended an olive branch calling for \"meaning..."}, {"source": {"id": null, "name": "Mercola.com"}, "author": "communities@mercola.com (Dr. Joseph Mercola)", "title": "Why Is the FDA Hiding the Pfizer Vaccine Data?", "description": "Despite the FDA\u2019s claim that it is committed to transparency, especially for COVID-19 emergency use authorizations (EUAs),1 the agency first requested 55 years to release the data supporting the approval of Comirnaty after a Freedom of Information Act (FOIA) \u2026", "url": "https://articles.mercola.com/sites/articles/archive/2022/01/11/fda-pfizer-vaccine-data-release.aspx", "urlToImage": "https://media.mercola.com/ImageServer/Public/2022/January/FB/fda-pfizer-vaccine-data-release-fb.jpg", "publishedAt": "2022-01-11T00:00:00Z", "content": "Mercola proudly supports these charities and organizations. View All \r\nDisclaimer: The entire contents of this website are based upon the opinions of Dr. Mercola, unless otherwise noted. Individual a\u2026 [+1007 chars]"}, {"source": {"id": null, "name": "Investmentwatchblog.com"}, "author": "alexmark", "title": "Booster #4 is ready: Pfizer CEO \u2014 Omicron Vaccine will be ready in 45 days", "description": null, "url": "https://www.investmentwatchblog.com/booster-4-is-ready-pfizer-ceo-omicron-vaccine-will-be-ready-in-45-days/", "urlToImage": null, "publishedAt": "2022-01-11T17:03:25Z", "content": "BUT, in 45 days there will be a new variant\r\nPfizer CEO Albert Bourla on Monday said that his company is aiming to have a vaccine that targets the omicron variant as well as other COVID-19 variants r\u2026 [+208 chars]"}, {"source": {"id": null, "name": "Seeking Alpha"}, "author": "Jonathan Block", "title": "Dren Bio in up to $1B deal with Pfizer for oncology bispecific antibody candidates", "description": "Dren Bio has brokered a research collaboration and license arrangement with Pfizer that could be worth more than $1B to the privately held biotech.", "url": "https://seekingalpha.com/news/3787201-dren-bio-in-up-to-1b-deal-with-pfizer-for-oncology-bispecific-antibody-candidates", "urlToImage": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1326631382/medium_image_1326631382.jpg", "publishedAt": "2022-01-11T17:15:05Z", "content": "Design Cells/iStock via Getty Images"}, {"source": {"id": null, "name": "Business Wire"}, "author": null, "title": "Dren Bio Announces Research Collaboration and License Agreement with Pfizer to Discover and Advance Multiple Therapeutic Antibodies Using its Targeted Myeloid Engager and Phagocytosis Platform for the Treatment of Cancer", "description": "REDWOOD CITY, Calif.--(BUSINESS WIRE)--Dren Bio announces Research Collaboration and License Agreement with Pfizer for leveraging its Targeted Myeloid Engager and Phagocytosis Platform", "url": "https://www.businesswire.com/news/home/20220111005199/en/Dren-Bio-Announces-Research-Collaboration-and-License-Agreement-with-Pfizer-to-Discover-and-Advance-Multiple-Therapeutic-Antibodies-Using-its-Targeted-Myeloid-Engager-and-Phagocytosis-Platform-for-the-Treatment-of-Cancer", "urlToImage": "https://mms.businesswire.com/media/20220111005199/en/1323668/23/Dren_Bio_Logo.jpg", "publishedAt": "2022-01-11T13:10:18Z", "content": "REDWOOD CITY, Calif.--(BUSINESS WIRE)--Dren Bio, Inc. (Dren Bio or the Company) today announced it has entered into a research collaboration and license agreement with Pfizer Inc. The strategic colla\u2026 [+6893 chars]"}, {"source": {"id": null, "name": "Lewrockwell.com"}, "author": "Daniel McAdams", "title": "Pfizer CEO\u2019s Covid Bombshell: Two Shots \u2018Offers Very Limited Protection, If Any\u2019", "description": "The post Pfizer CEO\u2019s Covid Bombshell: Two Shots \u2018Offers Very Limited Protection, If Any\u2019 appeared first on LewRockwell.", "url": "https://www.lewrockwell.com/lrc-blog/pfizer-ceos-covid-bombshell-two-shots-offers-very-limited-protection-if-any/", "urlToImage": "https://lrc-cdn.s3.amazonaws.com/assets/2021/02/LRC-share.jpg", "publishedAt": "2022-01-11T18:10:14Z", "content": "https://www.lewrockwell.com/lrc-blog/pfizer-ceos-covid-bombshell-two-shots-offers-very-limited-protection-if-any/\r\nTags:"}]}, "2022-01-10": {"status": "ok", "totalResults": 67, "articles": [{"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "Pfizer joins Beam Therapeutics to develop rare disease therapies - Reuters", "description": "Drugmaker Pfizer <a href=\"https://www.reuters.com/companies/PFE.N\" target=\"_blank\">(PFE.N)</a> will collaborate with gene-editing specialist Beam Therapeutics <a href=\"https://www.reuters.com/companies/BEAM.O\" target=\"_blank\">(BEAM.O)</a> in a deal worth as m\u2026", "url": "https://www.reuters.com/markets/deals/pfizer-joins-beam-therapeutics-develop-rare-disease-therapies-2022-01-10/", "urlToImage": "https://www.reuters.com/pf/resources/images/reuters/reuters-default.png?d=66", "publishedAt": "2022-01-10T11:00:00Z", "content": "Jan 10 (Reuters) - Drugmaker Pfizer (PFE.N) will collaborate with gene-editing specialist Beam Therapeutics (BEAM.O) in a deal worth as much as $1.35 billion to develop therapies for rare genetic dis\u2026 [+1376 chars]"}, {"source": {"id": null, "name": "Zacks.com"}, "author": "Zacks Equity Research", "title": "Why the Earnings Surprise Streak Could Continue for Pfizer (PFE)", "description": "Pfizer (PFE) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.", "url": "http://www.zacks.com/stock/news/1849824/why-the-earnings-surprise-streak-could-continue-for-pfizer-pfe?cid=CS-ENTREPRENEUR-FT-tale_of_the_tape|yseop_template_7-1849824", "urlToImage": "https://assets.entrepreneur.com/providers/zacks/hero-image-zacks-412396.jpeg", "publishedAt": "2022-01-10T17:10:15Z", "content": "Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? Pfizer (PFE), which belongs to the Zacks \u2026 [+3408 chars]"}, {"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "EU regulator could issue decision on Pfizer COVID-19 pill 'within weeks' - Reuters", "description": "The European Union's drug regulator said on Monday it could issue \"within weeks\" a decision on whether to approve the use of Pfizer's COVID-19 pill, Paxlovid, after the U.S. drugmaker submitted an application seeking authorisation.", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/eu-regulator-could-issue-decision-pfizer-covid-19-pill-within-weeks-2022-01-10/", "urlToImage": "https://www.reuters.com/resizer/HOVj_tOwqW7UOz3OcFVdO8QYqWk=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/Y6RMUMRRBNM3JHYVFHRW723ZNY.jpg", "publishedAt": "2022-01-10T14:19:00Z", "content": "Jan 10 (Reuters) - The European Union's drug regulator said on Monday it could issue \"within weeks\" a decision on whether to approve the use of Pfizer's COVID-19 pill, Paxlovid, after the U.S. drugma\u2026 [+1267 chars]"}, {"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "Pfizer CEO says Omicron-targeted vaccine is most likely outcome - Reuters", "description": "Pfizer Inc <a href=\"https://www.reuters.com/companies/PFE.N\" target=\"_blank\">(PFE.N)</a> Chief Executive Albert Bourla on Monday said a redesigned COVID-19 vaccine that specifically targets the Omicron coronavirus variant is likely needed and his company coul\u2026", "url": "https://www.reuters.com/markets/deals/pfizer-ceo-says-omicron-targeted-vaccine-is-most-likely-outcome-2022-01-10/", "urlToImage": "https://www.reuters.com/pf/resources/images/reuters/reuters-default.png?d=66", "publishedAt": "2022-01-10T22:04:00Z", "content": "Jan 10 (Reuters) - Pfizer Inc (PFE.N) Chief Executive Albert Bourla on Monday said a redesigned COVID-19 vaccine that specifically targets the Omicron coronavirus variant is likely needed and his com\u2026 [+2491 chars]"}, {"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "Pfizer CEO says Omicron variant targeted vaccine is most likely outcome - Reuters", "description": "Pfizer Inc <a href=\"https://www.reuters.com/companies/PFE.N\" target=\"_blank\">(PFE.N)</a> Chief Executive Albert Bourla said on Monday that moving toward a redesigned COVID-19 vaccine that is specifically targeted to combat the Omicron variant of the coronavir\u2026", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-ceo-says-omicron-variant-targeted-vaccine-is-most-likely-outcome-2022-01-10/", "urlToImage": "https://www.reuters.com/resizer/b4dQ_THnFhq6P7j3QzGjKrZETSU=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/5DUPQDNMUZOCFFDMTWWSMSLWKM.jpg", "publishedAt": "2022-01-10T20:37:00Z", "content": "Pfizer CEO Albert Bourla talks during a press conference with European Commission President Ursula von der Leyen after a visit to oversee the production of the Pfizer-BioNtech COVID-19 vaccine at the\u2026 [+914 chars]"}, {"source": {"id": "business-insider", "name": "Business Insider"}, "author": "adunn@insider.com (Andrew Dunn)", "title": "Exclusive: Pfizer plans to start human studies of its Omicron-specific COVID-19 vaccine before the end of January", "description": "The pharma giant is on track to have a new version of its vaccine ready by late March, chief scientist Mikael Dolsten told Insider.", "url": "https://www.businessinsider.com/pfizer-plans-to-launch-studies-for-omicron-specific-covid-19-shot-in-late-january-2022-1", "urlToImage": "https://i.insider.com/61dc59e8726b4f001802ba84?width=1200&format=jpeg", "publishedAt": "2022-01-10T16:00:50Z", "content": "Pfizer plans to start human testing for its Omicron variant-specific coronavirus vaccine before the end of January, the drugmaker's top scientist told Insider.\r\n\"We're going to test that starting now\u2026 [+2250 chars]"}, {"source": {"id": "the-washington-post", "name": "The Washington Post"}, "author": "Bryan Pietsch, Jennifer Hassan, Hannah Knowles, Reis Thebault", "title": "PFIZER predicts 'annual shots'...", "description": "PFIZER predicts 'annual shots'...\r\n\n \n \n \n (Top headline, 11th story, link)\r\n\n \r\n\n \r\n\n \n Related stories:POLL: Inflation up, virus down as priorities in USA...\r\nDems NOT shutting things down this time...\r\nENOUGH: More Saying They're 'Vaxxed and Done'...\r\nBori\u2026", "url": "https://www.washingtonpost.com/nation/2022/01/10/covid-omicron-variant-live-updates/", "urlToImage": "https://www.washingtonpost.com/wp-apps/imrs.php?src=https://arc-anglerfish-washpost-prod-washpost.s3.amazonaws.com/public/XCZYEQDSGQI6ZITNDQQ4C2Y4SM.jpg&w=1440", "publishedAt": "2022-01-10T22:01:37Z", "content": "Justice Sonia Sotomayor, during an oral argument at the Supreme Court, said Jan. 7: Those numbers show that omicron is as deadly and causes as much serious disease in the unvaccinated as delta did. W\u2026 [+1644 chars]"}, {"source": {"id": "bloomberg", "name": "Bloomberg"}, "author": "Riley Griffin, Angelica Peebles", "title": "Pfizer Deepens Commitment to Genetic-Drug Future With Deals", "description": "Pfizer Inc. deepened its commitment to the genetic approach to disease underpinning its Covid-19 vaccine on Monday, striking deals that will give access to three smaller companies\u2019 technology in the area.", "url": "https://www.bloomberg.com/news/articles/2022-01-10/pfizer-deepens-commitment-to-genetic-drug-future-with-deals", "urlToImage": "https://assets.bwbx.io/images/users/iqjWHBFdfxIU/i.Jl2aq7SEfc/v1/1200x799.jpg", "publishedAt": "2022-01-10T14:52:06Z", "content": "Pfizer Inc. deepened its commitment to the genetic approach to disease underpinning its Covid-19 vaccine on Monday, striking deals that will give access to three smaller companies technology in the a\u2026 [+3330 chars]"}, {"source": {"id": "bloomberg", "name": "Bloomberg"}, "author": "Riley Griffin", "title": "Pfizer Begins Making Shot That Targets Omicron, Original Virus", "description": "Pfizer Inc. is developing a hybrid vaccine that combines its original shot with a formulation that shields against the highly transmissible omicron variant, the drug giant\u2019s top executive said.", "url": "https://www.bloomberg.com/news/articles/2022-01-10/pfizer-begins-making-shot-that-targets-omicron-original-virus", "urlToImage": "https://assets.bwbx.io/images/users/iqjWHBFdfxIU/iYJVESCPNPmw/v0/1200x800.jpg", "publishedAt": "2022-01-10T21:10:15Z", "content": "Pfizer Inc. is developing a hybrid vaccine that combines its original shot with a formulation that shields against the highly transmissible omicron variant, the drug giants top executive said.\u00a0\r\nWhil\u2026 [+1503 chars]"}, {"source": {"id": null, "name": "SlashGear"}, "author": "Matt Milano", "title": "The Pfizer COVID Omicron Booster Is Already In Production", "description": "Pfizer has announced its Omicron COVID-19 booster is already in production as the variant has led to a massive increase in cases worldwide, accounting for as many as 95% of new cases in the US (via OHS). First reported in late November, in South Africa, Omicr\u2026", "url": "https://www.slashgear.com/the-pfizer-covid-omicron-booster-is-already-in-production-10706507/", "urlToImage": "https://cdn.slashgear.com/wp-content/uploads/2022/01/covid-vaccine.jpg", "publishedAt": "2022-01-10T20:39:43Z", "content": "Pfizer has announced its Omicron COVID-19 booster is already in production as the variant has led to a massive increase in cases worldwide, accounting for as many as 95% of new cases in the US (via O\u2026 [+2003 chars]"}, {"source": {"id": null, "name": "Forbes"}, "author": "Robert Hart, Forbes Staff, \n Robert Hart, Forbes Staff\n https://www.forbes.com/sites/roberthart/", "title": "Pfizer Bets Big On mRNA: New Deals Include $1.3 Billion Collaboration With Beam", "description": "The string of new deals announced Monday include a potential deal with gene editing specialist Beam Therapeutics, including a $300 million upfront payment.", "url": "https://www.forbes.com/sites/roberthart/2022/01/10/pfizer-bets-big-on-mrna-new-deals-include-13-billion-collaboration-with-beam/", "urlToImage": "https://thumbor.forbes.com/thumbor/fit-in/1200x0/filters%3Aformat%28jpg%29/https%3A%2F%2Fspecials-images.forbesimg.com%2Fimageserve%2F60eda71c0e5153e8a614c67e%2F0x0.jpg%3FcropX1%3D0%26cropX2%3D1069%26cropY1%3D53%26cropY2%3D654", "publishedAt": "2022-01-10T15:05:48Z", "content": "American pharmaceutical giant Pfizer announced a string of new deals Monday to expand and improve its use of mRNA technology, springboarding off the successes of its Covid-19 vaccine and including a \u2026 [+3017 chars]"}, {"source": {"id": null, "name": "Fox Business"}, "author": "Lucas Manfredi", "title": "Pfizer says Omicron-specific vaccine to be ready by March - Fox Business", "description": "<ol><li>Pfizer says Omicron-specific vaccine to be ready by March\u00a0\u00a0Fox Business\r\n</li><li>Pfizer CEO says omicron vaccine will be ready in March\u00a0\u00a0CNBC\r\n</li><li>Pfizer CEO Bourla: Omicron-specific Covid vaccine will be ready by March\u00a0\u00a0CNBC Television\r\n</li><l\u2026", "url": "https://www.foxbusiness.com/healthcare/pfizer-omicron-coronavirus-march", "urlToImage": "https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2021/07/0/0/Pfizer-Delta-Variant.jpg?ve=1&tl=1", "publishedAt": "2022-01-10T19:34:17Z", "content": "Pfizer is aiming to have a COVID-19 vaccine that specifically targets omicron and other circulating variants by March.\r\nBILLIONAIRE SUPERMARKET CEO WARNS OF POTENTIAL MEAT, EGG SHORTAGE AS OMICRON DI\u2026 [+2940 chars]"}, {"source": {"id": null, "name": "Investor's Business Daily"}, "author": "Investor's Business Daily", "title": "Biotech Bloodbath Continues Despite Gene-Editing Deals For Pfizer, Bayer", "description": "Pfizer and Bayer inked deals with several companies in gene-editing.", "url": "https://www.investors.com/news/technology/biotech-stocks-the-bloodbath-continues-despite-gene-editing-deals-for-pfizer-bayer/", "urlToImage": "https://www.investors.com/wp-content/uploads/2021/03/Stock-DrugsPills-14-adobe.jpg", "publishedAt": "2022-01-10T21:24:37Z", "content": "The bloodbath continued for biotech stocks Monday as the J.P. Morgan Healthcare Conference kicked off with massive deals for Pfizer (PFE) and Bayer (BAYRY).\r\nXPfizer is teaming up withBeam Therapeuti\u2026 [+3100 chars]"}, {"source": {"id": null, "name": "Forbes"}, "author": "Alison Durkee, Forbes Staff, \n Alison Durkee, Forbes Staff\n https://www.forbes.com/sites/alisondurkee/", "title": "Chile Latest Country To Roll Out 4th Covid Vaccine Shots \u2014 But Pfizer CEO Still Unsure Whether They\u2019re Necessary", "description": "Pfizer CEO Albert Bourla said the second booster shots are still \u201csomething that needs to be tested.\u201d", "url": "https://www.forbes.com/sites/alisondurkee/2022/01/10/chile-latest-country-to-roll-out-4th-covid-vaccine-shots---but-pfizer-ceo-still-unsure-whether-theyre-necessary/", "urlToImage": "https://thumbor.forbes.com/thumbor/fit-in/1200x0/filters%3Aformat%28jpg%29/https%3A%2F%2Fspecials-images.forbesimg.com%2Fimageserve%2F61dca311b4a4dff20d6660aa%2F0x0.jpg%3FcropX1%3D0%26cropX2%3D3179%26cropY1%3D0%26cropY2%3D1788", "publishedAt": "2022-01-10T21:43:25Z", "content": "Chile started rolling out fourth Covid-19 vaccine doses to higher-risk members of its population Monday, after Israel started administering the extra shots in late Decemberbut their effectiveness is \u2026 [+4605 chars]"}, {"source": {"id": "independent", "name": "Independent"}, "author": "Gustaf Kilander", "title": "Pfizer CEO announces Omicron vaccine to be ready in March", "description": "The CEO of Pfizer, Albert Bourla, has said that a vaccine for the highly transmissible Omicron variant of Covid-19 will be ready in March and that the pharmaceutical company has begun manufacturing the doses.", "url": "https://www.independent.co.uk/news/world/americas/pfizer-omicron-vaccine-covid-update-b1990113.html", "urlToImage": "https://static.independent.co.uk/2022/01/10/15/newFile-9.jpg?width=1200&auto=webp&quality=75", "publishedAt": "2022-01-10T15:49:02Z", "content": "The CEO of Pfizer, Albert Bourla, has said that a vaccine for the highly transmissible Omicron variant of Covid-19 will be ready in March and that the pharmaceutical company has begun manufacturing t\u2026 [+763 chars]"}, {"source": {"id": "cbs-news", "name": "CBS News"}, "author": "Megan Megan", "title": "Pfizer: Vaccine targeting Omicron will be ready in March", "description": "Drugmaker expects to be able to develop new variant-specific vaccines in roughly 100 days as COVID-19 mutates.", "url": "https://www.cbsnews.com/news/covid-vaccine-omicron-pfizer-march/", "urlToImage": "https://cbsnews1.cbsistatic.com/hub/i/r/2022/01/10/06538182-58cd-4915-a76c-46477f014ccd/thumbnail/1200x630/da8d7a6ff3c85d4f5b097da3ad47621d/gettyimages-1290225107.jpg", "publishedAt": "2022-01-10T21:12:13Z", "content": "Pfizer will have a COVID-19 vaccine that specifically targets the Omicron variant ready by March, the pharmaceutical company's chief executive said Monday.\u00a0\r\nPfizer CEO Albert Bourla said the company\u2026 [+2928 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "Anjalee Khemlani", "title": "Pfizer, Moderna focus on fall 2022 vaccine plans", "description": "Pfizer and Moderna are in the market lead for their mRNA vaccines for COVID-19. And with the pandemic raging on, demand only continues to grow.", "url": "https://finance.yahoo.com/news/pfizer-moderna-focus-on-fall-2022-vaccine-plans-220304748.html", "urlToImage": "https://s.yimg.com/ny/api/res/1.2/.AIzthWhLWtrf3qnbJddKA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://s.yimg.com/os/creatr-uploaded-images/2022-01/766add20-6fc8-11ec-a7fb-a1b5a1fc06d1", "publishedAt": "2022-01-10T22:03:04Z", "content": "Whether or not people will need to be perpetually boosting against the coronavirus and its seemingly never-ending stream of variants remains unknown, but vaccine manufacturers are already preparing f\u2026 [+4403 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "Reuters", "title": "Pfizer joins Beam Therapeutics to develop rare disease therapies", "description": "Beam will receive $300 million in upfront payment and lead research activities till three new therapy targets are selected for development from outside the...", "url": "https://news.yahoo.com/pfizer-joins-beam-therapeutics-develop-112658525.html", "urlToImage": "https://s.yimg.com/uu/api/res/1.2/hCTHBDsK8BJhchgG81GVWw--~B/aD01MzU7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/737c1e3f2ddd069b4feb41188adbaf7c", "publishedAt": "2022-01-10T11:26:58Z", "content": "(Reuters) - Drugmaker Pfizer will collaborate with gene-editing specialist Beam Therapeutics in a deal worth as much as $1.35 billion to develop therapies for rare genetic diseases.\r\nBeam will receiv\u2026 [+1181 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "Reuters", "title": "Pfizer CEO says Omicron variant targeted vaccine is most likely outcome", "description": "Pfizer Inc Chief Executive Albert Bourla said on Monday that moving toward a redesigned COVID-19 vaccine that is specifically targeted to combat the Omicron ...", "url": "https://news.yahoo.com/pfizer-ceo-says-omicron-variant-203740035.html", "urlToImage": "https://s.yimg.com/uu/api/res/1.2/V2f8a4OENagGn3oxO4_A9A--~B/aD01MjY7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/c59f7627b2a8c599bc1e798cc448eaf8", "publishedAt": "2022-01-10T20:37:40Z", "content": "NEW YORK (Reuters) - Pfizer Inc Chief Executive Albert Bourla said on Monday that moving toward a redesigned COVID-19 vaccine that is specifically targeted to combat the Omicron variant of the corona\u2026 [+484 chars]"}, {"source": {"id": null, "name": "The Boston Globe"}, "author": "Anissa Gardizy", "title": "Beam Therapeutics inks $300 million gene-editing collaboration with Pfizer", "description": "The companies announced Monday that they are partnering to work on new medicines for diseases involving the liver, muscles, and central nervous system.", "url": "https://www.bostonglobe.com/2022/01/10/business/beam-therapeutics-inks-300-million-gene-editing-collaboration-with-pfizer/", "urlToImage": "https://bostonglobe-prod.cdn.arcpublishing.com/resizer/eWfQTxQJDjxb0fMdU8Riho9jdMs=/506x0/cloudfront-us-east-1.images.arcpublishing.com/bostonglobe/S76TJWJ665HMZPBYDLL4UJPKAE.png", "publishedAt": "2022-01-10T11:00:02Z", "content": "The companies announced on Monday that they are partnering to work on genetic medicines for three undisclosed diseases involving the liver, muscles, and central nervous system. Pfizer will pay Beam $\u2026 [+2785 chars]"}]}, "2022-01-09": {"status": "ok", "totalResults": 7, "articles": [{"source": {"id": null, "name": "Bitchute.com"}, "author": "Mike Rivero", "title": "ADOLESCENT JAB INJURIES EXPLODE: PFIZER TRIAL NUMBERS REVEAL HORRIFIC TEEN DATA", "description": "Mirror. Source \r\nAdolescent Jab Injuries Explode: Pfizer Trial Numbers Reveal Horrific Teen Data https://rumble.com/vs57in-adolescent-jab-injuries-explode-pfizer-trial-numbers-reveal-horrific-teen-d.html\r\n\r\nQuote: \"Deanna Lorraine discusses the horr\u2026", "url": "https://www.bitchute.com/video/p8zunntzd9IK/", "urlToImage": "https://static-3.bitchute.com/live/cover_images/faE29csjg49w/p8zunntzd9IK_640x360.jpg", "publishedAt": "2022-01-09T13:15:29Z", "content": "Mirror. Source Adolescent Jab Injuries Explode: Pfizer Trial Numbers Reveal Horrific Teen Data https://rumble.com/vs57in-adolescent-jab-injuries-explode-pfizer-trial-numbers-reveal-horrific-teen-d.ht\u2026 [+4618 chars]"}, {"source": {"id": null, "name": "Investmentwatchblog.com"}, "author": "alexmark", "title": "Why Don't We Cut Out the Middleman and Just Elect Pfizer and Merck?", "description": null, "url": "https://www.investmentwatchblog.com/why-dont-we-cut-out-the-middleman-and-just-elect-pfizer-and-merck/", "urlToImage": null, "publishedAt": "2022-01-09T17:14:47Z", "content": "by Charles Hugh-Smith\r\nIf we no longer have the capacity to distinguish between moral legitimacy and self-serving corruption, then we might as well eliminate the Middleman and vote directly for Pfize\u2026 [+6349 chars]"}, {"source": {"id": "independent", "name": "Independent"}, "author": "Eleanor Sly", "title": "How effective are the Pfizer, AstraZeneca and Moderna vaccines against Omicron?", "description": "Booster jabs provide up to 70 per cent protection, study finds", "url": "https://www.independent.co.uk/news/health/vaccines-covid-pfizer-moderna-astrazeneca-b1989568.html", "urlToImage": "https://static.independent.co.uk/2021/12/09/16/GettyImages-89747046%20%281%29.jpg?width=1200&auto=webp&quality=75", "publishedAt": "2022-01-09T16:19:56Z", "content": "The more contagious Omicron variant of Covid-19 is continuing to spread rapidly across the UK and could eventually become the dominant strain of the coronavirus.\r\nSo far, more than 75 deaths from the\u2026 [+7421 chars]"}, {"source": {"id": null, "name": "Freerepublic.com"}, "author": "Breitbart", "title": "Judge Gives FDA 8 Months to Release Pfizer Vaccine Data After Agency Requested 75 Years", "description": "A federal judge on Thursday ordered the U.S. Food and Drug Administration (FDA) to release Pfizer vaccine data within approximately eight months after the agency had asked for 75 years to fully comply with an extensive public records request. President Donald\u2026", "url": "https://freerepublic.com/focus/f-news/4027883/posts", "urlToImage": null, "publishedAt": "2022-01-09T00:47:09Z", "content": "Skip to comments.\r\nJudge Gives FDA 8 Months to Release Pfizer Vaccine Data After Agency Requested 75 YearsBreitbart ^\r\n | 8 Jan 2022\r\n | KATHERINE HAMILTON\r\nPosted on 01/08/2022 4:47:09 PM PST by E. \u2026 [+2540 chars]"}, {"source": {"id": null, "name": "Freerepublic.com"}, "author": "Based Underground", "title": "7-Year-Old Dies 11 Days After Pfizer Shot, VAERS Report Shows", "description": "The Centers for Disease Control and Prevention today released new data showing a total of 1,017,001 reports of adverse events following COVID vaccines were submitted between Dec. 14, 2020, and Dec. 31, 2021, to the Vaccine Adverse Event Reporting System (VAER\u2026", "url": "https://freerepublic.com/focus/f-news/4027886/posts", "urlToImage": null, "publishedAt": "2022-01-09T00:57:33Z", "content": "Skip to comments.\r\n7-Year-Old Dies 11 Days After Pfizer Shot, VAERS Report ShowsBased Underground ^\r\n | January 8, 2022\r\n | Megan Redshaw \r\nPosted on 01/08/2022 4:57:33 PM PST by E. Pluribus Unum\r\nTh\u2026 [+3078 chars]"}, {"source": {"id": null, "name": "Freerepublic.com"}, "author": "Based Underground", "title": "7-Year-Old Dies 11 Days After Pfizer Shot, VAERS Report Shows", "description": "The Centers for Disease Control and Prevention today released new data showing a total of 1,017,001 reports of adverse events following COVID vaccines were submitted between Dec. 14, 2020, and Dec. 31, 2021, to the Vaccine Adverse Event Reporting System (VAER\u2026", "url": "https://freerepublic.com/focus/f-bloggers/4027886/posts", "urlToImage": null, "publishedAt": "2022-01-09T00:57:33Z", "content": "Skip to comments.\r\n7-Year-Old Dies 11 Days After Pfizer Shot, VAERS Report ShowsBased Underground ^\r\n | January 8, 2022\r\n | Megan Redshaw \r\nPosted on 01/08/2022 4:57:33 PM PST by E. Pluribus Unum\r\nTh\u2026 [+6554 chars]"}, {"source": {"id": null, "name": "Freethoughtblogs.com"}, "author": "Charly", "title": "Explaining Pfizer Vaccine in a Nutshell", "description": "I was just explaining how the Pfizer vaccine against Covid-19 works to my parents \u2013 not that they were vaccine skeptics or some such, my mother was just curious \u2013 so I put my teacher hat on and \u2013 inspired by yesterday\u2019s picture post by kestrel \u2013 I put it to t\u2026", "url": "https://freethoughtblogs.com/affinity/2022/01/09/explaining-pfizer-vaccine-in-a-nutshell/", "urlToImage": "https://freethoughtblogs.com/affinity/wp-content/themes/ftb2-theme/images/logo.png", "publishedAt": "2022-01-09T17:10:37Z", "content": "I was just explaining how the Pfizer vaccine against Covid-19 works to my parents \u2013 not that they were vaccine skeptics or some such, my mother was just curious \u2013 so I put my teacher hat on and \u2013 ins\u2026 [+853 chars]"}]}, "2022-01-08": {"status": "ok", "totalResults": 9, "articles": [{"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "Tiffany Razzano", "title": "Pfizer Boosters For Kids 12-15: What Florida Parents Need To Know", "description": "The Food and Drug Administration and Centers for Disease Control and Prevention authorize booster shots for children ages 12-15.", "url": "https://news.yahoo.com/pfizer-boosters-kids-12-15-151543668.html", "urlToImage": "https://s.yimg.com/uu/api/res/1.2/kUejMkl8WgrI4TGk4p_.CA--~B/aD04MDA7dz0xMDY2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/patch_hosted_articles_700/3e9250f5ecb6c74b503ba3741d938c18", "publishedAt": "2022-01-08T15:15:43Z", "content": "FLORIDA Federal health officials have authorized the Pfizer COVID-19 booster for children as young as 12 in our area, broadening access to the third dose of the vaccine as COVID-19 daily infection ra\u2026 [+2739 chars]"}, {"source": {"id": null, "name": "Bangkok Post"}, "author": "Online Reporters", "title": "Young children to receive Pfizer jabs", "description": "The government has prepared doses of the Pfizer-BioNTech Covid-19 vaccine for children between the ages of five and 11, deputy government spokeswoman Rachada Dhnadirek said on Saturday.", "url": "https://www.bangkokpost.com/thailand/general/2244155/young-children-to-receive-pfizer-jabs", "urlToImage": "https://static.bangkokpost.com/media/content/20220108/c1_2244155_700.jpg", "publishedAt": "2022-01-08T05:38:00Z", "content": "The government has prepared doses of the Pfizer-BioNTech Covid-19 vaccine for children between the ages of five and 11, deputy government spokeswoman Rachada Dhnadirek said on Saturday.\r\nThe vaccinat\u2026 [+1122 chars]"}, {"source": {"id": null, "name": "Tapnewswire.com"}, "author": "Mike Rivero", "title": "Hackers Crack Pfizer, Moderna & Pfizer Servers! All Vaccine Death Data Now Public From All Companies", "description": "GOOD NEWS!!!! Hackers broke into all the pharmaceutical companies and stole all the medial data on vaccines thank God!!!! The Great Awaking has lifted off!!! Forward this link everywhere!!!!\n**Displays number of deaths and disabilities associated with each ba\u2026", "url": "https://tapnewswire.com/2022/01/hackers-crack-pfizer-moderna-pfizer-servers-all-vaccine-death-data-now-public-from-all-companies-thanks-to-hackers/", "urlToImage": null, "publishedAt": "2022-01-08T13:34:01Z", "content": "Fri 10:37 am +00:00, 7 Jan 2022 \u00a03\r\nGOOD NEWS!!!! Hackers broke into all the pharmaceutical companies and stole all the medial data on vaccines thank God!!!! The Great Awaking has lifted off!!! Forwa\u2026 [+2329 chars]"}, {"source": {"id": null, "name": "Legalinsurrection.com"}, "author": "Leslie Eastman", "title": "Judge Gives FDA Eight Months Instead of 55 Years to Release Pfizer Vaccine Data", "description": "U.S. District Judge Mark Pittman: \"The court 'concludes that this FOIA request is of paramount public importance.'\"\nThe post Judge Gives FDA Eight Months Instead of 55 Years to Release Pfizer Vaccine Data first appeared on Le\u00b7gal In\u00b7sur\u00b7rec\u00b7tion.", "url": "https://legalinsurrection.com/2022/01/judge-gives-fda-eight-months-instead-of-55-years-to-release-pfizer-vaccine-data/", "urlToImage": "https://legalinsurrection.com/wp-content/uploads/2020/11/Pfizer-vaccine.jpg", "publishedAt": "2022-01-08T19:00:20Z", "content": "Last November, I reported that in response to a Freedom of Information Act request, the Food &amp; Drug Administration (FDA) asked a federal court to grant the agency until 2076, 55 years, to process\u2026 [+3153 chars]"}, {"source": {"id": null, "name": "Womensystems.com"}, "author": "mayaleo", "title": "Judge Gives FDA Just Over 8 Months To Produce Full Pfizer Data And Documentation On Safety Of COVID Vaccine\u2014-NOT 75 Years!", "description": "Women Entertainment Sysytem", "url": "http://www.womensystems.com/2022/01/judge-gives-fda-just-over-8-months-to.html", "urlToImage": null, "publishedAt": "2022-01-08T12:50:27Z", "content": "Back in December, the FDA requested they be given\u00a075 years to review and release all the data on Pfizer to the public.\u00a0Now, a federal judge has ruled that they have just over 8 months to turn in the \u2026 [+2015 chars]"}, {"source": {"id": null, "name": "Investmentwatchblog.com"}, "author": "alexmark", "title": "Moderna/Pfizer vaccine \"about 10% effective\" against Omicorn 20 weeks after dose 2. Booster efficacy drops. Likely need a 4th shot.", "description": null, "url": "https://www.investmentwatchblog.com/moderna-pfizer-vaccine-about-10-effective-against-omicorn-20-weeks-after-dose-2-booster-efficacy-drops-likely-need-a-4th-shot/", "urlToImage": null, "publishedAt": "2022-01-08T13:42:52Z", "content": "CNBC article.\r\nI will be surprised when we get that data in the coming weeks that its holding nicely over time I would expect that its not gonna hold great, Bancel said, referring to the strength of \u2026 [+1818 chars]"}, {"source": {"id": null, "name": "bdnews24.com"}, "author": null, "title": "Pfizer/BioNTech vaccine protects children against rare COVID-19 complication: CDC", "description": "Two doses of the Pfizer Inc and BioNTech COVID-19 vaccine are highly protective against a rare but often serious condition in children that causes organ inflammation weeks after COVID-19 infections, a US Centers for Disease Control and Prevention report said \u2026", "url": "https://bdnews24.com/coronavirus-pandemic/2022/01/08/pfizerbiontech-vaccine-protects-children-against-rare-covid-19-complication-cdc", "urlToImage": "https://d30fl32nd2baj9.cloudfront.net/media/2021/02/25/pfizer-vaccine-250221-01.jpg/ALTERNATES/w640/pfizer-vaccine-250221-01.jpg", "publishedAt": "2022-01-08T04:45:47Z", "content": "The vaccine was estimated to be 91% effective in preventing Multisystem Inflammatory Syndrome in Children (MIS-C) in 12- to 18-year-olds, the study said. MIS-C causes inflammation in children in orga\u2026 [+1108 chars]"}, {"source": {"id": null, "name": "Wykop.pl"}, "author": "kiwi007", "title": "Judge Gives FDA 8 Months, Not 75 Years, to Produce Pfizer Safety Data", "description": "The U.S. Food and Drug Administration will have eight months \u2014 not the 75 years it requested \u2014 to release all documents related to the licensing of Pfizer\u2019s Comirnaty COVID vaccine, a federal judge ruled Thursday.", "url": "https://www.wykop.pl/link/6446481/judge-gives-fda-8-months-not-75-years-to-produce-pfizer-safety-data/", "urlToImage": "https://www.wykop.pl/cdn/c3397993/link_1641643635FjdPlkShadhgKu4qpMjVgl,w1200h627f.jpg", "publishedAt": "2022-01-08T12:08:25Z", "content": "Drogi Wykopowiczu\r\nw zaczonym linku do Polityki Prywatnoci przypominamy podstawowe informacje z zakresu przetwarzania danych osobowych dostarczanych przez Ciebie podczas korzystania z naszego serwisu\u2026 [+108 chars]"}, {"source": {"id": "breitbart-news", "name": "Breitbart News"}, "author": "Katherine Hamilton", "title": "Judge Gives FDA 8 Months to Release Pfizer Vaccine Data After Agency Requested 75 Years", "description": "A federal judge gave the FDA eight months to release data pertaining to the safety of Pfizer's coronavirus vaccine after the FDA had asked for 75 years.", "url": "https://www.breitbart.com/science/2022/01/08/judge-gives-fda-8-months-to-release-pfizer-vaccine-data-after-agency-requested-75-years/", "urlToImage": "https://media.breitbart.com/media/2022/01/Suit-640x335.jpg", "publishedAt": "2022-01-08T18:17:31Z", "content": "A federal judge on Thursday ordered the U.S. Food and Drug Administration (FDA) to release Pfizer vaccine data within approximately eight months after the agency had asked for 75 years to fully compl\u2026 [+4952 chars]"}]}, "2022-01-07": {"status": "ok", "totalResults": 19, "articles": [{"source": {"id": null, "name": "Slashdot.org"}, "author": "BeauHD", "title": "Judge Orders FDA To Hasten Release of Pfizer Vaccine Docs", "description": "A federal judge in Texas on Thursday ordered the Food and Drug Administration to make public the data it relied on to license Pfizer's COVID-19 vaccine, imposing a dramatically accelerated schedule that should result in the release of all information within a\u2026", "url": "https://science.slashdot.org/story/22/01/07/2124212/judge-orders-fda-to-hasten-release-of-pfizer-vaccine-docs", "urlToImage": "https://a.fsdn.com/sd/topics/medicine_64.png?refresh=now", "publishedAt": "2022-01-07T22:50:00Z", "content": "A federal judge in Texas on Thursday ordered the Food and Drug Administration to make public the data it relied on to license Pfizer's COVID-19 vaccine, imposing a dramatically accelerated schedule t\u2026 [+2182 chars]"}, {"source": {"id": null, "name": "Zacks.com"}, "author": "Zacks Equity Research", "title": "Zacks Investment Ideas feature highlights: AbbVie, Inc. and Pfizer Inc", "description": "AbbVie, Inc. and Pfizer Inc are highlighted in this investment idea article.", "url": "http://www.zacks.com/stock/news/1848803/zacks-investment-ideas-feature-highlights-abbvie-inc-and-pfizer-inc?cid=CS-ENTREPRENEUR-FT-press_releases-1848803", "urlToImage": "https://assets.entrepreneur.com/providers/zacks/hero-image-zacks-411991.jpeg", "publishedAt": "2022-01-07T11:07:00Z", "content": "For Immediate Release\r\nChicago, IL January 7, 2022 Today, Zacks Investment Ideas features: AbbVie, Inc. ABBV and Pfizer Inc. PFE.\r\n - Zacks\r\nHow to Select Stocks During Volatile Market Periods\r\nThe p\u2026 [+8584 chars]"}, {"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "'Paramount importance': Judge orders FDA to hasten release of Pfizer vaccine docs - Reuters", "description": "'Paramount importance': Judge orders FDA to hasten release of Pfizer vaccine docs\u00a0\u00a0Reuters", "url": "https://www.reuters.com/legal/government/paramount-importance-judge-orders-fda-hasten-release-pfizer-vaccine-docs-2022-01-07/", "urlToImage": "https://www.reuters.com/resizer/_r8e9HZhMgbblmh4iWBhqQzMjhI=/728x381/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/NO2ZBBKLQRMULFDWRPMV3M2WOA.jpg", "publishedAt": "2022-01-07T03:12:00Z", "content": "<ul><li>\r\nLaw firms</li><li>\r\nRelated documents</li></ul>\r\nThe company and law firm names shown above are generated automatically based on the text of the article. We are improving this feature as we\u2026 [+4620 chars]"}, {"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "Pfizer/BioNTech vaccine protects children against rare COVID-19 complication - CDC - Reuters", "description": "Two doses of the Pfizer Inc <a href=\"https://www.reuters.com/companies/PFE.N\" target=\"_blank\">(PFE.N)</a> and BioNTech <a href=\"https://www.reuters.com/companies/22UAy.DE\" target=\"_blank\">(22UAy.DE)</a> COVID-19 vaccine are highly protective against a rare bu\u2026", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/pfizerbiontech-vaccine-protects-children-against-rare-covid-19-complication-cdc-2022-01-07/", "urlToImage": "https://www.reuters.com/resizer/eBPv4IcLDemACMoIfyzGngcc0xY=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/6FDEWO5RCFJGHAOB3ONP6RDJ54.jpg", "publishedAt": "2022-01-07T20:03:00Z", "content": "Jan 7 (Reuters) - Two doses of the Pfizer Inc (PFE.N) and BioNTech (22UAy.DE) COVID-19 vaccine are highly protective against a rare but often serious condition in children that causes organ inflammat\u2026 [+1655 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "AFP Videographics", "title": "Children 12 and up receive Pfizer booster after US approval", "description": "A group of children ages 12 and up receive their booster shots of Pfizer-BioNTech's Covid-19 vaccine in Hartford, Connecticut, after US health authorities...", "url": "https://news.yahoo.com/children-12-receive-pfizer-booster-170952329.html", "urlToImage": "https://s.yimg.com/ny/api/res/1.2/yhO3zdcPPw9lsXcyfNvBqA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzU-/https://s.yimg.com/hd/cp-video-transcode/prod/2022-01/07/61d8761724ffa931ebffc89a/61d8761724ffa931ebffc89b_o_U_v2.jpg", "publishedAt": "2022-01-07T17:09:52Z", "content": "A group of children ages 12 and up receive their booster shots of Pfizer-BioNTech's Covid-19 vaccine in Hartford, Connecticut, after US health authorities approved the jab on Monday for the age group\u2026 [+100 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "Reuters", "title": "Pfizer/BioNTech vaccine protects children against rare COVID-19 complication - CDC", "description": "The estimate is based on the assessment of 283 hospitalized patients aged 12\u201318 years at 24 children's hospitals in 20 states between July and early December...", "url": "https://news.yahoo.com/pfizer-biontech-vaccine-protects-children-200332767.html", "urlToImage": "https://s.yimg.com/uu/api/res/1.2/Ftz0Oc3nXPOG7uPjSwEt6g--~B/aD01MzM7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/596b4a4edb443be72c4d1cb461cc52a6", "publishedAt": "2022-01-07T20:03:32Z", "content": "(Reuters) - Two doses of the Pfizer Inc and BioNTech COVID-19 vaccine are highly protective against a rare but often serious condition in children that causes organ inflammation weeks after COVID-19 \u2026 [+1468 chars]"}, {"source": {"id": null, "name": "FierceBiotech"}, "author": "Annalee Armstrong", "title": "JPM 2022: Pfizer re-ups gene editing interest with $300M Beam pact, $1.35B in biobucks", "description": "Pfizer is taking a bigger bite out of the gene editing apple with $300 million upfront in a research collaboration with Beam Therapeutics focused on the biotech's base editing technique. The deal covers rare genetic diseases of the liver, muscle and central n\u2026", "url": "https://www.fiercebiotech.com/biotech/jpm-2022-pfizer-sees-bright-light-300m-beam-research-pact-for-base-editing-candidates", "urlToImage": "https://qtxasset.com/fiercebiotech/1641577831/spotlight-802633_1280.jpg/spotlight-802633_1280.jpg?VersionId=HmSDpu1CWvINtqI7ul_dlk7pJIjvjYb6", "publishedAt": "2022-01-07T17:50:42Z", "content": "Pfizer is taking a bigger bite out of the gene editing apple with $300 million upfront in a research collaboration with Beam Therapeutics focused on the biotech's base editing technique.\u00a0\r\nOn the lin\u2026 [+3667 chars]"}, {"source": {"id": null, "name": "The Daily Caller"}, "author": "Anders Hagstrom", "title": "Judge Orders Biden Admin To Release Info On Pfizer COVID Vaccine Within Months, Not 75 Years", "description": "A federal judge in Texas has ordered the Biden administration to release hundreds of thousands of pages relating to the COVID-19 vaccine by March 1.", "url": "https://dailycaller.com/2022/01/07/biden-vaccine-release-foia-fda-pfizer-covid/", "urlToImage": "https://cdn01.dailycaller.com/wp-content/uploads/2021/11/GettyImages-121279005-scaled-e1636507020604.jpg", "publishedAt": "2022-01-07T18:25:32Z", "content": "A federal judge in Texas has ordered President Joe Biden\u2019s administration to publicly release hundreds of thousands of pages of information relating to the Pfizer COVID-19 vaccine by March 1, accordi\u2026 [+2364 chars]"}, {"source": {"id": null, "name": "FiercePharma"}, "author": "Angus Liu", "title": "CEO pay for Pfizer, J&J, Moderna and AstraZeneca should be tied to COVID-19 vaccine equity, investors say", "description": "COVID-19 vaccine developers have enjoyed a windfall and so have their chief executives. Now, a group of investors are asking the companies to improve vaccine equity by heaping pressure at the C-suite level.", "url": "https://www.fiercepharma.com/pharma/pfizer-j-j-moderna-and-astrazeneca-ceo-pay-packages-should-consider-covid-19-vaccine-equity", "urlToImage": "https://qtxasset.com/fiercepharma/1641571492/Vaccine.jpg/Vaccine.jpg?VersionId=CqSQpyVwPQb2xpZ8FoOpGCyIknXPF0TI", "publishedAt": "2022-01-07T16:05:57Z", "content": "COVID-19 vaccine developers have enjoyed a windfall and so have their chief executives. Now, a group of investors are asking the companies to improve vaccine equity by heaping pressure at the C-suite\u2026 [+3657 chars]"}, {"source": {"id": null, "name": "Seeking Alpha"}, "author": "Jonathan Block", "title": "Pfizer/BioNTech vaccine protects teens against COVID inflammatory condition", "description": "A CDC study found that adolescents between the ages of 12 and 18 years old given the Pfizer/BioNTech COVID vaccine had a high level of protection against multisystem inflammatory syndrome.", "url": "https://seekingalpha.com/news/3786392-pfizer-biontech-vaccine-protects-teens-against-covid-inflammatory-condition", "urlToImage": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1325583644/medium_image_1325583644.jpg", "publishedAt": "2022-01-07T21:41:44Z", "content": "Omar Marques/Getty Images News"}, {"source": {"id": null, "name": "Cdc.gov"}, "author": "CDC", "title": "EARLY RELEASE: Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12-18 Years - United States, July-December 2021", "description": "This report describes how effective Pfizer-BioNTech COVID-19 vaccination was against multisystem inflammatory syndrome in children (MIS-C).", "url": "https://www.cdc.gov/mmwr/volumes/71/wr/mm7102e1.htm", "urlToImage": "https://www.cdc.gov/mmwr/volumes/71/wr/social-media/mm7102e1_PfizerMIS-C_IMAGE_07Jan22_1200x627.jpg?_=02907", "publishedAt": "2022-01-07T18:00:00Z", "content": "Laura D. Zambrano, PhD1,*; Margaret M. Newhams, MPH2,*; Samantha M. Olson, MPH1; Natasha B. Halasa, MD3; Ashley M. Price, MPH1; Julie A. Boom, MD4; Leila C. Sahni, PhD4; Satoshi Kamidani, MD5; Keiko \u2026 [+44404 chars]"}, {"source": {"id": null, "name": "Thegatewaypundit.com"}, "author": "Julian Conradson", "title": "JUST IN: Court REJECTS FDA Request to Release Vaccine FOIA Documents Over the Next 55 Years \u2013 Orders Agency to Turn Over Tens of Thousands of Pfizer Docs Monthly", "description": "On Thursday, a Federal Judge \u201csoundly\u201d rejected the FDA\u2019s panicked request for permission to produce hundreds of thousands of documents related to Pfizer and the Covid vaccines at a rate of 500 pages per month after the agency was ordered to comply with a Fre\u2026", "url": "https://www.thegatewaypundit.com/2022/01/just-court-rejects-fda-request-release-vaccine-foia-documents-next-55-years-orders-agency-turn-tens-thousands-pfizer-docs-monthly/", "urlToImage": "https://www.thegatewaypundit.com/wp-content/uploads/D1617591-2630-4428-BC62-1A7E9DC60F42.jpeg", "publishedAt": "2022-01-07T13:15:06Z", "content": "On Thursday, a Federal Judge \u201csoundly\u201d rejected the FDA\u2019s panicked request for permission to produce hundreds of thousands of documents related to Pfizer and the Covid vaccines at a rate of 500 pages\u2026 [+3607 chars]"}, {"source": {"id": "usa-today", "name": "USA Today"}, "author": "USA TODAY, Celina Tebor, Claire Thornton and Karen Weintraub, USA TODAY", "title": "Pfizer COVID-19 vaccine won't be ready for youngest kids for months: Live updates", "description": "Children younger than 5 may have to wait until spring to get a Pfizer shot. The Mayor Clinic fires workers who missed deadline. More COVID updates.", "url": "https://www.usatoday.com/story/news/health/2022/01/07/covid-vaccine-mandates-cases-deaths/9124194002/", "urlToImage": "https://www.gannett-cdn.com/presto/2021/12/24/USAT/78817802-c552-43a9-b4ee-ec0152297e23-COVID.jpg?auto=webp&crop=1904,1071,x0,y0&format=pjpg&width=1200", "publishedAt": "2022-01-07T10:00:12Z", "content": "Pfizer-BioNTech's\u00a0COVID-19 vaccine won't be available anytime soon for kids younger than 5 years old.\r\nIn early tests, the lower dose given to 2- to 5-year-olds didn't produce as much immune protecti\u2026 [+3961 chars]"}, {"source": {"id": "usa-today", "name": "USA Today"}, "author": "USA TODAY, Elizabeth Weise, USA TODAY", "title": "COVID-19 boosters\u00a0offer 'potent' protection against omicron, study says, recommending Pfizer and Moderna", "description": "COVID-19 boosters with an mRNA vaccine provide the best protection against omicron, according to a study published this week in the journal Cell.", "url": "https://www.usatoday.com/story/news/health/2022/01/07/covid-boosters-pfizer-moderna-omicron/9123578002/", "urlToImage": "https://www.gannett-cdn.com/presto/2021/08/18/USAT/d684cccc-d961-45b5-ba7c-1514a4d2e977-DESK.00_00_08_07.Still013.jpg?crop=1911,1075,x0,y0&width=1911&height=1075&format=pjpg&auto=webp", "publishedAt": "2022-01-07T10:02:53Z", "content": "<ul><li>The best antibody protection came from a two-dose series of one of the mRNA vaccines, either Pfizer-BioNTech or Moderna, followed by an mRNA booster.</li><li>A COVID-19 booster shot created s\u2026 [+4449 chars]"}, {"source": {"id": "usa-today", "name": "USA Today"}, "author": "USA TODAY, Karen Weintraub, USA TODAY", "title": "Pfizer COVID-19 shot won't be ready for youngest kids for months:\u00a0'Might be a three-dose vaccine'", "description": "The lower dose given to 2- to 5-year-olds hasn't produced the necessary immune protection in early tests, according to Pfizer.", "url": "https://www.usatoday.com/story/news/health/2022/01/06/covid-pfizer-vaccine-youngest-children/9122889002/", "urlToImage": "https://www.gannett-cdn.com/-mm-/909a7a305f8c09175fff3064657ca5a2883aa164/c=0-152-2000-1277/local/-/media/2021/12/13/Charleston/gda-covid-19-state-2021-12-13-img.jpg?auto=webp&format=pjpg&width=1200", "publishedAt": "2022-01-07T00:29:28Z", "content": "<ul><li>Pfizer hopes a third dose of its COVID-19 vaccine eight weeks after the first two shots will provide the desired effectiveness in early trials.</li><li>Other vaccine makers have lagged Pfizer\u2026 [+3341 chars]"}, {"source": {"id": null, "name": "CNBC"}, "author": "Spencer Kimball", "title": "Pfizer Covid vaccine protects adolescents against multisystem inflammatory syndrome, CDC says", "description": "MIS-C is a condition in which organs become inflamed, such as the heart, lungs, kidneys or brain.", "url": "https://www.cnbc.com/2022/01/07/covid-pfizer-vaccine-effective-protects-against-mis-c-cdc-says.html", "urlToImage": "https://image.cnbcfm.com/api/v1/image/106951692-1641579698762-abc.jpg?v=1641579723", "publishedAt": "2022-01-07T20:11:27Z", "content": "Two doses of Pfizer and BioNTech's vaccine are highly effective at protecting children 12 to 18 from a severe inflammatory condition associated with Covid infection, a new study found.\r\nThe Centers f\u2026 [+2096 chars]"}, {"source": {"id": null, "name": "Investmentwatchblog.com"}, "author": "alexmark", "title": "Judge quotes JFK and orders the FDA to release 55,000 pages per month of Pfizer data! \u201cA nation that is afraid to let its people judge the truth and falsehood in an open market is a nation that is afraid of its people.\u201d", "description": null, "url": "https://www.investmentwatchblog.com/judge-quotes-jfk-and-orders-the-fda-to-release-55000-pages-per-month-of-pfizer-data-a-nation-that-is-afraid-to-let-its-people-judge-the-truth-and-falsehood-in-an-open-market-is-a-nation-tha/", "urlToImage": null, "publishedAt": "2022-01-07T17:39:53Z", "content": "There are still some judges who have not been bought by Big Pharma.I am pleased to report a federal judge rejected the FDA's request to produce the Pfizer Covid vaccine data at 500 pages per month an\u2026 [+183 chars]"}, {"source": {"id": null, "name": "Regulatory Focus"}, "author": "Michael Mezher", "title": "This Week at FDA: Senate committee to vote on Califf\u2019s nomination; FDA ordered to speed release of Pfizer vaccine documents", "description": "Welcome back to This Week at FDA! There\u2019s lots of big news to cover in this week\u2019s installment, including some items from before the holidays, updates on COVID-19 vaccines and Robert Califf\u2019s nomination to lead the FDA. Plus, we get word that FDA\u2019s move to ha\u2026", "url": "https://www.raps.org/news-and-articles/news-articles/2022/1/this-week-at-fda-senate-committee-to-vote-on-calif?feed=Regulatory-Focus", "urlToImage": "https://www.raps.org/RAPS/media/news-images/June%202020%20Graphic%20Refresh/FDA-building-300x200px.jpg?ext=.jpg", "publishedAt": "2022-01-07T22:14:37Z", "content": "Regulatory Affairs Professionals Society (RAPS)5635 Fishers Lane, Suite 400Rockville, Maryland 20852"}, {"source": {"id": null, "name": "Slashdot.org"}, "author": "feedfeeder", "title": "Pfizer Covid vaccine protects adolescents against multisystem inflammatory syndrome, CDC says - CNBC", "description": "Pfizer Covid vaccine protects adolescents against multisystem inflammatory syndrome, CDC saysCNBC U.S. FDA cuts gap for Moderna COVID-19 booster dose as cases surgeYahoo News What Parents Need To Know As CDC Authorizes Covid Booster For Children 12 To 15NBC N\u2026", "url": "https://slashdot.org/firehose.pl?op=view&amp;id=157212061", "urlToImage": null, "publishedAt": "2022-01-07T21:33:25Z", "content": "Frankly, Scarlett, I don't have a fix.\r\n-- Rhett Buggler"}]}, "2022-01-06": {"status": "ok", "totalResults": 28, "articles": [{"source": {"id": null, "name": "NPR"}, "author": "Jonathan Franklin", "title": "Children as young as 12 should get Pfizer COVID-19 booster vaccines, CDC advisers say", "description": "If the CDC approves the advisory panel's recommendation, boosters for adolescents age 12-17 could be available as early as this week. The shots should be given five months after initial immunization.", "url": "https://www.npr.org/sections/health-shots/2022/01/05/1070744591/covid-19-boosters-pfizer-adolescents", "urlToImage": "https://media.npr.org/assets/img/2022/01/05/COVID-19vaccine_wide-f1965763458db5f5484d97724bc8319f8c96dad3.jpg?s=1400", "publishedAt": "2022-01-06T00:32:47Z", "content": "A doctor loads a dose of Pfizer COVID-19 vaccine into a syringe, on Dec. 2, 2021, at a mobile vaccination clinic in Worcester, Mass.\r\nSteven Senne/AP\r\nAdvisers to the Centers for Disease Control and \u2026 [+1853 chars]"}, {"source": {"id": "axios", "name": "Axios"}, "author": "Erin Doherty", "title": "CDC recommends Pfizer boosters for 12- to 17-year-olds", "description": "Centers for Disease Control and Prevention Director Rochelle Walensky on Wednesday approved a CDC advisory committee's vote to recommend booster doses of Pfizer-BioNTech's COVID-19 vaccine for 12- to 17-year-olds.Driving the news: The vote passed 13-1 earlier\u2026", "url": "https://www.axios.com/cdc-recommends-pfizer-booster-shots-children-76090871-996e-42e9-82fe-10a323a745ac.html", "urlToImage": "https://images.axios.com/rdAl0O9F1DV9hMk0ni-06J7qQGo=/0x81:3870x2258/1366x768/2022/01/04/1641310553780.jpg", "publishedAt": "2022-01-06T02:19:24Z", "content": "Centers for Disease Control and Prevention Director Rochelle Walensky on Wednesday approved a CDC advisory committee's vote to recommend booster doses of Pfizer-BioNTech's COVID-19 vaccine for 12- to\u2026 [+1348 chars]"}, {"source": {"id": null, "name": "The Indian Express"}, "author": "Reuters", "title": "US CDC advisory panel in favour of Pfizer vaccine booster for ages 12 to 15", "description": "The CDC said in a statement it now recommended that adolescents age 12 to 17 years old should receive a booster shot 5 months after their initial Pfizer/BioNTech vaccination series.", "url": "https://indianexpress.com/article/world/us-cdc-pfizer-vaccine-covid-booster-dose-children-7709501/", "urlToImage": "https://images.indianexpress.com/2022/01/2022-01-05T164906Z_743339459_RC21TR9ITATL_RTRMADP_3_HEALTH-CORONAVIRUS-BELGIUM-VACCINATION.jpg", "publishedAt": "2022-01-06T08:18:26Z", "content": "The US Centers for Disease Control and Prevention (CDC) said on Wednesday it expanded the eligibility of Pfizer Inc and BioNTech SE\u2019s booster doses to those 12 to 15 years old.The move came after a p\u2026 [+2879 chars]"}, {"source": {"id": null, "name": "Moneycontrol"}, "author": null, "title": "Omicron virus: CDC recommends Pfizer booster shots for children aged 12 and above", "description": "The COVID-19 vaccine made by Pfizer and its partner BioNTech is the only US option for children of any age.", "url": "https://www.moneycontrol.com/news/world/omicron-virus-cdc-recommends-pfizer-booster-shots-for-children-aged-12-and-above-7904891.html", "urlToImage": "https://images.moneycontrol.com/static-mcnews/2022/01/covid-19-vaccine-booster-770x433.jpg", "publishedAt": "2022-01-06T03:49:46Z", "content": "Amid an unprecedented surge of COVID-19 driven by the Omicron variant across the United States, the Centers for Disease Control and Prevention (CDC) has recommended expanding eligibility of booster d\u2026 [+2240 chars]"}, {"source": {"id": null, "name": "The Star Online"}, "author": "FATIMAH ZAINAL", "title": "Covid-19: Pfizer vaccine for children aged five to 11 given conditional approval", "description": "PETALING JAYA: The Drug Control Authority has granted conditional registration approval for the Pfizer vaccine for children aged between five and 11. Read full story", "url": "https://www.thestar.com.my/news/nation/2022/01/06/covid-19-pfizer-vaccine-for-children-aged-five-to-11-given-conditional-approval", "urlToImage": "https://apicms.thestar.com.my/uploads/images/2022/01/06/1433814.jpg", "publishedAt": "2022-01-06T09:59:00Z", "content": "PETALING JAYA: The Drug Control Authority has granted conditional registration approval for the Pfizer vaccine for children aged between five and 11.\r\nHealth Minister Khairy Jamaluddin said that the \u2026 [+381 chars]"}, {"source": {"id": null, "name": "Globalresearch.ca"}, "author": "Global Research News", "title": "Selected Articles: Pfizer 6 Month Data Shows COVID Shots May \u201cCause More Illness than They Prevent\u201d", "description": "Now People Are Dying from the Vaccine. \u201cAll Vaccinations Must be Stopped\u201d\nBy Dr. Paul Craig Roberts, January 05, 2022\nOneAmerica is a large life insurance company in Indianapolis. The chief executive officer, Scott Davison just announced that judging \u2026\nThe po\u2026", "url": "https://www.globalresearch.ca/selected-articles-pfizer-6-month-data-shows-covid-shots-may-cause-more-illness-than-they-prevent/5766387", "urlToImage": "https://www.globalresearch.ca/wp-content/uploads/2021/09/killer-covid-vaccine-1024x816-1.png", "publishedAt": "2022-01-06T07:05:30Z", "content": "Now People Are Dying from the Vaccine. All Vaccinations Must be Stopped\r\nBy Dr. Paul Craig Roberts, January 05, 2022\r\nOneAmerica is a large life insurance company in Indianapolis. The chief executive\u2026 [+5169 chars]"}, {"source": {"id": null, "name": "CNA"}, "author": null, "title": "Pfizer expects updated COVID-19 vaccine data for children under 5 by April", "description": "NEW YORK: Pfizer expects the latest results from a clinical trial for children under the age of 5 of the COVID-19 vaccine it developed with Germany's BioNTech SE by April, a top company scientist said on Wednesday (Jan 5).\r\n\r\n\"The study has been amended to gi\u2026", "url": "https://www.channelnewsasia.com/world/pfizer-expects-updated-covid-19-vaccine-data-children-under-5-april-2417796", "urlToImage": "https://onecms-res.cloudinary.com/image/upload/s--TCeon39w--/fl_relative%2Cg_south_east%2Cl_one-cms:core:watermark:reuters%2Cw_0.1/f_auto%2Cq_auto/c_fill%2Cg_auto%2Ch_676%2Cw_1200/v1/one-cms/core/2022-01-05t223545z_1_lynxmpei040x9_rtroptp_3_health-coronavirus-usa-children.jpg?itok=ab6XMZrW", "publishedAt": "2022-01-06T00:12:32Z", "content": "NEW YORK: Pfizer expects the latest results from a clinical trial for children under the age of 5 of the COVID-19 vaccine it developed with Germany's BioNTech SE by April, a top company scientist sai\u2026 [+439 chars]"}, {"source": {"id": null, "name": "Investmentwatchblog.com"}, "author": "alexmark", "title": "Jimmy Dore with \"CNN gives award to Pfizer CEO\"", "description": null, "url": "https://www.investmentwatchblog.com/jimmy-dore-with-cnn-gives-award-to-pfizer-ceo/", "urlToImage": null, "publishedAt": "2022-01-06T18:03:28Z", "content": "InvestmentWatchBlog.com \u00a9 2013-2021. All Rights Reserved."}, {"source": {"id": null, "name": "The Indian Express"}, "author": "Reuters", "title": "Pfizer expects updated COVID-19 vaccine data for kids under 5 by April", "description": "In December, Pfizer said it was changing the design of the trial because children between the ages of 2 and 4 who were given two 3-microgram doses of the vaccine did not have the same immune response that a larger dose of the vaccine generated in older childr\u2026", "url": "https://indianexpress.com/article/world/pfizer-expects-updated-covid-19-vaccine-data-for-kids-under-5-by-april-7709228/", "urlToImage": "https://images.indianexpress.com/2022/01/covid-vaccine-1200-4-5.jpg", "publishedAt": "2022-01-06T06:08:28Z", "content": "Pfizer Inc (PFE.N) expects the latest results from a clinical trial for kids under the age of 5 of the COVID-19 vaccine it developed with Germany\u2019s BioNTech SE by April, a top company scientist said \u2026 [+993 chars]"}, {"source": {"id": null, "name": "Gript.ie"}, "author": "Mike Rivero", "title": "CASE REPORT FINDS\u00a0PFIZER COVID VACCINE\u00a0\u201cMIGHT INDUCE RAPID PROGRESSION\u201d OF RARE CANCER, AITL", "description": "A case report, published in the peer-reviewed journal Frontiers in Medicine, has found that the researchers\u2019 observations suggest vaccination with the Pfizer mRNA vaccine might \u201cinduce rapid progression of AITL\u201d, a rare cancer.\nHowever, researchers have cauti\u2026", "url": "https://gript.ie/case-report-finds-pfizer-covid-vaccine-might-induce-rapid-progression-of-rare-cancer-aitl/", "urlToImage": "https://gript.ie/wp-content/uploads/2022/01/frontierslogo.jpg", "publishedAt": "2022-01-06T21:58:44Z", "content": "A case report, published in the peer-reviewed journal Frontiers in Medicine, has found that the researchers\u2019 observations suggest vaccination with the Pfizer mRNA vaccine might \u201cinduce rapid progress\u2026 [+5562 chars]"}, {"source": {"id": null, "name": "Stationgossip.com"}, "author": "orraz", "title": "CDC advisory panel votes in favor of recommending Pfizer vaccine booster for children ages 12 to 15", "description": "Your Daily Station of Entertainment !!", "url": "http://www.stationgossip.com/2022/01/cdc-advisory-panel-votes-in-favor-of.html", "urlToImage": "https://lh6.googleusercontent.com/proxy/flHqj3n2nq2aXlHpbsOuv8X6CZP0IB42hdxwn7ucByp6op8DlIKeKW6-imXlV7CDtJQXwFwiI8MhDJbCeXUTuPZWWSHT0yIwA7xrKKVTOArggFiN7XzoNVcA_SAsbzDbbjleWY_E2ZlCoSWmCw=w1200-h630-p-k-no-nu", "publishedAt": "2022-01-06T16:55:43Z", "content": "A panel of outside experts advising the US Centers for Disease Control and Prevention (CDC) on Wednesday voted to recommend booster shots of\u00a0Pfizer\u00a0Inc and BioNTech SE's\u00a0COVID-19\u00a0vaccine be made avai\u2026 [+6099 chars]"}, {"source": {"id": "the-times-of-india", "name": "The Times of India"}, "author": "Viswanath Pilla and Teena Thacker", "title": "Pfizer may offer Covid antiviral drug to India at lower price for now", "description": "Pfizer has entered into advance purchase agreements with multiple countries. Sources told ET that Pfizer is yet to apply for emergency use authorisation in India.", "url": "https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/pfizer-may-offer-covid-antiviral-drug-to-india-at-lower-price-for-now/articleshow/88724024.cms", "urlToImage": "https://img.etimg.com/thumb/msid-88722948,width-1070,height-580,imgsize-360851,overlay-etmarkets/photo.jpg", "publishedAt": "2022-01-06T00:51:13Z", "content": "may offer its Covid antiviral drug Paxlovid at lower prices for low and middle income countries (LMICs), including India, as an interim measure as the cheaper generic versions may not be available un\u2026 [+3713 chars]"}, {"source": {"id": null, "name": "Seeking Alpha"}, "author": "SA Transcripts", "title": "Pfizer Inc. (PFE) CEO Dr. Albert Bourla Presents at Goldman Sachs 14th Annual Healthcare CEOs Unscripted Conference (Transcript)", "description": "Pfizer Inc. (NYSE:PFE) Goldman Sachs 14th Annual Healthcare CEOs Unscripted Conference January 6, 2021 10:00 AM ETCompany ParticipantsDr.", "url": "https://seekingalpha.com/article/4478300-pfizer-inc-pfe-ceo-dr-albert-bourla-presents-goldman-sachs-14th-annual-healthcare-ceos", "urlToImage": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png", "publishedAt": "2022-01-06T20:12:10Z", "content": "Pfizer Inc. (NYSE:PFE) Goldman Sachs 14th Annual Healthcare CEOs Unscripted Conference January 6, 2021 10:00 AM ET\r\n\nCompany Participants\r\n\nDr. Albert Bourla - Chief Executive Officer\r\n\nChris Stevo -\u2026 [+45558 chars]"}, {"source": {"id": "the-times-of-india", "name": "The Times of India"}, "author": "Viswanath Pilla and Teena Thacker", "title": "Pfizer may offer Covid antiviral drug to India at lower price for now", "description": "Pfizer has entered into advance purchase agreements with multiple countries. Sources told ET that Pfizer is yet to apply for emergency use authorisation in India.", "url": "https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/pfizer-may-offer-covid-antiviral-drug-to-india-at-lower-price-for-now/articleshow/88722940.cms", "urlToImage": "https://img.etimg.com/thumb/msid-88722948,width-1070,height-580,imgsize-360851,overlay-economictimes/photo.jpg", "publishedAt": "2022-01-06T00:51:13Z", "content": "may offer its Covid antiviral drug Paxlovid at lower prices for low and middle income countries (LMICs), including India, as an interim measure as the cheaper generic versions may not be available un\u2026 [+3713 chars]"}, {"source": {"id": null, "name": "bdnews24.com"}, "author": null, "title": "CDC advisory panel in favour of Pfizer vaccine booster for ages 12 to 15", "description": "A panel of outside experts advising the US Centers for Disease Control and Prevention (CDC) on Wednesday voted to recommend booster shots of Pfizer Inc and BioNTech SE's COVID-19 vaccine be made available to 12- to 15-year-olds.", "url": "https://bdnews24.com/coronavirus-pandemic/2022/01/06/cdc-advisory-panel-in-favour-of-pfizer-vaccine-booster-for-ages-12-to-15", "urlToImage": "https://d30fl32nd2baj9.cloudfront.net/media/2022/01/06/pfizer-vaccine-children-060122-01-smr.jpg/BINARY/pfizer-vaccine-children-060122-01-smr.jpg", "publishedAt": "2022-01-06T02:49:22Z", "content": "The CDC's Advisory Committee on Immunization Practices (ACIP) voted 13 to 1 to recommend that the US health agency support booster shots for those aged 12 to 15 at least five months after their secon\u2026 [+2375 chars]"}, {"source": {"id": null, "name": "Seeking Alpha"}, "author": "SA Transcripts", "title": "Pfizer Inc.'s (PFE) CEO Dr. Albert Bourla Presents at Goldman Sachs 14th Annual Healthcare CEOs Unscripted Conference (Transcript)", "description": "Pfizer Inc. (NYSE:PFE) Goldman Sachs 14th Annual Healthcare CEOs Unscripted Conference January 6, 2021 10:00 AM ETCompany ParticipantsDr.", "url": "https://seekingalpha.com/article/4478300-pfizer-inc-s-pfe-ceo-dr-albert-bourla-presents-goldman-sachs-14th-annual-healthcare-ceos", "urlToImage": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png", "publishedAt": "2022-01-06T20:12:10Z", "content": "Pfizer Inc. (NYSE:PFE) Goldman Sachs 14th Annual Healthcare CEOs Unscripted Conference January 6, 2021 10:00 AM ET\r\n\nCompany Participants\r\n\nDr. Albert Bourla - Chief Executive Officer\r\n\nChris Stevo -\u2026 [+45593 chars]"}, {"source": {"id": "the-hill", "name": "The Hill"}, "author": "Nathaniel Weixel", "title": "CDC endorses booster shots of Pfizer COVID vaccine for adolescents", "description": "Booster doses of Pfizer-BioNTech's COVID-19 vaccine are now available to adolescents age 12 to 15 after the Centers for Disease Control and Prevention on Wednesday endorsed a recommendation from an agency advisory panel....", "url": "https://thehill.com/policy/healthcare/588498-cdc-endorses-booster-shots-of-pfizer-covid-vaccine-for-adolescents", "urlToImage": "https://thehill.com/sites/default/files/coronavirus_vaccine_ill_111721ap_lead.jpg", "publishedAt": "2022-01-06T02:58:38Z", "content": "The Hill 1625 K Street, NW Suite 900 Washington DC 20006 | 202-628-8500 tel | 202-628-8503 fax\r\nThe contents of this site are \u00a9 1998 - 2022 Nexstar Media Inc. | All Rights Reserved."}, {"source": {"id": null, "name": "Regulatory Focus"}, "author": "Joanne S. Eglovitch", "title": "Recon: CDC recommends Pfizer booster for 12- to 15-year-olds; Stryker to buy Vocera for nearly $3B", "description": "Welcome to Regulatory Reconnaissance, your daily regulatory news and intelligence briefing.", "url": "https://www.raps.org/news-and-articles/news-articles/2022/1/recon-cdc-recommends-pfizer-booster-for-12-to-15-y?feed=Regulatory-Focus", "urlToImage": "https://www.raps.org/RAPS/media/news-images/recon%20and%20roundups/0icon-RegRecon-200x200.png?ext=.png", "publishedAt": "2022-01-06T20:17:02Z", "content": "Regulatory Affairs Professionals Society (RAPS)5635 Fishers Lane, Suite 400Rockville, Maryland 20852"}, {"source": {"id": null, "name": "Daily Mail"}, "author": "", "title": "CDC panel backs Pfizer booster for younger teens", "description": "CDC panel backs Pfizer booster for younger teens.", "url": "https://www.dailymail.co.uk/video/news/video-2583219/CDC-panel-backs-Pfizer-booster-younger-teens.html", "urlToImage": "https://i.dailymail.co.uk/1s/2022/01/06/02/52598683-0-image-a-21_1641434707850.jpg", "publishedAt": "2022-01-06T01:59:52Z", "content": "0:48\r\nCanadian influencers vape, drink, and have big party abroad flight"}, {"source": {"id": null, "name": "VOA News"}, "author": "webdesk@voanews.com (Associated Press)", "title": "US Advisers Endorse Pfizer COVID Boosters for Younger Teens", "description": "Influential government advisers are strongly urging that teens as young as 12 get COVID-19 boosters as soon as they're eligible, a key move as the U.S. battles the omicron surge and schools struggle with how to restart classes amid the spike.\u00a0\n\n\nAll Americans\u2026", "url": "https://www.voanews.com/a/us-advisers-endorse-pfizer-covid-boosters-for-younger-teens-/6384852.html", "urlToImage": "https://gdb.voanews.com/BB312584-FA33-4859-A1A9-A90F8F7218BD_w1200_r1.jpg", "publishedAt": "2022-01-06T00:58:01Z", "content": "Influential government advisers are strongly urging that teens as young as 12 get COVID-19 boosters as soon as they're eligible, a key move as the U.S. battles the omicron surge and schools struggle \u2026 [+4240 chars]"}]}, "2022-01-05": {"status": "ok", "totalResults": 87, "articles": [{"source": {"id": null, "name": "Blogspot.com"}, "author": "noreply@blogger.com (Unknown)", "title": "Pfizer, BioNTech to jointly develop shingles vaccine", "description": "<table><tr><td></td></tr><tr><td>Pfizer headquarters in New York.\r\nGetty Images\r\n</td></tr>\r\n</table>Pfizer and Germany's BioNTech announced on Wednesday that they would develop a potential mRNA-based vaccine for the prevention of viral\u00a0 shingles, working tog\u2026", "url": "https://techncruncher.blogspot.com/2022/01/pfizer-biontech-to-jointly-develop.html", "urlToImage": "https://blogger.googleusercontent.com/img/a/AVvXsEhG6jZWLsFahlTL4DsUuApYlOtsrYERYN8v86G0PEt91h6hz8yuJXzg9Cdu6LpleSwS12vwYGyK18X8HQ7xtE_TpGFG1cwUZHq_J5J8oR0w-sFHzVcLUz9l9agQ25wo3RdJdVBgEcuzY1DF0z_mzook9TMtktBqv_a54WEHCGBGXe_W2gNRZlPa7bvoVA=w1200-h630-p-k-no-nu", "publishedAt": "2022-01-05T21:13:00Z", "content": "Pfizer and Germany's BioNTech announced on Wednesday that they would develop a potential mRNA-based vaccine for the prevention of viral\u00a0 shingles, working together for the third time after the succes\u2026 [+1002 chars]"}, {"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "Ireland seeks to buy Merck, Pfizer, GSK COVID-19 antiviral drugs - Reuters", "description": "Ireland's government agreed on Wednesday to fund the purchase of COVID-19 antiviral drugs from GlaxoSmithKline <a href=\"https://www.reuters.com/companies/GSK.L\" target=\"_blank\">(GSK.L)</a>, Pfizer <a href=\"https://www.reuters.com/companies/PFE.N\" target=\"_bla\u2026", "url": "https://www.reuters.com/world/europe/ireland-seeks-buy-merck-pfizer-gsk-covid-19-antiviral-drugs-2022-01-05/", "urlToImage": "https://www.reuters.com/resizer/wZPuTRJHFCXpSVhK9RlLgAxw6dM=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/6AV6BLQNYVMEDIVUCC7Q7M2QZQ.jpg", "publishedAt": "2022-01-05T15:03:00Z", "content": "An experimental COVID-19 treatment pill, called molnupiravir and being developed by Merck &amp; Co Inc and Ridgeback Biotherapeutics LP, is seen in this undated handout photo released by Merck &amp; \u2026 [+1055 chars]"}, {"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "Pfizer, biotech firm end patent fight over COVID-19 vaccine - Reuters", "description": "San Diego-based Allele Biotechnology and Pharmaceuticals Inc has resolved its patent dispute with Pfizer Inc and BioNTech SE over technology allegedly used in developing their COVID-19 vaccine, according to a <a href=\"https://tmsnrt.rs/3q6nBm9\" target=\"_blank\u2026", "url": "https://www.reuters.com/legal/government/pfizer-biotech-firm-end-patent-fight-over-covid-19-vaccine-2022-01-05/", "urlToImage": "https://www.reuters.com/resizer/X3DVHoK5yyNgvspFVbjyLVqdhVU=/728x381/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/UEUS5YTXBVNELB3UZ66OUYAZU4.jpg", "publishedAt": "2022-01-05T23:08:00Z", "content": "<ul><li>\r\nSummary</li><li>\r\nLaw firms</li><li>\r\nRelated documents</li></ul>\r\nThe company and law firm names shown above are generated automatically based on the text of the article. We are improving \u2026 [+2428 chars]"}, {"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "South Korea agrees to buy additional Pfizer COVID-19 pills - Reuters", "description": "South Korea signed an agreement to buy additional courses of Pfizer Inc's <a href=\"https://www.reuters.com/companies/PFE.N\" target=\"_blank\">(PFE.N)</a> antiviral COVID-19 pill Paxlovid to cover 400,000 people, the Korea Disease Control and Prevention Agency (\u2026", "url": "https://www.reuters.com/world/asia-pacific/south-korea-agrees-buy-additional-pfizer-covid-19-pills-2022-01-05/", "urlToImage": "https://www.reuters.com/resizer/HOVj_tOwqW7UOz3OcFVdO8QYqWk=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/Y6RMUMRRBNM3JHYVFHRW723ZNY.jpg", "publishedAt": "2022-01-05T12:03:00Z", "content": "Paxlovid, a Pfizer's coronavirus disease (COVID-19) pill, is seen manufactured in Ascoli, Italy, in this undated handout photo obtained by Reuters on November 16, 2021. Pfizer/Handout via REUTERSSEOU\u2026 [+864 chars]"}, {"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "CDC advisory panel in favor of Pfizer vaccine booster for ages 12 to 15 - Reuters", "description": "A panel of outside experts advising the U.S. Centers for Disease Control and Prevention (CDC) on Wednesday voted to recommend  booster shots of Pfizer Inc <a href=\"https://www.reuters.com/companies/PFE.N\" target=\"_blank\">(PFE.N)</a> and BioNTech SE's  COVID-1\u2026", "url": "https://www.reuters.com/world/us/cdc-advisory-panel-favor-pfizer-vaccine-booster-ages-12-15-2022-01-05/", "urlToImage": "https://www.reuters.com/resizer/1cSn2jGxJGJONEa4AmZW9bIygxI=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/WTRFASBFQFOYDJKN4755OTK5KY.jpg", "publishedAt": "2022-01-05T22:19:00Z", "content": "Jan 5 (Reuters) - A panel of outside experts advising the U.S. Centers for Disease Control and Prevention (CDC) on Wednesday voted to recommend booster shots of Pfizer Inc (PFE.N) and BioNTech SE's C\u2026 [+2856 chars]"}, {"source": {"id": "abc-news", "name": "ABC News"}, "author": "Cheyenne Haslett, Sasha Pezenik", "title": "CDC panel recommends Pfizer boosters for children aged 12-15", "description": "If the CDC director signs off, shots could go into arms as soon as Thursday morning.", "url": "https://abcnews.go.com/Politics/cdc-panel-recommends-pfizer-boosters-12-15-year/story?id=82092104", "urlToImage": "https://s.abcnews.com/images/GMA/teen-covid-pfizer-vaccine-01-gty-llr-220103_1641245544343_hpMain_16x9_992.jpg", "publishedAt": "2022-01-05T22:23:50Z", "content": "Boosters for children ages 12 to 15 are one step closer after a panel of advisers to the Centers for Disease Control and Prevention voted Wednesday to recommend the third Pfizer shots for adolescents\u2026 [+2508 chars]"}, {"source": {"id": null, "name": "WebMD"}, "author": "https://www.facebook.com/WebMD", "title": "CDC Panel Recommends Pfizer COVID Boosters for Ages 12-15", "description": "The 13-1 vote follows FDA approval for a booster dose in that age group on Monday. The committee backed a \u201cshould\u201d rather than a \u201cmay\u201d recommendation for ages 12-15 and for ages 16-17 as well.", "url": "https://www.webmd.com/vaccines/covid-19-vaccine/news/20220105/cdc-panel-backs-pfizer-boosters", "urlToImage": "https://img.webmd.com/dtmcms/live/webmd/consumer_assets/site_images/article_thumbnails/other/teen_vaccinations_other/650x350_teen_vaccinations_other.jpg", "publishedAt": "2022-01-05T23:02:58Z", "content": "Jan. 5, 2022 A CDC advisory panel today recommended that 12- to 17-year-olds in the U.S. should get the Pfizer COVID-19 booster shot 5 months after a primary series of vaccinations.\r\nThe CDC had alre\u2026 [+1215 chars]"}, {"source": {"id": "bloomberg", "name": "Bloomberg"}, "author": "Naomi Kresge", "title": "BioNTech and Pfizer to Work on Shingles Shot in Third mRNA Deal", "description": "Pfizer Inc. and BioNTech SE agreed to their third joint messenger RNA project, an experimental shingles vaccine, expanding once more the collaboration that led to their successful shot for Covid-19.", "url": "https://www.bloomberg.com/news/articles/2022-01-05/biontech-and-pfizer-to-work-on-shingles-shot-in-third-mrna-deal", "urlToImage": "https://assets.bwbx.io/images/users/iqjWHBFdfxIU/idRVI26SXeLY/v0/1200x800.jpg", "publishedAt": "2022-01-05T11:45:00Z", "content": "Pfizer Inc. and \r\nBioNTech SE agreed to their third joint messenger RNA project, an experimental shingles vaccine, expanding once more the collaboration that led to their successful shot for Covid-19\u2026 [+268 chars]"}, {"source": {"id": "bloomberg", "name": "Bloomberg"}, "author": "Fiona Rutherford", "title": "Pfizer Covid Booster for Young Teens Heads for CDC Panel's Vote", "description": "", "url": "https://www.bloomberg.com/news/articles/2022-01-05/pfizer-s-booster-for-young-teens-enters-cdc-panel-s-spotlight", "urlToImage": "https://assets.bwbx.io/images/users/iqjWHBFdfxIU/ieVzn3buUdh4/v1/1200x800.jpg", "publishedAt": "2022-01-05T16:03:49Z", "content": "Immunization experts who advise the U.S. Centers for Disease Control and Prevention will meet Wednesday to discuss the use of \r\nPfizer Inc. and \r\nBioNTech SEs Covid-19 booster shot for young teens.\r\n\u2026 [+1790 chars]"}, {"source": {"id": null, "name": "Forbes"}, "author": "Zachary Snowdon Smith, Forbes Staff, \n Zachary Snowdon Smith, Forbes Staff\n https://www.forbes.com/sites/zacharysmith/", "title": "CDC Panel Recommends Pfizer Covid Vaccine Boosters For Ages 12-15", "description": "The recommendation of a third Pfizer shot comes as record numbers of children are being hospitalized with the virus.", "url": "https://www.forbes.com/sites/zacharysmith/2022/01/05/cdc-panel-recommends-pfizer-covid-vaccine-boosters-for-ages-12-15/", "urlToImage": "https://thumbor.forbes.com/thumbor/fit-in/1200x0/filters%3Aformat%28jpg%29/https%3A%2F%2Fspecials-images.forbesimg.com%2Fimageserve%2F61d618e695861a841b077731%2F0x0.jpg%3FcropX1%3D0%26cropX2%3D4000%26cropY1%3D151%26cropY2%3D2401", "publishedAt": "2022-01-05T22:29:30Z", "content": "The Centers for Disease Control and Preventions Advisory Committee on Immunization Practices voted 13-1 Wednesday to recommend adolescents age 12-15 receive a booster of Pfizer and BioNTechs Covid-19\u2026 [+2806 chars]"}, {"source": {"id": null, "name": "Forbes"}, "author": "Robert Hart, Forbes Staff, \n Robert Hart, Forbes Staff\n https://www.forbes.com/sites/roberthart/", "title": "Pfizer, BioNTech Will Develop mRNA Shingles Vaccine After Covid-19 Shot Success", "description": "If successful, the vaccine could be the first mRNA shot for shingles.", "url": "https://www.forbes.com/sites/roberthart/2022/01/05/pfizer-biontech-will-develop-mrna-shingles-vaccine-after-covid-19-shot-success/", "urlToImage": "https://thumbor.forbes.com/thumbor/fit-in/1200x0/filters%3Aformat%28jpg%29/https%3A%2F%2Fspecials-images.forbesimg.com%2Fimageserve%2F611d065c98baac3c45cf31db%2F0x0.jpg%3FcropX1%3D0%26cropX2%3D2761%26cropY1%3D140%26cropY2%3D1693", "publishedAt": "2022-01-05T15:27:42Z", "content": "U.S. pharma giant Pfizer and German biotech BioNTech are teaming up to develop an mRNA vaccine for shingles, the companies announced Wednesday, building off the successes of their joint Covid-19 shot\u2026 [+2619 chars]"}, {"source": {"id": "axios", "name": "Axios"}, "author": "Erin Doherty", "title": "CDC panel backs Pfizer boosters for 12- to 17-year-olds", "description": "The Centers for Disease Control and Prevention's vaccine advisory committee voted 13-1 on Wednesday to endorse booster doses of Pfizer-BioNTech's COVID-19 vaccine for 12- to 17-year olds.Why it matters: CDC director Rochelle Walensky is expected to sign off o\u2026", "url": "https://www.axios.com/cdc-endorses-pfizer-booster-shots-children-76090871-996e-42e9-82fe-10a323a745ac.html", "urlToImage": "https://images.axios.com/rdAl0O9F1DV9hMk0ni-06J7qQGo=/0x81:3870x2258/1366x768/2022/01/04/1641310553780.jpg", "publishedAt": "2022-01-05T22:11:15Z", "content": "The Centers for Disease Control and Prevention's vaccine advisory committee voted 13-1 on Wednesday to endorse booster doses of Pfizer-BioNTech's COVID-19 vaccine for 12- to 17-year olds.\r\nWhy it mat\u2026 [+955 chars]"}, {"source": {"id": null, "name": "Investor's Business Daily"}, "author": "Investor's Business Daily", "title": "Earnings Preview: Pfizer Among 20 Growth Stocks Expecting Up To 520% Growth In Next Report", "description": "With earnings season about to begin, Pfizer is among 20 stocks expecting up to 520% EPS growth in their next report.", "url": "https://www.investors.com/research/best-growth-stocks-to-buy-and-watch-for-q4-2021/", "urlToImage": "https://www.investors.com/wp-content/uploads/2021/01/Stock-Q4budget-01-adobe.jpg", "publishedAt": "2022-01-05T19:24:52Z", "content": "With companies getting ready to report earnings, here's a look at the 20 of the best stocks to watch, expecting at least 75% earnings growth in Q4 or their current fiscal quarter.\u00a0 Steel stocks Nucor\u2026 [+5310 chars]"}, {"source": {"id": "independent", "name": "Independent"}, "author": "Via AP news wire", "title": "U.S. advisers debate Pfizer boosters for younger teens", "description": "An influential government advisory panel is considering COVID-19 boosters for younger teens, as the U.S. battles the omicron surge", "url": "https://www.independent.co.uk/news/pfizer-food-and-drug-administration-centers-for-disease-control-and-prevention-vaccines-biontech-b1987484.html", "urlToImage": "https://static.independent.co.uk/2022/01/05/18/Virus_Outbreak_Pfizer_Teen_Boosters_93077.jpg?width=1200&auto=webp&quality=75", "publishedAt": "2022-01-05T18:49:22Z", "content": "An influential government advisory panel is considering COVID-19 boosters for younger teens, as the U.S. battles the omicron surge and schools struggle with how to restart classes amid the spike.\r\nBo\u2026 [+2865 chars]"}, {"source": {"id": "rt", "name": "RT"}, "author": "RT", "title": "Boxing bombshell cites Pfizer jab \u2018boob effect\u2019 with chesty selfie", "description": "Aussie boxing sensation Ebanie \u2018Blonde Bomber\u2019 Bridges has poked fun at reports that the Pfizer jab has led to breast enlargement among some women by posting a close-up look at her own chest to fans online. Read Full Article at RT.com", "url": "https://www.rt.com/sport/545204-ebanie-bridges-pfizer-jab-breasts/", "urlToImage": "https://cdni.rt.com/files/2022.01/article/61d57c0e203027698328cc62.jpg", "publishedAt": "2022-01-05T11:12:22Z", "content": "Aussie boxing sensation Ebanie Blonde Bomber Bridges has poked fun at reports that the Pfizer jab has led to breast enlargement among some women by posting a close-up look at her own chest to fans on\u2026 [+2540 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "PR Newswire", "title": "Biohaven and Pfizer Complete Collaboration Transaction for Commercialization of Rimegepant and Zavegepant Outside United States", "description": "Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) and Pfizer Inc. (NYSE: PFE), today announced that the parties have completed the collaboration...", "url": "https://finance.yahoo.com/news/biohaven-pfizer-complete-collaboration-transaction-120000871.html", "urlToImage": "https://s.yimg.com/uu/api/res/1.2/u98YISOeFbQh0jpkfRwCcA--~B/aD0xMDQ7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/7e391b22fc581f49dc5be22ad89c731b", "publishedAt": "2022-01-05T12:00:00Z", "content": "Transaction triggers total upfront payment to Biohaven of $500 million\r\nNEW HAVEN, Conn. and NEW YORK, Jan. 5, 2022 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) and Pfize\u2026 [+14820 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "BioNTech SE", "title": "Pfizer and BioNTech Sign New Global Collaboration Agreement to Develop First mRNA-based Shingles Vaccine", "description": "Third mRNA vaccine collaboration between the companies aims to accelerate development of an improved vaccine for shingles, a debilitating, disfiguring and...", "url": "https://finance.yahoo.com/news/pfizer-biontech-sign-global-collaboration-114500210.html", "urlToImage": "https://s.yimg.com/ny/api/res/1.2/C3oL9NoDTmUj675NlaFEIg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD0xMzI-/https://s.yimg.com/uu/api/res/1.2/RTbgr5.LOqZ4O1Eb330Lyg--~B/aD0zMDE7dz0yNzI5O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/823794cd8a992e0c9057cc4e398068ea", "publishedAt": "2022-01-05T11:45:00Z", "content": "<ul><li>Third mRNA vaccine collaboration between the companies aims to accelerate development of an improved vaccine for shingles, a debilitating, disfiguring and painful disease that affects people \u2026 [+11029 chars]"}, {"source": {"id": null, "name": "The Boston Globe"}, "author": "The Associated Press", "title": "US advisers endorse Pfizer COVID-19 boosters for younger teens", "description": "Influential government advisers are strongly urging that teens as young as 12 get COVID-19 boosters as soon as they\u2019re eligible, a key move as the US battles the Omicron surge and schools struggle with how to restart classes amid the spike.", "url": "https://www.bostonglobe.com/2022/01/05/nation/cdcs-vaccine-advisers-recommend-pfizer-covid-19-boosters-younger-teens/", "urlToImage": "https://bostonglobe-prod.cdn.arcpublishing.com/resizer/wIy4OvQBU-wH1ozPipRR_mDiy4k=/506x0/cloudfront-us-east-1.images.arcpublishing.com/bostonglobe/AQBEJPZZEPIRE5B7MU3R4RSFOE.jpg", "publishedAt": "2022-01-05T22:24:06Z", "content": "Influential government advisers are strongly urging that teens as young as 12 get COVID-19 boosters as soon as theyre eligible, a key move as the U.S. battles the omicron surge and schools struggle w\u2026 [+4218 chars]"}, {"source": {"id": null, "name": "Business Wire"}, "author": null, "title": "Pfizer and BioNTech Sign New Global Collaboration Agreement to Develop First mRNA-based Shingles Vaccine", "description": "NEW YORK & MAINZ, Germany--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced a new research, development and commercialization collaboration to develop a potential first mRNA-based vaccine for the prevention of shingles (\u2026", "url": "https://www.businesswire.com/news/home/20220105005086/en/Pfizer-and-BioNTech-Sign-New-Global-Collaboration-Agreement-to-Develop-First-mRNA-based-Shingles-Vaccine", "urlToImage": "https://mms.businesswire.com/media/20220105005086/en/1045874/23/Pfizer_Logo_Color_RGB_APPROVED.jpg", "publishedAt": "2022-01-05T11:50:47Z", "content": "NEW YORK &amp; MAINZ, Germany--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced a new research, development and commercialization collaboration to develop a pot\u2026 [+9848 chars]"}, {"source": {"id": null, "name": "EURACTIV"}, "author": "Admin", "title": "Pfizer/BioNTech to develop mRNA-based shingles shot", "description": "Germany's BioNTech and US pharma giant Pfizer, which together developed a COVID-19 vaccine in record time, said Wednesday they are working on a shingles shot using the same mRNA technology.", "url": "http://www.euractiv.com/section/health-consumers/news/pfizer-biontech-to-develop-mrna-based-shingles-shot/", "urlToImage": "https://www.euractiv.com/wp-content/uploads/sites/2/2021/12/shutterstock_1726134715-800x450.jpg", "publishedAt": "2022-01-05T17:00:02Z", "content": "Germany\u2019s BioNTech and US pharma giant Pfizer, which together developed a COVID-19 vaccine in record time, said Wednesday they are working on a shingles shot using the same mRNA technology.\r\nModerna \u2026 [+2901 chars]"}]}, "2022-01-24": {"status": "ok", "totalResults": 2, "articles": [{"source": {"id": null, "name": "Motley Fool"}, "author": "newsfeedback@fool.com (Adria Cimino)", "title": "Should You Invest in Pfizer in 2022?", "description": "This may be another big year for coronavirus program revenue.", "url": "https://www.fool.com/investing/2022/01/24/should-you-invest-in-pfizer-in-2022/", "urlToImage": "https://g.foolcdn.com/editorial/images/662326/gettyimages-1345289043.jpg", "publishedAt": "2022-01-24T11:00:00Z", "content": "Historically, Pfizer(NYSE:PFE) hasn't been a big mover when it comes to stock performance. Over the past 10 years, the S&amp;P 500 Index has outperformed this big pharma company. But momentum is pick\u2026 [+4221 chars]"}, {"source": {"id": null, "name": "Business Today"}, "author": "Reuters", "title": "COVID-19: Annual vaccine preferred to frequent boosters, says Pfizer CEO", "description": "In an interview with Israel's N12 News, Bourla was asked whether he sees booster shots being administered every four to five months on a regular basis.", "url": "https://www.businesstoday.in/coronavirus/story/covid-19-annual-vaccine-preferred-to-frequent-boosters-says-pfizer-ceo-320070-2022-01-24", "urlToImage": "https://akm-img-a-in.tosshub.com/businesstoday/images/story/202201/pfizer-1200_1-sixteen_nine-sixteen_nine.jpg", "publishedAt": "2022-01-24T05:10:20Z", "content": "Pfizer Inc Chief Executive Albert Bourla has said that an annual Covid-19 vaccine would be preferable to more frequent booster shots in fighting the coronavirus pandemic.\r\nPfizer/BioNtech's Covid-19 \u2026 [+1277 chars]"}]}, "2022-01-23": {"status": "ok", "totalResults": 14, "articles": [{"source": {"id": "usa-today", "name": "USA Today"}, "author": "USA TODAY, John Bacon, USA TODAY", "title": "Mass testing ordered in Beijing before Olympics; Pfizer CEO sees annual shots, not every 4-5 months: COVID-19 updates", "description": "China is tightening its \"zero tolerance\" strategy aimed at isolating every infected person as Beijing preps for the Winter Games. Latest COVID news.", "url": "https://www.usatoday.com/story/news/health/2022/01/23/mass-testing-beijing-olympics-covid-19-updates/6623810001/", "urlToImage": "https://www.gannett-cdn.com/presto/2022/01/19/USAT/7bbc2c1c-2730-452c-82a1-50620b9c0a37-image_20.png?auto=webp&crop=1911,1075,x4,y0&format=pjpg&width=1200", "publishedAt": "2022-01-23T14:20:16Z", "content": "A Beijing district with 2 million residents began mass coronavirus testing Sunday following a series of infections as China tightened restrictions ahead of the Winter Olympics.\r\nThe government told p\u2026 [+4424 chars]"}, {"source": {"id": "rt", "name": "RT"}, "author": "RT", "title": "Pfizer CEO paints \u2018ideal\u2019 future of Covid vaccination", "description": "Pfizer CEO Albert Bourla has expressed hope that yearly vaccinations would be more palatable to skeptics than boosters every few months Read Full Article at RT.com", "url": "https://www.rt.com/news/546859-pfizer-ceo-future-vaccines/", "urlToImage": "https://cdni.rt.com/files/2022.01/article/61eca72c85f54019c51472ea.jpg", "publishedAt": "2022-01-23T01:01:35Z", "content": "The CEO of Pfizer has tried to appease vaccine skeptics with an idea of Covid-19 booster shots only once a year \u2013 instead of every few months \u2013 all while attacking the most vocal anti-vaxxers as \u201ccri\u2026 [+2310 chars]"}, {"source": {"id": null, "name": "Investmentwatchblog.com"}, "author": "alexmark", "title": "Ron Paul was banned off Facebook for referencing an old Pfizer CEO tweet", "description": null, "url": "https://www.investmentwatchblog.com/ron-paul-was-banned-off-facebook-for-referencing-an-old-pfizer-ceo-tweet/", "urlToImage": null, "publishedAt": "2022-01-23T14:42:28Z", "content": "This was the tweet in question\u00a0that Paul was referring to.\r\nIt would appear they don\u2019t want you noticing things, they\u2019d prefer you to \u201cmemoryhole\u201d yesteryears good news.\r\nh/t\u00a0 Le_Rekt_Guy"}, {"source": {"id": null, "name": "Seeking Alpha"}, "author": "Dulan Lokuwithana", "title": "Pfizer CEO says an annual COVID-19 vaccine preferable to frequent boosters", "description": "Pfizer (PFE) CEO Albert Bourla thinks that an annual COVID-19 vaccine could be preferable over frequent booster shots in terms of public health.In an interview with Israel's N12 News...", "url": "https://seekingalpha.com/news/3790496-pfizer-ceo-says-an-annual-covid-19-vaccine-preferable-to-frequent-boosters", "urlToImage": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1132313750/medium_image_1132313750.jpg", "publishedAt": "2022-01-23T02:30:06Z", "content": "Win McNamee/Getty Images News"}, {"source": {"id": null, "name": "Thegatewaypundit.com"}, "author": "JIM HOFT", "title": "Brazil: Child Vaccination Suspended After 10-Year-Old Girl Suffers Cardiac Arrest Hours After Receiving Pfizer Vaccine", "description": "A 10-year-old girl from S\u00e3o Paolo, Brazil has suffered a cardiac arrest and was in critical condition 12 hours after taking a dose of the Pfizer vaccine, the Covid World reported. Luisa Petenuci took the Pfizer shot on Tuesday, January 18th in Len\u00e7\u00f3is Paulist\u2026", "url": "https://www.thegatewaypundit.com/2022/01/brazil-child-vaccination-suspended-10-year-old-girl-suffers-cardiac-arrest-hours-receiving-pfizer-vaccine/", "urlToImage": "https://www.thegatewaypundit.com/wp-content/uploads/4619FD03-206D-4430-8F17-FAB86E4F8EB1-scaled.jpeg", "publishedAt": "2022-01-23T13:15:14Z", "content": "A 10-year-old girl from S\u00e3o Paolo, Brazil has suffered a cardiac arrest and was in critical condition 12 hours after taking a dose of the Pfizer vaccine, the Covid World reported.\r\nLuisa Petenuci too\u2026 [+3424 chars]"}, {"source": {"id": null, "name": "Daily Mail"}, "author": "Reuters", "title": "Pfizer CEO sees annual COVID vaccine rather than...", "description": "JERUSALEM, Jan 22 (Reuters) - Pfizer Inc Chief  Executive Albert Bourla said on Saturday that an annual COVID-19  vaccine would be preferable to more...", "url": "https://www.dailymail.co.uk/news/article-10430671/Pfizer-CEO-sees-annual-COVID-vaccine-frequent-boosters.html", "urlToImage": "https://i.dailymail.co.uk/i/pix/m_logo_636x382px.png", "publishedAt": "2022-01-23T04:00:35Z", "content": "Pfizer Inc Chief Executive Albert Bourla said on Saturday that an annual COVID-19 vaccine would be preferable to more frequent booster shots in fighting the coronavirus pandemic.\r\nPfizer/BioNtech's C\u2026 [+1691 chars]"}, {"source": {"id": null, "name": "bdnews24.com"}, "author": null, "title": "Pfizer CEO sees annual COVID vaccine rather than frequent boosters", "description": "Pfizer Inc Chief Executive Albert Bourla said on Saturday that an annual COVID-19 vaccine would be preferable to more frequent booster shots in fighting the coronavirus pandemic.", "url": "https://bdnews24.com/coronavirus-pandemic/2022/01/23/pfizer-ceo-sees-annual-covid-vaccine-rather-than-frequent-boosters", "urlToImage": "https://d30fl32nd2baj9.cloudfront.net/media/2021/10/27/pfizer-vaccine-271021-01-smr.jpg/BINARY/pfizer-vaccine-271021-01-smr.jpg", "publishedAt": "2022-01-23T04:18:24Z", "content": "Pfizer/BioNtech's COVID-19 vaccine has shown\r\nto be effective against severe disease and death caused by the heavily-mutated\r\nomicron variant but less effective in preventing transmission.\r\nWith case\u2026 [+1409 chars]"}, {"source": {"id": null, "name": "Business Standard"}, "author": "Reuters", "title": "Pfizer CEO sees annual Covid vaccine rather than frequent boosters", "description": "Albert Bourla has said Pfizer could be ready to file for approval for a redesigned vaccine to fight Omicron, and mass produce it, as soon as March", "url": "https://www.business-standard.com/article/international/pfizer-ceo-sees-annual-covid-vaccine-rather-than-frequent-boosters-122012300992_1.html", "urlToImage": "https://bsmedia.business-standard.com/_media/bs/img/article/2016-03/15/full/1458029734-1022.jpg", "publishedAt": "2022-01-23T16:47:00Z", "content": "Pfizer Inc Chief Executive Albert Bourla has said that an annual Covid-19 vaccine would be preferable to more frequent booster shots in fighting the coronavirus pandemic. Pfizer/BioNtech's Covid-19 v\u2026 [+3728 chars]"}, {"source": {"id": null, "name": "Freerepublic.com"}, "author": "Life Site News", "title": "FOIA docs reveal Pfizer shot caused avalanche of miscarriages, stillborn babies", "description": "Netflix reality TV star Maya Vander told her fans last week of her devastating grief after she delivered a stillborn baby at 38 weeks of pregnancy December 9.\u201cYesterday was the hardest day of my life,\u201d Vander, 39, posted on Instagram, with a picture of new ba\u2026", "url": "https://freerepublic.com/focus/f-chat/4032052/posts", "urlToImage": null, "publishedAt": "2022-01-23T21:22:03Z", "content": "Skip to comments.\r\nFOIA docs reveal Pfizer shot caused avalanche of miscarriages, stillborn babiesLife Site News ^\r\n | 12/23/2021\r\n | Celeste McGovern\r\nPosted on 01/23/2022 1:22:03 PM PST by Jan_Sobi\u2026 [+2498 chars]"}, {"source": {"id": null, "name": "Freerepublic.com"}, "author": "The Hill", "title": "Pfizer CEO says frequent boosters 'not a good scenario,' hopes for yearly vaccine", "description": "Pfizer CEO Albert Bourla on Saturday said people getting COVID-19 booster shots every four to five months is \"not a good scenario\" and argued that an annual vaccine would be a better approach to fighting the virus. Bourla told the Hebrew publication N12 News \u2026", "url": "https://freerepublic.com/focus/f-chat/4031815/posts", "urlToImage": null, "publishedAt": "2022-01-23T00:17:36Z", "content": "Skip to comments.\r\nPfizer CEO says frequent boosters 'not a good scenario,' hopes for yearly vaccineThe Hill ^\r\n | 1/22/22\r\n | Brad Dress\r\nPosted on 01/22/2022 4:17:36 PM PST by Libloather\r\nPfizer CE\u2026 [+3778 chars]"}, {"source": {"id": null, "name": "Freerepublic.com"}, "author": "Times Of Israel", "title": "Pfizer CEO to Israeli TV: World should be back to near-normal in \"a few months'", "description": "Albert Bourla says US-based pharma firm is aiming to produce annual shot to cover all COVID variants, accuses anti-vaxxers of causing millions of deaths by spreading misinformation In interviews with Israeli television aired Saturday Pfizer CEO Albert Bourla \u2026", "url": "https://freerepublic.com/focus/f-news/4031840/posts", "urlToImage": null, "publishedAt": "2022-01-23T01:33:17Z", "content": "Skip to comments.\r\nPfizer CEO to Israeli TV: World should be back to near-normal in \"a few months'Times Of Israel ^\r\n | 1/22/2022\r\n | TOI Staff\r\nPosted on 01/22/2022 5:33:17 PM PST by Nextrush\r\nAlber\u2026 [+2968 chars]"}, {"source": {"id": null, "name": "Freerepublic.com"}, "author": "Life Site News", "title": "\u2018All he wanted to do was play hockey\u2019: Grieving dad says Pfizer shot killed his 17-year old son", "description": "Toronto resident Dan Hartman testified to the Toronto City Council on Tuesday that he believes that the Pfizer jab killed his 17-year-old son, Sean.Hartman explained that his son experienced a bad reaction to his first shot, and just over a month later was de\u2026", "url": "https://freerepublic.com/focus/f-chat/4032054/posts", "urlToImage": null, "publishedAt": "2022-01-23T21:28:12Z", "content": "Skip to comments.\r\nAll he wanted to do was play hockey: Grieving dad says Pfizer shot killed his 17-year old sonLife Site News ^\r\n | 01/19/2022\r\n | Kennedy Hall\r\nPosted on 01/23/2022 1:28:12 PM PST b\u2026 [+2354 chars]"}, {"source": {"id": null, "name": "Freerepublic.com"}, "author": "The Blaze", "title": "Pfizer CEO pushes annual COVID-19 vaccine shot as company makes billions: 'It's Easier to convince people to do it'; CDC Planning to Change Definition of \"Fully Vaccinated\"", "description": "Pfizer CEO Albert Bourla admitted Saturday that he is hoping people around the world will receive annual COVID-19 vaccine shots. The admission comes as the global community implements booster campaigns because, as Reuters noted , the COVID vaccines have prove\u2026", "url": "https://freerepublic.com/focus/f-news/4031993/posts", "urlToImage": null, "publishedAt": "2022-01-23T17:45:20Z", "content": "Skip to comments.\r\nPfizer CEO pushes annual COVID-19 vaccine shot as company makes billions: 'It's Easier to convince people to do it'; CDC Planning to Change Definition of \"Fully Vaccinated\"The Blaz\u2026 [+6150 chars]"}, {"source": {"id": null, "name": "The Straits Times"}, "author": "Hermes Auto", "title": "Pfizer CEO sees annual Covid-19 vaccine rather than frequent boosters", "description": "He says it is easier to convince people to take it.\n. Read more at straitstimes.com.", "url": "https://www.straitstimes.com/world/middle-east/pfizer-ceo-sees-annual-covid-19-vaccine-rather-than-frequent-boosters", "urlToImage": "https://static1.straitstimes.com.sg/s3fs-public/styles/large30x20/public/articles/2022/01/23/ac_albertbourla_230122.jpg?VersionId=wmzeWRMrztVp3nH2dxJ3qe_g844lEjAc", "publishedAt": "2022-01-23T02:13:07Z", "content": "JERUSALEM (REUTERS) - Pfizer Chief Executive Albert Bourla said on Saturday (Jan 23) that an annual Covid-19 vaccine would be preferable to more frequent booster shots in fighting the coronavirus pan\u2026 [+1621 chars]"}]}, "2022-01-22": {"status": "ok", "totalResults": 16, "articles": [{"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "Pfizer CEO sees annual COVID vaccine rather than frequent boosters - Reuters", "description": "Pfizer Inc <a href=\"https://www.reuters.com/companies/PFE.N\" target=\"_blank\">(PFE.N)</a> Chief Executive Albert Bourla said on Saturday that an annual COVID-19 vaccine would be preferable to more frequent booster shots in fighting the coronavirus pandemic.", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-ceo-sees-annual-covid-vaccine-rather-than-frequent-boosters-2022-01-22/", "urlToImage": "https://www.reuters.com/resizer/sP0f01d7oYshrHz2tGtOTOMJsxo=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/RU4UZTKKKJKSPAI3Q7HFVA4UXY.jpg", "publishedAt": "2022-01-22T19:59:00Z", "content": "JERUSALEM, Jan 22 (Reuters) - Pfizer Inc (PFE.N) Chief Executive Albert Bourla said on Saturday that an annual COVID-19 vaccine would be preferable to more frequent booster shots in fighting the coro\u2026 [+1851 chars]"}, {"source": {"id": null, "name": "Rebelnews.com"}, "author": null, "title": "A CDC study says natural immunity is better than vaccines, so why are they still acting like Pfizer salesmen? - Rebel News", "description": "<ol><li>A CDC study says natural immunity is better than vaccines, so why are they still acting like Pfizer salesmen?\u00a0\u00a0Rebel News\r\n</li><li>Moderna vaccine recipients have lower risk of breakthrough infections, hospitalization: study\u00a0\u00a0CTV News\r\n</li><li>3 U.S\u2026", "url": "https://www.rebelnews.com/ezra_levant_show_january_21_2022", "urlToImage": "https://d3n8a8pro7vhmx.cloudfront.net/therebel/pages/56519/meta_images/original/els-jan21-2022-720p.jpg?1642811462", "publishedAt": "2022-01-22T01:00:44Z", "content": "Did you see this study?\r\nhttps://www.cdc.gov/mmwr/volumes/71/wr/mm7104e1.htm\r\nThis is from the CDC, the Centers for Disease Control.\r\nNow, its obviously a study full of scientific terminology. But th\u2026 [+2614 chars]"}, {"source": {"id": "al-jazeera-english", "name": "Al Jazeera English"}, "author": "Al Jazeera", "title": "Pfizer, Moderna boosters up to 90% effective against Omicron: CDC", "description": "Three US studies offer more evidence that third dose of COVID vaccine is highly effective against Omicron.", "url": "https://www.aljazeera.com/news/2022/1/22/boosters-90-effective-against-omicron-hospitalisations-study", "urlToImage": "https://www.aljazeera.com/wp-content/uploads/2021/12/AP21342448804833.jpg?resize=1200%2C630", "publishedAt": "2022-01-22T07:29:16Z", "content": "Booster shots of the Pfizer-BioNTech and Moderna\u00a0vaccines have proven highly effective at preventing\u00a0Omicron-related hospitalisations, according to three new studies by the US Centers for Disease Con\u2026 [+2883 chars]"}, {"source": {"id": null, "name": "Motley Fool"}, "author": "newsfeedback@fool.com (Keith Speights and Brian Orelli, PhD)", "title": "Why Is Pfizer Teaming Up With Acuitas Therapeutics?", "description": "The deal boosts Pfizer's internal mRNA development effort.", "url": "https://www.fool.com/investing/2022/01/22/why-is-pfizer-teaming-up-with-acuitas-therapeutics/", "urlToImage": "https://g.foolcdn.com/editorial/images/662337/handshake-between-2-people.jpg", "publishedAt": "2022-01-22T10:58:00Z", "content": "Pfizer(NYSE:PFE) is putting some of its growing cash stockpile to use. The big drugmaker recently announced a collaboration with Acuitas Therapeutics. In this Motley Fool Live video, recorded on Jan.\u2026 [+2943 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "Reuters", "title": "Pfizer CEO sees annual COVID vaccine rather than frequent boosters", "description": "Pfizer Inc Chief Executive Albert Bourla said on Saturday that an annual COVID-19 vaccine would be preferable to more frequent booster shots in fighting the ...", "url": "https://news.yahoo.com/pfizer-ceo-sees-annual-covid-195933594.html", "urlToImage": "https://s.yimg.com/uu/api/res/1.2/gAxfUjAOHQHzrPgpGBAa3A--~B/aD01MjY7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/5bbfdd25622b1f8e9a35f9247ea7e738", "publishedAt": "2022-01-22T19:59:33Z", "content": "JERUSALEM (Reuters) - Pfizer Inc Chief Executive Albert Bourla said on Saturday that an annual COVID-19 vaccine would be preferable to more frequent booster shots in fighting the coronavirus pandemic\u2026 [+1649 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "Simply Wall St", "title": "Should You Buy Pfizer Inc. (NYSE:PFE) For Its Upcoming Dividend?", "description": "Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Pfizer Inc...", "url": "https://finance.yahoo.com/news/buy-pfizer-inc-nyse-pfe-123536930.html", "urlToImage": "https://s.yimg.com/uu/api/res/1.2/gKoOH7Hn48_EpUBqnF4ohQ--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/8f018d189c2c443014c49845310ae091", "publishedAt": "2022-01-22T12:35:36Z", "content": "Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Pfizer Inc. (NYSE:PFE) is about to trade ex-dividend in the next 4 days. The ex-dividend date\u2026 [+4744 chars]"}, {"source": {"id": null, "name": "CNA"}, "author": null, "title": "Pfizer CEO sees annual COVID vaccine rather than frequent boosters", "description": "JERUSALEM: Pfizer Chief Executive Albert Bourla said on Saturday (Jan 22) that an annual COVID-19 vaccine would be preferable to more frequent booster shots in fighting the coronavirus pandemic.\r\n\r\nPfizer-BioNtech's COVID-19 vaccine has shown to be effective \u2026", "url": "https://www.channelnewsasia.com/world/pfizer-ceo-sees-annual-covid-vaccine-rather-frequent-boosters-2453486", "urlToImage": "https://onecms-res.cloudinary.com/image/upload/s--g7Ov1QW9--/fl_relative%2Cg_south_east%2Cl_one-cms:core:watermark:reuters%2Cw_0.1/f_auto%2Cq_auto/c_fill%2Cg_auto%2Ch_676%2Cw_1200/v1/one-cms/core/2022-01-22t195933z_1_lynxmpei0l0b0_rtroptp_3_health-coronavirus-pfizer.jpg?itok=mXzBh59Y", "publishedAt": "2022-01-22T21:58:31Z", "content": "JERUSALEM: Pfizer Chief Executive Albert Bourla said on Saturday (Jan 22) that an annual COVID-19 vaccine would be preferable to more frequent booster shots in fighting the coronavirus pandemic.\r\nPfi\u2026 [+1590 chars]"}, {"source": {"id": null, "name": "The Times of Israel"}, "author": null, "title": "Pfizer CEO to Israeli TV: We should be back to near-normal in \u2018a few months\u2019", "description": "Albert Bourla says US-based pharma firm is aiming to produce annual shot to cover all COVID variants; accuses anti-vaxxers of causing millions of deaths by spreading misinformation", "url": "https://www.timesofisrael.com/pfizer-ceo-to-israeli-tv-we-should-be-back-to-near-normal-in-a-few-months/", "urlToImage": "https://static.timesofisrael.com/www/uploads/2022/01/AP22018633864950-1024x640.jpg", "publishedAt": "2022-01-22T20:01:54Z", "content": "In interviews with Israeli television aired Saturday, Pfizer CEO Albert Bourla predicted the world will return to near-normal conditions within a few months and said the US-based pharmaceutical firm \u2026 [+3209 chars]"}, {"source": {"id": null, "name": "CNBC"}, "author": "Reuters", "title": "Pfizer CEO says an annual Covid vaccine is preferable to periodic boosters", "description": "Pfizer CEO Albert Bourla said that an annual Covid-19 vaccine would be better than booster shots every few months in fighting the coronavirus pandemic.", "url": "https://www.cnbc.com/2022/01/22/pfizer-ceo-says-an-annual-covid-vaccine-is-preferable-to-periodic-boosters.html", "urlToImage": "https://image.cnbcfm.com/api/v1/image/107005064-1642882834415-gettyimages-1231265667-AFP_93E3F8.jpeg?v=1642882872", "publishedAt": "2022-01-22T20:27:00Z", "content": "Pfizer Chief Executive Albert Bourla said on Saturday that an annual Covid-19 vaccine would be preferable to more frequent booster shots in fighting the coronavirus pandemic.\r\nPfizer/BioNtech's Covid\u2026 [+1557 chars]"}, {"source": {"id": null, "name": "Seeking Alpha"}, "author": "Dulan Lokuwithana", "title": "Pfizer, Merck trial antiviral combos amid concerns over resistance to COVID-19 pills", "description": "Pfizer (PFE) and Merck (MRK), the developers of the first oral medications for COVID-19 in the U.S., are advancing combination studies for their antiviral therapies as experts flag the...", "url": "https://seekingalpha.com/news/3790494-pfizer-merck-trial-antiviral-combos-amid-concerns-over-resistance-to-covid-19-pills", "urlToImage": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1211114995/medium_image_1211114995.jpg", "publishedAt": "2022-01-22T17:00:41Z", "content": "sittithat tangwitthayaphum/iStock via Getty Images"}, {"source": {"id": null, "name": "Freerepublic.com"}, "author": "AP via ABC News", "title": "Pfizer chief Albert Bourla wins $1 million Genesis Prize", "description": "Albert Bourla, chairman and chief executive of global pharmaceutical giant Pfizer Inc., was awarded on Wednesday the prestigious Genesis Prize for his efforts in leading the development of a COVID-19 vaccine. The $1 million award is granted each year to a per\u2026", "url": "https://freerepublic.com/focus/f-news/4031695/posts", "urlToImage": null, "publishedAt": "2022-01-22T15:15:03Z", "content": "Skip to comments.\r\nPfizer chief Albert Bourla wins $1 million Genesis Prize\r\nAP via ABC News ^\r\n | 01/22/22\r\n | JOSEF FEDERMAN \r\nPosted on 01/22/2022 7:15:03 AM PST by Kid Shelleen\r\nAlbert Bourla, ch\u2026 [+2017 chars]"}, {"source": {"id": null, "name": "Freerepublic.com"}, "author": "lifesitenews.com", "title": "FOIA docs reveal Pfizer shot caused avalanche of miscarriages, stillborn babies", "description": "[H/T Little Jeremiah](LifeSiteNews) \u2013 Netflix reality TV star Maya Vander told her fans last week of her devastating grief after she delivered a stillborn baby at 38 weeks of pregnancy December 9.\u201cYesterday was the hardest day of my life,\u201d Vander, 39, posted \u2026", "url": "https://freerepublic.com/focus/f-chat/4031782/posts", "urlToImage": null, "publishedAt": "2022-01-22T21:28:43Z", "content": "(LifeSiteNews) Netflix reality TV star Maya Vander told her fans last week of her devastating grief after she delivered a stillborn baby at 38 weeks of pregnancy December 9.\r\nYesterday was the hardes\u2026 [+4135 chars]"}, {"source": {"id": "the-hill", "name": "The Hill"}, "author": "Brad Dress", "title": "Pfizer CEO says frequent boosters 'not a good scenario,' hopes for yearly vaccine", "description": "Pfizer CEO\u00a0Albert Bourla on Saturday said people getting COVID-19 booster shots every\u00a0four to five months is \"not a good scenario\" and argued that an annual vaccine would be a better approach to fighting the virus....", "url": "https://thehill.com/policy/healthcare/590926-pfizer-ceo-says-frequent-boosters-not-a-good-scenario-hopes-for-yearly", "urlToImage": "https://thehill.com/sites/default/files/newsletter-bourla_120921ap.jpg", "publishedAt": "2022-01-22T22:22:09Z", "content": "Pfizer CEO\u00a0Albert Bourla on Saturday said people getting COVID-19 booster shots every\u00a0four to five months is \"not a good scenario\" and argued that an annual vaccine would be a better approach to figh\u2026 [+2571 chars]"}, {"source": {"id": null, "name": "Daily Mail"}, "author": "", "title": "Video: Pfizer CEO sees yearly COVID vaccine rather than frequent boosters", "description": "Pfizer Inc Chief Executive Albert Bourla said on an Israeli TV show that an annual COVID-19 vaccine would be preferable to more frequent booster shots in fighting the coronavirus pandemic.", "url": "https://www.dailymail.co.uk/video/news/video-2595909/Video-Pfizer-CEO-sees-yearly-COVID-vaccine-frequent-boosters.html", "urlToImage": "https://i.dailymail.co.uk/1s/2022/01/22/23/53253159-0-image-a-5_1642894811533.jpg", "publishedAt": "2022-01-22T23:41:42Z", "content": "1:09\r\nScientists reconstruct face of female mummy who died 6,200 years ago"}, {"source": {"id": null, "name": "Slashdot.org"}, "author": "feedfeeder", "title": "Pfizer, Moderna boosters up to 90% effective against Omicron: CDC - Al Jazeera English", "description": "Pfizer, Moderna boosters up to 90% effective against Omicron: CDCAl Jazeera English Booster shots needed against omicron, CDC studies showYahoo News Unvaccinated Adults 65 and Older Are Almost 50 Times More Likely to Be Hospitalized with COVIDPEOPLE Boosters \u2026", "url": "https://slashdot.org/firehose.pl?op=view&amp;id=157939205", "urlToImage": null, "publishedAt": "2022-01-22T10:12:17Z", "content": "The Fine Print: The following comments are owned by whoever posted them. We are not responsible for them in any way."}, {"source": {"id": null, "name": "Ctvnews.ca"}, "author": "Reuters", "title": "Annual COVID-19 shots over frequent boosters, Pfizer CEO says", "description": "Pfizer Inc. Chief Executive Albert Bourla said on Saturday that an annual COVID-19 vaccine would be preferable to more frequent booster shots in fighting the coronavirus pandemic.", "url": "https://www.ctvnews.ca/health/coronavirus/pfizer-ceo-sees-annual-covid-19-vaccine-rather-than-frequent-boosters-1.5750978", "urlToImage": "https://www.ctvnews.ca/polopoly_fs/1.5595845.1632322442!/httpImage/image.jpg_gen/derivatives/landscape_620/image.jpg", "publishedAt": "2022-01-22T23:30:15Z", "content": "JERUSALEM -- \r\nPfizer Inc. Chief Executive Albert Bourla said on Saturday that an annual COVID-19 vaccine would be preferable to more frequent booster shots in fighting the coronavirus pandemic.\r\nPfi\u2026 [+1642 chars]"}]}, "2022-01-21": {"status": "ok", "totalResults": 29, "articles": [{"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "Pfizer says has approval in Japan for COVID vaccine for children aged 5-11 - Reuters", "description": "Pfizer Inc <a href=\"https://www.reuters.com/companies/PFE.N\" target=\"_blank\">(PFE.N)</a> said on Friday it received special approval in Japan for its COVID-19 vaccine to be given to children aged 5-11.", "url": "https://www.reuters.com/world/asia-pacific/pfizer-says-has-approval-japan-covid-vaccine-children-aged-5-11-2022-01-21/", "urlToImage": "https://www.reuters.com/resizer/ik18fBTZNrX-N-XdYGDzxsh-OsM=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/MZSK23YAYBKCXPSIOOSJLOLSEA.jpg", "publishedAt": "2022-01-21T01:34:00Z", "content": "A health worker fills a syringe with a dose of the Pfizer-BioNTech coronavirus disease (COVID-19) vaccine at the Tokyo Dome, the home ground of the Japanese professional baseball team Yomiuri Giants \u2026 [+608 chars]"}, {"source": {"id": null, "name": "Novascotia.ca"}, "author": "Communications Nova Scotia", "title": "People 30 and Older Now Eligible for Pfizer COVID-19 Vaccine - Government of Nova Scotia", "description": "<ol><li>People 30 and Older Now Eligible for Pfizer COVID-19 Vaccine\u00a0\u00a0Government of Nova Scotia\r\n</li><li>Pfizer vaccine clinic set for Saturday at D-Z\u00a0\u00a0kinyradio.com\r\n</li><li>What does it mean to be 'fully vaccinated' against COVID-19?\u00a0\u00a0CNET\r\n</li><li>Moder\u2026", "url": "https://novascotia.ca/news/release/?id=20220121004", "urlToImage": null, "publishedAt": "2022-01-21T18:01:00Z", "content": "Nova Scotians who are 30 and older are now able to schedule an appointment for the Pfizer COVID-19 vaccine.\r\nMore than 55,000 Pfizer appointments were added to clinics across the province earlier thi\u2026 [+1540 chars]"}, {"source": {"id": null, "name": "Ctvnews.ca"}, "author": null, "title": "Nova Scotia opens Pfizer booster appointments to those aged 30 and over - CTV News Atlantic", "description": "<ol><li>Nova Scotia opens Pfizer booster appointments to those aged 30 and over\u00a0\u00a0CTV News Atlantic\r\n</li><li>Adults over 30 free to choose Pfizer or Moderna shot at Peel vaccine clinics\u00a0\u00a0Toronto Star\r\n</li><li>Nova Scotians aged 30 and older can now book Pfiz\u2026", "url": "https://atlantic.ctvnews.ca/nova-scotia-opens-pfizer-booster-appointments-to-those-aged-30-and-over-1.5749803", "urlToImage": "https://www.ctvnews.ca/content/dam/ctvnews/en/images/2021/10/17/covid-19-vaccines-1-5626761-1634507140388.png", "publishedAt": "2022-01-21T19:09:20Z", "content": "Nova Scotia has announced those aged 30 and over are able to schedule an appointment to receive the Pfizer COVID-19 vaccine.\r\nThe province says anyone 30 and over who currently has a Moderna appointm\u2026 [+1382 chars]"}, {"source": {"id": null, "name": "New York Times"}, "author": "Cora Engelbrecht", "title": "W.H.O. Panel Endorses Pfizer Vaccine for Children 5 to 11", "description": "Advisers endorsed the wider use of vaccines for children and boosters for high-risk people, bringing its guidance closer to that of most wealthy nations.", "url": "https://www.nytimes.com/2022/01/21/world/who-kids-covid-vaccine.html", "urlToImage": "https://static01.nyt.com/images/2022/01/21/multimedia/21virus-briefing-WHO-booster/21virus-briefing-WHO-booster-facebookJumbo.jpg", "publishedAt": "2022-01-21T15:56:38Z", "content": "In August, before the Omicron variant had been identified, the W.H.O. called for a global moratorium on boosters to increase the distribution of vaccine supplies to countries in the greatest need. Bu\u2026 [+1174 chars]"}, {"source": {"id": "axios", "name": "Axios"}, "author": "Axios", "title": "CDC: Pfizer and Moderna boosters overwhelmingly prevent Omicron hospitalizations", "description": "Booster doses of the Pfizer-BioNTech and Moderna vaccines overwhelmingly prevented hospitalizations from the Omicron variant, according to Center for Disease Control and Prevention data out Friday.Driving the news: Pfizer and Moderna boosters were 90% effecti\u2026", "url": "https://www.axios.com/cdc-pfizer-and-moderna-boosters-overwhelmingly-prevent-omicron-hospitalizations-7096882e-51af-4c5e-8ba6-66e1519885c9.html", "urlToImage": "https://images.axios.com/jwhjHVDwKD6bdgzzc69QktXjF0k=/0x22:1600x922/1366x768/2022/01/21/1642782530935.jpg", "publishedAt": "2022-01-21T16:32:47Z", "content": "Booster doses of the Pfizer-BioNTech and Moderna vaccines overwhelmingly prevented hospitalizations from the Omicron variant, according to Center for Disease Control and Prevention data out Friday.\r\n\u2026 [+576 chars]"}, {"source": {"id": "the-wall-street-journal", "name": "The Wall Street Journal"}, "author": "Felicia Schwartz, Sam Schechner, Jon Kamp", "title": "Third Dose of Pfizer, Moderna Covid-19 Vaccines Offers Strong Protection Against Omicron - The Wall Street Journal", "description": "Third Dose of Pfizer, Moderna Covid-19 Vaccines Offers Strong Protection Against Omicron\u00a0\u00a0The Wall Street JournalView Full Coverage on Google News", "url": "https://www.wsj.com/articles/omicron-wave-eases-in-parts-of-u-s-france-sets-plan-to-relax-curbs-11642770561", "urlToImage": "https://images.wsj.net/im-471659/social", "publishedAt": "2022-01-21T18:20:00Z", "content": "Vaccines and booster shots offer superior protection from the Delta and Omicron variants, according to three new studies released by the Centers for Disease Control and Prevention.The data back up ea\u2026 [+6811 chars]"}, {"source": {"id": "rt", "name": "RT"}, "author": "RT", "title": "Developers explain why Sputnik V seems to be better at tackling Omicron than Pfizer", "description": "Gamaleya Center\u2019s Alexander Gintsburg and RDIF\u2019s Kirill Dmitriev explain to RT why Sputnik V works better against Omicron than Pfizer jab Read Full Article at RT.com", "url": "https://www.rt.com/russia/546764-sputnik-pfizer-vaccine-omicron/", "urlToImage": "https://cdni.rt.com/files/2022.01/article/61eab52f2030276470766852.jpg", "publishedAt": "2022-01-21T16:18:03Z", "content": "The head of Moscow's Gamaleya National Center of Epidemiology and Microbiology, which created the Sputnik V Covid-19 vaccine, and the boss of the fund that bankrolled its development have spoken to\u00a0R\u2026 [+3576 chars]"}, {"source": {"id": null, "name": "Moneycontrol"}, "author": null, "title": "WHO advisory panel recommends extending use of Pfizer vaccine to 5-11 year olds", "description": "The recommendation comes after the Strategic Advisory Group of Experts (SAGE) on immunisation held a meeting on Wednesday to evaluate the companies#39; vaccine. The vaccine is currently recommended for use in people aged 12 years and above.", "url": "https://www.moneycontrol.com/news/trends/health-trends/who-advisory-panel-recommends-extending-use-of-pfizer-vaccine-to-5-11-year-olds-7969091.html", "urlToImage": "https://images.moneycontrol.com/static-mcnews/2021/02/Pfizer-770x433.jpg", "publishedAt": "2022-01-21T14:16:14Z", "content": "The World Health Organization's advisory panel on Friday recommended extending the use of a reduced dosage of Pfizer\u00a0and German partner BioNTech's COVID-19 vaccine to children aged 5 to 11 years old.\u2026 [+739 chars]"}, {"source": {"id": null, "name": "Moneycontrol"}, "author": null, "title": "Sputnik V COVID vaccine shows higher Omicron-specific antibodies than Pfizer: Study", "description": "The joint Russian-Italian study \u00e2\u0080\u0094 funded by the Russian Direct Investment Fund which markets Sputnik V \u00e2\u0080\u0094 compared the blood serum samples of people taken three to six months after the second dose of the two vaccines.", "url": "https://www.moneycontrol.com/news/trends/health-trends/sputnik-v-covid-vaccine-shows-higher-omicron-specific-antibodies-than-pfizer-study-7966891.html", "urlToImage": "https://images.moneycontrol.com/static-mcnews/2021/08/Sputnik-vaccine-image-via-AFP.-770x433.jpg", "publishedAt": "2022-01-21T07:25:26Z", "content": "The levels of Omicron-neutralising antibodies of people vaccinated with two doses of Russias Sputnik V vaccine did not decline as much as of those who had Pfizer shots, according to a small study.\r\nT\u2026 [+2433 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "PR Newswire", "title": "Insights on the Omics-Based Clinical Trials Global Market to 2030 - Featuring ICON, SGS and Pfizer Among Others", "description": "The \"Omics-Based Clinical Trials Market Size, Share & Trends Analysis Report by Phase (Phase I, Phase II, Phase III, Phase IV), by Study Design, by...", "url": "https://finance.yahoo.com/news/insights-omics-based-clinical-trials-210000334.html", "urlToImage": "https://s.yimg.com/uu/api/res/1.2/wDGPSO44TROYKbQSONxNmQ--~B/aD00Mjt3PTQwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/prnewswire.com/e75ef6f3096d7cb6f5dd43ba82eca2fe", "publishedAt": "2022-01-21T21:00:00Z", "content": "DUBLIN, Jan. 21, 2022 /PRNewswire/ -- The \"Omics-Based Clinical Trials Market Size, Share &amp; Trends Analysis Report by Phase (Phase I, Phase II, Phase III, Phase IV), by Study Design, by Indicatio\u2026 [+9821 chars]"}, {"source": {"id": null, "name": "Bangkok Post"}, "author": "Post Reporters", "title": "Pfizer jabs for 5-11s to arrive next week", "description": "The next batch of 3 million doses of Pfizer vaccines will arrive in the kingdom on Jan 26 to inoculate children aged 5-11 years, Public Health Minister Anutin Charnvirakul said on Thursday.", "url": "https://www.bangkokpost.com/thailand/general/2250923/pfizer-jabs-for-5-11s-to-arrive-next-week", "urlToImage": "https://static.bangkokpost.com/media/content/20220121/c1_2250923_220121073658_700.jpg", "publishedAt": "2022-01-21T00:33:00Z", "content": "The next batch of 3 million doses of Pfizer vaccines will arrive in the kingdom on Jan 26 to inoculate children aged 5-11 years, Public Health Minister Anutin Charnvirakul said on Thursday.\r\nMr Anuti\u2026 [+1764 chars]"}, {"source": {"id": null, "name": "Livemint"}, "author": "Reuters", "title": "WHO advisory panel recommends extending use of Pfizer vaccine to 5-11 year old - Mint", "description": "The recommended dosage for the younger population is 10 micrograms instead of 30 micrograms offered to those 12 years and older.", "url": "https://www.livemint.com/news/world/who-advisory-panel-recommends-extending-use-of-pfizer-vaccine-to-5-11-year-old-11642773353272.html", "urlToImage": "https://images.livemint.com/img/2022/01/21/600x338/Pfizer_1641860181676_1642773445952.jpg", "publishedAt": "2022-01-21T14:08:32Z", "content": "The World Health Organization's advisory panel on Friday recommended extending the use of a reduced dosage of Pfizer and German partner BioNTech's COVID-19 vaccine to children aged 5 to 11 years old."}, {"source": {"id": null, "name": "Business Wire"}, "author": null, "title": "Pfizer and OPKO Provide Update on the Biologics License Application for Somatrogon for Pediatric Growth Hormone Deficiency", "description": "NEW YORK & MIAMI--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and OPKO Health, Inc. (NASDAQ: OPK) announced today that the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) for the Biologics License Application (BLA) for somatrogon.\u2026", "url": "https://www.businesswire.com/news/home/20220121005474/en/Pfizer-and-OPKO-Provide-Update-on-the-Biologics-License-Application-for-Somatrogon-for-Pediatric-Growth-Hormone-Deficiency", "urlToImage": "https://mms.businesswire.com/media/20220121005474/en/1045874/23/Pfizer_Logo_Color_RGB_APPROVED.jpg", "publishedAt": "2022-01-21T21:36:25Z", "content": "NEW YORK &amp; MIAMI--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and OPKO Health, Inc. (NASDAQ: OPK) announced today that the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (\u2026 [+9281 chars]"}, {"source": {"id": null, "name": "News 5 Cleveland"}, "author": "Olivia Fecteau", "title": "CWRU School of Medicine study finds when it came to Delta, Moderna vaccine was better than Pfizer - News 5 Cleveland", "description": "<ol><li>CWRU School of Medicine study finds when it came to Delta, Moderna vaccine was better than Pfizer\u00a0\u00a0News 5 Cleveland\r\n</li><li>Study finds Moderna vax may lead to fewer breakthrough Covid infections than Pfizer\u00a0\u00a0Times of India\r\n</li><li>COVID booster s\u2026", "url": "https://www.news5cleveland.com/news/continuing-coverage/coronavirus/cwru-school-of-medicine-study-finds-when-it-came-to-delta-moderna-vaccine-was-better-than-pfizer", "urlToImage": "https://ewscripps.brightspotcdn.com/dims4/default/3c59579/2147483647/strip/true/crop/3546x1862+0+53/resize/1200x630!/quality/90/?url=https%3A%2F%2Fewscripps.brightspotcdn.com%2F52%2F09%2F12a05d034ab799baa0aa9bf776f1%2Fscreen-shot-2021-08-10-at-10.10.26%20AM.png", "publishedAt": "2022-01-21T02:55:00Z", "content": "CLEVELAND Researchers from Case Western Reserve University School of Medicine have found some advantages for those who received the Moderna vaccine, compared to the Pfizer-BioNTech vaccine, when it c\u2026 [+6742 chars]"}, {"source": {"id": null, "name": "Global News"}, "author": "Karla Reni\u0107", "title": "Nova Scotians aged 30 and older can now book Pfizer COVID-19 shots - Global News", "description": "<ol><li>Nova Scotians aged 30 and older can now book Pfizer COVID-19 shots\u00a0\u00a0Global News\r\n</li><li>Nova Scotia opens Pfizer booster appointments to those aged 30 and over\u00a0\u00a0CTV News Atlantic\r\n</li><li>Fauci hopeful on vaccine for kids under 5 in coming months: \u2026", "url": "https://globalnews.ca/news/8529795/nova-scotia-pfizer-appointments-available-covid-vaccine/", "urlToImage": "https://globalnews.ca/wp-content/uploads/2022/01/2022010314014-61d3496599ce6aec86e4672fjpeg.jpg?quality=85&strip=all&w=720&h=379&crop=1", "publishedAt": "2022-01-21T18:56:10Z", "content": "Nova Scotia is making the Pfizer COVID-19 vaccine available again to those aged 30 and older, after it had been restricted to younger demographics.\r\nOn Friday the province said 55,000 appointments fo\u2026 [+1724 chars]"}, {"source": {"id": null, "name": "Seeking Alpha"}, "author": "Jonathan Block", "title": "Pfizer, OPKO receive somatrogon Complete Respoinse Letter for growth hormone deficiency", "description": "The FDA has issued Pfizer and OPKO Health a Complete Response Letter for their Biologics License Application for somatrogon.", "url": "https://seekingalpha.com/news/3790463-pfizer-opko-receive-somatrogon-complete-respoinse-letter-for-growth-hormone-deficiency", "urlToImage": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1293101930/medium_image_1293101930.jpg", "publishedAt": "2022-01-21T22:06:19Z", "content": "JHVEPhoto/iStock Editorial via Getty Images"}, {"source": {"id": null, "name": "Lifesite"}, "author": "Mike Rivero", "title": "All he wanted to do was play hockey\u2019: Grieving dad says Pfizer shot killed his 17-year old son", "description": "Toronto resident Dan Hartman testified to the Toronto City Council on Tuesday that he believes that the Pfizer jab killed his 17-year-old son, Sean. Hartman explained that his son experienced a bad reaction to his first shot, and just over a month later was d\u2026", "url": "https://www.lifesitenews.com/video/all-he-wanted-to-do-was-play-hockey-grieving-dad-says-pfizer-shot-killed-his-17-year-old-son/?utm_source=top_news&utm_campaign=usa", "urlToImage": null, "publishedAt": "2022-01-21T12:26:58Z", "content": "Toronto resident Dan Hartman testified to the Toronto City Council on Tuesday that he believes that the Pfizer jab killed his 17-year-old son, Sean. Hartman explained that his son experienced a bad r\u2026 [+107 chars]"}, {"source": {"id": null, "name": "Daily Mail"}, "author": "Mansur Shaheen U.S.", "title": "WHO lowers recommended age for children to be eligible for Pfizer Covid vaccine to five years old", "description": "The WHO has lowered its minimum recommended age for the Pfizer COVID-19 vaccine to five years old, down from 12. It also now recommends use of the Pfizer booster shot, a reversal.", "url": "https://www.dailymail.co.uk/health/article-10428517/WHO-lowers-recommended-age-children-eligible-Pfizer-Covid-vaccine-five-years-old.html", "urlToImage": "https://i.dailymail.co.uk/1s/2022/01/21/21/53224869-0-image-a-56_1642802162373.jpg", "publishedAt": "2022-01-21T22:05:00Z", "content": "The World Health Organization (WHO) has lowered its minimum recommended age for the Pfizer-BioNTech Covid vaccine from 12 to five years old. The organization now recommends worldwide governments to e\u2026 [+4713 chars]"}, {"source": {"id": null, "name": "Business Standard"}, "author": "IANS", "title": "Moderna vax may lead to fewer breakthrough Covid infections than Pfizer", "description": "Those who have received the Moderna Covid-19 mRNA vaccine are less likely to experience \"breakthrough\" Covid-19 cases, compared to recipients of the Pfizer-BioNTech mRNA vaccine", "url": "https://www.business-standard.com/article/current-affairs/moderna-vax-may-lead-to-fewer-breakthrough-covid-infections-than-pfizer-122012100932_1.html", "urlToImage": "https://bsmedia.business-standard.com/_media/bs/img/article/2021-08/13/full/1628796774-9979.jpg", "publishedAt": "2022-01-21T12:33:00Z", "content": "Those who have received the Moderna Covid-19 mRNA vaccine are less likely to experience \"breakthrough\" Covid-19 cases, compared to recipients of the Pfizer-BioNTech mRNA vaccine, finds a new study.\r\n\u2026 [+2877 chars]"}, {"source": {"id": null, "name": "Business Standard"}, "author": "Reuters", "title": "Covid-19 pandemic: WHO panel for use of Pfizer jab on 5-11-year olds", "description": "The recommendation comes after the Strategic Advisory Group of Experts (SAGE) on immunisation held a meeting on Wednesday", "url": "https://www.business-standard.com/article/international/covid-19-pandemic-who-panel-for-use-of-pfizer-jab-on-5-11-year-olds-122012200063_1.html", "urlToImage": "https://bsmedia.business-standard.com/_media/bs/img/article/2016-03/15/full/1458029734-1022.jpg", "publishedAt": "2022-01-21T20:14:00Z", "content": "The World Health Organisation on Friday recommended extending the use of a reduced dosage of Pfizer's COVID-19 vaccine to children aged 5 to 11 years old. The recommendation comes after the Strategic\u2026 [+2131 chars]"}]}, "2022-01-20": {"status": "ok", "totalResults": 27, "articles": [{"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "Sputnik V shows higher Omicron-antibody levels than Pfizer in preliminary study - Reuters", "description": "A small preliminary laboratory study has shown that levels of Omicron-neutralising antibodies of people vaccinated with Russia's Sputnik V vaccine did not decline as much as of those who had Pfizer shots.", "url": "https://www.reuters.com/world/europe/sputnik-v-shows-higher-omicron-antibody-levels-than-pfizer-preliminary-study-2022-01-20/", "urlToImage": "https://www.reuters.com/resizer/ALdaaKis4LU8IS00voG5V9CBaBU=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/PH72ZRL5HJME5IGVTLIW5DCIO4.jpg", "publishedAt": "2022-01-20T15:31:00Z", "content": "MOSCOW, Jan 20 (Reuters) - A small preliminary laboratory study has shown that levels of Omicron-neutralising antibodies of people vaccinated with Russia's Sputnik V vaccine did not decline as much a\u2026 [+1966 chars]"}, {"source": {"id": "rt", "name": "RT"}, "author": "RT", "title": "Is the Sputnik V Covid-19 vaccine really more effective than Pfizer against Omicron?", "description": "A recent study claims Russia\u2019s Sputnik V is better in the fight against the Omicron variant of Covid than Pfizer\u2019s vaccine Read Full Article at RT.com", "url": "https://www.rt.com/russia/546659-sputnik-v-more-effective-than-pfizer/", "urlToImage": "https://cdni.rt.com/files/2022.01/article/61e97ffb2030275993331e35.jpg", "publishedAt": "2022-01-20T17:22:37Z", "content": "The Russian Direct Investment Fund (RDIF), which funded the creation of the Sputnik V Covid-19 vaccine, has released the results of a recent comparative study, indicating that the Russian shot is mor\u2026 [+4666 chars]"}, {"source": {"id": "independent", "name": "Independent"}, "author": "Sravasti Dasgupta", "title": "Fauci says children under 5 could be authorised for Pfizer vaccine in weeks", "description": "The US has seen record hospitalisations among children below 5 years due to the surge in Omicron cases", "url": "https://www.independent.co.uk/news/world/americas/fauci-pfizer-covid-vaccine-children-b1996864.html", "urlToImage": "https://static.independent.co.uk/2022/01/18/07/GettyImages-1237662446.jpg?width=1200&auto=webp&quality=75", "publishedAt": "2022-01-20T07:46:01Z", "content": "Children under five years are likely to be given Covid-19 vaccines by next month, according to White House medical adviser Anthony Fauci.\r\nAt a townhall interview on Wednesday with Blue Star Families\u2026 [+1906 chars]"}, {"source": {"id": "independent", "name": "Independent"}, "author": "Sravasti Dasgupta", "title": "Fauci says children under 5 could be authorised for Pfizer vaccine in weeks", "description": "The US has seen record hospitalisations among children below 5 years due to the surge in Omicron cases", "url": "https://www.independent.co.uk/news/world/americas/pfizer-covid-vaccine-children-fauci-b1997243.html", "urlToImage": "https://static.independent.co.uk/2022/01/18/07/GettyImages-1237662446.jpg?width=1200&auto=webp&quality=75", "publishedAt": "2022-01-20T14:58:46Z", "content": "Children under five years are likely to be given Covid-19 vaccines by next month, according to White House medical adviser Anthony Fauci.\r\nAt a townhall interview on Wednesday with Blue Star Families\u2026 [+1906 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "Syapse", "title": "Syapse Extends Collaboration with Pfizer to Continue to Generate Real-World Evidence in Breast Cancer", "description": "Syapse will continue to identify, validate, and address discrepancies in real-world data, producing an accurate and fully contextualized narrative of a...", "url": "https://finance.yahoo.com/news/syapse-extends-collaboration-pfizer-continue-150000987.html", "urlToImage": "https://s.yimg.com/uu/api/res/1.2/8poGkqofCo.eusmVfarKKw--~B/aD0xNTc7dz00Njk7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/a8cf430000c9e49e71726a7914e4a3a3", "publishedAt": "2022-01-20T15:00:00Z", "content": "Syapse will continue to identify, validate, and address discrepancies in real-world data, producing an accurate and fully contextualized narrative of a patients experience\r\nSAN FRANCISCO, Jan. 20, 20\u2026 [+3876 chars]"}, {"source": {"id": null, "name": "Japan Today"}, "author": null, "title": "Gov't panel OKs Pfizer COVID vaccine for children aged 5-11", "description": "A Japanese health ministry panel approved Thursday the administration of Pfizer Inc's coronavirus vaccine to children aged 5 to 11, making it the first in Japan to be available for the age group. Around 7 million children will be eligible to receive the COVID\u2026", "url": "https://japantoday.com/category/national/update1-japan-gov%27t-panel-oks-pfizer%27s-covid-vaccine-for-children-aged-5-11", "urlToImage": null, "publishedAt": "2022-01-20T21:40:31Z", "content": "A Japanese health ministry panel approved Thursday the administration of Pfizer Inc's coronavirus vaccine to children aged 5 to 11, making it the first in Japan to be available for the age group.\r\nAr\u2026 [+1615 chars]"}, {"source": {"id": null, "name": "Sputnik International"}, "author": "Sputnik International", "title": "Sputnik V Bests Pfizer Jab in Effectiveness Against Omicron, Research Shows", "description": "Previous data already suggested that Sputnik V vaccine is highly effective against the Omicron variant, with studies also pointing at a lesser and slower decline of antibody levels for the Russian jab when compared to other vaccines.", "url": "https://sputniknews.com/20220120/sputnik-v-bests-pfizer-jab-in-effectiveness-against-omicron-research-shows-1092359455.html", "urlToImage": "https://cdnn1.img.sputniknews.com/images/sharing/article/eng/1092359455.jpg?10824926401642676400", "publishedAt": "2022-01-20T11:00:00Z", "content": "Registration was successful!Please follow the link from the email sent to \r\nThe new COVID variant was initially detected in South Africa and Botswana and sparked major concerns due to its high number\u2026 [+12146 chars]"}, {"source": {"id": null, "name": "Kalkine Media"}, "author": null, "title": "Pfizer covid vaccine for kids under five on the anvil - Kalkine Media", "description": "<ol><li>Pfizer covid vaccine for kids under five on the anvil\u00a0\u00a0Kalkine Media\r\n</li><li>FDA Likely to Approve Pfizer's COVID-19 Vaccine for Kids under Five: Anthony Fauci | The Weather Channel - Articles from The Weather Channel | weather.com\u00a0\u00a0The Weather Chan\u2026", "url": "https://kalkinemedia.com/news/world-news/pfizer-covid-vaccine-for-kids-under-five-on-the-anvil", "urlToImage": "https://cdn.kalkinemedia.com/image/e368da1923624ae7b8b2988bced33755/image.jpg", "publishedAt": "2022-01-20T20:06:06Z", "content": "White House chief medical advisor Anthony Fauci has said that the US Food and Drug Administration (FDA) could authorize a Pfizer-BioNTech Covid-19 vaccine for children under five years next month.\r\nI\u2026 [+1517 chars]"}, {"source": {"id": null, "name": "FiercePharma"}, "author": "Ben Adams", "title": "COVID vaccines help Pfizer, Moderna reign supreme reputation-wise, but they're a double-edged sword for J&J and AZ", "description": "Pfizer and Moderna are now two of the leading pharma companies in the U.S. when it comes to public image, thanks to their COVID vaccines. On the flip side, vaccine rivals J&J and AstraZeneca have seen their reputations plummet.", "url": "https://www.fiercepharma.com/marketing/vaccines-helps-pfizer-moderna-reign-supreme-reputation-score-but-it-s-a-double-edged", "urlToImage": "https://qtxasset.com/fiercepharma/1642679318/GettyImages-1288838574.jpg/GettyImages-1288838574.jpg?VersionId=2wbS6y3XYvKpZTmtZesaUMsRc8aV4S0q", "publishedAt": "2022-01-20T11:49:35Z", "content": "Pfizer and Moderna are now two of the leading pharma companies in the U.S. when it comes to public image, thanks to their COVID vaccines. On the flip side, vaccine rivals J&amp;J and AstraZeneca have\u2026 [+5884 chars]"}, {"source": {"id": "the-times-of-india", "name": "The Times of India"}, "author": "PTI", "title": "Two doses of Sputnik provide two times higher antibodies against Omicron than Pfizer vaccine: Study", "description": "India News: NEW DELHI: A study has found that two doses of Sputnik V provide two times higher virus neutralising antibodies against the Omicron variant of Covid-1.", "url": "https://timesofindia.indiatimes.com/india/two-doses-of-sputnik-provide-two-times-higher-antibodies-against-omicron-than-pfizer-vaccine-study/articleshow/89021358.cms", "urlToImage": "https://static.toiimg.com/thumb/msid-89021347,width-1070,height-580,imgsize-724525,resizemode-75,overlay-toi_sw,pt-32,y_pad-40/photo.jpg", "publishedAt": "2022-01-20T13:00:15Z", "content": "Two doses of Sputnik provide two times higher antibodies against Omicron than Pfizer vaccine: Study\r\n<ul><li>News</li>\r\n<li>India News</li>\r\n<li>Two doses of Sputnik provide two times higher antibodi\u2026 [+54 chars]"}, {"source": {"id": null, "name": "Daily Mail"}, "author": "Mansur Shaheen U.S.", "title": "Fauci says Pfizer vaccine could soon receive authorization for kids under the age of 5", "description": "Dr Anthony Fauci said Wednesday that he expects children under the age of five to be eligible for the Pfizer-BioNTech Covid vaccine as soon as next month.", "url": "https://www.dailymail.co.uk/health/article-10424055/Fauci-says-Pfizer-vaccine-soon-receive-authorization-kids-age-5.html", "urlToImage": "https://i.dailymail.co.uk/1s/2022/01/20/20/53180935-0-image-a-9_1642711030128.jpg", "publishedAt": "2022-01-20T20:40:32Z", "content": "Dr Anthony Fauci, the nation's top infectious disease expert, said Wednesday that he expects the Food and Drug Administration to approve the Pfizer-BioNTech vaccine for children under the age of five\u2026 [+4261 chars]"}, {"source": {"id": null, "name": "Bangkok Post"}, "author": "AFP", "title": "Unilever won't up \u00a350bn offer for GSK-Pfizer unit", "description": "LONDON: Consumer goods giant Unilever on Wednesday said it would not increase a \u00a350-billion offer for the consumer healthcare unit owned by pharmaceutical groups GlaxoSmithKline and Pfizer.", "url": "https://www.bangkokpost.com/business/2250515/unilever-wont-up-\u00a350bn-offer-for-gsk-pfizer-unit", "urlToImage": "https://static.bangkokpost.com/media/content/20220120/c1_4205815_700.jpg", "publishedAt": "2022-01-20T01:45:00Z", "content": "LONDON: Consumer goods giant Unilever on Wednesday said it would not increase a \u00a350-billion offer for the consumer healthcare unit owned by pharmaceutical groups GlaxoSmithKline and Pfizer.\r\nBritish \u2026 [+2154 chars]"}, {"source": {"id": null, "name": "Seeking Alpha"}, "author": "Ravikash", "title": "Pfizer-OPKO's Ngenla approved in Japan for pediatric growth hormone deficiency", "description": "Pfizer <<PFE>> and OPKO Health's <<OPK>> growth hormone injection Ngenla (somatrogon) was approved in Japan for pediatric growth hormone deficiency.Ngenla is weekly long-acting...", "url": "https://seekingalpha.com/news/3789727-pfizer-opkos-ngenla-approved-in-japan-for-pediatric-growth-hormone-deficiency", "urlToImage": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1304677649/medium_image_1304677649.jpg", "publishedAt": "2022-01-20T16:07:55Z", "content": "BrianAJackson/iStock via Getty Images"}, {"source": {"id": null, "name": "Business Standard"}, "author": "Press Trust of India", "title": "Two Sputnik doses provide two times higher antibodies than Pfizer: Study", "description": "A study has found that two doses of Sputnik V provide two times higher virus neutralising antibodies against the Omicron variant of COVID-19 than two doses of the Pfizer vaccine", "url": "https://www.business-standard.com/article/current-affairs/two-sputnik-doses-provide-two-times-higher-antibodies-than-pfizer-study-122012001298_1.html", "urlToImage": "https://bsmedia.business-standard.com/_media/bs/img/article/2021-08/08/full/1628446060-6656.jpg", "publishedAt": "2022-01-20T14:47:00Z", "content": "A study has found that two doses of Sputnik V provide two times higher virus neutralising antibodies against the Omicron variant of COVID-19 than two doses of the Pfizer vaccine, Gamaleya National Re\u2026 [+3309 chars]"}, {"source": {"id": null, "name": "Seeking Alpha"}, "author": "Dulan Lokuwithana", "title": "Fauci says FDA could clear Pfizer/BioNTech COVID-19 shot next month for kids under five", "description": "President Biden\u2019s chief medical advisor Dr. Anthony Fauci said on Wednesday that the FDA could authorize the Pfizer (PFE)/ BioNTech (BNTX) COVID-19 vaccine next month for children under...", "url": "https://seekingalpha.com/news/3789519-fauci-says-fda-could-clear-pfizerbiontech-covid-19-shot-next-month-for-kids-under-five", "urlToImage": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1303673683/medium_image_1303673683.jpg", "publishedAt": "2022-01-20T11:33:00Z", "content": "carmengabriela/iStock Editorial via Getty Images"}, {"source": {"id": "the-times-of-india", "name": "The Times of India"}, "author": "PTI", "title": "Two doses of Sputnik provide two times higher antibodies against Omicron than Pfizer vaccine: Study", "description": "The study was conducted at the Italian Spallanzani Institute on comparable groups of sera from individuals vaccinated with Sputnik V and Pfizer. \"The joint study by the Gamaleya Center and Spallanzani Institute confirmed the results obtained in our separate s\u2026", "url": "https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/two-doses-of-sputnik-provide-two-times-higher-antibodies-against-omicron-than-pfizer-vaccine-study/articleshow/89022429.cms", "urlToImage": "https://img.etimg.com/thumb/msid-89022429,width-1070,height-580,imgsize-29690,overlay-economictimes/photo.jpg", "publishedAt": "2022-01-20T14:17:06Z", "content": "A study has found that two doses of Sputnik V provide two times higher virus neutralising antibodies against the Omicron variant of Covid-19 than two doses of the Pfizer vaccine, Gamaleya National Re\u2026 [+1909 chars]"}, {"source": {"id": null, "name": "Freerepublic.com"}, "author": "Daily Telegraph", "title": "Swiss sprinter Sarah Atcho diagnosed with pericarditis after Pfizer booster shot", "description": "An Olympic sprinter says she is \u201cupset\u201d at being diagnosed with a rare heart condition after getting her Pfizer booster shot. Swiss athlete Sarah Atcho, who competed in the four-by-100 metres relay at the 2016 Brazil Olympics, revealed in an Instagram post to\u2026", "url": "https://freerepublic.com/focus/f-news/4031144/posts", "urlToImage": null, "publishedAt": "2022-01-20T15:59:04Z", "content": "Skip to comments.\r\nSwiss sprinter Sarah Atcho diagnosed with pericarditis after Pfizer booster shotDaily Telegraph ^\r\n | 01/20/2022\r\n | Frank Chung\r\nPosted on 01/20/2022 7:59:04 AM PST by SeekAndFind\u2026 [+3206 chars]"}, {"source": {"id": null, "name": "bdnews24.com"}, "author": null, "title": "Sputnik V shows higher omicron-antibody levels than Pfizer in preliminary study", "description": "A small preliminary laboratory study has shown that levels of omicron-neutralising antibodies of people vaccinated with Russia's Sputnik V vaccine did not decline as much as of those who had Pfizer shots.", "url": "https://bdnews24.com/coronavirus-pandemic/2022/01/20/sputnik-v-shows-higher-omicron-antibody-levels-than-pfizer-in-preliminary-study", "urlToImage": "https://d30fl32nd2baj9.cloudfront.net/media/2022/01/20/a-vial-sputnik-200122-01-smr.jpg/BINARY/a-vial-sputnik-200122-01-smr.jpg", "publishedAt": "2022-01-20T16:22:41Z", "content": "The joint\r\nRussian-Italian study - funded by the Russian Direct Investment Fund, which\r\nmarkets Sputnik V abroad - compared the blood serum of people who had received\r\nthe different vaccines.\r\nResear\u2026 [+1447 chars]"}, {"source": {"id": null, "name": "Freerepublic.com"}, "author": "Daily Mail", "title": "Fauci says Pfizer vaccine could receive authorization for kids UNDER FIVE as early as next month - placing U.S. among countries with lowest age for the shots", "description": "Pfizer is trialing its jab in children as young as six months old and plans to submit data to regulators soon. Dr Anthony Fauci, the nation's top infectious disease expert, said Wednesday that he expects the Food and Drug Administration to approve the Pfizer-\u2026", "url": "https://freerepublic.com/focus/f-news/4031250/posts", "urlToImage": null, "publishedAt": "2022-01-20T21:50:20Z", "content": "Skip to comments.\r\nFauci says Pfizer vaccine could receive authorization for kids UNDER FIVE as early as next month - placing U.S. among countries with lowest age for the shotsDaily Mail ^\r\n | 1/20/2\u2026 [+5284 chars]"}, {"source": {"id": null, "name": "The BMJ"}, "author": "King, H., Deshpande, S., Woodbridge, T., Hilliard, T., Standing, J., Lewis, M., Ward, L., Finn, A., Roderick, M.", "title": "Initial experience of the safety and tolerability of the BNT162b2 (Pfizer-Bio-N-Tech) vaccine in extremely vulnerable children aged 12-15 years", "description": "Healthy children generally have a mild illness with SARS-COV-2; however, some comorbidities may predispose to severe COVID-19 disease. Neurological conditions were the predominant comorbidity of hospitalised children in the UK with COVID-19 (11%)1 and a large\u2026", "url": "https://adc.bmj.com/content/107/2/205?rss=1", "urlToImage": "https://adc.bmj.com/sites/default/files/highwire/archdischild/107/2.cover-source.jpg", "publishedAt": "2022-01-20T12:38:16Z", "content": "Healthy children generally have a mild illness with SARS-COV-2; however, some comorbidities may predispose to severe COVID-19 disease. Neurological conditions were the predominant comorbidity of hosp\u2026 [+3523 chars]"}]}, "2022-01-19": {"status": "ok", "totalResults": 33, "articles": [{"source": {"id": "al-jazeera-english", "name": "Al Jazeera English"}, "author": "Al Jazeera", "title": "Pfizer CEO awarded $1M Genesis Prize for developing COVID vaccine", "description": "Albert Bourla is recognised for being at the forefront of fighting the pandemic and developing a vaccine in record time.", "url": "https://www.aljazeera.com/economy/2022/1/19/pfizer-ceo-awarded-1m-genesis-prize-for-developing-covid-vaccine", "urlToImage": "https://www.aljazeera.com/wp-content/uploads/2022/01/albert.jpg?resize=1200%2C630", "publishedAt": "2022-01-19T18:06:34Z", "content": "Albert Bourla, chairman and CEO of Pfizer, has been awarded the 2022 Genesis Prize for his leadership, determination and especially for his willingness to assume great risks in developing a coronavir\u2026 [+3340 chars]"}, {"source": {"id": "the-times-of-india", "name": "The Times of India"}, "author": "AP", "title": "Pfizer chief Albert Bourla wins $1 million Genesis Prize for development of COVID-19 vaccine", "description": "The $1 million award is granted each year to a person for their professional achievements, contributions to humanity and commitment to Jewish values. The Genesis Prize Foundation said Bourla had received the largest number of votes in an online campaign in wh\u2026", "url": "https://economictimes.indiatimes.com/news/international/business/pfizer-chief-albert-bourla-wins-1-million-genesis-prize-for-development-of-covid-19-vaccine/articleshow/88990719.cms", "urlToImage": "https://img.etimg.com/thumb/msid-88990733,width-1070,height-580,imgsize-58816,overlay-economictimes/photo.jpg", "publishedAt": "2022-01-19T07:03:07Z", "content": "Albert Bourla, chairman and chief executive of global pharmaceutical giant Pfizer Inc., was awarded on Wednesday the prestigious Genesis Prize for his efforts in leading the development of a COVID-19\u2026 [+3498 chars]"}, {"source": {"id": null, "name": "Forbes"}, "author": "Zachary Snowdon Smith, Forbes Staff, \n Zachary Snowdon Smith, Forbes Staff\n https://www.forbes.com/sites/zacharysmith/", "title": "Pfizer Covid Vaccine For Kids Under 5 Could Be Authorized In The Next Month, Fauci Says", "description": "Pfizer is working on a three-dose regimen of its vaccine for young children after a two-dose course produced disappointing results in clinical trials.", "url": "https://www.forbes.com/sites/zacharysmith/2022/01/19/pfizer-covid-vaccine-for-kids-under-5-could-be-authorized-in-the-next-month-fauci-says/", "urlToImage": "https://imageio.forbes.com/specials-images/imageserve/61e898658c64edb22913a660/0x0.jpg?format=jpg&crop=4000,2250,x0,y299,safe&fit=crop", "publishedAt": "2022-01-19T23:10:54Z", "content": "Pfizer and BioNTechs Covid-19 vaccine will hopefully be approved\u00a0 for children under 5 by the U.S. Food and Drug Administration within the next month or so, White House chief medical advisor Dr. Anth\u2026 [+2415 chars]"}, {"source": {"id": null, "name": "Fox Business"}, "author": "Julia Musto", "title": "Pfizer pills effective against omicron, vaccine-maker's studies show - Fox Business", "description": "Pfizer Inc. said Tuesday that laboratory testing showed its COVID-19 pill Paxlovid appears to be effective against the omicron variant of the coronavirus.", "url": "https://www.foxbusiness.com/lifestyle/pfizer-pils-effective-omicron-vaccine", "urlToImage": "https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2021/11/0/0/2021-11-16T211908Z_1648590397_RC2C8Q9M6KMN_RTRMADP_3_HEALTH-CORONAVIRUS-USA-PFIZER.jpg?ve=1&tl=1", "publishedAt": "2022-01-19T12:27:02Z", "content": "Pfizer Inc. said Tuesday that laboratory testing showed its COVID-19pill Paxlovid appears to be effective against the omicron variant of the coronavirus.\r\nThe company\u00a0said three separate studies demo\u2026 [+3208 chars]"}, {"source": {"id": "cbs-news", "name": "CBS News"}, "author": null, "title": "Pfizer CEO awarded $1M Genesis Prize for COVID-19 vaccine", "description": "Albert Bourla said he accepted prize \"on behalf of all my Pfizer colleagues who answered the urgent call of history.\"", "url": "https://www.cbsnews.com/news/pfizer-ceo-wins-1-million-dollar-genesis-prize-for-leading-development-of-covid-19-vaccine/", "urlToImage": "https://cbsnews1.cbsistatic.com/hub/i/r/2022/01/19/7740fc2d-2863-4298-ba85-393029e40dbf/thumbnail/1200x630/7bdec686822f2b869ae7cd121f6b1f18/pfizer-ceo-bourla.jpg", "publishedAt": "2022-01-19T16:24:41Z", "content": "Albert Bourla, chairman and chief executive of global pharmaceutical giant Pfizer Inc., was awarded on Wednesday the prestigious Genesis Prize for his efforts in leading the development of a COVID-19\u2026 [+3725 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "AFP", "title": "Unilever won't up \u00a350 bn offer for GSK-Pfizer unit", "description": "Consumer goods giant Unilever on Wednesday said it would not increase a \u00a350-billion offer for the consumer healthcare unit owned by pharmaceutical groups...", "url": "https://news.yahoo.com/unilever-wont-50-bn-offer-203232716.html", "urlToImage": "https://s.yimg.com/uu/api/res/1.2/cOk3GE8MY7QFTFMVK.QiPg--~B/aD01MTE7dz03Njg7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/afp.com/e0f3b088959a60b3ec42ea43cecfab4b", "publishedAt": "2022-01-19T20:32:32Z", "content": "Consumer goods giant Unilever on Wednesday said it would not increase a \u00a350-billion offer for the consumer healthcare unit owned by pharmaceutical groups GlaxoSmithKline and Pfizer.\r\nBritish group GS\u2026 [+2153 chars]"}, {"source": {"id": null, "name": "Globalresearch.ca"}, "author": "Dr. Mark Trozzi", "title": "Pfizer Trials: All Injected Mothers Lost Their Unborn Babies", "description": "All Global Research articles\u00a0can be read in 51 languages by activating the \u201cTranslate Website\u201d\u00a0drop down menu on the top banner of our home page (Desktop version).\nTo receive Global Research\u2019s Daily Newsletter (selected articles),\u00a0click here.\nVisit \u2026\nThe post\u2026", "url": "https://www.globalresearch.ca/pfizer-trials-all-injected-mothers-lost-their-unborn-babies/5767532", "urlToImage": "https://www.globalresearch.ca/wp-content/uploads/2021/12/pfizer-covid-19.jpg", "publishedAt": "2022-01-19T15:27:12Z", "content": "All Global Research articles\u00a0can be read in 51 languages by activating the Translate Website\u00a0drop down menu on the top banner of our home page (Desktop version).\r\nTo receive Global Researchs Daily Ne\u2026 [+4787 chars]"}, {"source": {"id": null, "name": "Moneycontrol"}, "author": null, "title": "Pfizer chief Albert Bourla wins $1 million Genesis Prize for development of COVID-19 vaccine", "description": "The $1 million award is granted each year to a person for their professional achievements, contributions to humanity and commitment to Jewish values. The Genesis Prize Foundation said Bourla had received the largest number of votes in an online campaign in wh\u2026", "url": "https://www.moneycontrol.com/news/business/pfizer-chief-albert-bourla-wins-1-million-genesis-prize-for-development-of-covid-19-vaccine-7956901.html", "urlToImage": "https://images.moneycontrol.com/static-mcnews/2022/01/albert-bourla-770x433.jpeg", "publishedAt": "2022-01-19T07:37:17Z", "content": "Albert Bourla, chairman and chief executive of global pharmaceutical giant Pfizer Inc., was awarded on Wednesday the prestigious Genesis Prize for his efforts in leading the development of a COVID-19\u2026 [+3471 chars]"}, {"source": {"id": "independent", "name": "Independent"}, "author": "Via AP news wire", "title": "Pfizer chief Albert Bourla wins $1 million Genesis Prize", "description": "Pfizer's chief executive, Albert Bourla, has been awarded the prestigious Genesis Prize for his efforts in leading the development of a COVID-19 vaccine", "url": "https://www.independent.co.uk/news/world/americas/us-politics/pfizer-inc-covid-thessaloniki-anish-kapoor-jewish-b1995973.html", "urlToImage": "https://static.independent.co.uk/2022/01/19/06/Israel-People-Albert_Bourla_64950.jpg?width=1200&auto=webp&quality=75", "publishedAt": "2022-01-19T06:26:19Z", "content": "Albert Bourla, chairman and chief executive of global pharmaceutical giant Pfizer Inc. was awarded on Wednesday the prestigious Genesis Prize for his efforts in leading the development of a COVID-19 \u2026 [+3474 chars]"}, {"source": {"id": null, "name": "Sputnik International"}, "author": "Mary Manley", "title": "Pfizer Patients in San Francisco Area Received Wrong Amount of Vaccine Dosage - Report", "description": "The patients are offered a new shot of the correct dose, if desired. But according to the Health Maintenance Organization, experts from the Centers for Disease Control and Prevention (CDC) have informed them that the low dose should not significantly affect t\u2026", "url": "https://sputniknews.com/20220119/pfizer-patients-in-san-francisco-area-received-wrong-amount-of-vaccine-dosage---report-1092355213.html", "urlToImage": "https://cdnn1.img.sputniknews.com/images/sharing/article/eng/1092355213.jpg?10921955231642554380", "publishedAt": "2022-01-19T01:06:19Z", "content": "Kaiser reportedly released an apology: We are continuously monitoring so this does not happen again. We sincerely apologize for any concern or inconvenience this may cause for those patients we are c\u2026 [+27 chars]"}, {"source": {"id": null, "name": "The Times of Israel"}, "author": null, "title": "Pfizer CEO Albert Bourla awarded $1 million Genesis Prize for 2022", "description": "Foundation cites Jewish executive's leadership, willingness to take risks in order to produce vaccine as quickly as possible; will donate money to Holocaust education", "url": "https://www.timesofisrael.com/pfizer-ceo-albert-bourla-awarded-1-million-genesis-prize-for-2022/", "urlToImage": "https://static.timesofisrael.com/www/uploads/2022/01/AP21323076051775-e1642572311226-1024x640.jpg", "publishedAt": "2022-01-19T07:06:48Z", "content": "The Genesis Foundation announced Wednesday that the winner of its annual prize for 2022 is Albert Bourla, CEO of Pfizer, which produced a COVID-19 vaccine that has been used by Israel and other count\u2026 [+5330 chars]"}, {"source": {"id": null, "name": "Seeking Alpha"}, "author": "Manshi Mamtora", "title": "Pfizer secures ~$2B modification contract for 300M additional COVID doses", "description": "Pfizer (PFE) bags ~$2.05B modification contract W58P05-21-C-0002 for an additional 300M doses of COVID-19 vaccine for international donation to low and low-middle income countries", "url": "https://seekingalpha.com/news/3789448-pfizer-secures-2b-modification-contract-for-300m-additional-covid-doses", "urlToImage": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1292440976/medium_image_1292440976.jpg", "publishedAt": "2022-01-19T22:12:21Z", "content": "Alexandros Michailidis/iStock Editorial via Getty Images"}, {"source": {"id": null, "name": "Thegatewaypundit.com"}, "author": "Cristina Laila", "title": "Judicial Watch: FBI Letter Shows Pfizer Tied to Investigative File Targeting Project Veritas", "description": "Graphic created by Judicial Watch The FBI is working hand-in-glove with Pfizer to target Project Veritas, journalists and journalism. Conservative watchdog group Judicial Watch on Tuesday revealed the FBI has communications from Pfizer in an investigative fil\u2026", "url": "https://www.thegatewaypundit.com/2022/01/judicial-watch-fbi-letter-shows-pfizer-tied-investigative-file-targeting-project-veritas/", "urlToImage": "https://www.thegatewaypundit.com/wp-content/uploads/JudicialWatch_Social_PressRelease-1-18_1200x627_v2-768x401-1.jpg", "publishedAt": "2022-01-19T02:45:57Z", "content": "Graphic created by Judicial Watch\r\nThe FBI is working hand-in-glove with Pfizer to target Project Veritas, journalists and journalism.\r\nConservative watchdog group Judicial Watch on Tuesday revealed \u2026 [+3024 chars]"}, {"source": {"id": null, "name": "Lewrockwell.com"}, "author": "Joseph Mercola", "title": "Pfizer To Roll Out Omicron Shot in March", "description": "While a third COVID booster shot started rolling out in late September 2021,1\u00a0and people have been bullied into getting it, that booster is no different from the first two doses. It\u2019s not specific against Omicron, which is rapidly overtaking other variants an\u2026", "url": "https://www.lewrockwell.com/2022/01/joseph-mercola/pfizer-to-roll-out-omicron-shot-in-march/", "urlToImage": "https://www.lewrockwell.com/wp-content/uploads/2022/01/dr-mercola-covid-treatment-protocol-infographic.webp", "publishedAt": "2022-01-19T04:01:00Z", "content": "While a third COVID booster shot started rolling out in late September 2021,1\u00a0and people have been bullied into getting it, that booster is no different from the first two doses. It\u2019s not specific ag\u2026 [+12844 chars]"}, {"source": {"id": "abc-news", "name": "ABC News"}, "author": "JOSEF FEDERMAN Associated Press", "title": "Pfizer chief Albert Bourla wins $1 million Genesis Prize", "description": "Pfizer's chief executive, Albert Bourla, has been awarded the prestigious Genesis Prize for his efforts in leading the development of a COVID-19 vaccine", "url": "https://abcnews.go.com/Health/wireStory/pfizer-chief-albert-bourla-wins-million-genesis-prize-82343235", "urlToImage": "null", "publishedAt": "2022-01-19T06:26:46Z", "content": "JERUSALEM -- Albert Bourla, chairman and chief executive of global pharmaceutical giant Pfizer Inc., was awarded on Wednesday the prestigious Genesis Prize for his efforts in leading the development \u2026 [+3486 chars]"}, {"source": {"id": null, "name": "Business Standard"}, "author": "AP", "title": "Pfizer chief Albert Bourla wins $1 mn Genesis Prize for vaccine development", "description": "Albert Bourla, chairman and chief executive of global pharmaceutical giant Pfizer Inc., was awarded the prestigious Genesis Prize for his efforts in leading the development of a Covid-19 vaccine", "url": "https://www.business-standard.com/article/companies/pfizer-chief-albert-bourla-wins-1-mn-genesis-prize-for-vaccine-development-122011900537_1.html", "urlToImage": "https://bsmedia.business-standard.com/_media/bs/img/article/2021-06/22/full/1624385584-6821.jpg", "publishedAt": "2022-01-19T07:47:00Z", "content": "Albert Bourla, chairman and chief executive of global pharmaceutical giant Pfizer Inc., was awarded on Wednesday the prestigious Genesis Prize for his efforts in leading the development of a COVID-19\u2026 [+4878 chars]"}, {"source": {"id": "cbc-news", "name": "CBC News"}, "author": "Bobbi-Jean MacKinnon", "title": "N.B. COVID-19 roundup: 1st shipment of Pfizer pill 'like spitting on a house fire,' says Shephard", "description": "New Brunswick is scheduled to receive its first shipment of Pfizer's\u00a0new COVID-19 pill\u00a0by this weekend, but at this point, Paxlovid is just another \"tool in our toolbox\" in the pandemic fight, says Health Minister Dorothy Shephard.", "url": "https://www.cbc.ca/news/canada/new-brunswick/covid-19-new-brunswick-pfizer-pill-paxlovid-volunteers-1.6319782", "urlToImage": "https://i.cbc.ca/1.6318108.1642459426!/fileImage/httpImage/image.JPG_gen/derivatives/16x9_620/pfizer-medication.JPG", "publishedAt": "2022-01-19T16:14:32Z", "content": "New Brunswick is scheduled to receive its first shipment of Pfizer's\u00a0new COVID-19 pill\u00a0by this weekend, but at this point, Paxlovid is just another \"tool in our toolbox\" in the pandemic fight, says H\u2026 [+3025 chars]"}, {"source": {"id": "cbc-news", "name": "CBC News"}, "author": "Bobbi-Jean MacKinnon", "title": "N.B. COVID-19 roundup: 1st shipment of Pfizer pill 'like spitting on a house fire,' says Shephard", "description": "New Brunswick is scheduled to receive its first shipment of Pfizer's\u00a0new COVID-19 pill\u00a0by this weekend, but at this point, Plaxovid is just another \"tool in our toolbox\" in the pandemic fight, says Health Minister Dorothy Shephard.", "url": "https://www.cbc.ca/news/canada/new-brunswick/covid-19-new-brunswick-pfizer-pill-plaxovid-volunteers-1.6319782", "urlToImage": "https://i.cbc.ca/1.6318108.1642459426!/fileImage/httpImage/image.JPG_gen/derivatives/16x9_620/pfizer-medication.JPG", "publishedAt": "2022-01-19T16:14:32Z", "content": "New Brunswick is scheduled to receive its first shipment of Pfizer's\u00a0new COVID-19 pill\u00a0by this weekend, but at this point, Plaxovid is just another \"tool in our toolbox\" in the pandemic fight, says H\u2026 [+2770 chars]"}, {"source": {"id": null, "name": "Freerepublic.com"}, "author": "The White Rabbit News Channel via Gab TV", "title": "BREAKING: DOJ Documents Obtained by Judicial Watch Confirm Existence of Communications Between FBI & Pfizer about Project Veritas", "description": "Project Veritas just released a video of the results of a freedom of information act request by Judicial Watch about any communications between Pfizer and its employees or representatives and the FBI regarding Project Veritas. It was confirmed the FBI had mat\u2026", "url": "https://freerepublic.com/focus/f-news/4030687/posts", "urlToImage": null, "publishedAt": "2022-01-19T01:31:57Z", "content": "Skip to comments.\r\nBREAKING: DOJ Documents Obtained by Judicial Watch Confirm Existence of Communications Between FBI &amp; Pfizer about Project VeritasThe White Rabbit News Channel via Gab TV ^\r\n | \u2026 [+2133 chars]"}, {"source": {"id": null, "name": "PRNewswire"}, "author": null, "title": "\"JEWISH NOBEL\" AWARDED TO PFIZER CEO ALBERT BOURLA", "description": "Genesis Prize Chairman highlights immense role of Jewish scientists and doctors in combatting the pandemic: \"A very proud moment for the entire Jewish community\" JERUSALEM, Jan. 19, 2022 /PRNewswire/ -- Today, The Genesis Prize Foundation announced Dr. Albert\u2026", "url": "https://www.prnewswire.com/news-releases/jewish-nobel-awarded-to-pfizer-ceo-albert-bourla-301464272.html", "urlToImage": "https://mma.prnewswire.com/media/1729874/Dr_Albert_Bourla.jpg?p=facebook", "publishedAt": "2022-01-19T20:06:00Z", "content": "The Committee commended Dr. Bourla for his leadership, determination, and especially for his willingness to assume great risks. Unlike CEOs of most other major companies working on developing COVID-1\u2026 [+6511 chars]"}]}}